#begin document (1180855); part 000
1180855	0	1	Quantitative	JJ	-	-	-	-	-	-	-	-
1180855	0	2	trait	NN	-	-	-	-	-	-	-	-
1180855	0	3	analysis	NN	-	-	-	-	-	-	-	-
1180855	0	4	of	IN	-	-	-	-	-	-	-	-
1180855	0	5	the	DT	-	-	-	-	-	-	-	(1
1180855	0	6	development	NN	-	-	-	-	-	-	-	-
1180855	0	7	of	IN	-	-	-	-	-	-	-	-
1180855	0	8	pulmonary	JJ	-	-	-	-	-	-	-	(2
1180855	0	9	tolerance	NN	-	-	-	-	-	-	-	-
1180855	0	10	to	IN	-	-	-	-	-	-	-	-
1180855	0	11	inhaled	JJ	-	-	-	-	-	-	-	(3
1180855	0	12	zinc	NN	-	-	-	-	-	-	-	-
1180855	0	13	oxide	NN	-	-	-	-	-	-	-	3)|2)
1180855	0	14	in	IN	-	-	-	-	-	-	-	-
1180855	0	15	mice	NNS	-	-	-	-	-	-	-	(4)|1)

1180855	0	1	Abstract	NN	-	-	-	-	-	-	-	-

1180855	0	1	Background	NN	-	-	-	-	-	-	-	-

1180855	0	1	Individuals	NNS	-	-	-	-	-	-	-	(5)
1180855	0	2	may	MD	-	-	-	-	-	-	-	-
1180855	0	3	develop	VB	-	-	-	-	-	-	-	-
1180855	0	4	tolerance	NN	-	-	-	-	-	-	-	-
1180855	0	5	to	IN	-	-	-	-	-	-	-	-
1180855	0	6	the	DT	-	-	-	-	-	-	-	-
1180855	0	7	induction	NN	-	-	-	-	-	-	-	-
1180855	0	8	of	IN	-	-	-	-	-	-	-	-
1180855	0	9	adverse	JJ	-	-	-	-	-	-	-	-
1180855	0	10	pulmonary	JJ	-	-	-	-	-	-	-	-
1180855	0	11	effects	NNS	-	-	-	-	-	-	-	-
1180855	0	12	following	VBG	-	-	-	-	-	-	-	-
1180855	0	13	repeated	JJ	-	-	-	-	-	-	-	(6
1180855	0	14	exposures	NNS	-	-	-	-	-	-	-	-
1180855	0	15	to	IN	-	-	-	-	-	-	-	-
1180855	0	16	inhaled	VBN	-	-	-	-	-	-	-	(7
1180855	0	17	toxicants	NNS	-	-	-	-	-	-	-	7)|6)
1180855	0	18	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Previously	RB	-	-	-	-	-	-	-	-
1180855	0	2	,	,	-	-	-	-	-	-	-	-
1180855	0	3	we	PRP	-	-	-	-	-	-	-	(8)
1180855	0	4	demonstrated	VBD	-	-	-	-	-	-	-	-
1180855	0	5	that	IN	-	-	-	-	-	-	-	-
1180855	0	6	genetic	JJ	-	-	-	-	-	-	-	(9
1180855	0	7	background	NN	-	-	-	-	-	-	-	9)
1180855	0	8	plays	VBZ	-	-	-	-	-	-	-	-
1180855	0	9	an	DT	-	-	-	-	-	-	-	-
1180855	0	10	important	JJ	-	-	-	-	-	-	-	-
1180855	0	11	role	NN	-	-	-	-	-	-	-	-
1180855	0	12	in	IN	-	-	-	-	-	-	-	-
1180855	0	13	the	DT	-	-	-	-	-	-	-	(1
1180855	0	14	development	NN	-	-	-	-	-	-	-	-
1180855	0	15	of	IN	-	-	-	-	-	-	-	-
1180855	0	16	pulmonary	JJ	-	-	-	-	-	-	-	(2
1180855	0	17	tolerance	NN	-	-	-	-	-	-	-	-
1180855	0	18	to	IN	-	-	-	-	-	-	-	-
1180855	0	19	inhaled	VBN	-	-	-	-	-	-	-	(3
1180855	0	20	zinc	NN	-	-	-	-	-	-	-	(10
1180855	0	21	oxide	NN	-	-	-	-	-	-	-	2)|10)
1180855	0	22	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	23	ZnO	NN	-	-	-	-	-	-	-	-
1180855	0	24	)	-RRB-	-	-	-	-	-	-	-	3)
1180855	0	25	in	IN	-	-	-	-	-	-	-	-
1180855	0	26	inbred	VBN	-	-	-	-	-	-	-	(11
1180855	0	27	mouse	NN	-	-	-	-	-	-	-	-
1180855	0	28	strains	NNS	-	-	-	-	-	-	-	11)|1)
1180855	0	29	,	,	-	-	-	-	-	-	-	-
1180855	0	30	as	IN	-	-	-	-	-	-	-	-
1180855	0	31	assessed	VBN	-	-	-	-	-	-	-	-
1180855	0	32	by	IN	-	-	-	-	-	-	-	-
1180855	0	33	polymorphonuclear	JJ	-	-	-	-	-	-	-	(12
1180855	0	34	leukocytes	NNS	-	-	-	-	-	-	-	12)
1180855	0	35	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	36	PMNs	NNS	-	-	-	-	-	-	-	-
1180855	0	37	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	38	,	,	-	-	-	-	-	-	-	-
1180855	0	39	macrophages	NNS	-	-	-	-	-	-	-	(13)
1180855	0	40	,	,	-	-	-	-	-	-	-	-
1180855	0	41	and	CC	-	-	-	-	-	-	-	-
1180855	0	42	total	JJ	-	-	-	-	-	-	-	-
1180855	0	43	protein	NN	-	-	-	-	-	-	-	-
1180855	0	44	in	IN	-	-	-	-	-	-	-	-
1180855	0	45	bronchoalveolar	JJ	-	-	-	-	-	-	-	(14|(15
1180855	0	46	lavage	NN	-	-	-	-	-	-	-	14)
1180855	0	47	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	48	BAL	NN	-	-	-	-	-	-	-	-
1180855	0	49	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	50	phenotypes	NNS	-	-	-	-	-	-	-	15)
1180855	0	51	.	.	-	-	-	-	-	-	-	-

1180855	0	1	The	DT	-	-	-	-	-	-	-	(16a|(18|(17d)
1180855	0	2	BALB	NN	-	-	-	-	-	-	-	-
1180855	0	3	/	HYPH	-	-	-	-	-	-	-	-
1180855	0	4	cByJ	NN	-	-	-	-	-	-	-	-
1180855	0	5	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	6	CBy	NN	-	-	-	-	-	-	-	-
1180855	0	7	)	-RRB-	-	-	-	-	-	-	-	16a)
1180855	0	8	and	CC	-	-	-	-	-	-	-	-
1180855	0	9	DBA	NN	-	-	-	-	-	-	-	(17d
1180855	0	10	/	HYPH	-	-	-	-	-	-	-	-
1180855	0	11	2J	NN	-	-	-	-	-	-	-	-
1180855	0	12	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	13	D2	NN	-	-	-	-	-	-	-	-
1180855	0	14	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	15	strains	NNS	-	-	-	-	-	-	-	(16a)|18)|17d)
1180855	0	16	were	VBD	-	-	-	-	-	-	-	-
1180855	0	17	identified	VBN	-	-	-	-	-	-	-	-
1180855	0	18	as	IN	-	-	-	-	-	-	-	-
1180855	0	19	tolerant	JJ	-	-	-	-	-	-	-	-
1180855	0	20	and	CC	-	-	-	-	-	-	-	-
1180855	0	21	non-tolerant	JJ	-	-	-	-	-	-	-	-
1180855	0	22	,	,	-	-	-	-	-	-	-	-
1180855	0	23	respectively	RB	-	-	-	-	-	-	-	-
1180855	0	24	.	.	-	-	-	-	-	-	-	-

1180855	0	1	The	DT	-	-	-	-	-	-	-	(19
1180855	0	2	present	JJ	-	-	-	-	-	-	-	-
1180855	0	3	study	NN	-	-	-	-	-	-	-	19)
1180855	0	4	was	VBD	-	-	-	-	-	-	-	-
1180855	0	5	designed	VBN	-	-	-	-	-	-	-	-
1180855	0	6	to	TO	-	-	-	-	-	-	-	-
1180855	0	7	identify	VB	-	-	-	-	-	-	-	-
1180855	0	8	candidate	NN	-	-	-	-	-	-	-	(20
1180855	0	9	genes	NNS	-	-	-	-	-	-	-	-
1180855	0	10	that	WDT	-	-	-	-	-	-	-	-
1180855	0	11	control	VBP	-	-	-	-	-	-	-	-
1180855	0	12	the	DT	-	-	-	-	-	-	-	(1
1180855	0	13	development	NN	-	-	-	-	-	-	-	-
1180855	0	14	of	IN	-	-	-	-	-	-	-	-
1180855	0	15	pulmonary	JJ	-	-	-	-	-	-	-	(2
1180855	0	16	tolerance	NN	-	-	-	-	-	-	-	-
1180855	0	17	to	IN	-	-	-	-	-	-	-	-
1180855	0	18	inhaled	VBN	-	-	-	-	-	-	-	(3
1180855	0	19	ZnO	NN	-	-	-	-	-	-	-	3)|20)|2)|1)
1180855	0	20	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Methods	NNS	-	-	-	-	-	-	-	(21)

1180855	0	1	Genome	NN	-	-	-	-	-	-	-	-
1180855	0	2	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	3	wide	JJ	-	-	-	-	-	-	-	-
1180855	0	4	linkage	NN	-	-	-	-	-	-	-	-
1180855	0	5	analyses	NNS	-	-	-	-	-	-	-	-
1180855	0	6	were	VBD	-	-	-	-	-	-	-	-
1180855	0	7	performed	VBN	-	-	-	-	-	-	-	-
1180855	0	8	on	IN	-	-	-	-	-	-	-	-
1180855	0	9	a	DT	-	-	-	-	-	-	-	-
1180855	0	10	CByD2F2	NN	-	-	-	-	-	-	-	(22
1180855	0	11	mouse	NN	-	-	-	-	-	-	-	22)
1180855	0	12	cohort	NN	-	-	-	-	-	-	-	-
1180855	0	13	phenotyped	VBN	-	-	-	-	-	-	-	-
1180855	0	14	for	IN	-	-	-	-	-	-	-	-
1180855	0	15	BAL	NN	-	-	-	-	-	-	-	(23|(14)|(24b)|(25b)
1180855	0	16	protein	NN	-	-	-	-	-	-	-	23)
1180855	0	17	,	,	-	-	-	-	-	-	-	-
1180855	0	18	PMNs	NNS	-	-	-	-	-	-	-	(12)|(24b)
1180855	0	19	,	,	-	-	-	-	-	-	-	-
1180855	0	20	and	CC	-	-	-	-	-	-	-	-
1180855	0	21	macrophages	NNS	-	-	-	-	-	-	-	(25b)
1180855	0	22	following	VBG	-	-	-	-	-	-	-	-
1180855	0	23	5	CD	-	-	-	-	-	-	-	(26
1180855	0	24	consecutive	JJ	-	-	-	-	-	-	-	-
1180855	0	25	days	NNS	-	-	-	-	-	-	-	-
1180855	0	26	of	IN	-	-	-	-	-	-	-	-
1180855	0	27	exposure	NN	-	-	-	-	-	-	-	(27
1180855	0	28	to	IN	-	-	-	-	-	-	-	-
1180855	0	29	1.0	CD	-	-	-	-	-	-	-	(28
1180855	0	30	mg	NN	-	-	-	-	-	-	-	-
1180855	0	31	/	SYM	-	-	-	-	-	-	-	-
1180855	0	32	m3	NN	-	-	-	-	-	-	-	-
1180855	0	33	inhaled	VBN	-	-	-	-	-	-	-	-
1180855	0	34	ZnO	NN	-	-	-	-	-	-	-	28)|27)
1180855	0	35	for	IN	-	-	-	-	-	-	-	-
1180855	0	36	3	CD	-	-	-	-	-	-	-	-
1180855	0	37	hours	NNS	-	-	-	-	-	-	-	-
1180855	0	38	/	SYM	-	-	-	-	-	-	-	-
1180855	0	39	day	NN	-	-	-	-	-	-	-	26)
1180855	0	40	.	.	-	-	-	-	-	-	-	-

1180855	0	1	A	DT	-	-	-	-	-	-	-	(29
1180855	0	2	haplotype	NN	-	-	-	-	-	-	-	-
1180855	0	3	analysis	NN	-	-	-	-	-	-	-	29)
1180855	0	4	was	VBD	-	-	-	-	-	-	-	-
1180855	0	5	carried	VBN	-	-	-	-	-	-	-	-
1180855	0	6	out	RP	-	-	-	-	-	-	-	-
1180855	0	7	to	TO	-	-	-	-	-	-	-	-
1180855	0	8	determine	VB	-	-	-	-	-	-	-	-
1180855	0	9	the	DT	-	-	-	-	-	-	-	(30c|(31|(32a
1180855	0	10	contribution	NN	-	-	-	-	-	-	-	-
1180855	0	11	of	IN	-	-	-	-	-	-	-	-
1180855	0	12	each	DT	-	-	-	-	-	-	-	(33|(34|(33b)|(35a)|30c)
1180855	0	13	quantitative	JJ	-	-	-	-	-	-	-	-
1180855	0	14	trait	NN	-	-	-	-	-	-	-	-
1180855	0	15	locus	NN	-	-	-	-	-	-	-	-
1180855	0	16	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	17	QTL	NN	-	-	-	-	-	-	-	-
1180855	0	18	)	-RRB-	-	-	-	-	-	-	-	33)|32a)
1180855	0	19	and	CC	-	-	-	-	-	-	-	-
1180855	0	20	QTL	NN	-	-	-	-	-	-	-	(30c|(35a|(33b)|(36)
1180855	0	21	combination	NN	-	-	-	-	-	-	-	35a)|34)
1180855	0	22	to	IN	-	-	-	-	-	-	-	(32a
1180855	0	23	the	DT	-	-	-	-	-	-	-	(37
1180855	0	24	overall	JJ	-	-	-	-	-	-	-	-
1180855	0	25	BAL	NN	-	-	-	-	-	-	-	(23
1180855	0	26	protein	NN	-	-	-	-	-	-	-	23)
1180855	0	27	phenotype	NN	-	-	-	-	-	-	-	37)|32a)|31)|30c)
1180855	0	28	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Candidate	NN	-	-	-	-	-	-	-	(20
1180855	0	2	genes	NNS	-	-	-	-	-	-	-	20)
1180855	0	3	were	VBD	-	-	-	-	-	-	-	-
1180855	0	4	identified	VBN	-	-	-	-	-	-	-	-
1180855	0	5	within	IN	-	-	-	-	-	-	-	-
1180855	0	6	each	DT	-	-	-	-	-	-	-	(33
1180855	0	7	QTL	NN	-	-	-	-	-	-	-	33)
1180855	0	8	interval	NN	-	-	-	-	-	-	-	-
1180855	0	9	using	VBG	-	-	-	-	-	-	-	-
1180855	0	10	the	DT	-	-	-	-	-	-	-	(38
1180855	0	11	positional	JJ	-	-	-	-	-	-	-	(39
1180855	0	12	candidate	NN	-	-	-	-	-	-	-	-
1180855	0	13	gene	NN	-	-	-	-	-	-	-	39)
1180855	0	14	approach	NN	-	-	-	-	-	-	-	38)
1180855	0	15	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Results	NNS	-	-	-	-	-	-	-	(40)

1180855	0	1	A	DT	-	-	-	-	-	-	-	(41a
1180855	0	2	significant	JJ	-	-	-	-	-	-	-	-
1180855	0	3	quantitative	JJ	-	-	-	-	-	-	-	-
1180855	0	4	trait	NN	-	-	-	-	-	-	-	-
1180855	0	5	locus	NN	-	-	-	-	-	-	-	-
1180855	0	6	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	7	QTL	NN	-	-	-	-	-	-	-	-
1180855	0	8	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	9	on	IN	-	-	-	-	-	-	-	-
1180855	0	10	chromosome	NN	-	-	-	-	-	-	-	(43|(42)
1180855	0	11	1	CD	-	-	-	-	-	-	-	43)|41a)
1180855	0	12	,	,	-	-	-	-	-	-	-	-
1180855	0	13	as	RB	-	-	-	-	-	-	-	-
1180855	0	14	well	RB	-	-	-	-	-	-	-	-
1180855	0	15	as	IN	-	-	-	-	-	-	-	-
1180855	0	16	suggestive	JJ	-	-	-	-	-	-	-	(44|(44b|(45a|(45b|(46
1180855	0	17	QTLs	NNS	-	-	-	-	-	-	-	-
1180855	0	18	on	IN	-	-	-	-	-	-	-	-
1180855	0	19	chromosomes	NNS	-	-	-	-	-	-	-	(47|(48|(42)|(49i)|45b)|45a)
1180855	0	20	4	CD	-	-	-	-	-	-	-	47)|44b)|44)
1180855	0	21	and	CC	-	-	-	-	-	-	-	-
1180855	0	22	5	CD	-	-	-	-	-	-	-	(45a|(45b)|(49i)|48)
1180855	0	23	,	,	-	-	-	-	-	-	-	-
1180855	0	24	for	IN	-	-	-	-	-	-	-	(41a|(44b
1180855	0	25	the	DT	-	-	-	-	-	-	-	(15
1180855	0	26	BAL	NN	-	-	-	-	-	-	-	(23
1180855	0	27	protein	NN	-	-	-	-	-	-	-	23)
1180855	0	28	phenotype	NN	-	-	-	-	-	-	-	46)|45a)|44b)|41a)|15)
1180855	0	29	,	,	-	-	-	-	-	-	-	-
1180855	0	30	was	VBD	-	-	-	-	-	-	-	-
1180855	0	31	established	VBN	-	-	-	-	-	-	-	-
1180855	0	32	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Suggestive	JJ	-	-	-	-	-	-	-	(50a|(51a
1180855	0	2	QTLs	NNS	-	-	-	-	-	-	-	-
1180855	0	3	for	IN	-	-	-	-	-	-	-	-
1180855	0	4	the	DT	-	-	-	-	-	-	-	(52|(53a|(54b
1180855	0	5	BAL	NN	-	-	-	-	-	-	-	(24|(14)|(25f)|54b)|50a)
1180855	0	6	PMN	NN	-	-	-	-	-	-	-	53a)|51a)|24)
1180855	0	7	and	CC	-	-	-	-	-	-	-	-
1180855	0	8	macrophage	NN	-	-	-	-	-	-	-	(50a|(54b|(25f)
1180855	0	9	phenotypes	NNS	-	-	-	-	-	-	-	(51a)|(53a)|54b)|52)|50a)
1180855	0	10	were	VBD	-	-	-	-	-	-	-	-
1180855	0	11	also	RB	-	-	-	-	-	-	-	-
1180855	0	12	identified	VBN	-	-	-	-	-	-	-	-
1180855	0	13	on	IN	-	-	-	-	-	-	-	-
1180855	0	14	chromosomes	NNS	-	-	-	-	-	-	-	(43|(55|(42)|(49c)
1180855	0	15	1	CD	-	-	-	-	-	-	-	43)
1180855	0	16	and	CC	-	-	-	-	-	-	-	-
1180855	0	17	5	CD	-	-	-	-	-	-	-	(49c)|55)
1180855	0	18	,	,	-	-	-	-	-	-	-	-
1180855	0	19	respectively	RB	-	-	-	-	-	-	-	-
1180855	0	20	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Analysis	NN	-	-	-	-	-	-	-	(29
1180855	0	2	of	IN	-	-	-	-	-	-	-	-
1180855	0	3	specific	JJ	-	-	-	-	-	-	-	-
1180855	0	4	haplotypes	NNS	-	-	-	-	-	-	-	29)
1180855	0	5	supports	VBZ	-	-	-	-	-	-	-	-
1180855	0	6	the	DT	-	-	-	-	-	-	-	-
1180855	0	7	combined	VBN	-	-	-	-	-	-	-	-
1180855	0	8	effect	NN	-	-	-	-	-	-	-	-
1180855	0	9	of	IN	-	-	-	-	-	-	-	-
1180855	0	10	three	CD	-	-	-	-	-	-	-	(56
1180855	0	11	QTLs	NNS	-	-	-	-	-	-	-	56)
1180855	0	12	in	IN	-	-	-	-	-	-	-	-
1180855	0	13	the	DT	-	-	-	-	-	-	-	(37
1180855	0	14	overall	JJ	-	-	-	-	-	-	-	-
1180855	0	15	protein	NN	-	-	-	-	-	-	-	(57)
1180855	0	16	phenotype	NN	-	-	-	-	-	-	-	37)
1180855	0	17	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Toll	NN	-	-	-	-	-	-	-	(58
1180855	0	2	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	3	like	JJ	-	-	-	-	-	-	-	-
1180855	0	4	receptor	NN	-	-	-	-	-	-	-	-
1180855	0	5	5	CD	-	-	-	-	-	-	-	58)
1180855	0	6	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	7	Tlr5	NN	-	-	-	-	-	-	-	-
1180855	0	8	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	9	was	VBD	-	-	-	-	-	-	-	-
1180855	0	10	identified	VBN	-	-	-	-	-	-	-	-
1180855	0	11	as	IN	-	-	-	-	-	-	-	-
1180855	0	12	an	DT	-	-	-	-	-	-	-	-
1180855	0	13	interesting	JJ	-	-	-	-	-	-	-	-
1180855	0	14	candidate	NN	-	-	-	-	-	-	-	-
1180855	0	15	gene	NN	-	-	-	-	-	-	-	-
1180855	0	16	within	IN	-	-	-	-	-	-	-	-
1180855	0	17	the	DT	-	-	-	-	-	-	-	(41
1180855	0	18	significant	JJ	-	-	-	-	-	-	-	-
1180855	0	19	QTL	NN	-	-	-	-	-	-	-	-
1180855	0	20	for	IN	-	-	-	-	-	-	-	-
1180855	0	21	BAL	NN	-	-	-	-	-	-	-	(23|(14)
1180855	0	22	protein	NN	-	-	-	-	-	-	-	23)
1180855	0	23	on	IN	-	-	-	-	-	-	-	-
1180855	0	24	chromosome	NN	-	-	-	-	-	-	-	(43|(42)
1180855	0	25	1	CD	-	-	-	-	-	-	-	43)|41)
1180855	0	26	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Wild	JJ	-	-	-	-	-	-	-	(59
1180855	0	2	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	3	derived	VBN	-	-	-	-	-	-	-	-
1180855	0	4	Tlr5	NN	-	-	-	-	-	-	-	-
1180855	0	5	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	6	mutant	NN	-	-	-	-	-	-	-	-
1180855	0	7	MOLF	NN	-	-	-	-	-	-	-	-
1180855	0	8	/	HYPH	-	-	-	-	-	-	-	-
1180855	0	9	Ei	NN	-	-	-	-	-	-	-	-
1180855	0	10	mice	NNS	-	-	-	-	-	-	-	59)
1180855	0	11	were	VBD	-	-	-	-	-	-	-	-
1180855	0	12	tolerant	JJ	-	-	-	-	-	-	-	-
1180855	0	13	to	IN	-	-	-	-	-	-	-	-
1180855	0	14	BAL	NN	-	-	-	-	-	-	-	(23|(14)
1180855	0	15	protein	NN	-	-	-	-	-	-	-	23)
1180855	0	16	following	VBG	-	-	-	-	-	-	-	-
1180855	0	17	repeated	VBN	-	-	-	-	-	-	-	(60
1180855	0	18	ZnO	NN	-	-	-	-	-	-	-	(10)
1180855	0	19	exposure	NN	-	-	-	-	-	-	-	60)
1180855	0	20	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Conclusion	NN	-	-	-	-	-	-	-	(61)

1180855	0	1	Genetic	JJ	-	-	-	-	-	-	-	(9
1180855	0	2	background	NN	-	-	-	-	-	-	-	9)
1180855	0	3	is	VBZ	-	-	-	-	-	-	-	-
1180855	0	4	an	DT	-	-	-	-	-	-	-	-
1180855	0	5	important	JJ	-	-	-	-	-	-	-	-
1180855	0	6	influence	NN	-	-	-	-	-	-	-	-
1180855	0	7	in	IN	-	-	-	-	-	-	-	-
1180855	0	8	the	DT	-	-	-	-	-	-	-	-
1180855	0	9	acquisition	NN	-	-	-	-	-	-	-	-
1180855	0	10	of	IN	-	-	-	-	-	-	-	-
1180855	0	11	pulmonary	JJ	-	-	-	-	-	-	-	(62|(63b|(64b
1180855	0	12	tolerance	NN	-	-	-	-	-	-	-	-
1180855	0	13	to	IN	-	-	-	-	-	-	-	-
1180855	0	14	BAL	NN	-	-	-	-	-	-	-	(23|(14)|(24d)|(25h)|64b)|63b)
1180855	0	15	protein	NN	-	-	-	-	-	-	-	62)|23)
1180855	0	16	,	,	-	-	-	-	-	-	-	-
1180855	0	17	PMNs	NNS	-	-	-	-	-	-	-	(24d)|(63b)
1180855	0	18	,	,	-	-	-	-	-	-	-	-
1180855	0	19	and	CC	-	-	-	-	-	-	-	-
1180855	0	20	macrophages	NNS	-	-	-	-	-	-	-	(25h)|(64b)
1180855	0	21	following	VBG	-	-	-	-	-	-	-	-
1180855	0	22	ZnO	NN	-	-	-	-	-	-	-	(65|(10)
1180855	0	23	exposure	NN	-	-	-	-	-	-	-	65)
1180855	0	24	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Promising	JJ	-	-	-	-	-	-	-	-
1180855	0	2	candidate	NN	-	-	-	-	-	-	-	-
1180855	0	3	genes	NNS	-	-	-	-	-	-	-	-
1180855	0	4	exist	VBP	-	-	-	-	-	-	-	-
1180855	0	5	within	IN	-	-	-	-	-	-	-	-
1180855	0	6	the	DT	-	-	-	-	-	-	-	(66
1180855	0	7	identified	VBN	-	-	-	-	-	-	-	-
1180855	0	8	QTL	NN	-	-	-	-	-	-	-	-
1180855	0	9	intervals	NNS	-	-	-	-	-	-	-	66)
1180855	0	10	that	WDT	-	-	-	-	-	-	-	-
1180855	0	11	would	MD	-	-	-	-	-	-	-	-
1180855	0	12	be	VB	-	-	-	-	-	-	-	-
1180855	0	13	good	JJ	-	-	-	-	-	-	-	(67
1180855	0	14	targets	NNS	-	-	-	-	-	-	-	-
1180855	0	15	for	IN	-	-	-	-	-	-	-	-
1180855	0	16	additional	JJ	-	-	-	-	-	-	-	-
1180855	0	17	studies	NNS	-	-	-	-	-	-	-	67)
1180855	0	18	,	,	-	-	-	-	-	-	-	-
1180855	0	19	including	VBG	-	-	-	-	-	-	-	-
1180855	0	20	Tlr5	NN	-	-	-	-	-	-	-	(58)
1180855	0	21	.	.	-	-	-	-	-	-	-	-

1180855	0	1	The	DT	-	-	-	-	-	-	-	-
1180855	0	2	implications	NNS	-	-	-	-	-	-	-	-
1180855	0	3	of	IN	-	-	-	-	-	-	-	-
1180855	0	4	tolerance	NN	-	-	-	-	-	-	-	(68)
1180855	0	5	to	IN	-	-	-	-	-	-	-	-
1180855	0	6	health	NN	-	-	-	-	-	-	-	-
1180855	0	7	risks	NNS	-	-	-	-	-	-	-	-
1180855	0	8	in	IN	-	-	-	-	-	-	-	-
1180855	0	9	humans	NNS	-	-	-	-	-	-	-	(69)
1180855	0	10	are	VBP	-	-	-	-	-	-	-	-
1180855	0	11	numerous	JJ	-	-	-	-	-	-	-	-
1180855	0	12	,	,	-	-	-	-	-	-	-	-
1180855	0	13	and	CC	-	-	-	-	-	-	-	-
1180855	0	14	this	DT	-	-	-	-	-	-	-	(19
1180855	0	15	study	NN	-	-	-	-	-	-	-	19)
1180855	0	16	furthers	VBZ	-	-	-	-	-	-	-	-
1180855	0	17	the	DT	-	-	-	-	-	-	-	-
1180855	0	18	understanding	NN	-	-	-	-	-	-	-	-
1180855	0	19	of	IN	-	-	-	-	-	-	-	-
1180855	0	20	gene	NN	-	-	-	-	-	-	-	-
1180855	0	21	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	22	environment	NN	-	-	-	-	-	-	-	-
1180855	0	23	interactions	NNS	-	-	-	-	-	-	-	-
1180855	0	24	that	WDT	-	-	-	-	-	-	-	-
1180855	0	25	are	VBP	-	-	-	-	-	-	-	-
1180855	0	26	likely	JJ	-	-	-	-	-	-	-	-
1180855	0	27	to	TO	-	-	-	-	-	-	-	-
1180855	0	28	be	VB	-	-	-	-	-	-	-	-
1180855	0	29	important	JJ	-	-	-	-	-	-	-	-
1180855	0	30	factors	NNS	-	-	-	-	-	-	-	-
1180855	0	31	from	IN	-	-	-	-	-	-	-	-
1180855	0	32	person	NN	-	-	-	-	-	-	-	-
1180855	0	33	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	34	to	IN	-	-	-	-	-	-	-	-
1180855	0	35	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	36	person	NN	-	-	-	-	-	-	-	-
1180855	0	37	in	IN	-	-	-	-	-	-	-	-
1180855	0	38	regulating	VBG	-	-	-	-	-	-	-	-
1180855	0	39	the	DT	-	-	-	-	-	-	-	-
1180855	0	40	development	NN	-	-	-	-	-	-	-	-
1180855	0	41	of	IN	-	-	-	-	-	-	-	-
1180855	0	42	pulmonary	JJ	-	-	-	-	-	-	-	(70
1180855	0	43	tolerance	NN	-	-	-	-	-	-	-	-
1180855	0	44	to	IN	-	-	-	-	-	-	-	-
1180855	0	45	inhaled	VBN	-	-	-	-	-	-	-	(7
1180855	0	46	toxicants	NNS	-	-	-	-	-	-	-	70)|7)
1180855	0	47	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Introduction	NN	-	-	-	-	-	-	-	-

1180855	0	1	Individuals	NNS	-	-	-	-	-	-	-	(5)
1180855	0	2	may	MD	-	-	-	-	-	-	-	-
1180855	0	3	develop	VB	-	-	-	-	-	-	-	-
1180855	0	4	tolerance	NN	-	-	-	-	-	-	-	-
1180855	0	5	to	IN	-	-	-	-	-	-	-	-
1180855	0	6	adverse	JJ	-	-	-	-	-	-	-	-
1180855	0	7	health	NN	-	-	-	-	-	-	-	-
1180855	0	8	effects	NNS	-	-	-	-	-	-	-	-
1180855	0	9	elicited	VBN	-	-	-	-	-	-	-	-
1180855	0	10	from	IN	-	-	-	-	-	-	-	-
1180855	0	11	repeated	VBN	-	-	-	-	-	-	-	(6
1180855	0	12	exposure	NN	-	-	-	-	-	-	-	-
1180855	0	13	to	IN	-	-	-	-	-	-	-	-
1180855	0	14	inhaled	VBN	-	-	-	-	-	-	-	-
1180855	0	15	toxicants	NNS	-	-	-	-	-	-	-	6)
1180855	0	16	in	IN	-	-	-	-	-	-	-	-
1180855	0	17	several	JJ	-	-	-	-	-	-	-	-
1180855	0	18	different	JJ	-	-	-	-	-	-	-	-
1180855	0	19	occupational	JJ	-	-	-	-	-	-	-	-
1180855	0	20	and	CC	-	-	-	-	-	-	-	-
1180855	0	21	environmental	JJ	-	-	-	-	-	-	-	-
1180855	0	22	situations	NNS	-	-	-	-	-	-	-	-
1180855	0	23	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Pulmonary	JJ	-	-	-	-	-	-	-	(71
1180855	0	2	tolerance	NN	-	-	-	-	-	-	-	71)
1180855	0	3	can	MD	-	-	-	-	-	-	-	-
1180855	0	4	be	VB	-	-	-	-	-	-	-	-
1180855	0	5	defined	VBN	-	-	-	-	-	-	-	-
1180855	0	6	as	IN	-	-	-	-	-	-	-	-
1180855	0	7	the	DT	-	-	-	-	-	-	-	-
1180855	0	8	lung	NN	-	-	-	-	-	-	-	(72
1180855	0	9	's	POS	-	-	-	-	-	-	-	72)
1180855	0	10	ability	NN	-	-	-	-	-	-	-	-
1180855	0	11	to	TO	-	-	-	-	-	-	-	-
1180855	0	12	withstand	VB	-	-	-	-	-	-	-	-
1180855	0	13	the	DT	-	-	-	-	-	-	-	-
1180855	0	14	detrimental	JJ	-	-	-	-	-	-	-	-
1180855	0	15	effects	NNS	-	-	-	-	-	-	-	-
1180855	0	16	of	IN	-	-	-	-	-	-	-	-
1180855	0	17	a	DT	-	-	-	-	-	-	-	-
1180855	0	18	toxic	JJ	-	-	-	-	-	-	-	-
1180855	0	19	compound	NN	-	-	-	-	-	-	-	-
1180855	0	20	following	VBG	-	-	-	-	-	-	-	-
1180855	0	21	multiple	JJ	-	-	-	-	-	-	-	-
1180855	0	22	exposures	NNS	-	-	-	-	-	-	-	-
1180855	0	23	.	.	-	-	-	-	-	-	-	-

1180855	0	1	There	EX	-	-	-	-	-	-	-	-
1180855	0	2	are	VBP	-	-	-	-	-	-	-	-
1180855	0	3	several	JJ	-	-	-	-	-	-	-	-
1180855	0	4	implications	NNS	-	-	-	-	-	-	-	-
1180855	0	5	of	IN	-	-	-	-	-	-	-	-
1180855	0	6	tolerance	NN	-	-	-	-	-	-	-	(68)
1180855	0	7	to	IN	-	-	-	-	-	-	-	-
1180855	0	8	human	JJ	-	-	-	-	-	-	-	-
1180855	0	9	health	NN	-	-	-	-	-	-	-	-
1180855	0	10	,	,	-	-	-	-	-	-	-	-
1180855	0	11	having	VBG	-	-	-	-	-	-	-	-
1180855	0	12	both	DT	-	-	-	-	-	-	-	-
1180855	0	13	advantages	NNS	-	-	-	-	-	-	-	-
1180855	0	14	and	CC	-	-	-	-	-	-	-	-
1180855	0	15	disadvantages	NNS	-	-	-	-	-	-	-	-
1180855	0	16	with	IN	-	-	-	-	-	-	-	-
1180855	0	17	respect	NN	-	-	-	-	-	-	-	-
1180855	0	18	to	IN	-	-	-	-	-	-	-	-
1180855	0	19	the	DT	-	-	-	-	-	-	-	-
1180855	0	20	development	NN	-	-	-	-	-	-	-	-
1180855	0	21	of	IN	-	-	-	-	-	-	-	-
1180855	0	22	harmful	JJ	-	-	-	-	-	-	-	-
1180855	0	23	health	NN	-	-	-	-	-	-	-	-
1180855	0	24	effects	NNS	-	-	-	-	-	-	-	-
1180855	0	25	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Clinical	JJ	-	-	-	-	-	-	-	(73
1180855	0	2	investigations	NNS	-	-	-	-	-	-	-	-
1180855	0	3	of	IN	-	-	-	-	-	-	-	-
1180855	0	4	zinc	NN	-	-	-	-	-	-	-	(10|(74)
1180855	0	5	oxide	NN	-	-	-	-	-	-	-	10)
1180855	0	6	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	7	ZnO	NN	-	-	-	-	-	-	-	-
1180855	0	8	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	9	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	10	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	11	1	CD	-	-	-	-	-	-	-	-
1180855	0	12	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	13	,	,	-	-	-	-	-	-	-	-
1180855	0	14	endotoxin	NN	-	-	-	-	-	-	-	-
1180855	0	15	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	16	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	17	2	CD	-	-	-	-	-	-	-	-
1180855	0	18	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	19	,	,	-	-	-	-	-	-	-	-
1180855	0	20	and	CC	-	-	-	-	-	-	-	-
1180855	0	21	ozone	NN	-	-	-	-	-	-	-	-
1180855	0	22	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	23	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	24	3	CD	-	-	-	-	-	-	-	-
1180855	0	25	-	SYM	-	-	-	-	-	-	-	-
1180855	0	26	6	CD	-	-	-	-	-	-	-	-
1180855	0	27	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	28	induced	VBN	-	-	-	-	-	-	-	-
1180855	0	29	adverse	JJ	-	-	-	-	-	-	-	-
1180855	0	30	respiratory	JJ	-	-	-	-	-	-	-	-
1180855	0	31	effects	NNS	-	-	-	-	-	-	-	73)
1180855	0	32	have	VBP	-	-	-	-	-	-	-	-
1180855	0	33	demonstrated	VBN	-	-	-	-	-	-	-	-
1180855	0	34	inter-individual	JJ	-	-	-	-	-	-	-	-
1180855	0	35	variability	NN	-	-	-	-	-	-	-	-
1180855	0	36	in	IN	-	-	-	-	-	-	-	-
1180855	0	37	the	DT	-	-	-	-	-	-	-	-
1180855	0	38	capacity	NN	-	-	-	-	-	-	-	-
1180855	0	39	to	TO	-	-	-	-	-	-	-	-
1180855	0	40	develop	VB	-	-	-	-	-	-	-	-
1180855	0	41	pulmonary	JJ	-	-	-	-	-	-	-	(71
1180855	0	42	tolerance	NN	-	-	-	-	-	-	-	71)
1180855	0	43	following	VBG	-	-	-	-	-	-	-	-
1180855	0	44	inhalation	NN	-	-	-	-	-	-	-	(75
1180855	0	45	exposure	NN	-	-	-	-	-	-	-	75)
1180855	0	46	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Because	IN	-	-	-	-	-	-	-	-
1180855	0	2	these	DT	-	-	-	-	-	-	-	(73
1180855	0	3	clinical	JJ	-	-	-	-	-	-	-	-
1180855	0	4	studies	NNS	-	-	-	-	-	-	-	73)
1180855	0	5	are	VBP	-	-	-	-	-	-	-	-
1180855	0	6	more	RBR	-	-	-	-	-	-	-	-
1180855	0	7	tightly	RB	-	-	-	-	-	-	-	-
1180855	0	8	controlled	VBN	-	-	-	-	-	-	-	-
1180855	0	9	than	IN	-	-	-	-	-	-	-	-
1180855	0	10	epidemiologic	JJ	-	-	-	-	-	-	-	-
1180855	0	11	studies	NNS	-	-	-	-	-	-	-	-
1180855	0	12	,	,	-	-	-	-	-	-	-	-
1180855	0	13	they	PRP	-	-	-	-	-	-	-	(73)
1180855	0	14	suggest	VBP	-	-	-	-	-	-	-	-
1180855	0	15	that	IN	-	-	-	-	-	-	-	-
1180855	0	16	genetic	JJ	-	-	-	-	-	-	-	(9
1180855	0	17	background	NN	-	-	-	-	-	-	-	9)
1180855	0	18	and	CC	-	-	-	-	-	-	-	-
1180855	0	19	gene	NN	-	-	-	-	-	-	-	(76
1180855	0	20	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	21	environment	NN	-	-	-	-	-	-	-	-
1180855	0	22	interactions	NNS	-	-	-	-	-	-	-	76)
1180855	0	23	contribute	VBP	-	-	-	-	-	-	-	-
1180855	0	24	to	IN	-	-	-	-	-	-	-	-
1180855	0	25	the	DT	-	-	-	-	-	-	-	(77
1180855	0	26	development	NN	-	-	-	-	-	-	-	-
1180855	0	27	of	IN	-	-	-	-	-	-	-	-
1180855	0	28	pulmonary	JJ	-	-	-	-	-	-	-	-
1180855	0	29	tolerance	NN	-	-	-	-	-	-	-	-
1180855	0	30	in	IN	-	-	-	-	-	-	-	-
1180855	0	31	humans	NNS	-	-	-	-	-	-	-	(69)|77)
1180855	0	32	.	.	-	-	-	-	-	-	-	-

1180855	0	1	We	PRP	-	-	-	-	-	-	-	(8)
1180855	0	2	initially	RB	-	-	-	-	-	-	-	-
1180855	0	3	characterized	VBD	-	-	-	-	-	-	-	-
1180855	0	4	the	DT	-	-	-	-	-	-	-	-
1180855	0	5	pulmonary	JJ	-	-	-	-	-	-	-	(71
1180855	0	6	tolerance	NN	-	-	-	-	-	-	-	71)
1180855	0	7	phenotype	NN	-	-	-	-	-	-	-	-
1180855	0	8	in	IN	-	-	-	-	-	-	-	-
1180855	0	9	an	DT	-	-	-	-	-	-	-	-
1180855	0	10	outbred	JJ	-	-	-	-	-	-	-	-
1180855	0	11	mouse	NN	-	-	-	-	-	-	-	-
1180855	0	12	model	NN	-	-	-	-	-	-	-	-
1180855	0	13	by	IN	-	-	-	-	-	-	-	-
1180855	0	14	assessing	VBG	-	-	-	-	-	-	-	-
1180855	0	15	levels	NNS	-	-	-	-	-	-	-	-
1180855	0	16	of	IN	-	-	-	-	-	-	-	-
1180855	0	17	BAL	NN	-	-	-	-	-	-	-	(23|(14)|(24g)
1180855	0	18	protein	NN	-	-	-	-	-	-	-	23)
1180855	0	19	and	CC	-	-	-	-	-	-	-	-
1180855	0	20	polymorphonuclear	JJ	-	-	-	-	-	-	-	(24g
1180855	0	21	leukocytes	NNS	-	-	-	-	-	-	-	24g)
1180855	0	22	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	23	PMNs	NNS	-	-	-	-	-	-	-	-
1180855	0	24	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	25	following	VBG	-	-	-	-	-	-	-	-
1180855	0	26	single	JJ	-	-	-	-	-	-	-	(78|(79b
1180855	0	27	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	28	1	CD	-	-	-	-	-	-	-	-
1180855	0	29	X	SYM	-	-	-	-	-	-	-	-
1180855	0	30	)	-RRB-	-	-	-	-	-	-	-	79b)
1180855	0	31	and	CC	-	-	-	-	-	-	-	-
1180855	0	32	5	CD	-	-	-	-	-	-	-	(80
1180855	0	33	daily	RB	-	-	-	-	-	-	-	-
1180855	0	34	repeated	VBN	-	-	-	-	-	-	-	-
1180855	0	35	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	36	5	CD	-	-	-	-	-	-	-	-
1180855	0	37	X	SYM	-	-	-	-	-	-	-	-
1180855	0	38	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	39	exposures	NNS	-	-	-	-	-	-	-	(79b
1180855	0	40	to	IN	-	-	-	-	-	-	-	-
1180855	0	41	inhaled	VBN	-	-	-	-	-	-	-	(3
1180855	0	42	ZnO	NN	-	-	-	-	-	-	-	80)|79b)|78)|3)
1180855	0	43	to	TO	-	-	-	-	-	-	-	-
1180855	0	44	begin	VB	-	-	-	-	-	-	-	-
1180855	0	45	the	DT	-	-	-	-	-	-	-	-
1180855	0	46	identification	NN	-	-	-	-	-	-	-	-
1180855	0	47	of	IN	-	-	-	-	-	-	-	-
1180855	0	48	the	DT	-	-	-	-	-	-	-	(81
1180855	0	49	genes	NNS	-	-	-	-	-	-	-	-
1180855	0	50	regulating	VBG	-	-	-	-	-	-	-	-
1180855	0	51	the	DT	-	-	-	-	-	-	-	-
1180855	0	52	development	NN	-	-	-	-	-	-	-	-
1180855	0	53	of	IN	-	-	-	-	-	-	-	-
1180855	0	54	pulmonary	JJ	-	-	-	-	-	-	-	-
1180855	0	55	tolerance	NN	-	-	-	-	-	-	-	-
1180855	0	56	to	IN	-	-	-	-	-	-	-	-
1180855	0	57	repeated	VBN	-	-	-	-	-	-	-	-
1180855	0	58	toxicant	JJ	-	-	-	-	-	-	-	(82)
1180855	0	59	exposure	NN	-	-	-	-	-	-	-	81)
1180855	0	60	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	61	7	CD	-	-	-	-	-	-	-	-
1180855	0	62	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	63	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Significant	JJ	-	-	-	-	-	-	-	-
1180855	0	2	genetic	JJ	-	-	-	-	-	-	-	-
1180855	0	3	variability	NN	-	-	-	-	-	-	-	-
1180855	0	4	in	IN	-	-	-	-	-	-	-	-
1180855	0	5	the	DT	-	-	-	-	-	-	-	-
1180855	0	6	development	NN	-	-	-	-	-	-	-	-
1180855	0	7	of	IN	-	-	-	-	-	-	-	-
1180855	0	8	pulmonary	JJ	-	-	-	-	-	-	-	-
1180855	0	9	tolerance	NN	-	-	-	-	-	-	-	-
1180855	0	10	to	IN	-	-	-	-	-	-	-	-
1180855	0	11	ZnO	NN	-	-	-	-	-	-	-	(10)
1180855	0	12	,	,	-	-	-	-	-	-	-	-
1180855	0	13	endotoxin	NN	-	-	-	-	-	-	-	(83)
1180855	0	14	,	,	-	-	-	-	-	-	-	-
1180855	0	15	and	CC	-	-	-	-	-	-	-	-
1180855	0	16	ozone	NN	-	-	-	-	-	-	-	(84)
1180855	0	17	was	VBD	-	-	-	-	-	-	-	-
1180855	0	18	established	VBN	-	-	-	-	-	-	-	-
1180855	0	19	in	IN	-	-	-	-	-	-	-	-
1180855	0	20	several	JJ	-	-	-	-	-	-	-	(18
1180855	0	21	inbred	JJ	-	-	-	-	-	-	-	-
1180855	0	22	strains	NNS	-	-	-	-	-	-	-	-
1180855	0	23	of	IN	-	-	-	-	-	-	-	-
1180855	0	24	mice	NNS	-	-	-	-	-	-	-	(4)|18)
1180855	0	25	in	IN	-	-	-	-	-	-	-	-
1180855	0	26	a	DT	-	-	-	-	-	-	-	-
1180855	0	27	subsequent	JJ	-	-	-	-	-	-	-	-
1180855	0	28	study	NN	-	-	-	-	-	-	-	-
1180855	0	29	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	30	8	CD	-	-	-	-	-	-	-	-
1180855	0	31	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	32	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Of	IN	-	-	-	-	-	-	-	-
1180855	0	2	the	DT	-	-	-	-	-	-	-	(18
1180855	0	3	strains	NNS	-	-	-	-	-	-	-	-
1180855	0	4	tested	VBN	-	-	-	-	-	-	-	18)
1180855	0	5	,	,	-	-	-	-	-	-	-	-
1180855	0	6	the	DT	-	-	-	-	-	-	-	(16
1180855	0	7	BALB	NN	-	-	-	-	-	-	-	-
1180855	0	8	/	HYPH	-	-	-	-	-	-	-	-
1180855	0	9	cByJ	NN	-	-	-	-	-	-	-	-
1180855	0	10	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	11	CBy	NN	-	-	-	-	-	-	-	-
1180855	0	12	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	13	strain	NN	-	-	-	-	-	-	-	16)
1180855	0	14	was	VBD	-	-	-	-	-	-	-	-
1180855	0	15	tolerant	JJ	-	-	-	-	-	-	-	-
1180855	0	16	and	CC	-	-	-	-	-	-	-	-
1180855	0	17	the	DT	-	-	-	-	-	-	-	(17
1180855	0	18	DBA	NN	-	-	-	-	-	-	-	-
1180855	0	19	/	HYPH	-	-	-	-	-	-	-	-
1180855	0	20	2J	NN	-	-	-	-	-	-	-	-
1180855	0	21	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	22	D2	NN	-	-	-	-	-	-	-	-
1180855	0	23	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	24	strain	NN	-	-	-	-	-	-	-	17)
1180855	0	25	was	VBD	-	-	-	-	-	-	-	-
1180855	0	26	non-tolerant	JJ	-	-	-	-	-	-	-	-
1180855	0	27	to	IN	-	-	-	-	-	-	-	-
1180855	0	28	BAL	NN	-	-	-	-	-	-	-	(23|(14)|(24a)|(25c)
1180855	0	29	protein	NN	-	-	-	-	-	-	-	23)
1180855	0	30	,	,	-	-	-	-	-	-	-	-
1180855	0	31	PMNs	NNS	-	-	-	-	-	-	-	(24a)
1180855	0	32	,	,	-	-	-	-	-	-	-	-
1180855	0	33	and	CC	-	-	-	-	-	-	-	-
1180855	0	34	macrophages	NNS	-	-	-	-	-	-	-	(25c)
1180855	0	35	following	VBG	-	-	-	-	-	-	-	-
1180855	0	36	repeated	VBN	-	-	-	-	-	-	-	(60
1180855	0	37	ZnO	NN	-	-	-	-	-	-	-	(10)
1180855	0	38	exposure	NN	-	-	-	-	-	-	-	60)
1180855	0	39	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Because	IN	-	-	-	-	-	-	-	-
1180855	0	2	inbred	VBN	-	-	-	-	-	-	-	(11
1180855	0	3	mouse	NN	-	-	-	-	-	-	-	-
1180855	0	4	strains	NNS	-	-	-	-	-	-	-	11)
1180855	0	5	are	VBP	-	-	-	-	-	-	-	-
1180855	0	6	virtually	RB	-	-	-	-	-	-	-	-
1180855	0	7	identical	JJ	-	-	-	-	-	-	-	-
1180855	0	8	at	IN	-	-	-	-	-	-	-	-
1180855	0	9	all	DT	-	-	-	-	-	-	-	-
1180855	0	10	loci	NNS	-	-	-	-	-	-	-	-
1180855	0	11	throughout	IN	-	-	-	-	-	-	-	-
1180855	0	12	their	PRP$	-	-	-	-	-	-	-	(11)
1180855	0	13	genome	NN	-	-	-	-	-	-	-	-
1180855	0	14	,	,	-	-	-	-	-	-	-	-
1180855	0	15	and	CC	-	-	-	-	-	-	-	-
1180855	0	16	also	RB	-	-	-	-	-	-	-	-
1180855	0	17	share	VBP	-	-	-	-	-	-	-	-
1180855	0	18	several	JJ	-	-	-	-	-	-	-	-
1180855	0	19	chromosomal	JJ	-	-	-	-	-	-	-	-
1180855	0	20	regions	NNS	-	-	-	-	-	-	-	-
1180855	0	21	of	IN	-	-	-	-	-	-	-	-
1180855	0	22	conserved	VBN	-	-	-	-	-	-	-	-
1180855	0	23	synteny	NN	-	-	-	-	-	-	-	-
1180855	0	24	with	IN	-	-	-	-	-	-	-	-
1180855	0	25	humans	NNS	-	-	-	-	-	-	-	(69)
1180855	0	26	,	,	-	-	-	-	-	-	-	-
1180855	0	27	they	PRP	-	-	-	-	-	-	-	(11)
1180855	0	28	are	VBP	-	-	-	-	-	-	-	-
1180855	0	29	an	DT	-	-	-	-	-	-	-	-
1180855	0	30	ideal	JJ	-	-	-	-	-	-	-	-
1180855	0	31	animal	NN	-	-	-	-	-	-	-	(85)
1180855	0	32	model	NN	-	-	-	-	-	-	-	-
1180855	0	33	in	IN	-	-	-	-	-	-	-	-
1180855	0	34	which	WDT	-	-	-	-	-	-	-	-
1180855	0	35	to	TO	-	-	-	-	-	-	-	-
1180855	0	36	investigate	VB	-	-	-	-	-	-	-	-
1180855	0	37	genotype	NN	-	-	-	-	-	-	-	-
1180855	0	38	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	39	environment	NN	-	-	-	-	-	-	-	-
1180855	0	40	interactions	NNS	-	-	-	-	-	-	-	-
1180855	0	41	and	CC	-	-	-	-	-	-	-	-
1180855	0	42	identify	VB	-	-	-	-	-	-	-	-
1180855	0	43	genes	NNS	-	-	-	-	-	-	-	(81
1180855	0	44	controlling	VBG	-	-	-	-	-	-	-	-
1180855	0	45	pulmonary	JJ	-	-	-	-	-	-	-	-
1180855	0	46	responses	NNS	-	-	-	-	-	-	-	-
1180855	0	47	to	IN	-	-	-	-	-	-	-	-
1180855	0	48	inhaled	VBN	-	-	-	-	-	-	-	(7
1180855	0	49	toxicants	NNS	-	-	-	-	-	-	-	81)|7)
1180855	0	50	where	WRB	-	-	-	-	-	-	-	-
1180855	0	51	no	RB	-	-	-	-	-	-	-	-
1180855	0	52	a	FW	-	-	-	-	-	-	-	-
1180855	0	53	priori	FW	-	-	-	-	-	-	-	-
1180855	0	54	evidence	NN	-	-	-	-	-	-	-	-
1180855	0	55	for	IN	-	-	-	-	-	-	-	-
1180855	0	56	their	PRP$	-	-	-	-	-	-	-	(81)
1180855	0	57	location	NN	-	-	-	-	-	-	-	-
1180855	0	58	exists	VBZ	-	-	-	-	-	-	-	-
1180855	0	59	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	60	9	CD	-	-	-	-	-	-	-	-
1180855	0	61	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	62	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Inbred	JJ	-	-	-	-	-	-	-	(11
1180855	0	2	strains	NNS	-	-	-	-	-	-	-	-
1180855	0	3	of	IN	-	-	-	-	-	-	-	-
1180855	0	4	mice	NNS	-	-	-	-	-	-	-	(4)|11)
1180855	0	5	have	VBP	-	-	-	-	-	-	-	-
1180855	0	6	been	VBN	-	-	-	-	-	-	-	-
1180855	0	7	successfully	RB	-	-	-	-	-	-	-	-
1180855	0	8	utilized	VBN	-	-	-	-	-	-	-	-
1180855	0	9	in	IN	-	-	-	-	-	-	-	-
1180855	0	10	quantitative	JJ	-	-	-	-	-	-	-	(36
1180855	0	11	trait	NN	-	-	-	-	-	-	-	-
1180855	0	12	locus	NN	-	-	-	-	-	-	-	36)
1180855	0	13	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	14	QTL	NN	-	-	-	-	-	-	-	-
1180855	0	15	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	16	analyses	NNS	-	-	-	-	-	-	-	-
1180855	0	17	to	TO	-	-	-	-	-	-	-	-
1180855	0	18	identify	VB	-	-	-	-	-	-	-	-
1180855	0	19	candidate	NN	-	-	-	-	-	-	-	-
1180855	0	20	genes	NNS	-	-	-	-	-	-	-	-
1180855	0	21	that	WDT	-	-	-	-	-	-	-	-
1180855	0	22	control	VBP	-	-	-	-	-	-	-	-
1180855	0	23	susceptibility	NN	-	-	-	-	-	-	-	-
1180855	0	24	to	IN	-	-	-	-	-	-	-	-
1180855	0	25	adverse	JJ	-	-	-	-	-	-	-	-
1180855	0	26	pulmonary	JJ	-	-	-	-	-	-	-	-
1180855	0	27	responses	NNS	-	-	-	-	-	-	-	-
1180855	0	28	induced	VBN	-	-	-	-	-	-	-	-
1180855	0	29	by	IN	-	-	-	-	-	-	-	-
1180855	0	30	a	DT	-	-	-	-	-	-	-	-
1180855	0	31	variety	NN	-	-	-	-	-	-	-	-
1180855	0	32	of	IN	-	-	-	-	-	-	-	-
1180855	0	33	inhaled	VBN	-	-	-	-	-	-	-	(86|(88a|(87a)
1180855	0	34	gases	NNS	-	-	-	-	-	-	-	88a)|86)
1180855	0	35	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	36	10	CD	-	-	-	-	-	-	-	-
1180855	0	37	-	SYM	-	-	-	-	-	-	-	-
1180855	0	38	13	CD	-	-	-	-	-	-	-	-
1180855	0	39	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	40	and	CC	-	-	-	-	-	-	-	(88a
1180855	0	41	particulates	NNS	-	-	-	-	-	-	-	(87a)|88a)
1180855	0	42	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	43	14	CD	-	-	-	-	-	-	-	-
1180855	0	44	,	,	-	-	-	-	-	-	-	-
1180855	0	45	15	CD	-	-	-	-	-	-	-	-
1180855	0	46	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	47	.	.	-	-	-	-	-	-	-	-

1180855	0	1	In	IN	-	-	-	-	-	-	-	-
1180855	0	2	the	DT	-	-	-	-	-	-	-	(19
1180855	0	3	present	JJ	-	-	-	-	-	-	-	-
1180855	0	4	study	NN	-	-	-	-	-	-	-	19)
1180855	0	5	,	,	-	-	-	-	-	-	-	-
1180855	0	6	a	DT	-	-	-	-	-	-	-	-
1180855	0	7	CByD2F2	NN	-	-	-	-	-	-	-	(22
1180855	0	8	mouse	NN	-	-	-	-	-	-	-	22)
1180855	0	9	cohort	NN	-	-	-	-	-	-	-	-
1180855	0	10	was	VBD	-	-	-	-	-	-	-	-
1180855	0	11	used	VBN	-	-	-	-	-	-	-	-
1180855	0	12	to	TO	-	-	-	-	-	-	-	-
1180855	0	13	determine	VB	-	-	-	-	-	-	-	-
1180855	0	14	QTLs	NNS	-	-	-	-	-	-	-	-
1180855	0	15	linked	VBN	-	-	-	-	-	-	-	-
1180855	0	16	to	IN	-	-	-	-	-	-	-	-
1180855	0	17	the	DT	-	-	-	-	-	-	-	(89
1180855	0	18	development	NN	-	-	-	-	-	-	-	-
1180855	0	19	of	IN	-	-	-	-	-	-	-	-
1180855	0	20	pulmonary	JJ	-	-	-	-	-	-	-	(62|(63a|(64a
1180855	0	21	tolerance	NN	-	-	-	-	-	-	-	-
1180855	0	22	to	IN	-	-	-	-	-	-	-	63a)
1180855	0	23	BAL	NN	-	-	-	-	-	-	-	(15a|(23|(14)|(24f)|(25a)|(54d)|64a)
1180855	0	24	protein	NN	-	-	-	-	-	-	-	89)|62)|23)|15a)
1180855	0	25	,	,	-	-	-	-	-	-	-	-
1180855	0	26	PMN	NN	-	-	-	-	-	-	-	(24f)|(63a)
1180855	0	27	,	,	-	-	-	-	-	-	-	-
1180855	0	28	and	CC	-	-	-	-	-	-	-	-
1180855	0	29	macrophage	NN	-	-	-	-	-	-	-	(54d|(64a|(25a)
1180855	0	30	phenotypes	NNS	-	-	-	-	-	-	-	(15a)|64a)|54d)
1180855	0	31	following	VBG	-	-	-	-	-	-	-	-
1180855	0	32	repeated	VBN	-	-	-	-	-	-	-	(60
1180855	0	33	ZnO	NN	-	-	-	-	-	-	-	(10)
1180855	0	34	exposure	NN	-	-	-	-	-	-	-	60)
1180855	0	35	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Materials	NNS	-	-	-	-	-	-	-	-
1180855	0	2	and	CC	-	-	-	-	-	-	-	-
1180855	0	3	methods	NNS	-	-	-	-	-	-	-	(21)

1180855	0	1	Mice	NNS	-	-	-	-	-	-	-	(4)

1180855	0	1	Inbred	JJ	-	-	-	-	-	-	-	(90d|(17a)|(17b)|(91a)
1180855	0	2	BALB	NN	-	-	-	-	-	-	-	-
1180855	0	3	/	HYPH	-	-	-	-	-	-	-	-
1180855	0	4	cByJ	NN	-	-	-	-	-	-	-	-
1180855	0	5	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	6	CBy	NN	-	-	-	-	-	-	-	-
1180855	0	7	)	-RRB-	-	-	-	-	-	-	-	90d)
1180855	0	8	,	,	-	-	-	-	-	-	-	-
1180855	0	9	DBA	NN	-	-	-	-	-	-	-	(17a|(17b
1180855	0	10	/	HYPH	-	-	-	-	-	-	-	-
1180855	0	11	2J	NN	-	-	-	-	-	-	-	-
1180855	0	12	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	13	D2	NN	-	-	-	-	-	-	-	17a)
1180855	0	14	)	-RRB-	-	-	-	-	-	-	-	17b)
1180855	0	15	and	CC	-	-	-	-	-	-	-	-
1180855	0	16	CByD2F1	NN	-	-	-	-	-	-	-	(91a|(92
1180855	0	17	/	HYPH	-	-	-	-	-	-	-	-
1180855	0	18	J	NN	-	-	-	-	-	-	-	92)
1180855	0	19	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	20	F1	NN	-	-	-	-	-	-	-	-
1180855	0	21	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	22	mice	NNS	-	-	-	-	-	-	-	(17a)|(17b)|(90d)|91a)
1180855	0	23	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	24	6	CD	-	-	-	-	-	-	-	-
1180855	0	25	–	SYM	-	-	-	-	-	-	-	-
1180855	0	26	7	CD	-	-	-	-	-	-	-	-
1180855	0	27	weeks	NNS	-	-	-	-	-	-	-	-
1180855	0	28	of	IN	-	-	-	-	-	-	-	-
1180855	0	29	age	NN	-	-	-	-	-	-	-	(93)
1180855	0	30	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	31	were	VBD	-	-	-	-	-	-	-	-
1180855	0	32	purchased	VBN	-	-	-	-	-	-	-	-
1180855	0	33	from	IN	-	-	-	-	-	-	-	-
1180855	0	34	The	DT	-	-	-	-	-	-	-	-
1180855	0	35	Jackson	NNP	-	-	-	-	-	-	-	-
1180855	0	36	Laboratory	NNP	-	-	-	-	-	-	-	-
1180855	0	37	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	38	Bar	NNP	-	-	-	-	-	-	-	-
1180855	0	39	Harbor	NNP	-	-	-	-	-	-	-	-
1180855	0	40	,	,	-	-	-	-	-	-	-	-
1180855	0	41	ME	NNP	-	-	-	-	-	-	-	-
1180855	0	42	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	43	.	.	-	-	-	-	-	-	-	-

1180855	0	1	CByD2F1	NN	-	-	-	-	-	-	-	(91|(92
1180855	0	2	/	HYPH	-	-	-	-	-	-	-	-
1180855	0	3	J	NN	-	-	-	-	-	-	-	92)
1180855	0	4	mice	NNS	-	-	-	-	-	-	-	91)
1180855	0	5	were	VBD	-	-	-	-	-	-	-	-
1180855	0	6	crossed	VBN	-	-	-	-	-	-	-	-
1180855	0	7	to	TO	-	-	-	-	-	-	-	-
1180855	0	8	produce	VB	-	-	-	-	-	-	-	-
1180855	0	9	F2	NN	-	-	-	-	-	-	-	(22
1180855	0	10	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	11	intercross	NN	-	-	-	-	-	-	-	-
1180855	0	12	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	13	offspring	NN	-	-	-	-	-	-	-	22)
1180855	0	14	in	IN	-	-	-	-	-	-	-	-
1180855	0	15	our	PRP$	-	-	-	-	-	-	-	(8)
1180855	0	16	laboratory	NN	-	-	-	-	-	-	-	-
1180855	0	17	animal	NN	-	-	-	-	-	-	-	-
1180855	0	18	facility	NN	-	-	-	-	-	-	-	-
1180855	0	19	.	.	-	-	-	-	-	-	-	-

1180855	0	1	All	DT	-	-	-	-	-	-	-	(94
1180855	0	2	mice	NNS	-	-	-	-	-	-	-	94)
1180855	0	3	were	VBD	-	-	-	-	-	-	-	-
1180855	0	4	acclimated	VBN	-	-	-	-	-	-	-	-
1180855	0	5	for	IN	-	-	-	-	-	-	-	-
1180855	0	6	at	RB	-	-	-	-	-	-	-	-
1180855	0	7	least	RBS	-	-	-	-	-	-	-	-
1180855	0	8	1	CD	-	-	-	-	-	-	-	-
1180855	0	9	week	NN	-	-	-	-	-	-	-	-
1180855	0	10	before	IN	-	-	-	-	-	-	-	-
1180855	0	11	exposure	NN	-	-	-	-	-	-	-	(75)
1180855	0	12	,	,	-	-	-	-	-	-	-	-
1180855	0	13	housed	VBN	-	-	-	-	-	-	-	-
1180855	0	14	in	IN	-	-	-	-	-	-	-	-
1180855	0	15	a	DT	-	-	-	-	-	-	-	-
1180855	0	16	positive	JJ	-	-	-	-	-	-	-	-
1180855	0	17	pressure	NN	-	-	-	-	-	-	-	-
1180855	0	18	environment	NN	-	-	-	-	-	-	-	-
1180855	0	19	with	IN	-	-	-	-	-	-	-	-
1180855	0	20	a	DT	-	-	-	-	-	-	-	-
1180855	0	21	12	CD	-	-	-	-	-	-	-	-
1180855	0	22	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	23	hour	NN	-	-	-	-	-	-	-	-
1180855	0	24	light	NN	-	-	-	-	-	-	-	-
1180855	0	25	/	HYPH	-	-	-	-	-	-	-	-
1180855	0	26	dark	NN	-	-	-	-	-	-	-	-
1180855	0	27	cycle	NN	-	-	-	-	-	-	-	-
1180855	0	28	starting	VBG	-	-	-	-	-	-	-	-
1180855	0	29	at	IN	-	-	-	-	-	-	-	-
1180855	0	30	6	CD	-	-	-	-	-	-	-	-
1180855	0	31	:	:	-	-	-	-	-	-	-	-
1180855	0	32	00	CD	-	-	-	-	-	-	-	-
1180855	0	33	a.m.	RB	-	-	-	-	-	-	-	-
1180855	0	34	,	,	-	-	-	-	-	-	-	-
1180855	0	35	and	CC	-	-	-	-	-	-	-	-
1180855	0	36	provided	VBN	-	-	-	-	-	-	-	-
1180855	0	37	with	IN	-	-	-	-	-	-	-	-
1180855	0	38	water	NN	-	-	-	-	-	-	-	-
1180855	0	39	and	CC	-	-	-	-	-	-	-	-
1180855	0	40	standard	JJ	-	-	-	-	-	-	-	-
1180855	0	41	laboratory	NN	-	-	-	-	-	-	-	-
1180855	0	42	rodent	NN	-	-	-	-	-	-	-	-
1180855	0	43	chow	NN	-	-	-	-	-	-	-	-
1180855	0	44	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	45	Purina	NNP	-	-	-	-	-	-	-	-
1180855	0	46	,	,	-	-	-	-	-	-	-	-
1180855	0	47	Indianapolis	NNP	-	-	-	-	-	-	-	-
1180855	0	48	,	,	-	-	-	-	-	-	-	-
1180855	0	49	IN	NNP	-	-	-	-	-	-	-	-
1180855	0	50	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	51	ad	FW	-	-	-	-	-	-	-	-
1180855	0	52	libitum	FW	-	-	-	-	-	-	-	-
1180855	0	53	except	IN	-	-	-	-	-	-	-	-
1180855	0	54	during	IN	-	-	-	-	-	-	-	-
1180855	0	55	exposure	NN	-	-	-	-	-	-	-	(75)
1180855	0	56	.	.	-	-	-	-	-	-	-	-

1180855	0	1	All	DT	-	-	-	-	-	-	-	(94
1180855	0	2	mice	NNS	-	-	-	-	-	-	-	94)
1180855	0	3	were	VBD	-	-	-	-	-	-	-	-
1180855	0	4	handled	VBN	-	-	-	-	-	-	-	-
1180855	0	5	in	IN	-	-	-	-	-	-	-	-
1180855	0	6	accordance	NN	-	-	-	-	-	-	-	-
1180855	0	7	with	IN	-	-	-	-	-	-	-	-
1180855	0	8	the	DT	-	-	-	-	-	-	-	-
1180855	0	9	standards	NNS	-	-	-	-	-	-	-	-
1180855	0	10	established	VBN	-	-	-	-	-	-	-	-
1180855	0	11	by	IN	-	-	-	-	-	-	-	-
1180855	0	12	the	DT	-	-	-	-	-	-	-	-
1180855	0	13	U.S.	NNP	-	-	-	-	-	-	-	-
1180855	0	14	Animal	NNP	-	-	-	-	-	-	-	-
1180855	0	15	Welfare	NNP	-	-	-	-	-	-	-	-
1180855	0	16	Acts	NNPS	-	-	-	-	-	-	-	-
1180855	0	17	set	VBN	-	-	-	-	-	-	-	-
1180855	0	18	forth	RP	-	-	-	-	-	-	-	-
1180855	0	19	in	IN	-	-	-	-	-	-	-	-
1180855	0	20	National	NNP	-	-	-	-	-	-	-	-
1180855	0	21	Institutes	NNPS	-	-	-	-	-	-	-	-
1180855	0	22	of	IN	-	-	-	-	-	-	-	-
1180855	0	23	Health	NNP	-	-	-	-	-	-	-	-
1180855	0	24	guidelines	NNS	-	-	-	-	-	-	-	-
1180855	0	25	,	,	-	-	-	-	-	-	-	-
1180855	0	26	and	CC	-	-	-	-	-	-	-	-
1180855	0	27	by	IN	-	-	-	-	-	-	-	-
1180855	0	28	the	DT	-	-	-	-	-	-	-	-
1180855	0	29	New	NNP	-	-	-	-	-	-	-	(95
1180855	0	30	York	NNP	-	-	-	-	-	-	-	-
1180855	0	31	University	NNP	-	-	-	-	-	-	-	95)
1180855	0	32	School	NNP	-	-	-	-	-	-	-	-
1180855	0	33	of	IN	-	-	-	-	-	-	-	-
1180855	0	34	Medicine	NNP	-	-	-	-	-	-	-	-
1180855	0	35	Division	NNP	-	-	-	-	-	-	-	-
1180855	0	36	of	IN	-	-	-	-	-	-	-	-
1180855	0	37	Laboratory	NNP	-	-	-	-	-	-	-	-
1180855	0	38	Animal	NNP	-	-	-	-	-	-	-	-
1180855	0	39	Resources	NNPS	-	-	-	-	-	-	-	-
1180855	0	40	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Zinc	NN	-	-	-	-	-	-	-	(65a|(74)
1180855	0	2	oxide	NN	-	-	-	-	-	-	-	65a)
1180855	0	3	generation	NN	-	-	-	-	-	-	-	-
1180855	0	4	,	,	-	-	-	-	-	-	-	-
1180855	0	5	characterization	NN	-	-	-	-	-	-	-	-
1180855	0	6	,	,	-	-	-	-	-	-	-	-
1180855	0	7	and	CC	-	-	-	-	-	-	-	-
1180855	0	8	exposure	NN	-	-	-	-	-	-	-	(65a)

1180855	0	1	Mice	NNS	-	-	-	-	-	-	-	(4)
1180855	0	2	were	VBD	-	-	-	-	-	-	-	-
1180855	0	3	exposed	VBN	-	-	-	-	-	-	-	-
1180855	0	4	to	IN	-	-	-	-	-	-	-	-
1180855	0	5	ZnO	NN	-	-	-	-	-	-	-	(10)
1180855	0	6	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	7	1.0	CD	-	-	-	-	-	-	-	-
1180855	0	8	±	SYM	-	-	-	-	-	-	-	-
1180855	0	9	0.2	CD	-	-	-	-	-	-	-	-
1180855	0	10	mg	NN	-	-	-	-	-	-	-	-
1180855	0	11	/	SYM	-	-	-	-	-	-	-	-
1180855	0	12	m3	NN	-	-	-	-	-	-	-	-
1180855	0	13	,	,	-	-	-	-	-	-	-	-
1180855	0	14	mean	NN	-	-	-	-	-	-	-	-
1180855	0	15	±	SYM	-	-	-	-	-	-	-	-
1180855	0	16	SD	NN	-	-	-	-	-	-	-	-
1180855	0	17	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	18	in	IN	-	-	-	-	-	-	-	-
1180855	0	19	stainless	JJ	-	-	-	-	-	-	-	-
1180855	0	20	steel	NN	-	-	-	-	-	-	-	-
1180855	0	21	cages	NNS	-	-	-	-	-	-	-	-
1180855	0	22	placed	VBN	-	-	-	-	-	-	-	-
1180855	0	23	inside	IN	-	-	-	-	-	-	-	-
1180855	0	24	a	DT	-	-	-	-	-	-	-	(96
1180855	0	25	0.07	CD	-	-	-	-	-	-	-	-
1180855	0	26	m3	NN	-	-	-	-	-	-	-	-
1180855	0	27	Plexiglas	NN	-	-	-	-	-	-	-	-
1180855	0	28	chamber	NN	-	-	-	-	-	-	-	96)
1180855	0	29	.	.	-	-	-	-	-	-	-	-

1180855	0	1	ZnO	NN	-	-	-	-	-	-	-	(10)
1180855	0	2	fumes	NNS	-	-	-	-	-	-	-	-
1180855	0	3	were	VBD	-	-	-	-	-	-	-	-
1180855	0	4	generated	VBN	-	-	-	-	-	-	-	-
1180855	0	5	in	IN	-	-	-	-	-	-	-	-
1180855	0	6	a	DT	-	-	-	-	-	-	-	-
1180855	0	7	furnace	NN	-	-	-	-	-	-	-	-
1180855	0	8	as	IN	-	-	-	-	-	-	-	-
1180855	0	9	previously	RB	-	-	-	-	-	-	-	-
1180855	0	10	described	VBN	-	-	-	-	-	-	-	-
1180855	0	11	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	12	7	CD	-	-	-	-	-	-	-	-
1180855	0	13	,	,	-	-	-	-	-	-	-	-
1180855	0	14	16	CD	-	-	-	-	-	-	-	-
1180855	0	15	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	16	.	.	-	-	-	-	-	-	-	-

1180855	0	1	The	DT	-	-	-	-	-	-	-	-
1180855	0	2	ZnO	NN	-	-	-	-	-	-	-	(10)
1180855	0	3	particles	NNS	-	-	-	-	-	-	-	-
1180855	0	4	had	VBD	-	-	-	-	-	-	-	-
1180855	0	5	a	DT	-	-	-	-	-	-	-	-
1180855	0	6	mass	NN	-	-	-	-	-	-	-	-
1180855	0	7	median	JJ	-	-	-	-	-	-	-	-
1180855	0	8	aerodynamic	JJ	-	-	-	-	-	-	-	-
1180855	0	9	diameter	NN	-	-	-	-	-	-	-	-
1180855	0	10	of	IN	-	-	-	-	-	-	-	-
1180855	0	11	0.3	CD	-	-	-	-	-	-	-	-
1180855	0	12	μm	NN	-	-	-	-	-	-	-	-
1180855	0	13	and	CC	-	-	-	-	-	-	-	-
1180855	0	14	geometric	JJ	-	-	-	-	-	-	-	-
1180855	0	15	standard	JJ	-	-	-	-	-	-	-	-
1180855	0	16	deviation	NN	-	-	-	-	-	-	-	-
1180855	0	17	of	IN	-	-	-	-	-	-	-	-
1180855	0	18	1.5	CD	-	-	-	-	-	-	-	-
1180855	0	19	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Samples	NNS	-	-	-	-	-	-	-	-
1180855	0	2	of	IN	-	-	-	-	-	-	-	-
1180855	0	3	the	DT	-	-	-	-	-	-	-	-
1180855	0	4	chamber	NN	-	-	-	-	-	-	-	(96)
1180855	0	5	atmosphere	NN	-	-	-	-	-	-	-	-
1180855	0	6	were	VBD	-	-	-	-	-	-	-	-
1180855	0	7	collected	VBN	-	-	-	-	-	-	-	-
1180855	0	8	approximately	RB	-	-	-	-	-	-	-	-
1180855	0	9	every	DT	-	-	-	-	-	-	-	-
1180855	0	10	40	CD	-	-	-	-	-	-	-	-
1180855	0	11	minutes	NNS	-	-	-	-	-	-	-	-
1180855	0	12	from	IN	-	-	-	-	-	-	-	-
1180855	0	13	the	DT	-	-	-	-	-	-	-	-
1180855	0	14	manifold	NN	-	-	-	-	-	-	-	-
1180855	0	15	of	IN	-	-	-	-	-	-	-	-
1180855	0	16	the	DT	-	-	-	-	-	-	-	-
1180855	0	17	exposure	NN	-	-	-	-	-	-	-	(75)
1180855	0	18	system	NN	-	-	-	-	-	-	-	-
1180855	0	19	with	IN	-	-	-	-	-	-	-	-
1180855	0	20	polytetrafluoroethylene	NN	-	-	-	-	-	-	-	-
1180855	0	21	filters	NNS	-	-	-	-	-	-	-	-
1180855	0	22	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	23	Type	NN	-	-	-	-	-	-	-	-
1180855	0	24	TX40HI20	NN	-	-	-	-	-	-	-	-
1180855	0	25	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	26	WW	NN	-	-	-	-	-	-	-	-
1180855	0	27	,	,	-	-	-	-	-	-	-	-
1180855	0	28	Pallflex	NNP	-	-	-	-	-	-	-	-
1180855	0	29	Products	NNP	-	-	-	-	-	-	-	-
1180855	0	30	Corp.	NNP	-	-	-	-	-	-	-	-
1180855	0	31	,	,	-	-	-	-	-	-	-	-
1180855	0	32	Putnam	NNP	-	-	-	-	-	-	-	-
1180855	0	33	,	,	-	-	-	-	-	-	-	-
1180855	0	34	CT	NNP	-	-	-	-	-	-	-	-
1180855	0	35	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	36	,	,	-	-	-	-	-	-	-	-
1180855	0	37	and	CC	-	-	-	-	-	-	-	-
1180855	0	38	the	DT	-	-	-	-	-	-	-	-
1180855	0	39	ZnO	NN	-	-	-	-	-	-	-	(10)
1180855	0	40	concentration	NN	-	-	-	-	-	-	-	-
1180855	0	41	was	VBD	-	-	-	-	-	-	-	-
1180855	0	42	determined	VBN	-	-	-	-	-	-	-	-
1180855	0	43	gravimetrically	RB	-	-	-	-	-	-	-	-
1180855	0	44	using	VBG	-	-	-	-	-	-	-	-
1180855	0	45	a	DT	-	-	-	-	-	-	-	-
1180855	0	46	microbalance	NN	-	-	-	-	-	-	-	-
1180855	0	47	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	48	Model	NN	-	-	-	-	-	-	-	-
1180855	0	49	C	NN	-	-	-	-	-	-	-	-
1180855	0	50	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	51	30	CD	-	-	-	-	-	-	-	-
1180855	0	52	,	,	-	-	-	-	-	-	-	-
1180855	0	53	Cahn	NNP	-	-	-	-	-	-	-	-
1180855	0	54	Instruments	NNP	-	-	-	-	-	-	-	-
1180855	0	55	,	,	-	-	-	-	-	-	-	-
1180855	0	56	Cerritos	NNP	-	-	-	-	-	-	-	-
1180855	0	57	,	,	-	-	-	-	-	-	-	-
1180855	0	58	CA	NNP	-	-	-	-	-	-	-	-
1180855	0	59	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	60	.	.	-	-	-	-	-	-	-	-

1180855	0	1	For	IN	-	-	-	-	-	-	-	-
1180855	0	2	linkage	NN	-	-	-	-	-	-	-	(97
1180855	0	3	analyses	NNS	-	-	-	-	-	-	-	97)
1180855	0	4	,	,	-	-	-	-	-	-	-	-
1180855	0	5	all	DT	-	-	-	-	-	-	-	-
1180855	0	6	F2	NN	-	-	-	-	-	-	-	-
1180855	0	7	offspring	NN	-	-	-	-	-	-	-	-
1180855	0	8	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	9	n	NN	-	-	-	-	-	-	-	(98)
1180855	0	10	=	SYM	-	-	-	-	-	-	-	-
1180855	0	11	299	CD	-	-	-	-	-	-	-	-
1180855	0	12	,	,	-	-	-	-	-	-	-	-
1180855	0	13	138	CD	-	-	-	-	-	-	-	-
1180855	0	14	males	NNS	-	-	-	-	-	-	-	-
1180855	0	15	and	CC	-	-	-	-	-	-	-	-
1180855	0	16	161	CD	-	-	-	-	-	-	-	-
1180855	0	17	females	NNS	-	-	-	-	-	-	-	-
1180855	0	18	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	19	were	VBD	-	-	-	-	-	-	-	-
1180855	0	20	exposed	VBN	-	-	-	-	-	-	-	-
1180855	0	21	at	IN	-	-	-	-	-	-	-	-
1180855	0	22	7	CD	-	-	-	-	-	-	-	-
1180855	0	23	–	SYM	-	-	-	-	-	-	-	-
1180855	0	24	12	CD	-	-	-	-	-	-	-	-
1180855	0	25	weeks	NNS	-	-	-	-	-	-	-	-
1180855	0	26	of	IN	-	-	-	-	-	-	-	-
1180855	0	27	age	NN	-	-	-	-	-	-	-	(93)
1180855	0	28	in	IN	-	-	-	-	-	-	-	-
1180855	0	29	a	DT	-	-	-	-	-	-	-	-
1180855	0	30	total	NN	-	-	-	-	-	-	-	-
1180855	0	31	of	IN	-	-	-	-	-	-	-	-
1180855	0	32	seven	CD	-	-	-	-	-	-	-	-
1180855	0	33	5	CD	-	-	-	-	-	-	-	-
1180855	0	34	X	SYM	-	-	-	-	-	-	-	-
1180855	0	35	exposure	NN	-	-	-	-	-	-	-	-
1180855	0	36	regimens	NNS	-	-	-	-	-	-	-	-
1180855	0	37	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Development	NN	-	-	-	-	-	-	-	(99
1180855	0	2	of	IN	-	-	-	-	-	-	-	-
1180855	0	3	pulmonary	JJ	-	-	-	-	-	-	-	(71
1180855	0	4	tolerance	NN	-	-	-	-	-	-	-	99)|71)
1180855	0	5	was	VBD	-	-	-	-	-	-	-	-
1180855	0	6	assessed	VBN	-	-	-	-	-	-	-	-
1180855	0	7	24	CD	-	-	-	-	-	-	-	-
1180855	0	8	hours	NNS	-	-	-	-	-	-	-	-
1180855	0	9	after	IN	-	-	-	-	-	-	-	-
1180855	0	10	the	DT	-	-	-	-	-	-	-	-
1180855	0	11	fifth	JJ	-	-	-	-	-	-	-	-
1180855	0	12	exposure	NN	-	-	-	-	-	-	-	-
1180855	0	13	,	,	-	-	-	-	-	-	-	-
1180855	0	14	and	CC	-	-	-	-	-	-	-	-
1180855	0	15	exposure	NN	-	-	-	-	-	-	-	-
1180855	0	16	group	NN	-	-	-	-	-	-	-	-
1180855	0	17	sizes	NNS	-	-	-	-	-	-	-	-
1180855	0	18	ranged	VBD	-	-	-	-	-	-	-	-
1180855	0	19	from	IN	-	-	-	-	-	-	-	-
1180855	0	20	36	CD	-	-	-	-	-	-	-	-
1180855	0	21	to	IN	-	-	-	-	-	-	-	-
1180855	0	22	45	CD	-	-	-	-	-	-	-	-
1180855	0	23	animals	NNS	-	-	-	-	-	-	-	-
1180855	0	24	.	.	-	-	-	-	-	-	-	-

1180855	0	1	All	DT	-	-	-	-	-	-	-	-
1180855	0	2	ZnO	NN	-	-	-	-	-	-	-	(10)
1180855	0	3	exposures	NNS	-	-	-	-	-	-	-	-
1180855	0	4	of	IN	-	-	-	-	-	-	-	-
1180855	0	5	F2	NN	-	-	-	-	-	-	-	(22
1180855	0	6	mice	NNS	-	-	-	-	-	-	-	22)
1180855	0	7	also	RB	-	-	-	-	-	-	-	-
1180855	0	8	contained	VBD	-	-	-	-	-	-	-	-
1180855	0	9	at	RB	-	-	-	-	-	-	-	-
1180855	0	10	least	RBS	-	-	-	-	-	-	-	-
1180855	0	11	two	CD	-	-	-	-	-	-	-	-
1180855	0	12	CBy	NN	-	-	-	-	-	-	-	-
1180855	0	13	,	,	-	-	-	-	-	-	-	-
1180855	0	14	D2	NN	-	-	-	-	-	-	-	-
1180855	0	15	,	,	-	-	-	-	-	-	-	-
1180855	0	16	and	CC	-	-	-	-	-	-	-	-
1180855	0	17	F1	NN	-	-	-	-	-	-	-	-
1180855	0	18	mice	NNS	-	-	-	-	-	-	-	-
1180855	0	19	for	IN	-	-	-	-	-	-	-	-
1180855	0	20	control	NN	-	-	-	-	-	-	-	-
1180855	0	21	purposes	NNS	-	-	-	-	-	-	-	-
1180855	0	22	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Bronchoalveolar	JJ	-	-	-	-	-	-	-	(14
1180855	0	2	lavage	NN	-	-	-	-	-	-	-	14)
1180855	0	3	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	4	BAL	NN	-	-	-	-	-	-	-	-
1180855	0	5	)	-RRB-	-	-	-	-	-	-	-	-

1180855	0	1	Mice	NNS	-	-	-	-	-	-	-	(4)
1180855	0	2	were	VBD	-	-	-	-	-	-	-	-
1180855	0	3	euthanized	VBN	-	-	-	-	-	-	-	-
1180855	0	4	by	IN	-	-	-	-	-	-	-	-
1180855	0	5	intraperitoneal	JJ	-	-	-	-	-	-	-	-
1180855	0	6	injections	NNS	-	-	-	-	-	-	-	-
1180855	0	7	of	IN	-	-	-	-	-	-	-	-
1180855	0	8	ketamine	NN	-	-	-	-	-	-	-	-
1180855	0	9	HCl	NN	-	-	-	-	-	-	-	-
1180855	0	10	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	11	100	CD	-	-	-	-	-	-	-	-
1180855	0	12	mg	NN	-	-	-	-	-	-	-	-
1180855	0	13	/	SYM	-	-	-	-	-	-	-	-
1180855	0	14	kg	NN	-	-	-	-	-	-	-	-
1180855	0	15	,	,	-	-	-	-	-	-	-	-
1180855	0	16	Vetalar	NNP	-	-	-	-	-	-	-	-
1180855	0	17	,	,	-	-	-	-	-	-	-	-
1180855	0	18	Fort	NNP	-	-	-	-	-	-	-	(100|(101
1180855	0	19	Dodge	NNP	-	-	-	-	-	-	-	100)
1180855	0	20	Laboratories	NNP	-	-	-	-	-	-	-	-
1180855	0	21	,	,	-	-	-	-	-	-	-	-
1180855	0	22	Inc.	NNP	-	-	-	-	-	-	-	101)
1180855	0	23	,	,	-	-	-	-	-	-	-	-
1180855	0	24	Fort	NNP	-	-	-	-	-	-	-	(100
1180855	0	25	Dodge	NNP	-	-	-	-	-	-	-	100)
1180855	0	26	,	,	-	-	-	-	-	-	-	-
1180855	0	27	IA	NNP	-	-	-	-	-	-	-	-
1180855	0	28	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	29	and	CC	-	-	-	-	-	-	-	-
1180855	0	30	sodium	NN	-	-	-	-	-	-	-	-
1180855	0	31	pentobarbital	NN	-	-	-	-	-	-	-	-
1180855	0	32	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	33	175	CD	-	-	-	-	-	-	-	-
1180855	0	34	mg	NN	-	-	-	-	-	-	-	-
1180855	0	35	/	SYM	-	-	-	-	-	-	-	-
1180855	0	36	kg	NN	-	-	-	-	-	-	-	-
1180855	0	37	,	,	-	-	-	-	-	-	-	-
1180855	0	38	Sleepaway	NNP	-	-	-	-	-	-	-	-
1180855	0	39	,	,	-	-	-	-	-	-	-	-
1180855	0	40	Fort	NNP	-	-	-	-	-	-	-	(100|(101
1180855	0	41	Dodge	NNP	-	-	-	-	-	-	-	100)
1180855	0	42	Laboratories	NNP	-	-	-	-	-	-	-	-
1180855	0	43	,	,	-	-	-	-	-	-	-	-
1180855	0	44	Inc.	NNP	-	-	-	-	-	-	-	101)
1180855	0	45	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	46	,	,	-	-	-	-	-	-	-	-
1180855	0	47	and	CC	-	-	-	-	-	-	-	-
1180855	0	48	the	DT	-	-	-	-	-	-	-	-
1180855	0	49	posterior	JJ	-	-	-	-	-	-	-	-
1180855	0	50	abdominal	JJ	-	-	-	-	-	-	-	-
1180855	0	51	aorta	NN	-	-	-	-	-	-	-	-
1180855	0	52	was	VBD	-	-	-	-	-	-	-	-
1180855	0	53	severed	VBN	-	-	-	-	-	-	-	-
1180855	0	54	.	.	-	-	-	-	-	-	-	-

1180855	0	1	The	DT	-	-	-	-	-	-	-	-
1180855	0	2	lungs	NNS	-	-	-	-	-	-	-	-
1180855	0	3	of	IN	-	-	-	-	-	-	-	-
1180855	0	4	each	DT	-	-	-	-	-	-	-	-
1180855	0	5	mouse	NN	-	-	-	-	-	-	-	-
1180855	0	6	were	VBD	-	-	-	-	-	-	-	-
1180855	0	7	lavaged	VBN	-	-	-	-	-	-	-	-
1180855	0	8	two	CD	-	-	-	-	-	-	-	-
1180855	0	9	times	NNS	-	-	-	-	-	-	-	-
1180855	0	10	with	IN	-	-	-	-	-	-	-	-
1180855	0	11	1.2	CD	-	-	-	-	-	-	-	-
1180855	0	12	ml	NN	-	-	-	-	-	-	-	-
1180855	0	13	of	IN	-	-	-	-	-	-	-	-
1180855	0	14	Dulbecco	NNP	-	-	-	-	-	-	-	-
1180855	0	15	's	POS	-	-	-	-	-	-	-	-
1180855	0	16	phosphate	NN	-	-	-	-	-	-	-	-
1180855	0	17	buffered	VBN	-	-	-	-	-	-	-	-
1180855	0	18	saline	NN	-	-	-	-	-	-	-	-
1180855	0	19	without	IN	-	-	-	-	-	-	-	-
1180855	0	20	Ca2	NN	-	-	-	-	-	-	-	-
1180855	0	21	+	SYM	-	-	-	-	-	-	-	-
1180855	0	22	or	CC	-	-	-	-	-	-	-	-
1180855	0	23	Mg2	NN	-	-	-	-	-	-	-	-
1180855	0	24	+	SYM	-	-	-	-	-	-	-	-
1180855	0	25	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	26	pH	NN	-	-	-	-	-	-	-	-
1180855	0	27	7.2	CD	-	-	-	-	-	-	-	-
1180855	0	28	–	SYM	-	-	-	-	-	-	-	-
1180855	0	29	7.4	CD	-	-	-	-	-	-	-	-
1180855	0	30	,	,	-	-	-	-	-	-	-	-
1180855	0	31	37	CD	-	-	-	-	-	-	-	-
1180855	0	32	°C	NN	-	-	-	-	-	-	-	-
1180855	0	33	,	,	-	-	-	-	-	-	-	-
1180855	0	34	Invitrogen	NNP	-	-	-	-	-	-	-	(102)
1180855	0	35	,	,	-	-	-	-	-	-	-	-
1180855	0	36	Carlsbad	NNP	-	-	-	-	-	-	-	-
1180855	0	37	,	,	-	-	-	-	-	-	-	-
1180855	0	38	CA	NNP	-	-	-	-	-	-	-	-
1180855	0	39	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	40	.	.	-	-	-	-	-	-	-	-

1180855	0	1	The	DT	-	-	-	-	-	-	-	-
1180855	0	2	collected	VBN	-	-	-	-	-	-	-	-
1180855	0	3	BAL	NN	-	-	-	-	-	-	-	-
1180855	0	4	was	VBD	-	-	-	-	-	-	-	-
1180855	0	5	immediately	RB	-	-	-	-	-	-	-	-
1180855	0	6	placed	VBN	-	-	-	-	-	-	-	-
1180855	0	7	on	IN	-	-	-	-	-	-	-	-
1180855	0	8	ice	NN	-	-	-	-	-	-	-	-
1180855	0	9	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	10	4	CD	-	-	-	-	-	-	-	(103
1180855	0	11	°C	NN	-	-	-	-	-	-	-	103)
1180855	0	12	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	13	following	VBG	-	-	-	-	-	-	-	-
1180855	0	14	recovery	NN	-	-	-	-	-	-	-	-
1180855	0	15	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Measurement	NN	-	-	-	-	-	-	-	-
1180855	0	2	of	IN	-	-	-	-	-	-	-	-
1180855	0	3	BAL	NN	-	-	-	-	-	-	-	(23|(14)
1180855	0	4	protein	NN	-	-	-	-	-	-	-	23)
1180855	0	5	,	,	-	-	-	-	-	-	-	-
1180855	0	6	total	JJ	-	-	-	-	-	-	-	-
1180855	0	7	cell	NN	-	-	-	-	-	-	-	(104)
1180855	0	8	counts	NNS	-	-	-	-	-	-	-	-
1180855	0	9	,	,	-	-	-	-	-	-	-	-
1180855	0	10	and	CC	-	-	-	-	-	-	-	-
1180855	0	11	differential	JJ	-	-	-	-	-	-	-	-
1180855	0	12	cell	NN	-	-	-	-	-	-	-	(104)
1180855	0	13	counts	NNS	-	-	-	-	-	-	-	-
1180855	0	14	were	VBD	-	-	-	-	-	-	-	-
1180855	0	15	performed	VBN	-	-	-	-	-	-	-	-
1180855	0	16	as	IN	-	-	-	-	-	-	-	-
1180855	0	17	previously	RB	-	-	-	-	-	-	-	-
1180855	0	18	described	VBN	-	-	-	-	-	-	-	-
1180855	0	19	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	20	8	CD	-	-	-	-	-	-	-	-
1180855	0	21	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	22	.	.	-	-	-	-	-	-	-	-

1180855	0	1	DNA	NN	-	-	-	-	-	-	-	-
1180855	0	2	isolation	NN	-	-	-	-	-	-	-	-
1180855	0	3	and	CC	-	-	-	-	-	-	-	-
1180855	0	4	genotyping	NN	-	-	-	-	-	-	-	-

1180855	0	1	Genomic	JJ	-	-	-	-	-	-	-	(105
1180855	0	2	DNA	NN	-	-	-	-	-	-	-	105)
1180855	0	3	was	VBD	-	-	-	-	-	-	-	-
1180855	0	4	isolated	VBN	-	-	-	-	-	-	-	-
1180855	0	5	from	IN	-	-	-	-	-	-	-	-
1180855	0	6	kidney	NN	-	-	-	-	-	-	-	-
1180855	0	7	tissue	NN	-	-	-	-	-	-	-	-
1180855	0	8	of	IN	-	-	-	-	-	-	-	-
1180855	0	9	each	DT	-	-	-	-	-	-	-	-
1180855	0	10	phenotyped	VBN	-	-	-	-	-	-	-	-
1180855	0	11	F2	NN	-	-	-	-	-	-	-	-
1180855	0	12	animal	NN	-	-	-	-	-	-	-	-
1180855	0	13	and	CC	-	-	-	-	-	-	-	-
1180855	0	14	for	IN	-	-	-	-	-	-	-	-
1180855	0	15	CBy	NN	-	-	-	-	-	-	-	(16)
1180855	0	16	,	,	-	-	-	-	-	-	-	-
1180855	0	17	D2	NN	-	-	-	-	-	-	-	-
1180855	0	18	,	,	-	-	-	-	-	-	-	-
1180855	0	19	and	CC	-	-	-	-	-	-	-	-
1180855	0	20	F1	NN	-	-	-	-	-	-	-	(92)
1180855	0	21	controls	NNS	-	-	-	-	-	-	-	-
1180855	0	22	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	23	Wizard	NNP	-	-	-	-	-	-	-	-
1180855	0	24	Genomic	NNP	-	-	-	-	-	-	-	-
1180855	0	25	DNA	NNP	-	-	-	-	-	-	-	-
1180855	0	26	Purification	NNP	-	-	-	-	-	-	-	-
1180855	0	27	Kit	NNP	-	-	-	-	-	-	-	-
1180855	0	28	,	,	-	-	-	-	-	-	-	-
1180855	0	29	Promega	NNP	-	-	-	-	-	-	-	(106)
1180855	0	30	,	,	-	-	-	-	-	-	-	-
1180855	0	31	Madison	NNP	-	-	-	-	-	-	-	-
1180855	0	32	,	,	-	-	-	-	-	-	-	-
1180855	0	33	WI	NNP	-	-	-	-	-	-	-	-
1180855	0	34	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	35	.	.	-	-	-	-	-	-	-	-

1180855	0	1	DNA	NN	-	-	-	-	-	-	-	-
1180855	0	2	concentration	NN	-	-	-	-	-	-	-	-
1180855	0	3	was	VBD	-	-	-	-	-	-	-	-
1180855	0	4	determined	VBN	-	-	-	-	-	-	-	-
1180855	0	5	using	VBG	-	-	-	-	-	-	-	-
1180855	0	6	a	DT	-	-	-	-	-	-	-	-
1180855	0	7	Beckman	NNP	-	-	-	-	-	-	-	-
1180855	0	8	DU	NN	-	-	-	-	-	-	-	-
1180855	0	9	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	10	650	CD	-	-	-	-	-	-	-	-
1180855	0	11	spectrophotometer	NN	-	-	-	-	-	-	-	-
1180855	0	12	,	,	-	-	-	-	-	-	-	-
1180855	0	13	and	CC	-	-	-	-	-	-	-	-
1180855	0	14	each	DT	-	-	-	-	-	-	-	-
1180855	0	15	sample	NN	-	-	-	-	-	-	-	-
1180855	0	16	was	VBD	-	-	-	-	-	-	-	-
1180855	0	17	diluted	VBN	-	-	-	-	-	-	-	-
1180855	0	18	to	IN	-	-	-	-	-	-	-	-
1180855	0	19	10	CD	-	-	-	-	-	-	-	-
1180855	0	20	ng	NN	-	-	-	-	-	-	-	-
1180855	0	21	/	SYM	-	-	-	-	-	-	-	-
1180855	0	22	μl	NN	-	-	-	-	-	-	-	-
1180855	0	23	for	IN	-	-	-	-	-	-	-	-
1180855	0	24	genotype	NN	-	-	-	-	-	-	-	(107)
1180855	0	25	analysis	NN	-	-	-	-	-	-	-	-
1180855	0	26	.	.	-	-	-	-	-	-	-	-

1180855	0	1	PCRs	NNS	-	-	-	-	-	-	-	(108)
1180855	0	2	were	VBD	-	-	-	-	-	-	-	-
1180855	0	3	performed	VBN	-	-	-	-	-	-	-	-
1180855	0	4	to	TO	-	-	-	-	-	-	-	-
1180855	0	5	genotype	VB	-	-	-	-	-	-	-	-
1180855	0	6	F2	NN	-	-	-	-	-	-	-	(22
1180855	0	7	offspring	NN	-	-	-	-	-	-	-	22)
1180855	0	8	for	IN	-	-	-	-	-	-	-	-
1180855	0	9	SSLPs	NNS	-	-	-	-	-	-	-	-
1180855	0	10	located	VBN	-	-	-	-	-	-	-	-
1180855	0	11	throughout	IN	-	-	-	-	-	-	-	-
1180855	0	12	the	DT	-	-	-	-	-	-	-	-
1180855	0	13	mouse	NN	-	-	-	-	-	-	-	(4)
1180855	0	14	genome	NN	-	-	-	-	-	-	-	-
1180855	0	15	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Eighty	CD	-	-	-	-	-	-	-	(109
1180855	0	2	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	3	six	CD	-	-	-	-	-	-	-	-
1180855	0	4	unlabeled	JJ	-	-	-	-	-	-	-	-
1180855	0	5	primer	NN	-	-	-	-	-	-	-	-
1180855	0	6	pairs	NNS	-	-	-	-	-	-	-	-
1180855	0	7	for	IN	-	-	-	-	-	-	-	-
1180855	0	8	SSLPs	NNS	-	-	-	-	-	-	-	-
1180855	0	9	that	WDT	-	-	-	-	-	-	-	-
1180855	0	10	differed	VBD	-	-	-	-	-	-	-	-
1180855	0	11	in	IN	-	-	-	-	-	-	-	-
1180855	0	12	length	NN	-	-	-	-	-	-	-	-
1180855	0	13	by	IN	-	-	-	-	-	-	-	-
1180855	0	14	at	RB	-	-	-	-	-	-	-	-
1180855	0	15	least	RBS	-	-	-	-	-	-	-	-
1180855	0	16	5	CD	-	-	-	-	-	-	-	-
1180855	0	17	%	NN	-	-	-	-	-	-	-	-
1180855	0	18	between	IN	-	-	-	-	-	-	-	-
1180855	0	19	the	DT	-	-	-	-	-	-	-	(111|(112a|(110b)
1180855	0	20	CBy	NN	-	-	-	-	-	-	-	112a)
1180855	0	21	and	CC	-	-	-	-	-	-	-	-
1180855	0	22	D2	NN	-	-	-	-	-	-	-	(110b
1180855	0	23	progenitor	NN	-	-	-	-	-	-	-	(112a
1180855	0	24	strains	NNS	-	-	-	-	-	-	-	112a)|111)|110b)|109)
1180855	0	25	were	VBD	-	-	-	-	-	-	-	-
1180855	0	26	purchased	VBN	-	-	-	-	-	-	-	-
1180855	0	27	from	IN	-	-	-	-	-	-	-	-
1180855	0	28	Research	NNP	-	-	-	-	-	-	-	(113
1180855	0	29	Genetics	NNP	-	-	-	-	-	-	-	113)
1180855	0	30	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	31	ResGen	NNP	-	-	-	-	-	-	-	-
1180855	0	32	/	HYPH	-	-	-	-	-	-	-	-
1180855	0	33	Invitrogen	NNP	-	-	-	-	-	-	-	-
1180855	0	34	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	35	.	.	-	-	-	-	-	-	-	-

1180855	0	1	PCR	NN	-	-	-	-	-	-	-	(108)
1180855	0	2	was	VBD	-	-	-	-	-	-	-	-
1180855	0	3	performed	VBN	-	-	-	-	-	-	-	-
1180855	0	4	in	IN	-	-	-	-	-	-	-	-
1180855	0	5	20	CD	-	-	-	-	-	-	-	-
1180855	0	6	μl	NN	-	-	-	-	-	-	-	-
1180855	0	7	reaction	NN	-	-	-	-	-	-	-	-
1180855	0	8	volumes	NNS	-	-	-	-	-	-	-	-
1180855	0	9	in	IN	-	-	-	-	-	-	-	-
1180855	0	10	96	CD	-	-	-	-	-	-	-	-
1180855	0	11	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	12	well	NN	-	-	-	-	-	-	-	-
1180855	0	13	low	JJ	-	-	-	-	-	-	-	-
1180855	0	14	profile	NN	-	-	-	-	-	-	-	-
1180855	0	15	plates	NNS	-	-	-	-	-	-	-	-
1180855	0	16	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	17	Fisherbrand	NNP	-	-	-	-	-	-	-	-
1180855	0	18	,	,	-	-	-	-	-	-	-	-
1180855	0	19	Fisher	NNP	-	-	-	-	-	-	-	-
1180855	0	20	Scientific	NNP	-	-	-	-	-	-	-	-
1180855	0	21	,	,	-	-	-	-	-	-	-	-
1180855	0	22	Fairlawn	NNP	-	-	-	-	-	-	-	-
1180855	0	23	,	,	-	-	-	-	-	-	-	-
1180855	0	24	NJ	NNP	-	-	-	-	-	-	-	-
1180855	0	25	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	26	using	VBG	-	-	-	-	-	-	-	-
1180855	0	27	a	DT	-	-	-	-	-	-	-	-
1180855	0	28	PTC	NN	-	-	-	-	-	-	-	-
1180855	0	29	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	30	100	CD	-	-	-	-	-	-	-	-
1180855	0	31	thermal	JJ	-	-	-	-	-	-	-	-
1180855	0	32	cycler	NN	-	-	-	-	-	-	-	-
1180855	0	33	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	34	MJ	NNP	-	-	-	-	-	-	-	-
1180855	0	35	Research	NNP	-	-	-	-	-	-	-	-
1180855	0	36	,	,	-	-	-	-	-	-	-	-
1180855	0	37	Watertown	NNP	-	-	-	-	-	-	-	-
1180855	0	38	,	,	-	-	-	-	-	-	-	-
1180855	0	39	MA	NNP	-	-	-	-	-	-	-	-
1180855	0	40	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	41	.	.	-	-	-	-	-	-	-	-

1180855	0	1	The	DT	-	-	-	-	-	-	-	(114
1180855	0	2	final	JJ	-	-	-	-	-	-	-	-
1180855	0	3	concentration	NN	-	-	-	-	-	-	-	-
1180855	0	4	for	IN	-	-	-	-	-	-	-	-
1180855	0	5	each	DT	-	-	-	-	-	-	-	-
1180855	0	6	reaction	NN	-	-	-	-	-	-	-	114)
1180855	0	7	was	VBD	-	-	-	-	-	-	-	-
1180855	0	8	:	:	-	-	-	-	-	-	-	-
1180855	0	9	10	CD	-	-	-	-	-	-	-	-
1180855	0	10	mM	NN	-	-	-	-	-	-	-	-
1180855	0	11	Tris	NN	-	-	-	-	-	-	-	-
1180855	0	12	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	13	HCl	NN	-	-	-	-	-	-	-	-
1180855	0	14	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	15	pH	NN	-	-	-	-	-	-	-	-
1180855	0	16	8.3	CD	-	-	-	-	-	-	-	-
1180855	0	17	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	18	,	,	-	-	-	-	-	-	-	-
1180855	0	19	50	CD	-	-	-	-	-	-	-	-
1180855	0	20	mM	NN	-	-	-	-	-	-	-	-
1180855	0	21	KCL	NN	-	-	-	-	-	-	-	-
1180855	0	22	,	,	-	-	-	-	-	-	-	-
1180855	0	23	2.5	CD	-	-	-	-	-	-	-	-
1180855	0	24	mM	NN	-	-	-	-	-	-	-	-
1180855	0	25	MgCl2	NN	-	-	-	-	-	-	-	-
1180855	0	26	,	,	-	-	-	-	-	-	-	-
1180855	0	27	0.2	CD	-	-	-	-	-	-	-	-
1180855	0	28	mM	NN	-	-	-	-	-	-	-	-
1180855	0	29	of	IN	-	-	-	-	-	-	-	-
1180855	0	30	each	DT	-	-	-	-	-	-	-	-
1180855	0	31	deoxynucleotide	NN	-	-	-	-	-	-	-	-
1180855	0	32	triphosphate	NN	-	-	-	-	-	-	-	-
1180855	0	33	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	34	Promega	NNP	-	-	-	-	-	-	-	(106)
1180855	0	35	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	36	,	,	-	-	-	-	-	-	-	-
1180855	0	37	1.1	CD	-	-	-	-	-	-	-	-
1180855	0	38	X	SYM	-	-	-	-	-	-	-	-
1180855	0	39	Rediload	NNP	-	-	-	-	-	-	-	-
1180855	0	40	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	41	ResGen	NNP	-	-	-	-	-	-	-	(113
1180855	0	42	/	HYPH	-	-	-	-	-	-	-	-
1180855	0	43	Invitrogen	NNP	-	-	-	-	-	-	-	113)
1180855	0	44	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	45	,	,	-	-	-	-	-	-	-	-
1180855	0	46	and	CC	-	-	-	-	-	-	-	-
1180855	0	47	0.132	CD	-	-	-	-	-	-	-	-
1180855	0	48	μM	NN	-	-	-	-	-	-	-	-
1180855	0	49	of	IN	-	-	-	-	-	-	-	-
1180855	0	50	each	DT	-	-	-	-	-	-	-	-
1180855	0	51	SSLP	NN	-	-	-	-	-	-	-	(115)
1180855	0	52	primer	NN	-	-	-	-	-	-	-	-
1180855	0	53	pair	NN	-	-	-	-	-	-	-	-
1180855	0	54	.	.	-	-	-	-	-	-	-	-

1180855	0	1	This	DT	-	-	-	-	-	-	-	(114
1180855	0	2	reaction	NN	-	-	-	-	-	-	-	-
1180855	0	3	mixture	NN	-	-	-	-	-	-	-	114)
1180855	0	4	was	VBD	-	-	-	-	-	-	-	-
1180855	0	5	added	VBN	-	-	-	-	-	-	-	-
1180855	0	6	to	IN	-	-	-	-	-	-	-	-
1180855	0	7	100	CD	-	-	-	-	-	-	-	-
1180855	0	8	ng	NN	-	-	-	-	-	-	-	-
1180855	0	9	of	IN	-	-	-	-	-	-	-	-
1180855	0	10	genomic	JJ	-	-	-	-	-	-	-	(105
1180855	0	11	DNA	NN	-	-	-	-	-	-	-	105)
1180855	0	12	and	CC	-	-	-	-	-	-	-	-
1180855	0	13	0.45	CD	-	-	-	-	-	-	-	-
1180855	0	14	U	NN	-	-	-	-	-	-	-	-
1180855	0	15	of	IN	-	-	-	-	-	-	-	-
1180855	0	16	Taq	NN	-	-	-	-	-	-	-	-
1180855	0	17	DNA	NN	-	-	-	-	-	-	-	-
1180855	0	18	polymerase	NN	-	-	-	-	-	-	-	-
1180855	0	19	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	20	Roche	NNP	-	-	-	-	-	-	-	-
1180855	0	21	Applied	NNP	-	-	-	-	-	-	-	-
1180855	0	22	Science	NNP	-	-	-	-	-	-	-	-
1180855	0	23	,	,	-	-	-	-	-	-	-	-
1180855	0	24	Indianapolis	NNP	-	-	-	-	-	-	-	-
1180855	0	25	,	,	-	-	-	-	-	-	-	-
1180855	0	26	IN	NNP	-	-	-	-	-	-	-	-
1180855	0	27	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	28	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Final	JJ	-	-	-	-	-	-	-	-
1180855	0	2	reaction	NN	-	-	-	-	-	-	-	-
1180855	0	3	mixtures	NNS	-	-	-	-	-	-	-	-
1180855	0	4	were	VBD	-	-	-	-	-	-	-	-
1180855	0	5	initially	RB	-	-	-	-	-	-	-	-
1180855	0	6	denatured	VBN	-	-	-	-	-	-	-	-
1180855	0	7	at	IN	-	-	-	-	-	-	-	-
1180855	0	8	94	CD	-	-	-	-	-	-	-	(116
1180855	0	9	°C	NN	-	-	-	-	-	-	-	116)
1180855	0	10	for	IN	-	-	-	-	-	-	-	-
1180855	0	11	3	CD	-	-	-	-	-	-	-	-
1180855	0	12	min	NN	-	-	-	-	-	-	-	-
1180855	0	13	,	,	-	-	-	-	-	-	-	-
1180855	0	14	followed	VBN	-	-	-	-	-	-	-	-
1180855	0	15	by	IN	-	-	-	-	-	-	-	-
1180855	0	16	36	CD	-	-	-	-	-	-	-	-
1180855	0	17	amplification	NN	-	-	-	-	-	-	-	-
1180855	0	18	cycles	NNS	-	-	-	-	-	-	-	-
1180855	0	19	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	20	94	CD	-	-	-	-	-	-	-	(116
1180855	0	21	°C	NN	-	-	-	-	-	-	-	116)
1180855	0	22	for	IN	-	-	-	-	-	-	-	-
1180855	0	23	30	CD	-	-	-	-	-	-	-	(117
1180855	0	24	seconds	NNS	-	-	-	-	-	-	-	117)
1180855	0	25	,	,	-	-	-	-	-	-	-	-
1180855	0	26	57	CD	-	-	-	-	-	-	-	-
1180855	0	27	°C	NN	-	-	-	-	-	-	-	-
1180855	0	28	for	IN	-	-	-	-	-	-	-	-
1180855	0	29	45	CD	-	-	-	-	-	-	-	-
1180855	0	30	seconds	NNS	-	-	-	-	-	-	-	-
1180855	0	31	,	,	-	-	-	-	-	-	-	-
1180855	0	32	and	CC	-	-	-	-	-	-	-	-
1180855	0	33	72	CD	-	-	-	-	-	-	-	(118
1180855	0	34	°C	NN	-	-	-	-	-	-	-	118)
1180855	0	35	for	IN	-	-	-	-	-	-	-	-
1180855	0	36	30	CD	-	-	-	-	-	-	-	(117
1180855	0	37	seconds	NNS	-	-	-	-	-	-	-	117)
1180855	0	38	+	SYM	-	-	-	-	-	-	-	-
1180855	0	39	1	CD	-	-	-	-	-	-	-	-
1180855	0	40	second	NN	-	-	-	-	-	-	-	-
1180855	0	41	/	SYM	-	-	-	-	-	-	-	-
1180855	0	42	cycle	NN	-	-	-	-	-	-	-	-
1180855	0	43	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	44	.	.	-	-	-	-	-	-	-	-

1180855	0	1	A	DT	-	-	-	-	-	-	-	-
1180855	0	2	final	JJ	-	-	-	-	-	-	-	-
1180855	0	3	extension	NN	-	-	-	-	-	-	-	-
1180855	0	4	step	NN	-	-	-	-	-	-	-	-
1180855	0	5	at	IN	-	-	-	-	-	-	-	-
1180855	0	6	72	CD	-	-	-	-	-	-	-	(118
1180855	0	7	°C	NN	-	-	-	-	-	-	-	118)
1180855	0	8	for	IN	-	-	-	-	-	-	-	-
1180855	0	9	7	CD	-	-	-	-	-	-	-	-
1180855	0	10	min	NN	-	-	-	-	-	-	-	-
1180855	0	11	was	VBD	-	-	-	-	-	-	-	-
1180855	0	12	followed	VBN	-	-	-	-	-	-	-	-
1180855	0	13	by	IN	-	-	-	-	-	-	-	-
1180855	0	14	refrigeration	NN	-	-	-	-	-	-	-	-
1180855	0	15	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	16	4	CD	-	-	-	-	-	-	-	(103
1180855	0	17	°C	NN	-	-	-	-	-	-	-	103)
1180855	0	18	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	19	.	.	-	-	-	-	-	-	-	-

1180855	0	1	PCR	NN	-	-	-	-	-	-	-	(108)
1180855	0	2	products	NNS	-	-	-	-	-	-	-	-
1180855	0	3	were	VBD	-	-	-	-	-	-	-	-
1180855	0	4	differentiated	VBN	-	-	-	-	-	-	-	-
1180855	0	5	on	IN	-	-	-	-	-	-	-	-
1180855	0	6	3	CD	-	-	-	-	-	-	-	-
1180855	0	7	%	NN	-	-	-	-	-	-	-	-
1180855	0	8	agarose	NN	-	-	-	-	-	-	-	-
1180855	0	9	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	10	Invitrogen	NNP	-	-	-	-	-	-	-	(102)
1180855	0	11	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	12	gels	NNS	-	-	-	-	-	-	-	-
1180855	0	13	and	CC	-	-	-	-	-	-	-	-
1180855	0	14	all	DT	-	-	-	-	-	-	-	-
1180855	0	15	samples	NNS	-	-	-	-	-	-	-	-
1180855	0	16	were	VBD	-	-	-	-	-	-	-	-
1180855	0	17	visualized	VBN	-	-	-	-	-	-	-	-
1180855	0	18	by	IN	-	-	-	-	-	-	-	-
1180855	0	19	ethidium	NN	-	-	-	-	-	-	-	-
1180855	0	20	bromide	NN	-	-	-	-	-	-	-	-
1180855	0	21	staining	NN	-	-	-	-	-	-	-	-
1180855	0	22	using	VBG	-	-	-	-	-	-	-	-
1180855	0	23	a	DT	-	-	-	-	-	-	-	-
1180855	0	24	ChemiImager	NNP	-	-	-	-	-	-	-	-
1180855	0	25	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	26	4400	CD	-	-	-	-	-	-	-	-
1180855	0	27	low	JJ	-	-	-	-	-	-	-	-
1180855	0	28	light	NN	-	-	-	-	-	-	-	-
1180855	0	29	imaging	NN	-	-	-	-	-	-	-	-
1180855	0	30	system	NN	-	-	-	-	-	-	-	-
1180855	0	31	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	32	Imgen	NNP	-	-	-	-	-	-	-	-
1180855	0	33	Technologies	NNP	-	-	-	-	-	-	-	-
1180855	0	34	,	,	-	-	-	-	-	-	-	-
1180855	0	35	Alexandria	NNP	-	-	-	-	-	-	-	-
1180855	0	36	,	,	-	-	-	-	-	-	-	-
1180855	0	37	VA	NNP	-	-	-	-	-	-	-	-
1180855	0	38	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	39	and	CC	-	-	-	-	-	-	-	-
1180855	0	40	called	VBN	-	-	-	-	-	-	-	-
1180855	0	41	by	IN	-	-	-	-	-	-	-	-
1180855	0	42	a	DT	-	-	-	-	-	-	-	-
1180855	0	43	single	JJ	-	-	-	-	-	-	-	-
1180855	0	44	investigator	NN	-	-	-	-	-	-	-	-
1180855	0	45	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Any	DT	-	-	-	-	-	-	-	-
1180855	0	2	questionable	JJ	-	-	-	-	-	-	-	-
1180855	0	3	calls	NNS	-	-	-	-	-	-	-	-
1180855	0	4	in	IN	-	-	-	-	-	-	-	-
1180855	0	5	reading	VBG	-	-	-	-	-	-	-	-
1180855	0	6	the	DT	-	-	-	-	-	-	-	(107
1180855	0	7	genotype	NN	-	-	-	-	-	-	-	107)
1180855	0	8	from	IN	-	-	-	-	-	-	-	-
1180855	0	9	the	DT	-	-	-	-	-	-	-	(119
1180855	0	10	image	NN	-	-	-	-	-	-	-	119)
1180855	0	11	were	VBD	-	-	-	-	-	-	-	-
1180855	0	12	reviewed	VBN	-	-	-	-	-	-	-	-
1180855	0	13	by	IN	-	-	-	-	-	-	-	-
1180855	0	14	a	DT	-	-	-	-	-	-	-	-
1180855	0	15	second	JJ	-	-	-	-	-	-	-	-
1180855	0	16	investigator	NN	-	-	-	-	-	-	-	-
1180855	0	17	and	CC	-	-	-	-	-	-	-	-
1180855	0	18	if	IN	-	-	-	-	-	-	-	-
1180855	0	19	not	RB	-	-	-	-	-	-	-	-
1180855	0	20	resolved	VBN	-	-	-	-	-	-	-	-
1180855	0	21	,	,	-	-	-	-	-	-	-	-
1180855	0	22	that	DT	-	-	-	-	-	-	-	(119
1180855	0	23	sample	NN	-	-	-	-	-	-	-	119)
1180855	0	24	was	VBD	-	-	-	-	-	-	-	-
1180855	0	25	rerun	VBN	-	-	-	-	-	-	-	-
1180855	0	26	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Estimation	NN	-	-	-	-	-	-	-	-
1180855	0	2	of	IN	-	-	-	-	-	-	-	-
1180855	0	3	loci	NNS	-	-	-	-	-	-	-	(120)

1180855	0	1	The	DT	-	-	-	-	-	-	-	(121
1180855	0	2	number	NN	-	-	-	-	-	-	-	-
1180855	0	3	of	IN	-	-	-	-	-	-	-	-
1180855	0	4	independently	RB	-	-	-	-	-	-	-	(120
1180855	0	5	segregating	VBG	-	-	-	-	-	-	-	-
1180855	0	6	loci	NNS	-	-	-	-	-	-	-	121)|120)
1180855	0	7	was	VBD	-	-	-	-	-	-	-	-
1180855	0	8	calculated	VBN	-	-	-	-	-	-	-	-
1180855	0	9	using	VBG	-	-	-	-	-	-	-	-
1180855	0	10	the	DT	-	-	-	-	-	-	-	(122
1180855	0	11	following	VBG	-	-	-	-	-	-	-	-
1180855	0	12	formula	NN	-	-	-	-	-	-	-	-
1180855	0	13	by	IN	-	-	-	-	-	-	-	-
1180855	0	14	Wright	NNP	-	-	-	-	-	-	-	(123)|122)
1180855	0	15	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	16	17	CD	-	-	-	-	-	-	-	-
1180855	0	17	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	18	:	:	-	-	-	-	-	-	-	-
1180855	0	19	n	NN	-	-	-	-	-	-	-	(98)
1180855	0	20	=	SYM	-	-	-	-	-	-	-	-
1180855	0	21	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	22	P2	NN	-	-	-	-	-	-	-	-
1180855	0	23	-	SYM	-	-	-	-	-	-	-	-
1180855	0	24	F1	NN	-	-	-	-	-	-	-	-
1180855	0	25	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	26	2	CD	-	-	-	-	-	-	-	-
1180855	0	27	/	SYM	-	-	-	-	-	-	-	-
1180855	0	28	4	CD	-	-	-	-	-	-	-	-
1180855	0	29	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	30	|	SYM	-	-	-	-	-	-	-	-
1180855	0	31	σ2F2	NN	-	-	-	-	-	-	-	(124)
1180855	0	32	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	33	σ2F1	NN	-	-	-	-	-	-	-	(125)
1180855	0	34	|	SYM	-	-	-	-	-	-	-	-
1180855	0	35	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	36	,	,	-	-	-	-	-	-	-	-
1180855	0	37	where	WRB	-	-	-	-	-	-	-	-
1180855	0	38	n	NN	-	-	-	-	-	-	-	(98)
1180855	0	39	is	VBZ	-	-	-	-	-	-	-	-
1180855	0	40	an	DT	-	-	-	-	-	-	-	-
1180855	0	41	estimate	NN	-	-	-	-	-	-	-	-
1180855	0	42	of	IN	-	-	-	-	-	-	-	-
1180855	0	43	the	DT	-	-	-	-	-	-	-	(121
1180855	0	44	number	NN	-	-	-	-	-	-	-	-
1180855	0	45	of	IN	-	-	-	-	-	-	-	-
1180855	0	46	independent	JJ	-	-	-	-	-	-	-	(120
1180855	0	47	loci	NNS	-	-	-	-	-	-	-	121)|120)
1180855	0	48	;	:	-	-	-	-	-	-	-	-
1180855	0	49	P2	NN	-	-	-	-	-	-	-	-
1180855	0	50	and	CC	-	-	-	-	-	-	-	-
1180855	0	51	F1	NN	-	-	-	-	-	-	-	(92)
1180855	0	52	are	VBP	-	-	-	-	-	-	-	-
1180855	0	53	the	DT	-	-	-	-	-	-	-	-
1180855	0	54	mean	NN	-	-	-	-	-	-	-	(126
1180855	0	55	BAL	NN	-	-	-	-	-	-	-	(23
1180855	0	56	protein	NN	-	-	-	-	-	-	-	23)|126)
1180855	0	57	responses	NNS	-	-	-	-	-	-	-	-
1180855	0	58	following	VBG	-	-	-	-	-	-	-	-
1180855	0	59	5	CD	-	-	-	-	-	-	-	(80
1180855	0	60	X	SYM	-	-	-	-	-	-	-	-
1180855	0	61	ZnO	NN	-	-	-	-	-	-	-	(10)
1180855	0	62	exposure	NN	-	-	-	-	-	-	-	80)
1180855	0	63	in	IN	-	-	-	-	-	-	-	-
1180855	0	64	CBy	NN	-	-	-	-	-	-	-	(16)|(90c)
1180855	0	65	and	CC	-	-	-	-	-	-	-	-
1180855	0	66	CByD2F1	NN	-	-	-	-	-	-	-	(91|(92)
1180855	0	67	mice	NNS	-	-	-	-	-	-	-	(90c)|91)
1180855	0	68	,	,	-	-	-	-	-	-	-	-
1180855	0	69	respectively	RB	-	-	-	-	-	-	-	-
1180855	0	70	;	:	-	-	-	-	-	-	-	-
1180855	0	71	σ2F2	NN	-	-	-	-	-	-	-	(124)
1180855	0	72	and	CC	-	-	-	-	-	-	-	-
1180855	0	73	σ2F1	NN	-	-	-	-	-	-	-	(125)
1180855	0	74	are	VBP	-	-	-	-	-	-	-	-
1180855	0	75	the	DT	-	-	-	-	-	-	-	-
1180855	0	76	computed	VBN	-	-	-	-	-	-	-	-
1180855	0	77	variances	NNS	-	-	-	-	-	-	-	-
1180855	0	78	of	IN	-	-	-	-	-	-	-	-
1180855	0	79	the	DT	-	-	-	-	-	-	-	(22a
1180855	0	80	F2	NN	-	-	-	-	-	-	-	22a)
1180855	0	81	and	CC	-	-	-	-	-	-	-	-
1180855	0	82	CByD2F1	NN	-	-	-	-	-	-	-	(91|(92)
1180855	0	83	mice	NNS	-	-	-	-	-	-	-	(22a)|91)
1180855	0	84	,	,	-	-	-	-	-	-	-	-
1180855	0	85	respectively	RB	-	-	-	-	-	-	-	-
1180855	0	86	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Linkage	NN	-	-	-	-	-	-	-	(97
1180855	0	2	analyses	NNS	-	-	-	-	-	-	-	97)

1180855	0	1	A	DT	-	-	-	-	-	-	-	(127
1180855	0	2	genome	NN	-	-	-	-	-	-	-	-
1180855	0	3	scan	NN	-	-	-	-	-	-	-	127)
1180855	0	4	was	VBD	-	-	-	-	-	-	-	-
1180855	0	5	performed	VBN	-	-	-	-	-	-	-	-
1180855	0	6	to	TO	-	-	-	-	-	-	-	-
1180855	0	7	identify	VB	-	-	-	-	-	-	-	-
1180855	0	8	associations	NNS	-	-	-	-	-	-	-	-
1180855	0	9	between	IN	-	-	-	-	-	-	-	-
1180855	0	10	genotypes	NNS	-	-	-	-	-	-	-	(107)
1180855	0	11	and	CC	-	-	-	-	-	-	-	-
1180855	0	12	the	DT	-	-	-	-	-	-	-	(15
1180855	0	13	BAL	NN	-	-	-	-	-	-	-	(23
1180855	0	14	protein	NN	-	-	-	-	-	-	-	23)
1180855	0	15	phenotype	NN	-	-	-	-	-	-	-	15)
1180855	0	16	using	VBG	-	-	-	-	-	-	-	-
1180855	0	17	a	DT	-	-	-	-	-	-	-	(128
1180855	0	18	CByD2F2	NN	-	-	-	-	-	-	-	(22
1180855	0	19	mouse	NN	-	-	-	-	-	-	-	22)
1180855	0	20	cohort	NN	-	-	-	-	-	-	-	128)
1180855	0	21	.	.	-	-	-	-	-	-	-	-

1180855	0	1	All	DT	-	-	-	-	-	-	-	-
1180855	0	2	phenotypic	JJ	-	-	-	-	-	-	-	-
1180855	0	3	data	NNS	-	-	-	-	-	-	-	-
1180855	0	4	were	VBD	-	-	-	-	-	-	-	-
1180855	0	5	natural	JJ	-	-	-	-	-	-	-	-
1180855	0	6	log	NN	-	-	-	-	-	-	-	-
1180855	0	7	normalized	VBN	-	-	-	-	-	-	-	-
1180855	0	8	to	TO	-	-	-	-	-	-	-	-
1180855	0	9	generate	VB	-	-	-	-	-	-	-	-
1180855	0	10	a	DT	-	-	-	-	-	-	-	-
1180855	0	11	normal	JJ	-	-	-	-	-	-	-	-
1180855	0	12	distribution	NN	-	-	-	-	-	-	-	-
1180855	0	13	to	TO	-	-	-	-	-	-	-	-
1180855	0	14	meet	VB	-	-	-	-	-	-	-	-
1180855	0	15	normality	NN	-	-	-	-	-	-	-	-
1180855	0	16	assumptions	NNS	-	-	-	-	-	-	-	-
1180855	0	17	of	IN	-	-	-	-	-	-	-	-
1180855	0	18	the	DT	-	-	-	-	-	-	-	(129
1180855	0	19	Map	NNP	-	-	-	-	-	-	-	-
1180855	0	20	Manager	NNP	-	-	-	-	-	-	-	-
1180855	0	21	QT	NNP	-	-	-	-	-	-	-	-
1180855	0	22	computer	NN	-	-	-	-	-	-	-	-
1180855	0	23	program	NN	-	-	-	-	-	-	-	129)
1180855	0	24	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Interval	NN	-	-	-	-	-	-	-	(130
1180855	0	2	analyses	NNS	-	-	-	-	-	-	-	130)
1180855	0	3	were	VBD	-	-	-	-	-	-	-	-
1180855	0	4	then	RB	-	-	-	-	-	-	-	-
1180855	0	5	performed	VBN	-	-	-	-	-	-	-	-
1180855	0	6	by	IN	-	-	-	-	-	-	-	-
1180855	0	7	fitting	VBG	-	-	-	-	-	-	-	-
1180855	0	8	a	DT	-	-	-	-	-	-	-	-
1180855	0	9	regression	NN	-	-	-	-	-	-	-	-
1180855	0	10	equation	NN	-	-	-	-	-	-	-	-
1180855	0	11	for	IN	-	-	-	-	-	-	-	-
1180855	0	12	the	DT	-	-	-	-	-	-	-	-
1180855	0	13	effect	NN	-	-	-	-	-	-	-	-
1180855	0	14	of	IN	-	-	-	-	-	-	-	-
1180855	0	15	a	DT	-	-	-	-	-	-	-	-
1180855	0	16	theoretical	JJ	-	-	-	-	-	-	-	-
1180855	0	17	QTL	NN	-	-	-	-	-	-	-	-
1180855	0	18	at	IN	-	-	-	-	-	-	-	-
1180855	0	19	the	DT	-	-	-	-	-	-	-	-
1180855	0	20	position	NN	-	-	-	-	-	-	-	-
1180855	0	21	of	IN	-	-	-	-	-	-	-	-
1180855	0	22	each	DT	-	-	-	-	-	-	-	(115
1180855	0	23	SSLP	NN	-	-	-	-	-	-	-	115)
1180855	0	24	and	CC	-	-	-	-	-	-	-	-
1180855	0	25	at	IN	-	-	-	-	-	-	-	-
1180855	0	26	1	CD	-	-	-	-	-	-	-	-
1180855	0	27	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	28	centimorgan	NN	-	-	-	-	-	-	-	-
1180855	0	29	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	30	cM	NN	-	-	-	-	-	-	-	-
1180855	0	31	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	32	intervals	NNS	-	-	-	-	-	-	-	-
1180855	0	33	between	IN	-	-	-	-	-	-	-	-
1180855	0	34	SSLPs	NNS	-	-	-	-	-	-	-	(115)
1180855	0	35	using	VBG	-	-	-	-	-	-	-	-
1180855	0	36	free	JJ	-	-	-	-	-	-	-	-
1180855	0	37	,	,	-	-	-	-	-	-	-	-
1180855	0	38	additive	JJ	-	-	-	-	-	-	-	-
1180855	0	39	,	,	-	-	-	-	-	-	-	-
1180855	0	40	recessive	JJ	-	-	-	-	-	-	-	-
1180855	0	41	,	,	-	-	-	-	-	-	-	-
1180855	0	42	and	CC	-	-	-	-	-	-	-	-
1180855	0	43	dominant	JJ	-	-	-	-	-	-	-	-
1180855	0	44	regression	NN	-	-	-	-	-	-	-	-
1180855	0	45	models	NNS	-	-	-	-	-	-	-	-
1180855	0	46	.	.	-	-	-	-	-	-	-	-

1180855	0	1	The	DT	-	-	-	-	-	-	-	-
1180855	0	2	regressions	NNS	-	-	-	-	-	-	-	-
1180855	0	3	and	CC	-	-	-	-	-	-	-	-
1180855	0	4	significance	NN	-	-	-	-	-	-	-	-
1180855	0	5	of	IN	-	-	-	-	-	-	-	-
1180855	0	6	each	DT	-	-	-	-	-	-	-	-
1180855	0	7	genotype	NN	-	-	-	-	-	-	-	-
1180855	0	8	/	HYPH	-	-	-	-	-	-	-	-
1180855	0	9	phenotype	NN	-	-	-	-	-	-	-	-
1180855	0	10	association	NN	-	-	-	-	-	-	-	-
1180855	0	11	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	12	or	CC	-	-	-	-	-	-	-	-
1180855	0	13	likelihood	NN	-	-	-	-	-	-	-	(131
1180855	0	14	χ2	NN	-	-	-	-	-	-	-	-
1180855	0	15	statistic	NN	-	-	-	-	-	-	-	131)
1180855	0	16	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	17	were	VBD	-	-	-	-	-	-	-	-
1180855	0	18	calculated	VBN	-	-	-	-	-	-	-	-
1180855	0	19	by	IN	-	-	-	-	-	-	-	-
1180855	0	20	Map	NNP	-	-	-	-	-	-	-	(129
1180855	0	21	Manager	NNP	-	-	-	-	-	-	-	129)
1180855	0	22	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	23	18	CD	-	-	-	-	-	-	-	-
1180855	0	24	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	25	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Permutation	NN	-	-	-	-	-	-	-	-
1180855	0	2	tests	NNS	-	-	-	-	-	-	-	-
1180855	0	3	were	VBD	-	-	-	-	-	-	-	-
1180855	0	4	performed	VBN	-	-	-	-	-	-	-	-
1180855	0	5	on	IN	-	-	-	-	-	-	-	-
1180855	0	6	the	DT	-	-	-	-	-	-	-	-
1180855	0	7	phenotypic	JJ	-	-	-	-	-	-	-	-
1180855	0	8	and	CC	-	-	-	-	-	-	-	-
1180855	0	9	genotypic	JJ	-	-	-	-	-	-	-	-
1180855	0	10	data	NNS	-	-	-	-	-	-	-	-
1180855	0	11	using	VBG	-	-	-	-	-	-	-	-
1180855	0	12	Map	NNP	-	-	-	-	-	-	-	(129
1180855	0	13	Manager	NNP	-	-	-	-	-	-	-	129)
1180855	0	14	to	TO	-	-	-	-	-	-	-	-
1180855	0	15	generate	VB	-	-	-	-	-	-	-	-
1180855	0	16	empirical	JJ	-	-	-	-	-	-	-	-
1180855	0	17	thresholds	NNS	-	-	-	-	-	-	-	-
1180855	0	18	for	IN	-	-	-	-	-	-	-	-
1180855	0	19	significance	NN	-	-	-	-	-	-	-	-
1180855	0	20	following	VBG	-	-	-	-	-	-	-	-
1180855	0	21	the	DT	-	-	-	-	-	-	-	-
1180855	0	22	methods	NNS	-	-	-	-	-	-	-	-
1180855	0	23	of	IN	-	-	-	-	-	-	-	-
1180855	0	24	Churchill	NNP	-	-	-	-	-	-	-	-
1180855	0	25	and	CC	-	-	-	-	-	-	-	-
1180855	0	26	Doerge	NNP	-	-	-	-	-	-	-	-
1180855	0	27	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	28	19	CD	-	-	-	-	-	-	-	-
1180855	0	29	,	,	-	-	-	-	-	-	-	-
1180855	0	30	20	CD	-	-	-	-	-	-	-	-
1180855	0	31	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	32	.	.	-	-	-	-	-	-	-	-

1180855	0	1	For	IN	-	-	-	-	-	-	-	-
1180855	0	2	the	DT	-	-	-	-	-	-	-	(127
1180855	0	3	initial	JJ	-	-	-	-	-	-	-	-
1180855	0	4	genome	NN	-	-	-	-	-	-	-	-
1180855	0	5	scan	NN	-	-	-	-	-	-	-	127)
1180855	0	6	,	,	-	-	-	-	-	-	-	-
1180855	0	7	the	DT	-	-	-	-	-	-	-	(132a|(133|(134b)
1180855	0	8	15	CD	-	-	-	-	-	-	-	-
1180855	0	9	most	RBS	-	-	-	-	-	-	-	-
1180855	0	10	tolerant	JJ	-	-	-	-	-	-	-	132a)
1180855	0	11	and	CC	-	-	-	-	-	-	-	-
1180855	0	12	15	CD	-	-	-	-	-	-	-	(134b
1180855	0	13	most	RBS	-	-	-	-	-	-	-	-
1180855	0	14	non-tolerant	JJ	-	-	-	-	-	-	-	-
1180855	0	15	F2	NN	-	-	-	-	-	-	-	(132a
1180855	0	16	animals	NNS	-	-	-	-	-	-	-	134b)|133)|132a)
1180855	0	17	with	IN	-	-	-	-	-	-	-	-
1180855	0	18	respect	NN	-	-	-	-	-	-	-	-
1180855	0	19	to	IN	-	-	-	-	-	-	-	-
1180855	0	20	BAL	NN	-	-	-	-	-	-	-	(23|(14)|(24e)|(25g)
1180855	0	21	protein	NN	-	-	-	-	-	-	-	23)
1180855	0	22	,	,	-	-	-	-	-	-	-	-
1180855	0	23	PMNs	NNS	-	-	-	-	-	-	-	(24e)
1180855	0	24	,	,	-	-	-	-	-	-	-	-
1180855	0	25	and	CC	-	-	-	-	-	-	-	-
1180855	0	26	macrophages	NNS	-	-	-	-	-	-	-	(25g)
1180855	0	27	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	28	i.e.	FW	-	-	-	-	-	-	-	-
1180855	0	29	,	,	-	-	-	-	-	-	-	-
1180855	0	30	the	DT	-	-	-	-	-	-	-	-
1180855	0	31	phenotypic	JJ	-	-	-	-	-	-	-	-
1180855	0	32	extremes	NNS	-	-	-	-	-	-	-	-
1180855	0	33	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	34	were	VBD	-	-	-	-	-	-	-	-
1180855	0	35	used	VBN	-	-	-	-	-	-	-	-
1180855	0	36	for	IN	-	-	-	-	-	-	-	-
1180855	0	37	selective	JJ	-	-	-	-	-	-	-	(135
1180855	0	38	genotyping	NN	-	-	-	-	-	-	-	135)
1180855	0	39	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	40	9	CD	-	-	-	-	-	-	-	-
1180855	0	41	,	,	-	-	-	-	-	-	-	-
1180855	0	42	21	CD	-	-	-	-	-	-	-	-
1180855	0	43	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	44	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Interval	NN	-	-	-	-	-	-	-	(130
1180855	0	2	analyses	NNS	-	-	-	-	-	-	-	130)
1180855	0	3	were	VBD	-	-	-	-	-	-	-	-
1180855	0	4	done	VBN	-	-	-	-	-	-	-	-
1180855	0	5	as	IN	-	-	-	-	-	-	-	-
1180855	0	6	stated	VBN	-	-	-	-	-	-	-	-
1180855	0	7	previously	RB	-	-	-	-	-	-	-	-
1180855	0	8	,	,	-	-	-	-	-	-	-	-
1180855	0	9	and	CC	-	-	-	-	-	-	-	-
1180855	0	10	10,000	CD	-	-	-	-	-	-	-	(136
1180855	0	11	permutations	NNS	-	-	-	-	-	-	-	136)
1180855	0	12	were	VBD	-	-	-	-	-	-	-	-
1180855	0	13	performed	VBN	-	-	-	-	-	-	-	-
1180855	0	14	to	TO	-	-	-	-	-	-	-	-
1180855	0	15	generate	VB	-	-	-	-	-	-	-	-
1180855	0	16	significant	JJ	-	-	-	-	-	-	-	-
1180855	0	17	and	CC	-	-	-	-	-	-	-	-
1180855	0	18	suggestive	JJ	-	-	-	-	-	-	-	-
1180855	0	19	likelihood	NN	-	-	-	-	-	-	-	(131
1180855	0	20	χ2	NN	-	-	-	-	-	-	-	-
1180855	0	21	statistic	NN	-	-	-	-	-	-	-	131)
1180855	0	22	thresholds	NNS	-	-	-	-	-	-	-	-
1180855	0	23	for	IN	-	-	-	-	-	-	-	-
1180855	0	24	the	DT	-	-	-	-	-	-	-	(15
1180855	0	25	BAL	NN	-	-	-	-	-	-	-	(23
1180855	0	26	protein	NN	-	-	-	-	-	-	-	23)
1180855	0	27	phenotype	NN	-	-	-	-	-	-	-	15)
1180855	0	28	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Following	VBG	-	-	-	-	-	-	-	-
1180855	0	2	the	DT	-	-	-	-	-	-	-	-
1180855	0	3	identification	NN	-	-	-	-	-	-	-	-
1180855	0	4	of	IN	-	-	-	-	-	-	-	-
1180855	0	5	a	DT	-	-	-	-	-	-	-	-
1180855	0	6	suggestive	JJ	-	-	-	-	-	-	-	-
1180855	0	7	QTL	NN	-	-	-	-	-	-	-	-
1180855	0	8	for	IN	-	-	-	-	-	-	-	-
1180855	0	9	BAL	NN	-	-	-	-	-	-	-	(23|(14)
1180855	0	10	protein	NN	-	-	-	-	-	-	-	23)
1180855	0	11	on	IN	-	-	-	-	-	-	-	-
1180855	0	12	chromosome	NN	-	-	-	-	-	-	-	(43|(42)
1180855	0	13	1	CD	-	-	-	-	-	-	-	43)
1180855	0	14	,	,	-	-	-	-	-	-	-	-
1180855	0	15	the	DT	-	-	-	-	-	-	-	(128
1180855	0	16	entire	JJ	-	-	-	-	-	-	-	-
1180855	0	17	F2	NN	-	-	-	-	-	-	-	-
1180855	0	18	cohort	NN	-	-	-	-	-	-	-	128)
1180855	0	19	was	VBD	-	-	-	-	-	-	-	-
1180855	0	20	examined	VBN	-	-	-	-	-	-	-	-
1180855	0	21	for	IN	-	-	-	-	-	-	-	-
1180855	0	22	additional	JJ	-	-	-	-	-	-	-	-
1180855	0	23	QTLs	NNS	-	-	-	-	-	-	-	-
1180855	0	24	.	.	-	-	-	-	-	-	-	-

1180855	0	1	For	IN	-	-	-	-	-	-	-	-
1180855	0	2	the	DT	-	-	-	-	-	-	-	(15
1180855	0	3	BAL	NN	-	-	-	-	-	-	-	(23
1180855	0	4	protein	NN	-	-	-	-	-	-	-	23)
1180855	0	5	phenotype	NN	-	-	-	-	-	-	-	15)
1180855	0	6	,	,	-	-	-	-	-	-	-	-
1180855	0	7	three	CD	-	-	-	-	-	-	-	(137
1180855	0	8	additional	JJ	-	-	-	-	-	-	-	-
1180855	0	9	SSLPs	NNS	-	-	-	-	-	-	-	-
1180855	0	10	on	IN	-	-	-	-	-	-	-	-
1180855	0	11	chromosome	NN	-	-	-	-	-	-	-	(43|(42)
1180855	0	12	1	CD	-	-	-	-	-	-	-	43)|137)
1180855	0	13	were	VBD	-	-	-	-	-	-	-	-
1180855	0	14	analyzed	VBN	-	-	-	-	-	-	-	-
1180855	0	15	,	,	-	-	-	-	-	-	-	-
1180855	0	16	and	CC	-	-	-	-	-	-	-	-
1180855	0	17	a	DT	-	-	-	-	-	-	-	-
1180855	0	18	permutation	NN	-	-	-	-	-	-	-	-
1180855	0	19	test	NN	-	-	-	-	-	-	-	-
1180855	0	20	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	21	10,000	CD	-	-	-	-	-	-	-	(136
1180855	0	22	permutations	NNS	-	-	-	-	-	-	-	136)
1180855	0	23	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	24	was	VBD	-	-	-	-	-	-	-	-
1180855	0	25	performed	VBN	-	-	-	-	-	-	-	-
1180855	0	26	with	IN	-	-	-	-	-	-	-	-
1180855	0	27	only	RB	-	-	-	-	-	-	-	-
1180855	0	28	chromosome	NN	-	-	-	-	-	-	-	(43|(42)
1180855	0	29	1	CD	-	-	-	-	-	-	-	43)
1180855	0	30	.	.	-	-	-	-	-	-	-	-

1180855	0	1	This	DT	-	-	-	-	-	-	-	-
1180855	0	2	method	NN	-	-	-	-	-	-	-	-
1180855	0	3	was	VBD	-	-	-	-	-	-	-	-
1180855	0	4	similar	JJ	-	-	-	-	-	-	-	-
1180855	0	5	to	IN	-	-	-	-	-	-	-	-
1180855	0	6	that	DT	-	-	-	-	-	-	-	-
1180855	0	7	used	VBN	-	-	-	-	-	-	-	-
1180855	0	8	in	IN	-	-	-	-	-	-	-	-
1180855	0	9	previous	JJ	-	-	-	-	-	-	-	(138
1180855	0	10	linkage	NN	-	-	-	-	-	-	-	-
1180855	0	11	studies	NNS	-	-	-	-	-	-	-	-
1180855	0	12	with	IN	-	-	-	-	-	-	-	-
1180855	0	13	inhaled	VBN	-	-	-	-	-	-	-	(87|(88|(86a)
1180855	0	14	particles	NNS	-	-	-	-	-	-	-	87)
1180855	0	15	and	CC	-	-	-	-	-	-	-	-
1180855	0	16	gases	NNS	-	-	-	-	-	-	-	(86a)|88)
1180855	0	17	that	WDT	-	-	-	-	-	-	-	-
1180855	0	18	utilized	VBD	-	-	-	-	-	-	-	-
1180855	0	19	Map	NNP	-	-	-	-	-	-	-	(129
1180855	0	20	Manager	NNP	-	-	-	-	-	-	-	-
1180855	0	21	QT	NNP	-	-	-	-	-	-	-	138)|129)
1180855	0	22	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	23	10	CD	-	-	-	-	-	-	-	-
1180855	0	24	,	,	-	-	-	-	-	-	-	-
1180855	0	25	14	CD	-	-	-	-	-	-	-	-
1180855	0	26	,	,	-	-	-	-	-	-	-	-
1180855	0	27	22	CD	-	-	-	-	-	-	-	-
1180855	0	28	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	29	.	.	-	-	-	-	-	-	-	-

1180855	0	1	All	DT	-	-	-	-	-	-	-	-
1180855	0	2	likelihood	NN	-	-	-	-	-	-	-	(131
1180855	0	3	χ2	NN	-	-	-	-	-	-	-	-
1180855	0	4	statistic	NN	-	-	-	-	-	-	-	131)
1180855	0	5	thresholds	NNS	-	-	-	-	-	-	-	-
1180855	0	6	corresponded	VBD	-	-	-	-	-	-	-	-
1180855	0	7	to	IN	-	-	-	-	-	-	-	-
1180855	0	8	those	DT	-	-	-	-	-	-	-	-
1180855	0	9	reported	VBN	-	-	-	-	-	-	-	-
1180855	0	10	in	IN	-	-	-	-	-	-	-	-
1180855	0	11	the	DT	-	-	-	-	-	-	-	(138
1180855	0	12	aforementioned	JJ	-	-	-	-	-	-	-	-
1180855	0	13	linkage	NN	-	-	-	-	-	-	-	-
1180855	0	14	studies	NNS	-	-	-	-	-	-	-	138)
1180855	0	15	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Haplotype	NN	-	-	-	-	-	-	-	(29
1180855	0	2	analysis	NN	-	-	-	-	-	-	-	29)

1180855	0	1	A	DT	-	-	-	-	-	-	-	(139
1180855	0	2	haplotype	NN	-	-	-	-	-	-	-	-
1180855	0	3	analysis	NN	-	-	-	-	-	-	-	139)
1180855	0	4	was	VBD	-	-	-	-	-	-	-	-
1180855	0	5	carried	VBN	-	-	-	-	-	-	-	-
1180855	0	6	out	RP	-	-	-	-	-	-	-	-
1180855	0	7	similar	JJ	-	-	-	-	-	-	-	-
1180855	0	8	to	IN	-	-	-	-	-	-	-	-
1180855	0	9	that	DT	-	-	-	-	-	-	-	-
1180855	0	10	done	VBN	-	-	-	-	-	-	-	-
1180855	0	11	previously	RB	-	-	-	-	-	-	-	-
1180855	0	12	by	IN	-	-	-	-	-	-	-	-
1180855	0	13	Prows	NNP	-	-	-	-	-	-	-	(140)
1180855	0	14	and	CC	-	-	-	-	-	-	-	-
1180855	0	15	Leikauf	NNP	-	-	-	-	-	-	-	(141)
1180855	0	16	to	TO	-	-	-	-	-	-	-	-
1180855	0	17	determine	VB	-	-	-	-	-	-	-	-
1180855	0	18	the	DT	-	-	-	-	-	-	-	(30a|(31|(32c
1180855	0	19	contribution	NN	-	-	-	-	-	-	-	-
1180855	0	20	of	IN	-	-	-	-	-	-	-	-
1180855	0	21	each	DT	-	-	-	-	-	-	-	(33|(34|(33c)|(35b)|30a)
1180855	0	22	QTL	NN	-	-	-	-	-	-	-	33)|32c)
1180855	0	23	and	CC	-	-	-	-	-	-	-	-
1180855	0	24	QTL	NN	-	-	-	-	-	-	-	(30a|(35b|(33c)|(36)
1180855	0	25	combination	NN	-	-	-	-	-	-	-	35b)|34)
1180855	0	26	to	IN	-	-	-	-	-	-	-	(32c
1180855	0	27	the	DT	-	-	-	-	-	-	-	(37
1180855	0	28	overall	JJ	-	-	-	-	-	-	-	-
1180855	0	29	BAL	NN	-	-	-	-	-	-	-	(23
1180855	0	30	protein	NN	-	-	-	-	-	-	-	23)
1180855	0	31	phenotype	NN	-	-	-	-	-	-	-	37)|32c)|31)|30a)
1180855	0	32	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	33	15	CD	-	-	-	-	-	-	-	-
1180855	0	34	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	35	.	.	-	-	-	-	-	-	-	-

1180855	0	1	This	DT	-	-	-	-	-	-	-	(139
1180855	0	2	method	NN	-	-	-	-	-	-	-	139)
1180855	0	3	quantifies	VBZ	-	-	-	-	-	-	-	-
1180855	0	4	any	DT	-	-	-	-	-	-	-	-
1180855	0	5	difference	NN	-	-	-	-	-	-	-	-
1180855	0	6	in	IN	-	-	-	-	-	-	-	-
1180855	0	7	mean	NN	-	-	-	-	-	-	-	(126|(142
1180855	0	8	BAL	NN	-	-	-	-	-	-	-	(23
1180855	0	9	protein	NN	-	-	-	-	-	-	-	23)|126)
1180855	0	10	levels	NNS	-	-	-	-	-	-	-	142)
1180855	0	11	that	WDT	-	-	-	-	-	-	-	-
1180855	0	12	are	VBP	-	-	-	-	-	-	-	-
1180855	0	13	linked	VBN	-	-	-	-	-	-	-	-
1180855	0	14	with	IN	-	-	-	-	-	-	-	-
1180855	0	15	a	DT	-	-	-	-	-	-	-	-
1180855	0	16	particular	JJ	-	-	-	-	-	-	-	-
1180855	0	17	haplotype	NN	-	-	-	-	-	-	-	-
1180855	0	18	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Haplotypes	NNS	-	-	-	-	-	-	-	-
1180855	0	2	for	IN	-	-	-	-	-	-	-	-
1180855	0	3	the	DT	-	-	-	-	-	-	-	-
1180855	0	4	following	VBG	-	-	-	-	-	-	-	-
1180855	0	5	SSLPs	NNS	-	-	-	-	-	-	-	-
1180855	0	6	were	VBD	-	-	-	-	-	-	-	-
1180855	0	7	used	VBN	-	-	-	-	-	-	-	-
1180855	0	8	for	IN	-	-	-	-	-	-	-	-
1180855	0	9	this	DT	-	-	-	-	-	-	-	(139
1180855	0	10	analysis	NN	-	-	-	-	-	-	-	139)
1180855	0	11	:	:	-	-	-	-	-	-	-	-
1180855	0	12	D1Mit291	NN	-	-	-	-	-	-	-	(143)
1180855	0	13	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	14	101.5	CD	-	-	-	-	-	-	-	-
1180855	0	15	cM	NN	-	-	-	-	-	-	-	-
1180855	0	16	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	17	,	,	-	-	-	-	-	-	-	-
1180855	0	18	D4Mit254	NN	-	-	-	-	-	-	-	(144)
1180855	0	19	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	20	82.5	CD	-	-	-	-	-	-	-	-
1180855	0	21	cM	NN	-	-	-	-	-	-	-	-
1180855	0	22	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	23	,	,	-	-	-	-	-	-	-	-
1180855	0	24	and	CC	-	-	-	-	-	-	-	-
1180855	0	25	D5Mit193	NN	-	-	-	-	-	-	-	(145)
1180855	0	26	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	27	1.0	CD	-	-	-	-	-	-	-	(146
1180855	0	28	cM	NN	-	-	-	-	-	-	-	146)
1180855	0	29	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	30	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Mean	NN	-	-	-	-	-	-	-	(126|(147
1180855	0	2	BAL	NN	-	-	-	-	-	-	-	(23
1180855	0	3	protein	NN	-	-	-	-	-	-	-	23)|126)
1180855	0	4	concentrations	NNS	-	-	-	-	-	-	-	-
1180855	0	5	for	IN	-	-	-	-	-	-	-	-
1180855	0	6	groups	NNS	-	-	-	-	-	-	-	-
1180855	0	7	of	IN	-	-	-	-	-	-	-	-
1180855	0	8	F2	NN	-	-	-	-	-	-	-	(148|(148
1180855	0	9	mice	NNS	-	-	-	-	-	-	-	-
1180855	0	10	with	IN	-	-	-	-	-	-	-	-
1180855	0	11	the	DT	-	-	-	-	-	-	-	-
1180855	0	12	same	JJ	-	-	-	-	-	-	-	-
1180855	0	13	haplotype	NN	-	-	-	-	-	-	-	148)
1180855	0	14	at	IN	-	-	-	-	-	-	-	-
1180855	0	15	each	DT	-	-	-	-	-	-	-	(33|(33a)|(35c)
1180855	0	16	QTL	NN	-	-	-	-	-	-	-	33)|148)
1180855	0	17	or	CC	-	-	-	-	-	-	-	-
1180855	0	18	QTL	NN	-	-	-	-	-	-	-	(35c|(33a)|(36)
1180855	0	19	combinations	NNS	-	-	-	-	-	-	-	35c)|147)
1180855	0	20	were	VBD	-	-	-	-	-	-	-	-
1180855	0	21	calculated	VBN	-	-	-	-	-	-	-	-
1180855	0	22	and	CC	-	-	-	-	-	-	-	-
1180855	0	23	compared	VBN	-	-	-	-	-	-	-	-
1180855	0	24	with	IN	-	-	-	-	-	-	-	-
1180855	0	25	the	DT	-	-	-	-	-	-	-	(149
1180855	0	26	mean	NN	-	-	-	-	-	-	-	-
1180855	0	27	BAL	NN	-	-	-	-	-	-	-	(14)
1180855	0	28	protein	NN	-	-	-	-	-	-	-	-
1180855	0	29	of	IN	-	-	-	-	-	-	-	-
1180855	0	30	F2	NN	-	-	-	-	-	-	-	(150|(22
1180855	0	31	mice	NNS	-	-	-	-	-	-	-	22)
1180855	0	32	with	IN	-	-	-	-	-	-	-	-
1180855	0	33	the	DT	-	-	-	-	-	-	-	-
1180855	0	34	other	JJ	-	-	-	-	-	-	-	-
1180855	0	35	haplotypes	NNS	-	-	-	-	-	-	-	150)|149)
1180855	0	36	to	TO	-	-	-	-	-	-	-	-
1180855	0	37	determine	VB	-	-	-	-	-	-	-	-
1180855	0	38	the	DT	-	-	-	-	-	-	-	-
1180855	0	39	contributions	NNS	-	-	-	-	-	-	-	-
1180855	0	40	of	IN	-	-	-	-	-	-	-	-
1180855	0	41	these	DT	-	-	-	-	-	-	-	-
1180855	0	42	QTLs	NNS	-	-	-	-	-	-	-	-
1180855	0	43	to	IN	-	-	-	-	-	-	-	-
1180855	0	44	the	DT	-	-	-	-	-	-	-	(37
1180855	0	45	overall	JJ	-	-	-	-	-	-	-	-
1180855	0	46	BAL	NN	-	-	-	-	-	-	-	(23
1180855	0	47	protein	NN	-	-	-	-	-	-	-	23)
1180855	0	48	phenotype	NN	-	-	-	-	-	-	-	37)
1180855	0	49	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Results	NNS	-	-	-	-	-	-	-	(40)

1180855	0	1	Phenotypes	NNS	-	-	-	-	-	-	-	-
1180855	0	2	of	IN	-	-	-	-	-	-	-	-
1180855	0	3	the	DT	-	-	-	-	-	-	-	(128
1180855	0	4	CByD2F2	NN	-	-	-	-	-	-	-	-
1180855	0	5	cohort	NN	-	-	-	-	-	-	-	128)

1180855	0	1	To	TO	-	-	-	-	-	-	-	-
1180855	0	2	further	RB	-	-	-	-	-	-	-	-
1180855	0	3	understand	VB	-	-	-	-	-	-	-	-
1180855	0	4	the	DT	-	-	-	-	-	-	-	-
1180855	0	5	role	NN	-	-	-	-	-	-	-	-
1180855	0	6	of	IN	-	-	-	-	-	-	-	-
1180855	0	7	genetic	JJ	-	-	-	-	-	-	-	(9
1180855	0	8	background	NN	-	-	-	-	-	-	-	9)
1180855	0	9	in	IN	-	-	-	-	-	-	-	-
1180855	0	10	the	DT	-	-	-	-	-	-	-	(99
1180855	0	11	development	NN	-	-	-	-	-	-	-	-
1180855	0	12	of	IN	-	-	-	-	-	-	-	-
1180855	0	13	pulmonary	JJ	-	-	-	-	-	-	-	(71
1180855	0	14	tolerance	NN	-	-	-	-	-	-	-	99)|71)
1180855	0	15	,	,	-	-	-	-	-	-	-	-
1180855	0	16	an	DT	-	-	-	-	-	-	-	(128
1180855	0	17	F2	NN	-	-	-	-	-	-	-	-
1180855	0	18	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	19	backcross	NN	-	-	-	-	-	-	-	-
1180855	0	20	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	21	cohort	NN	-	-	-	-	-	-	-	-
1180855	0	22	derived	VBN	-	-	-	-	-	-	-	-
1180855	0	23	from	IN	-	-	-	-	-	-	-	-
1180855	0	24	the	DT	-	-	-	-	-	-	-	(111|(112b|(110a)
1180855	0	25	CBy	NN	-	-	-	-	-	-	-	(16)|112b)
1180855	0	26	and	CC	-	-	-	-	-	-	-	-
1180855	0	27	D2	NN	-	-	-	-	-	-	-	(110a
1180855	0	28	progenitors	NNS	-	-	-	-	-	-	-	(112b)|128)|111)|110a)
1180855	0	29	was	VBD	-	-	-	-	-	-	-	-
1180855	0	30	phenotyped	VBN	-	-	-	-	-	-	-	-
1180855	0	31	.	.	-	-	-	-	-	-	-	-

1180855	0	1	The	DT	-	-	-	-	-	-	-	-
1180855	0	2	frequency	NN	-	-	-	-	-	-	-	-
1180855	0	3	distribution	NN	-	-	-	-	-	-	-	-
1180855	0	4	of	IN	-	-	-	-	-	-	-	-
1180855	0	5	the	DT	-	-	-	-	-	-	-	-
1180855	0	6	BAL	NN	-	-	-	-	-	-	-	(14)|(24c)|(25d)
1180855	0	7	protein	NN	-	-	-	-	-	-	-	-
1180855	0	8	,	,	-	-	-	-	-	-	-	-
1180855	0	9	PMN	NN	-	-	-	-	-	-	-	(24c)
1180855	0	10	,	,	-	-	-	-	-	-	-	-
1180855	0	11	and	CC	-	-	-	-	-	-	-	-
1180855	0	12	macrophage	NN	-	-	-	-	-	-	-	(25d)
1180855	0	13	phenotypic	JJ	-	-	-	-	-	-	-	-
1180855	0	14	responses	NNS	-	-	-	-	-	-	-	-
1180855	0	15	of	IN	-	-	-	-	-	-	-	-
1180855	0	16	the	DT	-	-	-	-	-	-	-	(128
1180855	0	17	F2	NN	-	-	-	-	-	-	-	-
1180855	0	18	cohort	NN	-	-	-	-	-	-	-	128)
1180855	0	19	were	VBD	-	-	-	-	-	-	-	-
1180855	0	20	within	IN	-	-	-	-	-	-	-	-
1180855	0	21	the	DT	-	-	-	-	-	-	-	-
1180855	0	22	ranges	NNS	-	-	-	-	-	-	-	-
1180855	0	23	of	IN	-	-	-	-	-	-	-	-
1180855	0	24	similarly	RB	-	-	-	-	-	-	-	-
1180855	0	25	exposed	VBN	-	-	-	-	-	-	-	-
1180855	0	26	CBy	NN	-	-	-	-	-	-	-	-
1180855	0	27	and	CC	-	-	-	-	-	-	-	-
1180855	0	28	D2	NN	-	-	-	-	-	-	-	-
1180855	0	29	progenitor	NN	-	-	-	-	-	-	-	-
1180855	0	30	mice	NNS	-	-	-	-	-	-	-	-
1180855	0	31	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	32	Figure	NN	-	-	-	-	-	-	-	(151
1180855	0	33	1	CD	-	-	-	-	-	-	-	151)
1180855	0	34	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	35	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Figure	NN	-	-	-	-	-	-	-	(151
1180855	0	2	1	CD	-	-	-	-	-	-	-	151)

1180855	0	1	Frequency	NN	-	-	-	-	-	-	-	-
1180855	0	2	distribution	NN	-	-	-	-	-	-	-	-
1180855	0	3	of	IN	-	-	-	-	-	-	-	-
1180855	0	4	the	DT	-	-	-	-	-	-	-	-
1180855	0	5	number	NN	-	-	-	-	-	-	-	-
1180855	0	6	of	IN	-	-	-	-	-	-	-	-
1180855	0	7	BAL	NN	-	-	-	-	-	-	-	(24|(14)|(23a)|(25e)
1180855	0	8	PMNs	NNS	-	-	-	-	-	-	-	24)
1180855	0	9	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	10	×	SYM	-	-	-	-	-	-	-	(152
1180855	0	11	104	CD	-	-	-	-	-	-	-	152)
1180855	0	12	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	13	,	,	-	-	-	-	-	-	-	-
1180855	0	14	macrophages	NNS	-	-	-	-	-	-	-	(25e)
1180855	0	15	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	16	×	SYM	-	-	-	-	-	-	-	(152
1180855	0	17	104	CD	-	-	-	-	-	-	-	152)
1180855	0	18	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	19	,	,	-	-	-	-	-	-	-	-
1180855	0	20	and	CC	-	-	-	-	-	-	-	-
1180855	0	21	protein	NN	-	-	-	-	-	-	-	(23a)
1180855	0	22	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	23	μg	NN	-	-	-	-	-	-	-	-
1180855	0	24	/	SYM	-	-	-	-	-	-	-	-
1180855	0	25	ml	NN	-	-	-	-	-	-	-	-
1180855	0	26	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	27	in	IN	-	-	-	-	-	-	-	-
1180855	0	28	BALB	NN	-	-	-	-	-	-	-	(16|(90b
1180855	0	29	/	HYPH	-	-	-	-	-	-	-	-
1180855	0	30	cByJ	NN	-	-	-	-	-	-	-	90b)|16)
1180855	0	31	,	,	-	-	-	-	-	-	-	-
1180855	0	32	DBA	NN	-	-	-	-	-	-	-	(17c
1180855	0	33	/	HYPH	-	-	-	-	-	-	-	-
1180855	0	34	2J	NN	-	-	-	-	-	-	-	17c)
1180855	0	35	,	,	-	-	-	-	-	-	-	-
1180855	0	36	CByD2F1	NN	-	-	-	-	-	-	-	(91b|(92
1180855	0	37	/	HYPH	-	-	-	-	-	-	-	-
1180855	0	38	J	NN	-	-	-	-	-	-	-	92)|91b)
1180855	0	39	,	,	-	-	-	-	-	-	-	-
1180855	0	40	and	CC	-	-	-	-	-	-	-	-
1180855	0	41	CByD2F2	NN	-	-	-	-	-	-	-	(22
1180855	0	42	mice	NNS	-	-	-	-	-	-	-	(17c)|(90b)|(91b)|22)
1180855	0	43	following	VBG	-	-	-	-	-	-	-	-
1180855	0	44	5	CD	-	-	-	-	-	-	-	(26
1180855	0	45	consecutive	JJ	-	-	-	-	-	-	-	-
1180855	0	46	days	NNS	-	-	-	-	-	-	-	-
1180855	0	47	of	IN	-	-	-	-	-	-	-	-
1180855	0	48	exposure	NN	-	-	-	-	-	-	-	(27
1180855	0	49	to	IN	-	-	-	-	-	-	-	-
1180855	0	50	1.0	CD	-	-	-	-	-	-	-	(28
1180855	0	51	mg	NN	-	-	-	-	-	-	-	-
1180855	0	52	/	SYM	-	-	-	-	-	-	-	-
1180855	0	53	m3	NN	-	-	-	-	-	-	-	-
1180855	0	54	ZnO	NN	-	-	-	-	-	-	-	28)|27)
1180855	0	55	for	IN	-	-	-	-	-	-	-	-
1180855	0	56	3	CD	-	-	-	-	-	-	-	-
1180855	0	57	h	NN	-	-	-	-	-	-	-	-
1180855	0	58	/	SYM	-	-	-	-	-	-	-	-
1180855	0	59	day	NN	-	-	-	-	-	-	-	26)
1180855	0	60	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Vertical	JJ	-	-	-	-	-	-	-	-
1180855	0	2	dashed	JJ	-	-	-	-	-	-	-	-
1180855	0	3	lines	NNS	-	-	-	-	-	-	-	-
1180855	0	4	represent	VBP	-	-	-	-	-	-	-	-
1180855	0	5	approximate	JJ	-	-	-	-	-	-	-	-
1180855	0	6	separation	NN	-	-	-	-	-	-	-	-
1180855	0	7	points	NNS	-	-	-	-	-	-	-	-
1180855	0	8	between	IN	-	-	-	-	-	-	-	-
1180855	0	9	BALB	NN	-	-	-	-	-	-	-	(16
1180855	0	10	/	HYPH	-	-	-	-	-	-	-	-
1180855	0	11	cByJ	NN	-	-	-	-	-	-	-	16)
1180855	0	12	and	CC	-	-	-	-	-	-	-	-
1180855	0	13	DBA	NN	-	-	-	-	-	-	-	-
1180855	0	14	/	HYPH	-	-	-	-	-	-	-	-
1180855	0	15	2J	NN	-	-	-	-	-	-	-	-
1180855	0	16	phenotypes	NNS	-	-	-	-	-	-	-	-
1180855	0	17	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Selective	JJ	-	-	-	-	-	-	-	(135
1180855	0	2	genotyping	NN	-	-	-	-	-	-	-	135)

1180855	0	1	A	DT	-	-	-	-	-	-	-	-
1180855	0	2	genome	NN	-	-	-	-	-	-	-	-
1180855	0	3	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	4	wide	JJ	-	-	-	-	-	-	-	-
1180855	0	5	scan	NN	-	-	-	-	-	-	-	-
1180855	0	6	was	VBD	-	-	-	-	-	-	-	-
1180855	0	7	performed	VBN	-	-	-	-	-	-	-	-
1180855	0	8	using	VBG	-	-	-	-	-	-	-	-
1180855	0	9	the	DT	-	-	-	-	-	-	-	(132b|(133|(134a)
1180855	0	10	15	CD	-	-	-	-	-	-	-	-
1180855	0	11	most	RBS	-	-	-	-	-	-	-	-
1180855	0	12	tolerant	JJ	-	-	-	-	-	-	-	132b)
1180855	0	13	and	CC	-	-	-	-	-	-	-	-
1180855	0	14	15	CD	-	-	-	-	-	-	-	(134a
1180855	0	15	most	RBS	-	-	-	-	-	-	-	-
1180855	0	16	non-tolerant	JJ	-	-	-	-	-	-	-	-
1180855	0	17	mice	NNS	-	-	-	-	-	-	-	(132b)|134a)|133)
1180855	0	18	to	TO	-	-	-	-	-	-	-	-
1180855	0	19	initially	RB	-	-	-	-	-	-	-	-
1180855	0	20	identify	VB	-	-	-	-	-	-	-	-
1180855	0	21	possible	JJ	-	-	-	-	-	-	-	-
1180855	0	22	QTLs	NNS	-	-	-	-	-	-	-	-
1180855	0	23	influencing	VBG	-	-	-	-	-	-	-	-
1180855	0	24	the	DT	-	-	-	-	-	-	-	(99
1180855	0	25	development	NN	-	-	-	-	-	-	-	-
1180855	0	26	of	IN	-	-	-	-	-	-	-	-
1180855	0	27	pulmonary	JJ	-	-	-	-	-	-	-	(71
1180855	0	28	tolerance	NN	-	-	-	-	-	-	-	99)|71)
1180855	0	29	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Permutation	NN	-	-	-	-	-	-	-	-
1180855	0	2	tests	NNS	-	-	-	-	-	-	-	-
1180855	0	3	on	IN	-	-	-	-	-	-	-	-
1180855	0	4	the	DT	-	-	-	-	-	-	-	-
1180855	0	5	BAL	NN	-	-	-	-	-	-	-	-
1180855	0	6	protein	NN	-	-	-	-	-	-	-	-
1180855	0	7	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	8	extreme	JJ	-	-	-	-	-	-	-	-
1180855	0	9	data	NNS	-	-	-	-	-	-	-	-
1180855	0	10	set	NN	-	-	-	-	-	-	-	-
1180855	0	11	established	VBD	-	-	-	-	-	-	-	-
1180855	0	12	a	DT	-	-	-	-	-	-	-	(153|(154
1180855	0	13	suggestive	JJ	-	-	-	-	-	-	-	-
1180855	0	14	likelihood	NN	-	-	-	-	-	-	-	(131
1180855	0	15	χ2	NN	-	-	-	-	-	-	-	-
1180855	0	16	statistic	NN	-	-	-	-	-	-	-	131)
1180855	0	17	threshold	NN	-	-	-	-	-	-	-	-
1180855	0	18	of	IN	-	-	-	-	-	-	-	-
1180855	0	19	9.9	CD	-	-	-	-	-	-	-	153)
1180855	0	20	and	CC	-	-	-	-	-	-	-	-
1180855	0	21	a	DT	-	-	-	-	-	-	-	(155
1180855	0	22	significant	JJ	-	-	-	-	-	-	-	-
1180855	0	23	likelihood	NN	-	-	-	-	-	-	-	(131
1180855	0	24	χ2	NN	-	-	-	-	-	-	-	-
1180855	0	25	statistic	NN	-	-	-	-	-	-	-	131)
1180855	0	26	threshold	NN	-	-	-	-	-	-	-	-
1180855	0	27	of	IN	-	-	-	-	-	-	-	-
1180855	0	28	17.4	CD	-	-	-	-	-	-	-	155)|154)
1180855	0	29	.	.	-	-	-	-	-	-	-	-

1180855	0	1	These	DT	-	-	-	-	-	-	-	(154
1180855	0	2	values	NNS	-	-	-	-	-	-	-	154)
1180855	0	3	were	VBD	-	-	-	-	-	-	-	-
1180855	0	4	consistent	JJ	-	-	-	-	-	-	-	-
1180855	0	5	with	IN	-	-	-	-	-	-	-	-
1180855	0	6	the	DT	-	-	-	-	-	-	-	-
1180855	0	7	genome	NN	-	-	-	-	-	-	-	-
1180855	0	8	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	9	wide	JJ	-	-	-	-	-	-	-	-
1180855	0	10	probabilities	NNS	-	-	-	-	-	-	-	-
1180855	0	11	projected	VBN	-	-	-	-	-	-	-	-
1180855	0	12	by	IN	-	-	-	-	-	-	-	-
1180855	0	13	Lander	NNP	-	-	-	-	-	-	-	-
1180855	0	14	and	CC	-	-	-	-	-	-	-	-
1180855	0	15	Kruglyak	NNP	-	-	-	-	-	-	-	-
1180855	0	16	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	17	23	CD	-	-	-	-	-	-	-	-
1180855	0	18	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	19	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Interval	JJ	-	-	-	-	-	-	-	-
1180855	0	2	mapping	NN	-	-	-	-	-	-	-	-
1180855	0	3	identified	VBD	-	-	-	-	-	-	-	-
1180855	0	4	a	DT	-	-	-	-	-	-	-	-
1180855	0	5	suggestive	JJ	-	-	-	-	-	-	-	-
1180855	0	6	QTL	NN	-	-	-	-	-	-	-	-
1180855	0	7	for	IN	-	-	-	-	-	-	-	-
1180855	0	8	the	DT	-	-	-	-	-	-	-	(15
1180855	0	9	BAL	NN	-	-	-	-	-	-	-	(23
1180855	0	10	protein	NN	-	-	-	-	-	-	-	23)
1180855	0	11	phenotype	NN	-	-	-	-	-	-	-	15)
1180855	0	12	on	IN	-	-	-	-	-	-	-	-
1180855	0	13	the	DT	-	-	-	-	-	-	-	(156
1180855	0	14	distal	JJ	-	-	-	-	-	-	-	-
1180855	0	15	end	NN	-	-	-	-	-	-	-	-
1180855	0	16	of	IN	-	-	-	-	-	-	-	-
1180855	0	17	chromosome	NN	-	-	-	-	-	-	-	(43|(42)
1180855	0	18	1	CD	-	-	-	-	-	-	-	43)|156)
1180855	0	19	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	20	Figure	NN	-	-	-	-	-	-	-	(157
1180855	0	21	2	CD	-	-	-	-	-	-	-	157)
1180855	0	22	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	23	.	.	-	-	-	-	-	-	-	-

1180855	0	1	No	DT	-	-	-	-	-	-	-	-
1180855	0	2	QTLs	NNS	-	-	-	-	-	-	-	-
1180855	0	3	were	VBD	-	-	-	-	-	-	-	-
1180855	0	4	identified	VBN	-	-	-	-	-	-	-	-
1180855	0	5	for	IN	-	-	-	-	-	-	-	-
1180855	0	6	the	DT	-	-	-	-	-	-	-	-
1180855	0	7	PMN	NN	-	-	-	-	-	-	-	(12)
1180855	0	8	and	CC	-	-	-	-	-	-	-	-
1180855	0	9	macrophage	NN	-	-	-	-	-	-	-	(13)
1180855	0	10	phenotypes	NNS	-	-	-	-	-	-	-	-
1180855	0	11	from	IN	-	-	-	-	-	-	-	-
1180855	0	12	selective	JJ	-	-	-	-	-	-	-	(135
1180855	0	13	genotyping	NN	-	-	-	-	-	-	-	135)
1180855	0	14	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Figure	NN	-	-	-	-	-	-	-	(157
1180855	0	2	2	CD	-	-	-	-	-	-	-	157)

1180855	0	1	Genome	NN	-	-	-	-	-	-	-	-
1180855	0	2	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	3	wide	JJ	-	-	-	-	-	-	-	-
1180855	0	4	scan	NN	-	-	-	-	-	-	-	-
1180855	0	5	for	IN	-	-	-	-	-	-	-	-
1180855	0	6	QTLs	NNS	-	-	-	-	-	-	-	-
1180855	0	7	associated	JJ	-	-	-	-	-	-	-	-
1180855	0	8	with	IN	-	-	-	-	-	-	-	-
1180855	0	9	the	DT	-	-	-	-	-	-	-	(15
1180855	0	10	BAL	NN	-	-	-	-	-	-	-	(23
1180855	0	11	protein	NN	-	-	-	-	-	-	-	23)
1180855	0	12	phenotype	NN	-	-	-	-	-	-	-	15)
1180855	0	13	by	IN	-	-	-	-	-	-	-	-
1180855	0	14	selective	JJ	-	-	-	-	-	-	-	-
1180855	0	15	genotyping	NN	-	-	-	-	-	-	-	-
1180855	0	16	of	IN	-	-	-	-	-	-	-	-
1180855	0	17	the	DT	-	-	-	-	-	-	-	(128
1180855	0	18	CByD2F2	NN	-	-	-	-	-	-	-	-
1180855	0	19	cohort	NN	-	-	-	-	-	-	-	128)
1180855	0	20	.	.	-	-	-	-	-	-	-	-

1180855	0	1	For	IN	-	-	-	-	-	-	-	-
1180855	0	2	each	DT	-	-	-	-	-	-	-	-
1180855	0	3	plot	NN	-	-	-	-	-	-	-	-
1180855	0	4	,	,	-	-	-	-	-	-	-	-
1180855	0	5	the	DT	-	-	-	-	-	-	-	-
1180855	0	6	x	NN	-	-	-	-	-	-	-	-
1180855	0	7	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	8	axis	NN	-	-	-	-	-	-	-	-
1180855	0	9	is	VBZ	-	-	-	-	-	-	-	-
1180855	0	10	the	DT	-	-	-	-	-	-	-	(158
1180855	0	11	length	NN	-	-	-	-	-	-	-	-
1180855	0	12	of	IN	-	-	-	-	-	-	-	-
1180855	0	13	the	DT	-	-	-	-	-	-	-	(42
1180855	0	14	chromosome	NN	-	-	-	-	-	-	-	42)
1180855	0	15	in	IN	-	-	-	-	-	-	-	-
1180855	0	16	centimorgans	NNS	-	-	-	-	-	-	-	(159)|158)
1180855	0	17	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	18	cM	NN	-	-	-	-	-	-	-	-
1180855	0	19	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	20	,	,	-	-	-	-	-	-	-	-
1180855	0	21	and	CC	-	-	-	-	-	-	-	-
1180855	0	22	the	DT	-	-	-	-	-	-	-	-
1180855	0	23	y	NN	-	-	-	-	-	-	-	-
1180855	0	24	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	25	axis	NN	-	-	-	-	-	-	-	-
1180855	0	26	is	VBZ	-	-	-	-	-	-	-	-
1180855	0	27	the	DT	-	-	-	-	-	-	-	(160
1180855	0	28	likelihood	NN	-	-	-	-	-	-	-	(131
1180855	0	29	χ2	NN	-	-	-	-	-	-	-	-
1180855	0	30	statistic	NN	-	-	-	-	-	-	-	131)
1180855	0	31	value	NN	-	-	-	-	-	-	-	-
1180855	0	32	as	IN	-	-	-	-	-	-	-	-
1180855	0	33	calculated	VBN	-	-	-	-	-	-	-	-
1180855	0	34	by	IN	-	-	-	-	-	-	-	-
1180855	0	35	Map	NNP	-	-	-	-	-	-	-	(129
1180855	0	36	Manager	NNP	-	-	-	-	-	-	-	160)|129)
1180855	0	37	.	.	-	-	-	-	-	-	-	-

1180855	0	1	The	DT	-	-	-	-	-	-	-	-
1180855	0	2	upper	JJ	-	-	-	-	-	-	-	-
1180855	0	3	and	CC	-	-	-	-	-	-	-	-
1180855	0	4	lower	JJ	-	-	-	-	-	-	-	-
1180855	0	5	dashed	JJ	-	-	-	-	-	-	-	-
1180855	0	6	lines	NNS	-	-	-	-	-	-	-	-
1180855	0	7	represent	VBP	-	-	-	-	-	-	-	-
1180855	0	8	significant	JJ	-	-	-	-	-	-	-	(161c)|(162c)
1180855	0	9	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	10	LRS	NN	-	-	-	-	-	-	-	(155
1180855	0	11	=	SYM	-	-	-	-	-	-	-	-
1180855	0	12	17.4	CD	-	-	-	-	-	-	-	155)
1180855	0	13	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	14	and	CC	-	-	-	-	-	-	-	(161c
1180855	0	15	suggestive	JJ	-	-	-	-	-	-	-	(163b)|161c)
1180855	0	16	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	17	LRS	NN	-	-	-	-	-	-	-	(153
1180855	0	18	=	SYM	-	-	-	-	-	-	-	-
1180855	0	19	9.9	CD	-	-	-	-	-	-	-	153)
1180855	0	20	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	21	linkage	NN	-	-	-	-	-	-	-	(161c|(162c|(163b
1180855	0	22	thresholds	NNS	-	-	-	-	-	-	-	163b)|162c)|161c)
1180855	0	23	,	,	-	-	-	-	-	-	-	-
1180855	0	24	respectively	RB	-	-	-	-	-	-	-	-
1180855	0	25	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Genotyping	NN	-	-	-	-	-	-	-	-
1180855	0	2	of	IN	-	-	-	-	-	-	-	-
1180855	0	3	the	DT	-	-	-	-	-	-	-	(128
1180855	0	4	entire	JJ	-	-	-	-	-	-	-	-
1180855	0	5	F2	NN	-	-	-	-	-	-	-	-
1180855	0	6	cohort	NN	-	-	-	-	-	-	-	128)

1180855	0	1	The	DT	-	-	-	-	-	-	-	(128
1180855	0	2	entire	JJ	-	-	-	-	-	-	-	-
1180855	0	3	F2	NN	-	-	-	-	-	-	-	-
1180855	0	4	cohort	NN	-	-	-	-	-	-	-	128)
1180855	0	5	was	VBD	-	-	-	-	-	-	-	-
1180855	0	6	genotyped	VBN	-	-	-	-	-	-	-	-
1180855	0	7	with	IN	-	-	-	-	-	-	-	-
1180855	0	8	three	CD	-	-	-	-	-	-	-	(137
1180855	0	9	additional	JJ	-	-	-	-	-	-	-	-
1180855	0	10	SSLPs	NNS	-	-	-	-	-	-	-	-
1180855	0	11	on	IN	-	-	-	-	-	-	-	-
1180855	0	12	distal	JJ	-	-	-	-	-	-	-	(156
1180855	0	13	chromosome	NN	-	-	-	-	-	-	-	-
1180855	0	14	1	CD	-	-	-	-	-	-	-	156)|137)
1180855	0	15	to	TO	-	-	-	-	-	-	-	-
1180855	0	16	further	RB	-	-	-	-	-	-	-	-
1180855	0	17	analyze	VB	-	-	-	-	-	-	-	-
1180855	0	18	the	DT	-	-	-	-	-	-	-	(164
1180855	0	19	suggestive	JJ	-	-	-	-	-	-	-	-
1180855	0	20	BAL	NN	-	-	-	-	-	-	-	(23
1180855	0	21	protein	NN	-	-	-	-	-	-	-	23)
1180855	0	22	QTL	NN	-	-	-	-	-	-	-	-
1180855	0	23	on	IN	-	-	-	-	-	-	-	-
1180855	0	24	chromosome	NN	-	-	-	-	-	-	-	(43|(42)
1180855	0	25	1	CD	-	-	-	-	-	-	-	43)
1180855	0	26	identified	VBN	-	-	-	-	-	-	-	-
1180855	0	27	from	IN	-	-	-	-	-	-	-	-
1180855	0	28	selective	JJ	-	-	-	-	-	-	-	(135
1180855	0	29	genotyping	NN	-	-	-	-	-	-	-	164)|135)
1180855	0	30	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Interval	JJ	-	-	-	-	-	-	-	-
1180855	0	2	mapping	NN	-	-	-	-	-	-	-	-
1180855	0	3	of	IN	-	-	-	-	-	-	-	-
1180855	0	4	the	DT	-	-	-	-	-	-	-	(128
1180855	0	5	entire	JJ	-	-	-	-	-	-	-	-
1180855	0	6	F2	NN	-	-	-	-	-	-	-	-
1180855	0	7	cohort	NN	-	-	-	-	-	-	-	128)
1180855	0	8	confirmed	VBD	-	-	-	-	-	-	-	-
1180855	0	9	the	DT	-	-	-	-	-	-	-	(164
1180855	0	10	QTL	NN	-	-	-	-	-	-	-	-
1180855	0	11	on	IN	-	-	-	-	-	-	-	-
1180855	0	12	chromosome	NN	-	-	-	-	-	-	-	(43|(42)
1180855	0	13	1	CD	-	-	-	-	-	-	-	43)|164)
1180855	0	14	between	IN	-	-	-	-	-	-	-	-
1180855	0	15	101.0	CD	-	-	-	-	-	-	-	-
1180855	0	16	cM	NN	-	-	-	-	-	-	-	-
1180855	0	17	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	18	D1Mit426	NN	-	-	-	-	-	-	-	-
1180855	0	19	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	20	and	CC	-	-	-	-	-	-	-	-
1180855	0	21	109.6	CD	-	-	-	-	-	-	-	-
1180855	0	22	cM	NN	-	-	-	-	-	-	-	-
1180855	0	23	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	24	D1Mit293	NN	-	-	-	-	-	-	-	-
1180855	0	25	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	26	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	27	Figure	NN	-	-	-	-	-	-	-	(165
1180855	0	28	3	CD	-	-	-	-	-	-	-	165)
1180855	0	29	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	30	.	.	-	-	-	-	-	-	-	-

1180855	0	1	The	DT	-	-	-	-	-	-	-	-
1180855	0	2	peak	NN	-	-	-	-	-	-	-	-
1180855	0	3	likelihood	NN	-	-	-	-	-	-	-	(131
1180855	0	4	χ2	NN	-	-	-	-	-	-	-	-
1180855	0	5	statistic	NN	-	-	-	-	-	-	-	131)
1180855	0	6	value	NN	-	-	-	-	-	-	-	-
1180855	0	7	for	IN	-	-	-	-	-	-	-	-
1180855	0	8	this	DT	-	-	-	-	-	-	-	(164
1180855	0	9	QTL	NN	-	-	-	-	-	-	-	164)
1180855	0	10	exceeded	VBD	-	-	-	-	-	-	-	-
1180855	0	11	the	DT	-	-	-	-	-	-	-	(166
1180855	0	12	threshold	NN	-	-	-	-	-	-	-	-
1180855	0	13	value	NN	-	-	-	-	-	-	-	-
1180855	0	14	of	IN	-	-	-	-	-	-	-	-
1180855	0	15	10.0	CD	-	-	-	-	-	-	-	166)
1180855	0	16	for	IN	-	-	-	-	-	-	-	-
1180855	0	17	significant	JJ	-	-	-	-	-	-	-	(167
1180855	0	18	linkage	NN	-	-	-	-	-	-	-	167)
1180855	0	19	as	IN	-	-	-	-	-	-	-	-
1180855	0	20	determined	VBN	-	-	-	-	-	-	-	-
1180855	0	21	by	IN	-	-	-	-	-	-	-	-
1180855	0	22	10,000	CD	-	-	-	-	-	-	-	(136
1180855	0	23	permutations	NNS	-	-	-	-	-	-	-	-
1180855	0	24	with	IN	-	-	-	-	-	-	-	-
1180855	0	25	all	DT	-	-	-	-	-	-	-	-
1180855	0	26	loci	NNS	-	-	-	-	-	-	-	-
1180855	0	27	from	IN	-	-	-	-	-	-	-	-
1180855	0	28	chromosome	NN	-	-	-	-	-	-	-	(43
1180855	0	29	1	CD	-	-	-	-	-	-	-	-
1180855	0	30	only	RB	-	-	-	-	-	-	-	43)|136)
1180855	0	31	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Figure	NN	-	-	-	-	-	-	-	(165
1180855	0	2	3	CD	-	-	-	-	-	-	-	165)

1180855	0	1	Plot	NN	-	-	-	-	-	-	-	-
1180855	0	2	of	IN	-	-	-	-	-	-	-	-
1180855	0	3	a	DT	-	-	-	-	-	-	-	(168
1180855	0	4	significant	JJ	-	-	-	-	-	-	-	-
1180855	0	5	QTL	NN	-	-	-	-	-	-	-	-
1180855	0	6	on	IN	-	-	-	-	-	-	-	-
1180855	0	7	chromosome	NN	-	-	-	-	-	-	-	(43|(42)
1180855	0	8	1	CD	-	-	-	-	-	-	-	43)
1180855	0	9	that	WDT	-	-	-	-	-	-	-	-
1180855	0	10	is	VBZ	-	-	-	-	-	-	-	-
1180855	0	11	associated	JJ	-	-	-	-	-	-	-	-
1180855	0	12	with	IN	-	-	-	-	-	-	-	-
1180855	0	13	the	DT	-	-	-	-	-	-	-	(15
1180855	0	14	BAL	NN	-	-	-	-	-	-	-	(23
1180855	0	15	protein	NN	-	-	-	-	-	-	-	23)
1180855	0	16	phenotype	NN	-	-	-	-	-	-	-	15)
1180855	0	17	from	IN	-	-	-	-	-	-	-	-
1180855	0	18	analysis	NN	-	-	-	-	-	-	-	(169
1180855	0	19	of	IN	-	-	-	-	-	-	-	-
1180855	0	20	the	DT	-	-	-	-	-	-	-	(128
1180855	0	21	entire	JJ	-	-	-	-	-	-	-	-
1180855	0	22	CByD2F2	NN	-	-	-	-	-	-	-	-
1180855	0	23	cohort	NN	-	-	-	-	-	-	-	169)|168)|128)
1180855	0	24	.	.	-	-	-	-	-	-	-	-

1180855	0	1	The	DT	-	-	-	-	-	-	-	-
1180855	0	2	x	NN	-	-	-	-	-	-	-	-
1180855	0	3	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	4	axis	NN	-	-	-	-	-	-	-	-
1180855	0	5	is	VBZ	-	-	-	-	-	-	-	-
1180855	0	6	the	DT	-	-	-	-	-	-	-	(158
1180855	0	7	length	NN	-	-	-	-	-	-	-	-
1180855	0	8	of	IN	-	-	-	-	-	-	-	-
1180855	0	9	the	DT	-	-	-	-	-	-	-	(43
1180855	0	10	chromosome	NN	-	-	-	-	-	-	-	43)
1180855	0	11	in	IN	-	-	-	-	-	-	-	-
1180855	0	12	centimorgans	NNS	-	-	-	-	-	-	-	(159)|158)
1180855	0	13	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	14	cM	NN	-	-	-	-	-	-	-	-
1180855	0	15	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	16	,	,	-	-	-	-	-	-	-	-
1180855	0	17	and	CC	-	-	-	-	-	-	-	-
1180855	0	18	the	DT	-	-	-	-	-	-	-	-
1180855	0	19	y	NN	-	-	-	-	-	-	-	-
1180855	0	20	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	21	axis	NN	-	-	-	-	-	-	-	-
1180855	0	22	is	VBZ	-	-	-	-	-	-	-	-
1180855	0	23	the	DT	-	-	-	-	-	-	-	(160
1180855	0	24	likelihood	NN	-	-	-	-	-	-	-	(131
1180855	0	25	χ2	NN	-	-	-	-	-	-	-	-
1180855	0	26	statistic	NN	-	-	-	-	-	-	-	131)
1180855	0	27	value	NN	-	-	-	-	-	-	-	-
1180855	0	28	as	IN	-	-	-	-	-	-	-	-
1180855	0	29	calculated	VBN	-	-	-	-	-	-	-	-
1180855	0	30	by	IN	-	-	-	-	-	-	-	-
1180855	0	31	Map	NNP	-	-	-	-	-	-	-	(129
1180855	0	32	Manager	NNP	-	-	-	-	-	-	-	160)|129)
1180855	0	33	.	.	-	-	-	-	-	-	-	-

1180855	0	1	The	DT	-	-	-	-	-	-	-	-
1180855	0	2	lower	JJ	-	-	-	-	-	-	-	-
1180855	0	3	dashed	JJ	-	-	-	-	-	-	-	-
1180855	0	4	line	NN	-	-	-	-	-	-	-	-
1180855	0	5	represents	VBZ	-	-	-	-	-	-	-	-
1180855	0	6	the	DT	-	-	-	-	-	-	-	(163
1180855	0	7	suggestive	JJ	-	-	-	-	-	-	-	-
1180855	0	8	linkage	NN	-	-	-	-	-	-	-	-
1180855	0	9	threshold	NN	-	-	-	-	-	-	-	163)
1180855	0	10	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	11	LRS	NN	-	-	-	-	-	-	-	-
1180855	0	12	=	SYM	-	-	-	-	-	-	-	-
1180855	0	13	3.8	CD	-	-	-	-	-	-	-	-
1180855	0	14	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	15	,	,	-	-	-	-	-	-	-	-
1180855	0	16	the	DT	-	-	-	-	-	-	-	-
1180855	0	17	middle	JJ	-	-	-	-	-	-	-	-
1180855	0	18	dashed	JJ	-	-	-	-	-	-	-	-
1180855	0	19	line	NN	-	-	-	-	-	-	-	-
1180855	0	20	represents	VBZ	-	-	-	-	-	-	-	-
1180855	0	21	significant	JJ	-	-	-	-	-	-	-	(162|(167
1180855	0	22	linkage	NN	-	-	-	-	-	-	-	167)
1180855	0	23	threshold	NN	-	-	-	-	-	-	-	162)
1180855	0	24	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	25	LRS	NN	-	-	-	-	-	-	-	(166
1180855	0	26	=	SYM	-	-	-	-	-	-	-	-
1180855	0	27	10.0	CD	-	-	-	-	-	-	-	166)
1180855	0	28	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	29	,	,	-	-	-	-	-	-	-	-
1180855	0	30	and	CC	-	-	-	-	-	-	-	-
1180855	0	31	the	DT	-	-	-	-	-	-	-	-
1180855	0	32	upper	JJ	-	-	-	-	-	-	-	-
1180855	0	33	dashed	JJ	-	-	-	-	-	-	-	-
1180855	0	34	line	NN	-	-	-	-	-	-	-	-
1180855	0	35	represents	VBZ	-	-	-	-	-	-	-	-
1180855	0	36	the	DT	-	-	-	-	-	-	-	-
1180855	0	37	highly	RB	-	-	-	-	-	-	-	-
1180855	0	38	significant	JJ	-	-	-	-	-	-	-	-
1180855	0	39	linkage	NN	-	-	-	-	-	-	-	-
1180855	0	40	threshold	NN	-	-	-	-	-	-	-	-
1180855	0	41	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	42	LRS	NN	-	-	-	-	-	-	-	-
1180855	0	43	=	SYM	-	-	-	-	-	-	-	-
1180855	0	44	18.8	CD	-	-	-	-	-	-	-	-
1180855	0	45	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	46	.	.	-	-	-	-	-	-	-	-

1180855	0	1	The	DT	-	-	-	-	-	-	-	(128
1180855	0	2	entire	JJ	-	-	-	-	-	-	-	-
1180855	0	3	F2	NN	-	-	-	-	-	-	-	-
1180855	0	4	cohort	NN	-	-	-	-	-	-	-	128)
1180855	0	5	was	VBD	-	-	-	-	-	-	-	-
1180855	0	6	further	RBR	-	-	-	-	-	-	-	-
1180855	0	7	analyzed	VBN	-	-	-	-	-	-	-	-
1180855	0	8	with	IN	-	-	-	-	-	-	-	-
1180855	0	9	the	DT	-	-	-	-	-	-	-	(109
1180855	0	10	initial	JJ	-	-	-	-	-	-	-	-
1180855	0	11	86	CD	-	-	-	-	-	-	-	-
1180855	0	12	SSLPs	NNS	-	-	-	-	-	-	-	109)
1180855	0	13	for	IN	-	-	-	-	-	-	-	-
1180855	0	14	the	DT	-	-	-	-	-	-	-	(15b|(54c
1180855	0	15	BAL	NN	-	-	-	-	-	-	-	(23|(14)|(24h)|54c)
1180855	0	16	protein	NN	-	-	-	-	-	-	-	23)|15b)
1180855	0	17	,	,	-	-	-	-	-	-	-	-
1180855	0	18	PMN	NN	-	-	-	-	-	-	-	(24h)
1180855	0	19	,	,	-	-	-	-	-	-	-	-
1180855	0	20	and	CC	-	-	-	-	-	-	-	-
1180855	0	21	macrophage	NN	-	-	-	-	-	-	-	(54c
1180855	0	22	phenotypes	NNS	-	-	-	-	-	-	-	(15)|(15b)|54c)
1180855	0	23	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Suggestive	JJ	-	-	-	-	-	-	-	-
1180855	0	2	QTLs	NNS	-	-	-	-	-	-	-	-
1180855	0	3	for	IN	-	-	-	-	-	-	-	-
1180855	0	4	the	DT	-	-	-	-	-	-	-	(15
1180855	0	5	BAL	NN	-	-	-	-	-	-	-	(23
1180855	0	6	protein	NN	-	-	-	-	-	-	-	23)
1180855	0	7	phenotype	NN	-	-	-	-	-	-	-	15)
1180855	0	8	that	WDT	-	-	-	-	-	-	-	-
1180855	0	9	were	VBD	-	-	-	-	-	-	-	-
1180855	0	10	not	RB	-	-	-	-	-	-	-	-
1180855	0	11	previously	RB	-	-	-	-	-	-	-	-
1180855	0	12	characterized	VBN	-	-	-	-	-	-	-	-
1180855	0	13	by	IN	-	-	-	-	-	-	-	-
1180855	0	14	selective	JJ	-	-	-	-	-	-	-	(135
1180855	0	15	genotyping	NN	-	-	-	-	-	-	-	135)
1180855	0	16	were	VBD	-	-	-	-	-	-	-	-
1180855	0	17	identified	VBN	-	-	-	-	-	-	-	-
1180855	0	18	on	IN	-	-	-	-	-	-	-	-
1180855	0	19	chromosome	NN	-	-	-	-	-	-	-	(47|(42)
1180855	0	20	4	CD	-	-	-	-	-	-	-	47)
1180855	0	21	between	IN	-	-	-	-	-	-	-	-
1180855	0	22	53.6	CD	-	-	-	-	-	-	-	-
1180855	0	23	cM	NN	-	-	-	-	-	-	-	-
1180855	0	24	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	25	D4Mit146	NN	-	-	-	-	-	-	-	-
1180855	0	26	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	27	and	CC	-	-	-	-	-	-	-	-
1180855	0	28	82.5	CD	-	-	-	-	-	-	-	-
1180855	0	29	cM	NN	-	-	-	-	-	-	-	-
1180855	0	30	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	31	D4Mit254	NN	-	-	-	-	-	-	-	(144)
1180855	0	32	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	33	,	,	-	-	-	-	-	-	-	-
1180855	0	34	and	CC	-	-	-	-	-	-	-	-
1180855	0	35	on	IN	-	-	-	-	-	-	-	-
1180855	0	36	chromosome	NN	-	-	-	-	-	-	-	(42)
1180855	0	37	5	CD	-	-	-	-	-	-	-	-
1180855	0	38	between	IN	-	-	-	-	-	-	-	-
1180855	0	39	1.0	CD	-	-	-	-	-	-	-	(146
1180855	0	40	cM	NN	-	-	-	-	-	-	-	146)
1180855	0	41	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	42	D5Mit193	NN	-	-	-	-	-	-	-	(145)
1180855	0	43	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	44	and	CC	-	-	-	-	-	-	-	-
1180855	0	45	18.0	CD	-	-	-	-	-	-	-	-
1180855	0	46	cM	NN	-	-	-	-	-	-	-	-
1180855	0	47	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	48	D5Mit148	NN	-	-	-	-	-	-	-	-
1180855	0	49	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	50	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	51	Figure	NN	-	-	-	-	-	-	-	(170
1180855	0	52	4	CD	-	-	-	-	-	-	-	170)
1180855	0	53	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	54	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Suggestive	JJ	-	-	-	-	-	-	-	(50b|(51
1180855	0	2	QTLs	NNS	-	-	-	-	-	-	-	-
1180855	0	3	for	IN	-	-	-	-	-	-	-	-
1180855	0	4	the	DT	-	-	-	-	-	-	-	(24|50b)
1180855	0	5	BAL	NN	-	-	-	-	-	-	-	(14)
1180855	0	6	PMN	NN	-	-	-	-	-	-	-	51)|24)
1180855	0	7	and	CC	-	-	-	-	-	-	-	-
1180855	0	8	macrophages	NNS	-	-	-	-	-	-	-	(50b)
1180855	0	9	were	VBD	-	-	-	-	-	-	-	-
1180855	0	10	identified	VBN	-	-	-	-	-	-	-	-
1180855	0	11	on	IN	-	-	-	-	-	-	-	-
1180855	0	12	chromosomes	NNS	-	-	-	-	-	-	-	(43|(55|(42)|(49k)
1180855	0	13	1	CD	-	-	-	-	-	-	-	43)
1180855	0	14	and	CC	-	-	-	-	-	-	-	-
1180855	0	15	5	CD	-	-	-	-	-	-	-	(49k)|55)
1180855	0	16	,	,	-	-	-	-	-	-	-	-
1180855	0	17	respectively	RB	-	-	-	-	-	-	-	-
1180855	0	18	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	19	Figure	NN	-	-	-	-	-	-	-	(171
1180855	0	20	5	CD	-	-	-	-	-	-	-	171)
1180855	0	21	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	22	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Figure	NN	-	-	-	-	-	-	-	(170
1180855	0	2	4	CD	-	-	-	-	-	-	-	170)

1180855	0	1	Plots	NNS	-	-	-	-	-	-	-	-
1180855	0	2	of	IN	-	-	-	-	-	-	-	-
1180855	0	3	suggestive	JJ	-	-	-	-	-	-	-	(44a|(45c|(46
1180855	0	4	QTLs	NNS	-	-	-	-	-	-	-	-
1180855	0	5	on	IN	-	-	-	-	-	-	-	-
1180855	0	6	chromosomes	NNS	-	-	-	-	-	-	-	(47|(48|(42)|(49m)|45c)
1180855	0	7	4	CD	-	-	-	-	-	-	-	47)|44a)
1180855	0	8	and	CC	-	-	-	-	-	-	-	-
1180855	0	9	5	CD	-	-	-	-	-	-	-	(45c|(49m)|48)
1180855	0	10	associated	JJ	-	-	-	-	-	-	-	(44a
1180855	0	11	with	IN	-	-	-	-	-	-	-	-
1180855	0	12	the	DT	-	-	-	-	-	-	-	(15
1180855	0	13	BAL	NN	-	-	-	-	-	-	-	(23
1180855	0	14	protein	NN	-	-	-	-	-	-	-	23)
1180855	0	15	phenotype	NN	-	-	-	-	-	-	-	46)|45c)|44a)|15)
1180855	0	16	from	IN	-	-	-	-	-	-	-	-
1180855	0	17	analysis	NN	-	-	-	-	-	-	-	(169
1180855	0	18	of	IN	-	-	-	-	-	-	-	-
1180855	0	19	the	DT	-	-	-	-	-	-	-	(128
1180855	0	20	entire	JJ	-	-	-	-	-	-	-	-
1180855	0	21	CByD2F2	NN	-	-	-	-	-	-	-	-
1180855	0	22	cohort	NN	-	-	-	-	-	-	-	169)|128)
1180855	0	23	.	.	-	-	-	-	-	-	-	-

1180855	0	1	The	DT	-	-	-	-	-	-	-	-
1180855	0	2	x	NN	-	-	-	-	-	-	-	-
1180855	0	3	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	4	axis	NN	-	-	-	-	-	-	-	-
1180855	0	5	is	VBZ	-	-	-	-	-	-	-	-
1180855	0	6	the	DT	-	-	-	-	-	-	-	(158
1180855	0	7	length	NN	-	-	-	-	-	-	-	-
1180855	0	8	of	IN	-	-	-	-	-	-	-	-
1180855	0	9	the	DT	-	-	-	-	-	-	-	(42
1180855	0	10	chromosome	NN	-	-	-	-	-	-	-	42)
1180855	0	11	in	IN	-	-	-	-	-	-	-	-
1180855	0	12	centimorgans	NNS	-	-	-	-	-	-	-	(159)|158)
1180855	0	13	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	14	cM	NN	-	-	-	-	-	-	-	-
1180855	0	15	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	16	,	,	-	-	-	-	-	-	-	-
1180855	0	17	and	CC	-	-	-	-	-	-	-	-
1180855	0	18	the	DT	-	-	-	-	-	-	-	-
1180855	0	19	y	NN	-	-	-	-	-	-	-	-
1180855	0	20	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	21	axis	NN	-	-	-	-	-	-	-	-
1180855	0	22	is	VBZ	-	-	-	-	-	-	-	-
1180855	0	23	the	DT	-	-	-	-	-	-	-	(160
1180855	0	24	likelihood	NN	-	-	-	-	-	-	-	-
1180855	0	25	χ2	NN	-	-	-	-	-	-	-	-
1180855	0	26	statistic	NN	-	-	-	-	-	-	-	-
1180855	0	27	as	IN	-	-	-	-	-	-	-	-
1180855	0	28	calculated	VBN	-	-	-	-	-	-	-	-
1180855	0	29	by	IN	-	-	-	-	-	-	-	-
1180855	0	30	Map	NNP	-	-	-	-	-	-	-	(129
1180855	0	31	Manager	NNP	-	-	-	-	-	-	-	160)|129)
1180855	0	32	.	.	-	-	-	-	-	-	-	-

1180855	0	1	The	DT	-	-	-	-	-	-	-	-
1180855	0	2	upper	JJ	-	-	-	-	-	-	-	-
1180855	0	3	and	CC	-	-	-	-	-	-	-	-
1180855	0	4	lower	JJ	-	-	-	-	-	-	-	-
1180855	0	5	dashed	JJ	-	-	-	-	-	-	-	-
1180855	0	6	lines	NNS	-	-	-	-	-	-	-	-
1180855	0	7	in	IN	-	-	-	-	-	-	-	-
1180855	0	8	each	DT	-	-	-	-	-	-	-	-
1180855	0	9	plot	NN	-	-	-	-	-	-	-	-
1180855	0	10	represent	VBP	-	-	-	-	-	-	-	-
1180855	0	11	significant	JJ	-	-	-	-	-	-	-	(161a)|(162a)
1180855	0	12	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	13	LRS	NN	-	-	-	-	-	-	-	-
1180855	0	14	=	SYM	-	-	-	-	-	-	-	-
1180855	0	15	15.8	CD	-	-	-	-	-	-	-	-
1180855	0	16	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	17	and	CC	-	-	-	-	-	-	-	(161a
1180855	0	18	suggestive	JJ	-	-	-	-	-	-	-	(163a)|161a)
1180855	0	19	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	20	LRS	NN	-	-	-	-	-	-	-	(172
1180855	0	21	=	SYM	-	-	-	-	-	-	-	-
1180855	0	22	9.2	CD	-	-	-	-	-	-	-	172)
1180855	0	23	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	24	linkage	NN	-	-	-	-	-	-	-	(161a|(162a|(163a
1180855	0	25	thresholds	NNS	-	-	-	-	-	-	-	163a)|162a)|161a)
1180855	0	26	,	,	-	-	-	-	-	-	-	-
1180855	0	27	respectively	RB	-	-	-	-	-	-	-	-
1180855	0	28	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Figure	NN	-	-	-	-	-	-	-	(171
1180855	0	2	5	CD	-	-	-	-	-	-	-	171)

1180855	0	1	Plots	NNS	-	-	-	-	-	-	-	-
1180855	0	2	of	IN	-	-	-	-	-	-	-	-
1180855	0	3	suggestive	JJ	-	-	-	-	-	-	-	(45d
1180855	0	4	QTLs	NNS	-	-	-	-	-	-	-	-
1180855	0	5	on	IN	-	-	-	-	-	-	-	-
1180855	0	6	chromosomes	NNS	-	-	-	-	-	-	-	(43|(55|(42)|(49a)|45d)
1180855	0	7	1	CD	-	-	-	-	-	-	-	43)
1180855	0	8	and	CC	-	-	-	-	-	-	-	-
1180855	0	9	5	CD	-	-	-	-	-	-	-	(45d)|(49a)|55)
1180855	0	10	associated	JJ	-	-	-	-	-	-	-	-
1180855	0	11	with	IN	-	-	-	-	-	-	-	-
1180855	0	12	the	DT	-	-	-	-	-	-	-	(52|(53b|(54a
1180855	0	13	BAL	NN	-	-	-	-	-	-	-	(24|54a)
1180855	0	14	PMN	NN	-	-	-	-	-	-	-	53b)|24)
1180855	0	15	and	CC	-	-	-	-	-	-	-	-
1180855	0	16	macrophage	NN	-	-	-	-	-	-	-	(54a
1180855	0	17	phenotypes	NNS	-	-	-	-	-	-	-	(53b)|54a)|52)
1180855	0	18	,	,	-	-	-	-	-	-	-	-
1180855	0	19	respectively	RB	-	-	-	-	-	-	-	-
1180855	0	20	,	,	-	-	-	-	-	-	-	-
1180855	0	21	from	IN	-	-	-	-	-	-	-	-
1180855	0	22	analysis	NN	-	-	-	-	-	-	-	(169
1180855	0	23	of	IN	-	-	-	-	-	-	-	-
1180855	0	24	the	DT	-	-	-	-	-	-	-	(128
1180855	0	25	entire	JJ	-	-	-	-	-	-	-	-
1180855	0	26	CByD2F2	NN	-	-	-	-	-	-	-	-
1180855	0	27	cohort	NN	-	-	-	-	-	-	-	169)|128)
1180855	0	28	.	.	-	-	-	-	-	-	-	-

1180855	0	1	The	DT	-	-	-	-	-	-	-	-
1180855	0	2	x	NN	-	-	-	-	-	-	-	-
1180855	0	3	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	4	axis	NN	-	-	-	-	-	-	-	-
1180855	0	5	is	VBZ	-	-	-	-	-	-	-	-
1180855	0	6	the	DT	-	-	-	-	-	-	-	(158
1180855	0	7	length	NN	-	-	-	-	-	-	-	-
1180855	0	8	of	IN	-	-	-	-	-	-	-	-
1180855	0	9	the	DT	-	-	-	-	-	-	-	(42
1180855	0	10	chromosome	NN	-	-	-	-	-	-	-	42)
1180855	0	11	in	IN	-	-	-	-	-	-	-	-
1180855	0	12	centimorgans	NNS	-	-	-	-	-	-	-	(159)|158)
1180855	0	13	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	14	cM	NN	-	-	-	-	-	-	-	-
1180855	0	15	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	16	,	,	-	-	-	-	-	-	-	-
1180855	0	17	and	CC	-	-	-	-	-	-	-	-
1180855	0	18	the	DT	-	-	-	-	-	-	-	-
1180855	0	19	y	NN	-	-	-	-	-	-	-	-
1180855	0	20	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	21	axis	NN	-	-	-	-	-	-	-	-
1180855	0	22	is	VBZ	-	-	-	-	-	-	-	-
1180855	0	23	the	DT	-	-	-	-	-	-	-	(160
1180855	0	24	likelihood	NN	-	-	-	-	-	-	-	-
1180855	0	25	χ2	NN	-	-	-	-	-	-	-	-
1180855	0	26	statistic	NN	-	-	-	-	-	-	-	-
1180855	0	27	as	IN	-	-	-	-	-	-	-	-
1180855	0	28	calculated	VBN	-	-	-	-	-	-	-	-
1180855	0	29	by	IN	-	-	-	-	-	-	-	-
1180855	0	30	Map	NNP	-	-	-	-	-	-	-	(129
1180855	0	31	Manager	NNP	-	-	-	-	-	-	-	160)|129)
1180855	0	32	.	.	-	-	-	-	-	-	-	-

1180855	0	1	The	DT	-	-	-	-	-	-	-	-
1180855	0	2	upper	JJ	-	-	-	-	-	-	-	-
1180855	0	3	and	CC	-	-	-	-	-	-	-	-
1180855	0	4	lower	JJ	-	-	-	-	-	-	-	-
1180855	0	5	dashed	JJ	-	-	-	-	-	-	-	-
1180855	0	6	lines	NNS	-	-	-	-	-	-	-	-
1180855	0	7	in	IN	-	-	-	-	-	-	-	-
1180855	0	8	each	DT	-	-	-	-	-	-	-	-
1180855	0	9	plot	NN	-	-	-	-	-	-	-	-
1180855	0	10	represent	VBP	-	-	-	-	-	-	-	-
1180855	0	11	significant	JJ	-	-	-	-	-	-	-	(161b)|(162b)
1180855	0	12	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	13	LRS	NN	-	-	-	-	-	-	-	-
1180855	0	14	=	SYM	-	-	-	-	-	-	-	-
1180855	0	15	15.6	CD	-	-	-	-	-	-	-	-
1180855	0	16	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	17	and	CC	-	-	-	-	-	-	-	(161b
1180855	0	18	suggestive	JJ	-	-	-	-	-	-	-	(163c)|161b)
1180855	0	19	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	20	LRS	NN	-	-	-	-	-	-	-	(172
1180855	0	21	=	SYM	-	-	-	-	-	-	-	-
1180855	0	22	9.2	CD	-	-	-	-	-	-	-	172)
1180855	0	23	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	24	linkage	NN	-	-	-	-	-	-	-	(161b|(162b|(163c
1180855	0	25	thresholds	NNS	-	-	-	-	-	-	-	163c)|162b)|161b)
1180855	0	26	,	,	-	-	-	-	-	-	-	-
1180855	0	27	respectively	RB	-	-	-	-	-	-	-	-
1180855	0	28	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Haplotype	NN	-	-	-	-	-	-	-	(139
1180855	0	2	analysis	NN	-	-	-	-	-	-	-	139)

1180855	0	1	Mean	NN	-	-	-	-	-	-	-	(126|(147
1180855	0	2	BAL	NN	-	-	-	-	-	-	-	(23
1180855	0	3	protein	NN	-	-	-	-	-	-	-	23)|126)
1180855	0	4	levels	NNS	-	-	-	-	-	-	-	-
1180855	0	5	of	IN	-	-	-	-	-	-	-	-
1180855	0	6	F2	NN	-	-	-	-	-	-	-	(148
1180855	0	7	mice	NNS	-	-	-	-	-	-	-	-
1180855	0	8	with	IN	-	-	-	-	-	-	-	-
1180855	0	9	the	DT	-	-	-	-	-	-	-	-
1180855	0	10	same	JJ	-	-	-	-	-	-	-	-
1180855	0	11	haplotype	NN	-	-	-	-	-	-	-	148)|147)
1180855	0	12	were	VBD	-	-	-	-	-	-	-	-
1180855	0	13	calculated	VBN	-	-	-	-	-	-	-	-
1180855	0	14	and	CC	-	-	-	-	-	-	-	-
1180855	0	15	compared	VBN	-	-	-	-	-	-	-	-
1180855	0	16	with	IN	-	-	-	-	-	-	-	-
1180855	0	17	the	DT	-	-	-	-	-	-	-	(149
1180855	0	18	mean	JJ	-	-	-	-	-	-	-	(126
1180855	0	19	BAL	NN	-	-	-	-	-	-	-	-
1180855	0	20	protein	NN	-	-	-	-	-	-	-	126)
1180855	0	21	levels	NNS	-	-	-	-	-	-	-	-
1180855	0	22	of	IN	-	-	-	-	-	-	-	-
1180855	0	23	F2	NN	-	-	-	-	-	-	-	(150
1180855	0	24	mice	NNS	-	-	-	-	-	-	-	-
1180855	0	25	with	IN	-	-	-	-	-	-	-	-
1180855	0	26	the	DT	-	-	-	-	-	-	-	-
1180855	0	27	opposite	JJ	-	-	-	-	-	-	-	-
1180855	0	28	haplotype	NN	-	-	-	-	-	-	-	150)|149)
1180855	0	29	in	IN	-	-	-	-	-	-	-	-
1180855	0	30	order	NN	-	-	-	-	-	-	-	-
1180855	0	31	to	TO	-	-	-	-	-	-	-	-
1180855	0	32	determine	VB	-	-	-	-	-	-	-	-
1180855	0	33	the	DT	-	-	-	-	-	-	-	(30b|(31|(32d
1180855	0	34	contribution	NN	-	-	-	-	-	-	-	-
1180855	0	35	of	IN	-	-	-	-	-	-	-	30b)
1180855	0	36	each	DT	-	-	-	-	-	-	-	(33
1180855	0	37	QTL	NN	-	-	-	-	-	-	-	33)|32d)
1180855	0	38	and	CC	-	-	-	-	-	-	-	-
1180855	0	39	combinations	NNS	-	-	-	-	-	-	-	(30b
1180855	0	40	of	IN	-	-	-	-	-	-	-	-
1180855	0	41	QTLs	NNS	-	-	-	-	-	-	-	(36)
1180855	0	42	to	IN	-	-	-	-	-	-	-	(32d
1180855	0	43	the	DT	-	-	-	-	-	-	-	(37
1180855	0	44	overall	JJ	-	-	-	-	-	-	-	-
1180855	0	45	BAL	NN	-	-	-	-	-	-	-	(23
1180855	0	46	protein	NN	-	-	-	-	-	-	-	23)
1180855	0	47	phenotype	NN	-	-	-	-	-	-	-	37)|32d)|31)|30b)
1180855	0	48	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	49	Figure	NN	-	-	-	-	-	-	-	(173
1180855	0	50	6	CD	-	-	-	-	-	-	-	173)
1180855	0	51	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	52	.	.	-	-	-	-	-	-	-	-

1180855	0	1	For	IN	-	-	-	-	-	-	-	-
1180855	0	2	each	DT	-	-	-	-	-	-	-	(115
1180855	0	3	SSLP	NN	-	-	-	-	-	-	-	115)
1180855	0	4	,	,	-	-	-	-	-	-	-	-
1180855	0	5	F2	NN	-	-	-	-	-	-	-	(22
1180855	0	6	animals	NNS	-	-	-	-	-	-	-	22)
1180855	0	7	were	VBD	-	-	-	-	-	-	-	-
1180855	0	8	genotyped	VBN	-	-	-	-	-	-	-	-
1180855	0	9	as	IN	-	-	-	-	-	-	-	-
1180855	0	10	a	DT	-	-	-	-	-	-	-	-
1180855	0	11	homozygous	JJ	-	-	-	-	-	-	-	-
1180855	0	12	CBy	NN	-	-	-	-	-	-	-	-
1180855	0	13	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	14	CC	NN	-	-	-	-	-	-	-	(174)
1180855	0	15	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	16	,	,	-	-	-	-	-	-	-	-
1180855	0	17	a	DT	-	-	-	-	-	-	-	-
1180855	0	18	homozygous	JJ	-	-	-	-	-	-	-	-
1180855	0	19	D2	NN	-	-	-	-	-	-	-	-
1180855	0	20	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	21	DD	NN	-	-	-	-	-	-	-	(175)
1180855	0	22	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	23	or	CC	-	-	-	-	-	-	-	-
1180855	0	24	heterozygous	JJ	-	-	-	-	-	-	-	(176)
1180855	0	25	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	26	H	NN	-	-	-	-	-	-	-	-
1180855	0	27	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	28	.	.	-	-	-	-	-	-	-	-

1180855	0	1	For	IN	-	-	-	-	-	-	-	-
1180855	0	2	any	DT	-	-	-	-	-	-	-	-
1180855	0	3	individual	JJ	-	-	-	-	-	-	-	-
1180855	0	4	SSLP	NN	-	-	-	-	-	-	-	-
1180855	0	5	,	,	-	-	-	-	-	-	-	-
1180855	0	6	the	DT	-	-	-	-	-	-	-	-
1180855	0	7	greatest	JJS	-	-	-	-	-	-	-	-
1180855	0	8	difference	NN	-	-	-	-	-	-	-	-
1180855	0	9	in	IN	-	-	-	-	-	-	-	-
1180855	0	10	mean	NN	-	-	-	-	-	-	-	(126
1180855	0	11	BAL	NN	-	-	-	-	-	-	-	(14)
1180855	0	12	protein	NN	-	-	-	-	-	-	-	126)
1180855	0	13	was	VBD	-	-	-	-	-	-	-	-
1180855	0	14	found	VBN	-	-	-	-	-	-	-	-
1180855	0	15	for	IN	-	-	-	-	-	-	-	-
1180855	0	16	D1Mit291	NN	-	-	-	-	-	-	-	(143)
1180855	0	17	.	.	-	-	-	-	-	-	-	-

1180855	0	1	F2	NN	-	-	-	-	-	-	-	(177
1180855	0	2	mice	NNS	-	-	-	-	-	-	-	-
1180855	0	3	that	WDT	-	-	-	-	-	-	-	-
1180855	0	4	were	VBD	-	-	-	-	-	-	-	-
1180855	0	5	DD	NN	-	-	-	-	-	-	-	(175)
1180855	0	6	at	IN	-	-	-	-	-	-	-	-
1180855	0	7	that	DT	-	-	-	-	-	-	-	(143
1180855	0	8	locus	NN	-	-	-	-	-	-	-	177)|143)
1180855	0	9	had	VBD	-	-	-	-	-	-	-	-
1180855	0	10	an	DT	-	-	-	-	-	-	-	-
1180855	0	11	average	NN	-	-	-	-	-	-	-	-
1180855	0	12	of	IN	-	-	-	-	-	-	-	-
1180855	0	13	156	CD	-	-	-	-	-	-	-	-
1180855	0	14	μg	NN	-	-	-	-	-	-	-	-
1180855	0	15	/	SYM	-	-	-	-	-	-	-	-
1180855	0	16	ml	NN	-	-	-	-	-	-	-	-
1180855	0	17	more	JJR	-	-	-	-	-	-	-	-
1180855	0	18	BAL	NN	-	-	-	-	-	-	-	(23
1180855	0	19	protein	NN	-	-	-	-	-	-	-	23)
1180855	0	20	than	IN	-	-	-	-	-	-	-	-
1180855	0	21	those	DT	-	-	-	-	-	-	-	(178a
1180855	0	22	mice	NNS	-	-	-	-	-	-	-	-
1180855	0	23	that	WDT	-	-	-	-	-	-	-	-
1180855	0	24	had	VBD	-	-	-	-	-	-	-	-
1180855	0	25	CC	NN	-	-	-	-	-	-	-	(174a)|178a)
1180855	0	26	or	CC	-	-	-	-	-	-	-	-
1180855	0	27	H	NN	-	-	-	-	-	-	-	(176
1180855	0	28	haplotypes	NNS	-	-	-	-	-	-	-	(174a)|(178a)|176)
1180855	0	29	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Figure	NN	-	-	-	-	-	-	-	(173
1180855	0	2	6	CD	-	-	-	-	-	-	-	173)

1180855	0	1	Differences	NNS	-	-	-	-	-	-	-	-
1180855	0	2	in	IN	-	-	-	-	-	-	-	-
1180855	0	3	mean	NN	-	-	-	-	-	-	-	(126|(142
1180855	0	4	BAL	NN	-	-	-	-	-	-	-	(23
1180855	0	5	protein	NN	-	-	-	-	-	-	-	23)|126)
1180855	0	6	levels	NNS	-	-	-	-	-	-	-	142)
1180855	0	7	of	IN	-	-	-	-	-	-	-	-
1180855	0	8	CByD2F2	NN	-	-	-	-	-	-	-	-
1180855	0	9	mice	NNS	-	-	-	-	-	-	-	-
1180855	0	10	with	IN	-	-	-	-	-	-	-	-
1180855	0	11	tolerant	JJ	-	-	-	-	-	-	-	(179b)
1180855	0	12	versus	CC	-	-	-	-	-	-	-	-
1180855	0	13	non-tolerant	JJ	-	-	-	-	-	-	-	(180
1180855	0	14	haplotypes	NNS	-	-	-	-	-	-	-	(179b)|180)
1180855	0	15	at	IN	-	-	-	-	-	-	-	-
1180855	0	16	SSLPs	NNS	-	-	-	-	-	-	-	-
1180855	0	17	representing	VBG	-	-	-	-	-	-	-	-
1180855	0	18	the	DT	-	-	-	-	-	-	-	-
1180855	0	19	identified	VBN	-	-	-	-	-	-	-	-
1180855	0	20	QTLs	NNS	-	-	-	-	-	-	-	-
1180855	0	21	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Open	JJ	-	-	-	-	-	-	-	(181
1180855	0	2	bars	NNS	-	-	-	-	-	-	-	181)
1180855	0	3	,	,	-	-	-	-	-	-	-	-
1180855	0	4	F2	NN	-	-	-	-	-	-	-	(178b
1180855	0	5	mice	NNS	-	-	-	-	-	-	-	-
1180855	0	6	with	IN	-	-	-	-	-	-	-	-
1180855	0	7	CC	NN	-	-	-	-	-	-	-	(174b)|178b)
1180855	0	8	or	CC	-	-	-	-	-	-	-	-
1180855	0	9	CD	NN	-	-	-	-	-	-	-	-
1180855	0	10	genotypes	NNS	-	-	-	-	-	-	-	(174b)|(178b)
1180855	0	11	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	12	represented	VBN	-	-	-	-	-	-	-	-
1180855	0	13	as	IN	-	-	-	-	-	-	-	-
1180855	0	14	H	NN	-	-	-	-	-	-	-	(176)
1180855	0	15	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	16	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Filled	VBN	-	-	-	-	-	-	-	(182
1180855	0	2	bars	NNS	-	-	-	-	-	-	-	182)
1180855	0	3	,	,	-	-	-	-	-	-	-	-
1180855	0	4	F2	NN	-	-	-	-	-	-	-	(177
1180855	0	5	mice	NNS	-	-	-	-	-	-	-	-
1180855	0	6	with	IN	-	-	-	-	-	-	-	-
1180855	0	7	a	DT	-	-	-	-	-	-	-	-
1180855	0	8	DD	NN	-	-	-	-	-	-	-	-
1180855	0	9	genotype	NN	-	-	-	-	-	-	-	177)
1180855	0	10	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	11	represented	VBN	-	-	-	-	-	-	-	-
1180855	0	12	as	IN	-	-	-	-	-	-	-	-
1180855	0	13	D	NN	-	-	-	-	-	-	-	-
1180855	0	14	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	15	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Number	NN	-	-	-	-	-	-	-	-
1180855	0	2	within	IN	-	-	-	-	-	-	-	-
1180855	0	3	each	DT	-	-	-	-	-	-	-	-
1180855	0	4	bar	NN	-	-	-	-	-	-	-	-
1180855	0	5	is	VBZ	-	-	-	-	-	-	-	-
1180855	0	6	the	DT	-	-	-	-	-	-	-	-
1180855	0	7	number	NN	-	-	-	-	-	-	-	-
1180855	0	8	of	IN	-	-	-	-	-	-	-	-
1180855	0	9	F2	NN	-	-	-	-	-	-	-	-
1180855	0	10	mice	NNS	-	-	-	-	-	-	-	-
1180855	0	11	with	IN	-	-	-	-	-	-	-	-
1180855	0	12	the	DT	-	-	-	-	-	-	-	-
1180855	0	13	given	VBN	-	-	-	-	-	-	-	-
1180855	0	14	genotype	NN	-	-	-	-	-	-	-	-
1180855	0	15	or	CC	-	-	-	-	-	-	-	-
1180855	0	16	haplotype	NN	-	-	-	-	-	-	-	-
1180855	0	17	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Values	NNS	-	-	-	-	-	-	-	-
1180855	0	2	are	VBP	-	-	-	-	-	-	-	-
1180855	0	3	means	NNS	-	-	-	-	-	-	-	-
1180855	0	4	±	SYM	-	-	-	-	-	-	-	-
1180855	0	5	SE	NN	-	-	-	-	-	-	-	-
1180855	0	6	.	.	-	-	-	-	-	-	-	-

1180855	0	1	All	DT	-	-	-	-	-	-	-	-
1180855	0	2	comparisons	NNS	-	-	-	-	-	-	-	-
1180855	0	3	of	IN	-	-	-	-	-	-	-	-
1180855	0	4	tolerant	JJ	-	-	-	-	-	-	-	(179a)
1180855	0	5	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	6	open	JJ	-	-	-	-	-	-	-	(181
1180855	0	7	bars	NNS	-	-	-	-	-	-	-	181)
1180855	0	8	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	9	haplotypes	NNS	-	-	-	-	-	-	-	(179a)
1180855	0	10	versus	CC	-	-	-	-	-	-	-	-
1180855	0	11	non-tolerant	JJ	-	-	-	-	-	-	-	(180
1180855	0	12	haplotypes	NNS	-	-	-	-	-	-	-	180)
1180855	0	13	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	14	filled	VBN	-	-	-	-	-	-	-	(182
1180855	0	15	bars	NNS	-	-	-	-	-	-	-	182)
1180855	0	16	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	17	were	VBD	-	-	-	-	-	-	-	-
1180855	0	18	significant	JJ	-	-	-	-	-	-	-	-
1180855	0	19	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	20	P	NN	-	-	-	-	-	-	-	(183
1180855	0	21	<	SYM	-	-	-	-	-	-	-	-
1180855	0	22	0.05	CD	-	-	-	-	-	-	-	183)
1180855	0	23	,	,	-	-	-	-	-	-	-	-
1180855	0	24	t	NN	-	-	-	-	-	-	-	-
1180855	0	25	test	NN	-	-	-	-	-	-	-	-
1180855	0	26	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	27	.	.	-	-	-	-	-	-	-	-

1180855	0	1	The	DT	-	-	-	-	-	-	-	-
1180855	0	2	combinatorial	JJ	-	-	-	-	-	-	-	-
1180855	0	3	effect	NN	-	-	-	-	-	-	-	-
1180855	0	4	of	IN	-	-	-	-	-	-	-	-
1180855	0	5	the	DT	-	-	-	-	-	-	-	(184|(185a|(186a|(56
1180855	0	6	QTLs	NNS	-	-	-	-	-	-	-	-
1180855	0	7	on	IN	-	-	-	-	-	-	-	-
1180855	0	8	chromosomes	NNS	-	-	-	-	-	-	-	(187|(43|(42)|(47a)|(49j)|186a)|185a)
1180855	0	9	1	CD	-	-	-	-	-	-	-	43)|184)
1180855	0	10	,	,	-	-	-	-	-	-	-	-
1180855	0	11	4	CD	-	-	-	-	-	-	-	(185a)|(47a)
1180855	0	12	,	,	-	-	-	-	-	-	-	-
1180855	0	13	and	CC	-	-	-	-	-	-	-	-
1180855	0	14	5	CD	-	-	-	-	-	-	-	(186a)|(49j)|56)|187)
1180855	0	15	were	VBD	-	-	-	-	-	-	-	-
1180855	0	16	also	RB	-	-	-	-	-	-	-	-
1180855	0	17	examined	VBN	-	-	-	-	-	-	-	-
1180855	0	18	.	.	-	-	-	-	-	-	-	-

1180855	0	1	For	IN	-	-	-	-	-	-	-	-
1180855	0	2	any	DT	-	-	-	-	-	-	-	-
1180855	0	3	combination	NN	-	-	-	-	-	-	-	-
1180855	0	4	of	IN	-	-	-	-	-	-	-	-
1180855	0	5	two	CD	-	-	-	-	-	-	-	-
1180855	0	6	QTLs	NNS	-	-	-	-	-	-	-	-
1180855	0	7	,	,	-	-	-	-	-	-	-	-
1180855	0	8	F2	NN	-	-	-	-	-	-	-	-
1180855	0	9	mice	NNS	-	-	-	-	-	-	-	-
1180855	0	10	that	WDT	-	-	-	-	-	-	-	-
1180855	0	11	had	VBD	-	-	-	-	-	-	-	-
1180855	0	12	a	DT	-	-	-	-	-	-	-	-
1180855	0	13	DD	NN	-	-	-	-	-	-	-	-
1180855	0	14	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	15	DD	NN	-	-	-	-	-	-	-	-
1180855	0	16	haplotype	NN	-	-	-	-	-	-	-	-
1180855	0	17	for	IN	-	-	-	-	-	-	-	-
1180855	0	18	markers	NNS	-	-	-	-	-	-	-	-
1180855	0	19	on	IN	-	-	-	-	-	-	-	-
1180855	0	20	chromosomes	NNS	-	-	-	-	-	-	-	(43|(55|(42)
1180855	0	21	1	CD	-	-	-	-	-	-	-	43)
1180855	0	22	and	CC	-	-	-	-	-	-	-	-
1180855	0	23	5	CD	-	-	-	-	-	-	-	55)
1180855	0	24	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	25	D1Mit291	NN	-	-	-	-	-	-	-	(188|(143)
1180855	0	26	and	CC	-	-	-	-	-	-	-	-
1180855	0	27	D5Mit193	NN	-	-	-	-	-	-	-	(145)|188)
1180855	0	28	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	29	had	VBD	-	-	-	-	-	-	-	-
1180855	0	30	an	DT	-	-	-	-	-	-	-	-
1180855	0	31	average	NN	-	-	-	-	-	-	-	-
1180855	0	32	of	IN	-	-	-	-	-	-	-	-
1180855	0	33	310	CD	-	-	-	-	-	-	-	-
1180855	0	34	μg	NN	-	-	-	-	-	-	-	-
1180855	0	35	/	SYM	-	-	-	-	-	-	-	-
1180855	0	36	ml	NN	-	-	-	-	-	-	-	-
1180855	0	37	more	JJR	-	-	-	-	-	-	-	-
1180855	0	38	BAL	NN	-	-	-	-	-	-	-	(23
1180855	0	39	protein	NN	-	-	-	-	-	-	-	23)
1180855	0	40	than	IN	-	-	-	-	-	-	-	-
1180855	0	41	those	DT	-	-	-	-	-	-	-	-
1180855	0	42	that	WDT	-	-	-	-	-	-	-	-
1180855	0	43	were	VBD	-	-	-	-	-	-	-	-
1180855	0	44	CC	NN	-	-	-	-	-	-	-	(189
1180855	0	45	or	CC	-	-	-	-	-	-	-	-
1180855	0	46	H	NN	-	-	-	-	-	-	-	189)
1180855	0	47	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	48	CC	NN	-	-	-	-	-	-	-	-
1180855	0	49	/	HYPH	-	-	-	-	-	-	-	-
1180855	0	50	H	NN	-	-	-	-	-	-	-	-
1180855	0	51	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	52	for	IN	-	-	-	-	-	-	-	-
1180855	0	53	those	DT	-	-	-	-	-	-	-	(188
1180855	0	54	markers	NNS	-	-	-	-	-	-	-	188)
1180855	0	55	.	.	-	-	-	-	-	-	-	-

1180855	0	1	The	DT	-	-	-	-	-	-	-	-
1180855	0	2	greatest	JJS	-	-	-	-	-	-	-	-
1180855	0	3	difference	NN	-	-	-	-	-	-	-	-
1180855	0	4	in	IN	-	-	-	-	-	-	-	-
1180855	0	5	mean	NN	-	-	-	-	-	-	-	(126|(142
1180855	0	6	BAL	NN	-	-	-	-	-	-	-	(23
1180855	0	7	protein	NN	-	-	-	-	-	-	-	23)|126)
1180855	0	8	levels	NNS	-	-	-	-	-	-	-	142)
1180855	0	9	were	VBD	-	-	-	-	-	-	-	-
1180855	0	10	found	VBN	-	-	-	-	-	-	-	-
1180855	0	11	in	IN	-	-	-	-	-	-	-	-
1180855	0	12	F2	NN	-	-	-	-	-	-	-	(190
1180855	0	13	mice	NNS	-	-	-	-	-	-	-	-
1180855	0	14	that	WDT	-	-	-	-	-	-	-	-
1180855	0	15	had	VBD	-	-	-	-	-	-	-	-
1180855	0	16	a	DT	-	-	-	-	-	-	-	-
1180855	0	17	DD	NN	-	-	-	-	-	-	-	-
1180855	0	18	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	19	CC	NN	-	-	-	-	-	-	-	-
1180855	0	20	/	HYPH	-	-	-	-	-	-	-	-
1180855	0	21	H	NN	-	-	-	-	-	-	-	-
1180855	0	22	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	23	DD	NN	-	-	-	-	-	-	-	-
1180855	0	24	haplotype	NN	-	-	-	-	-	-	-	-
1180855	0	25	for	IN	-	-	-	-	-	-	-	-
1180855	0	26	the	DT	-	-	-	-	-	-	-	(56
1180855	0	27	three	CD	-	-	-	-	-	-	-	-
1180855	0	28	QTLs	NNS	-	-	-	-	-	-	-	-
1180855	0	29	on	IN	-	-	-	-	-	-	-	-
1180855	0	30	chromosomes	NNS	-	-	-	-	-	-	-	(187|(43|(42)|(47b)|(49l)
1180855	0	31	1	CD	-	-	-	-	-	-	-	43)
1180855	0	32	,	,	-	-	-	-	-	-	-	-
1180855	0	33	4	CD	-	-	-	-	-	-	-	(47b)
1180855	0	34	,	,	-	-	-	-	-	-	-	-
1180855	0	35	and	CC	-	-	-	-	-	-	-	-
1180855	0	36	5	CD	-	-	-	-	-	-	-	(49l)|56)|190)|187)
1180855	0	37	,	,	-	-	-	-	-	-	-	-
1180855	0	38	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	39	i.e.	FW	-	-	-	-	-	-	-	-
1180855	0	40	,	,	-	-	-	-	-	-	-	-
1180855	0	41	D1Mit291	NN	-	-	-	-	-	-	-	(191|(143)
1180855	0	42	,	,	-	-	-	-	-	-	-	-
1180855	0	43	D4Mit254	NN	-	-	-	-	-	-	-	(144)
1180855	0	44	,	,	-	-	-	-	-	-	-	-
1180855	0	45	and	CC	-	-	-	-	-	-	-	-
1180855	0	46	D5Mit193	NN	-	-	-	-	-	-	-	(145)|191)
1180855	0	47	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	48	,	,	-	-	-	-	-	-	-	-
1180855	0	49	respectively	RB	-	-	-	-	-	-	-	-
1180855	0	50	.	.	-	-	-	-	-	-	-	-

1180855	0	1	These	DT	-	-	-	-	-	-	-	(190
1180855	0	2	mice	NNS	-	-	-	-	-	-	-	190)
1180855	0	3	had	VBD	-	-	-	-	-	-	-	-
1180855	0	4	an	DT	-	-	-	-	-	-	-	-
1180855	0	5	average	NN	-	-	-	-	-	-	-	-
1180855	0	6	of	IN	-	-	-	-	-	-	-	-
1180855	0	7	345	CD	-	-	-	-	-	-	-	-
1180855	0	8	μg	NN	-	-	-	-	-	-	-	-
1180855	0	9	/	SYM	-	-	-	-	-	-	-	-
1180855	0	10	ml	NN	-	-	-	-	-	-	-	-
1180855	0	11	more	JJR	-	-	-	-	-	-	-	-
1180855	0	12	BAL	NN	-	-	-	-	-	-	-	(23
1180855	0	13	protein	NN	-	-	-	-	-	-	-	23)
1180855	0	14	than	IN	-	-	-	-	-	-	-	-
1180855	0	15	those	DT	-	-	-	-	-	-	-	-
1180855	0	16	that	WDT	-	-	-	-	-	-	-	-
1180855	0	17	were	VBD	-	-	-	-	-	-	-	-
1180855	0	18	CC	NN	-	-	-	-	-	-	-	(189
1180855	0	19	/	HYPH	-	-	-	-	-	-	-	-
1180855	0	20	H	NN	-	-	-	-	-	-	-	189)
1180855	0	21	at	IN	-	-	-	-	-	-	-	-
1180855	0	22	the	DT	-	-	-	-	-	-	-	(191
1180855	0	23	markers	NNS	-	-	-	-	-	-	-	-
1180855	0	24	across	IN	-	-	-	-	-	-	-	-
1180855	0	25	the	DT	-	-	-	-	-	-	-	-
1180855	0	26	three	CD	-	-	-	-	-	-	-	-
1180855	0	27	chromosomes	NNS	-	-	-	-	-	-	-	191)
1180855	0	28	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Identification	NN	-	-	-	-	-	-	-	-
1180855	0	2	of	IN	-	-	-	-	-	-	-	-
1180855	0	3	candidate	NN	-	-	-	-	-	-	-	(20
1180855	0	4	genes	NNS	-	-	-	-	-	-	-	20)

1180855	0	1	Within	IN	-	-	-	-	-	-	-	-
1180855	0	2	all	DT	-	-	-	-	-	-	-	-
1180855	0	3	of	IN	-	-	-	-	-	-	-	-
1180855	0	4	the	DT	-	-	-	-	-	-	-	-
1180855	0	5	QTLs	NNS	-	-	-	-	-	-	-	-
1180855	0	6	,	,	-	-	-	-	-	-	-	-
1180855	0	7	candidate	NN	-	-	-	-	-	-	-	(20
1180855	0	8	genes	NNS	-	-	-	-	-	-	-	-
1180855	0	9	discovered	VBN	-	-	-	-	-	-	-	-
1180855	0	10	with	IN	-	-	-	-	-	-	-	-
1180855	0	11	potential	JJ	-	-	-	-	-	-	-	-
1180855	0	12	roles	NNS	-	-	-	-	-	-	-	-
1180855	0	13	in	IN	-	-	-	-	-	-	-	-
1180855	0	14	controlling	VBG	-	-	-	-	-	-	-	-
1180855	0	15	the	DT	-	-	-	-	-	-	-	(1
1180855	0	16	development	NN	-	-	-	-	-	-	-	-
1180855	0	17	of	IN	-	-	-	-	-	-	-	-
1180855	0	18	tolerance	NN	-	-	-	-	-	-	-	-
1180855	0	19	to	IN	-	-	-	-	-	-	-	-
1180855	0	20	inhaled	VBN	-	-	-	-	-	-	-	(3
1180855	0	21	ZnO	NN	-	-	-	-	-	-	-	3)|20)|1)
1180855	0	22	are	VBP	-	-	-	-	-	-	-	-
1180855	0	23	presented	VBN	-	-	-	-	-	-	-	-
1180855	0	24	in	IN	-	-	-	-	-	-	-	-
1180855	0	25	Tables	NNS	-	-	-	-	-	-	-	(192|(193a)
1180855	0	26	1	CD	-	-	-	-	-	-	-	192)
1180855	0	27	and	CC	-	-	-	-	-	-	-	-
1180855	0	28	2	CD	-	-	-	-	-	-	-	(193a)
1180855	0	29	.	.	-	-	-	-	-	-	-	-

1180855	0	1	These	DT	-	-	-	-	-	-	-	(20
1180855	0	2	genes	NNS	-	-	-	-	-	-	-	20)
1180855	0	3	were	VBD	-	-	-	-	-	-	-	-
1180855	0	4	chosen	VBN	-	-	-	-	-	-	-	-
1180855	0	5	as	IN	-	-	-	-	-	-	-	-
1180855	0	6	candidates	NNS	-	-	-	-	-	-	-	-
1180855	0	7	from	IN	-	-	-	-	-	-	-	-
1180855	0	8	a	DT	-	-	-	-	-	-	-	-
1180855	0	9	thorough	JJ	-	-	-	-	-	-	-	-
1180855	0	10	review	NN	-	-	-	-	-	-	-	-
1180855	0	11	of	IN	-	-	-	-	-	-	-	-
1180855	0	12	the	DT	-	-	-	-	-	-	-	-
1180855	0	13	existing	VBG	-	-	-	-	-	-	-	-
1180855	0	14	literature	NN	-	-	-	-	-	-	-	-
1180855	0	15	and	CC	-	-	-	-	-	-	-	-
1180855	0	16	through	IN	-	-	-	-	-	-	-	-
1180855	0	17	the	DT	-	-	-	-	-	-	-	(38
1180855	0	18	positional	JJ	-	-	-	-	-	-	-	(39
1180855	0	19	candidate	NN	-	-	-	-	-	-	-	-
1180855	0	20	gene	NN	-	-	-	-	-	-	-	39)
1180855	0	21	approach	NN	-	-	-	-	-	-	-	38)
1180855	0	22	,	,	-	-	-	-	-	-	-	-
1180855	0	23	which	WDT	-	-	-	-	-	-	-	-
1180855	0	24	combines	VBZ	-	-	-	-	-	-	-	-
1180855	0	25	knowledge	NN	-	-	-	-	-	-	-	-
1180855	0	26	of	IN	-	-	-	-	-	-	-	-
1180855	0	27	map	NN	-	-	-	-	-	-	-	-
1180855	0	28	position	NN	-	-	-	-	-	-	-	-
1180855	0	29	with	IN	-	-	-	-	-	-	-	-
1180855	0	30	the	DT	-	-	-	-	-	-	-	-
1180855	0	31	mouse	NN	-	-	-	-	-	-	-	-
1180855	0	32	transcript	NN	-	-	-	-	-	-	-	-
1180855	0	33	map	NN	-	-	-	-	-	-	-	-
1180855	0	34	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	35	24	CD	-	-	-	-	-	-	-	-
1180855	0	36	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	37	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Table	NN	-	-	-	-	-	-	-	(192
1180855	0	2	1	CD	-	-	-	-	-	-	-	192)

1180855	0	1	Positional	JJ	-	-	-	-	-	-	-	-
1180855	0	2	candidate	NN	-	-	-	-	-	-	-	-
1180855	0	3	genes	NNS	-	-	-	-	-	-	-	-
1180855	0	4	from	IN	-	-	-	-	-	-	-	-
1180855	0	5	linkage	NN	-	-	-	-	-	-	-	-
1180855	0	6	analysis	NN	-	-	-	-	-	-	-	-
1180855	0	7	of	IN	-	-	-	-	-	-	-	-
1180855	0	8	pulmonary	JJ	-	-	-	-	-	-	-	(62
1180855	0	9	tolerance	NN	-	-	-	-	-	-	-	-
1180855	0	10	to	IN	-	-	-	-	-	-	-	-
1180855	0	11	BAL	NN	-	-	-	-	-	-	-	(23|(14)
1180855	0	12	protein	NN	-	-	-	-	-	-	-	62)|23)
1180855	0	13	following	VBG	-	-	-	-	-	-	-	-
1180855	0	14	repeated	VBN	-	-	-	-	-	-	-	(60
1180855	0	15	ZnO	NN	-	-	-	-	-	-	-	(10)
1180855	0	16	exposure	NN	-	-	-	-	-	-	-	60)
1180855	0	17	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Table	NN	-	-	-	-	-	-	-	(193
1180855	0	2	2	CD	-	-	-	-	-	-	-	193)

1180855	0	1	Positional	JJ	-	-	-	-	-	-	-	-
1180855	0	2	candidate	NN	-	-	-	-	-	-	-	-
1180855	0	3	genes	NNS	-	-	-	-	-	-	-	-
1180855	0	4	from	IN	-	-	-	-	-	-	-	-
1180855	0	5	linkage	NN	-	-	-	-	-	-	-	-
1180855	0	6	analysis	NN	-	-	-	-	-	-	-	-
1180855	0	7	of	IN	-	-	-	-	-	-	-	-
1180855	0	8	pulmonary	JJ	-	-	-	-	-	-	-	-
1180855	0	9	tolerance	NN	-	-	-	-	-	-	-	-
1180855	0	10	to	IN	-	-	-	-	-	-	-	-
1180855	0	11	BAL	NN	-	-	-	-	-	-	-	(24|(14)
1180855	0	12	PMNs	NNS	-	-	-	-	-	-	-	24)
1180855	0	13	and	CC	-	-	-	-	-	-	-	-
1180855	0	14	macrophages	NNS	-	-	-	-	-	-	-	-
1180855	0	15	following	VBG	-	-	-	-	-	-	-	-
1180855	0	16	repeated	VBN	-	-	-	-	-	-	-	(60
1180855	0	17	ZnO	NN	-	-	-	-	-	-	-	(10)
1180855	0	18	exposure	NN	-	-	-	-	-	-	-	60)
1180855	0	19	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Development	NN	-	-	-	-	-	-	-	-
1180855	0	2	of	IN	-	-	-	-	-	-	-	-
1180855	0	3	pulmonary	JJ	-	-	-	-	-	-	-	-
1180855	0	4	tolerance	NN	-	-	-	-	-	-	-	-
1180855	0	5	in	IN	-	-	-	-	-	-	-	-
1180855	0	6	MOLF	NN	-	-	-	-	-	-	-	(59
1180855	0	7	/	HYPH	-	-	-	-	-	-	-	-
1180855	0	8	Ei	NN	-	-	-	-	-	-	-	-
1180855	0	9	mice	NNS	-	-	-	-	-	-	-	59)

1180855	0	1	We	PRP	-	-	-	-	-	-	-	(8)
1180855	0	2	identified	VBD	-	-	-	-	-	-	-	-
1180855	0	3	toll	NN	-	-	-	-	-	-	-	(58
1180855	0	4	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	5	like	JJ	-	-	-	-	-	-	-	-
1180855	0	6	receptor	NN	-	-	-	-	-	-	-	-
1180855	0	7	5	CD	-	-	-	-	-	-	-	58)
1180855	0	8	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	9	Tlr5	NN	-	-	-	-	-	-	-	-
1180855	0	10	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	11	as	IN	-	-	-	-	-	-	-	-
1180855	0	12	an	DT	-	-	-	-	-	-	-	-
1180855	0	13	interesting	JJ	-	-	-	-	-	-	-	-
1180855	0	14	candidate	NN	-	-	-	-	-	-	-	-
1180855	0	15	gene	NN	-	-	-	-	-	-	-	-
1180855	0	16	within	IN	-	-	-	-	-	-	-	-
1180855	0	17	the	DT	-	-	-	-	-	-	-	(168
1180855	0	18	significant	JJ	-	-	-	-	-	-	-	-
1180855	0	19	QTL	NN	-	-	-	-	-	-	-	-
1180855	0	20	for	IN	-	-	-	-	-	-	-	-
1180855	0	21	BAL	NN	-	-	-	-	-	-	-	(23|(14)
1180855	0	22	protein	NN	-	-	-	-	-	-	-	23)
1180855	0	23	on	IN	-	-	-	-	-	-	-	-
1180855	0	24	chromosome	NN	-	-	-	-	-	-	-	(43|(42)
1180855	0	25	1	CD	-	-	-	-	-	-	-	43)|168)
1180855	0	26	.	.	-	-	-	-	-	-	-	-

1180855	0	1	A	DT	-	-	-	-	-	-	-	-
1180855	0	2	wild	JJ	-	-	-	-	-	-	-	-
1180855	0	3	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	4	derived	VBN	-	-	-	-	-	-	-	-
1180855	0	5	inbred	JJ	-	-	-	-	-	-	-	-
1180855	0	6	mouse	NN	-	-	-	-	-	-	-	-
1180855	0	7	strain	NN	-	-	-	-	-	-	-	-
1180855	0	8	called	VBN	-	-	-	-	-	-	-	-
1180855	0	9	MOLF	NN	-	-	-	-	-	-	-	-
1180855	0	10	/	HYPH	-	-	-	-	-	-	-	-
1180855	0	11	Ei	NN	-	-	-	-	-	-	-	-
1180855	0	12	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	13	M.	NN	-	-	-	-	-	-	-	(59
1180855	0	14	m.	NN	-	-	-	-	-	-	-	-
1180855	0	15	molossinus	NN	-	-	-	-	-	-	-	59)
1180855	0	16	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	17	which	WDT	-	-	-	-	-	-	-	-
1180855	0	18	has	VBZ	-	-	-	-	-	-	-	-
1180855	0	19	non-conservative	JJ	-	-	-	-	-	-	-	-
1180855	0	20	mutations	NNS	-	-	-	-	-	-	-	-
1180855	0	21	in	IN	-	-	-	-	-	-	-	-
1180855	0	22	Tlr5	NN	-	-	-	-	-	-	-	(58)
1180855	0	23	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	24	25	CD	-	-	-	-	-	-	-	-
1180855	0	25	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	26	was	VBD	-	-	-	-	-	-	-	-
1180855	0	27	phenotyped	VBN	-	-	-	-	-	-	-	-
1180855	0	28	for	IN	-	-	-	-	-	-	-	-
1180855	0	29	BAL	NN	-	-	-	-	-	-	-	(23|(14)
1180855	0	30	protein	NN	-	-	-	-	-	-	-	23)
1180855	0	31	following	VBG	-	-	-	-	-	-	-	-
1180855	0	32	1	CD	-	-	-	-	-	-	-	(78|(79a
1180855	0	33	X	SYM	-	-	-	-	-	-	-	79a)
1180855	0	34	and	CC	-	-	-	-	-	-	-	-
1180855	0	35	5	CD	-	-	-	-	-	-	-	(80
1180855	0	36	X	SYM	-	-	-	-	-	-	-	-
1180855	0	37	ZnO	NN	-	-	-	-	-	-	-	(79a|(10)
1180855	0	38	exposure	NN	-	-	-	-	-	-	-	80)|79a)|78)
1180855	0	39	to	TO	-	-	-	-	-	-	-	-
1180855	0	40	determine	VB	-	-	-	-	-	-	-	-
1180855	0	41	whether	IN	-	-	-	-	-	-	-	-
1180855	0	42	Tlr5	NN	-	-	-	-	-	-	-	(58)
1180855	0	43	may	MD	-	-	-	-	-	-	-	-
1180855	0	44	function	VB	-	-	-	-	-	-	-	-
1180855	0	45	in	IN	-	-	-	-	-	-	-	-
1180855	0	46	the	DT	-	-	-	-	-	-	-	(99
1180855	0	47	development	NN	-	-	-	-	-	-	-	-
1180855	0	48	of	IN	-	-	-	-	-	-	-	-
1180855	0	49	pulmonary	JJ	-	-	-	-	-	-	-	(71
1180855	0	50	tolerance	NN	-	-	-	-	-	-	-	99)|71)
1180855	0	51	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	52	Figure	NN	-	-	-	-	-	-	-	(194
1180855	0	53	7	CD	-	-	-	-	-	-	-	194)
1180855	0	54	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	55	.	.	-	-	-	-	-	-	-	-

1180855	0	1	MOLF	NN	-	-	-	-	-	-	-	(59
1180855	0	2	/	HYPH	-	-	-	-	-	-	-	-
1180855	0	3	Ei	NN	-	-	-	-	-	-	-	59)
1180855	0	4	BAL	NN	-	-	-	-	-	-	-	-
1180855	0	5	protein	NN	-	-	-	-	-	-	-	-
1180855	0	6	was	VBD	-	-	-	-	-	-	-	-
1180855	0	7	significantly	RB	-	-	-	-	-	-	-	-
1180855	0	8	increased	VBN	-	-	-	-	-	-	-	-
1180855	0	9	above	IN	-	-	-	-	-	-	-	-
1180855	0	10	control	NN	-	-	-	-	-	-	-	-
1180855	0	11	values	NNS	-	-	-	-	-	-	-	-
1180855	0	12	following	VBG	-	-	-	-	-	-	-	-
1180855	0	13	1	CD	-	-	-	-	-	-	-	(79
1180855	0	14	X	SYM	-	-	-	-	-	-	-	-
1180855	0	15	ZnO	NN	-	-	-	-	-	-	-	(10)
1180855	0	16	exposure	NN	-	-	-	-	-	-	-	79)
1180855	0	17	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	18	395	CD	-	-	-	-	-	-	-	-
1180855	0	19	±	SYM	-	-	-	-	-	-	-	-
1180855	0	20	38	CD	-	-	-	-	-	-	-	-
1180855	0	21	μg	NN	-	-	-	-	-	-	-	-
1180855	0	22	/	SYM	-	-	-	-	-	-	-	-
1180855	0	23	ml	NN	-	-	-	-	-	-	-	-
1180855	0	24	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	25	.	.	-	-	-	-	-	-	-	-

1180855	0	1	However	RB	-	-	-	-	-	-	-	-
1180855	0	2	,	,	-	-	-	-	-	-	-	-
1180855	0	3	MOLF	NN	-	-	-	-	-	-	-	(59
1180855	0	4	/	HYPH	-	-	-	-	-	-	-	-
1180855	0	5	Ei	NN	-	-	-	-	-	-	-	-
1180855	0	6	mice	NNS	-	-	-	-	-	-	-	59)
1180855	0	7	exhibited	VBD	-	-	-	-	-	-	-	-
1180855	0	8	a	DT	-	-	-	-	-	-	-	-
1180855	0	9	tolerant	JJ	-	-	-	-	-	-	-	-
1180855	0	10	phenotype	NN	-	-	-	-	-	-	-	-
1180855	0	11	,	,	-	-	-	-	-	-	-	-
1180855	0	12	as	IN	-	-	-	-	-	-	-	-
1180855	0	13	5	CD	-	-	-	-	-	-	-	-
1180855	0	14	X	SYM	-	-	-	-	-	-	-	-
1180855	0	15	BAL	NN	-	-	-	-	-	-	-	(23
1180855	0	16	protein	NN	-	-	-	-	-	-	-	23)
1180855	0	17	values	NNS	-	-	-	-	-	-	-	-
1180855	0	18	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	19	215	CD	-	-	-	-	-	-	-	-
1180855	0	20	±	SYM	-	-	-	-	-	-	-	-
1180855	0	21	22	CD	-	-	-	-	-	-	-	-
1180855	0	22	μg	NN	-	-	-	-	-	-	-	-
1180855	0	23	/	SYM	-	-	-	-	-	-	-	-
1180855	0	24	ml	NN	-	-	-	-	-	-	-	-
1180855	0	25	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	26	were	VBD	-	-	-	-	-	-	-	-
1180855	0	27	significantly	RB	-	-	-	-	-	-	-	-
1180855	0	28	decreased	VBN	-	-	-	-	-	-	-	-
1180855	0	29	below	IN	-	-	-	-	-	-	-	-
1180855	0	30	that	DT	-	-	-	-	-	-	-	-
1180855	0	31	of	IN	-	-	-	-	-	-	-	-
1180855	0	32	the	DT	-	-	-	-	-	-	-	(195
1180855	0	33	1	CD	-	-	-	-	-	-	-	-
1180855	0	34	X	SYM	-	-	-	-	-	-	-	-
1180855	0	35	exposure	NN	-	-	-	-	-	-	-	-
1180855	0	36	group	NN	-	-	-	-	-	-	-	195)
1180855	0	37	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Figure	NN	-	-	-	-	-	-	-	(194
1180855	0	2	7	CD	-	-	-	-	-	-	-	194)

1180855	0	1	BAL	NN	-	-	-	-	-	-	-	-
1180855	0	2	protein	NN	-	-	-	-	-	-	-	-
1180855	0	3	levels	NNS	-	-	-	-	-	-	-	-
1180855	0	4	in	IN	-	-	-	-	-	-	-	-
1180855	0	5	wild	JJ	-	-	-	-	-	-	-	-
1180855	0	6	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	7	derived	VBN	-	-	-	-	-	-	-	-
1180855	0	8	MOLF	NN	-	-	-	-	-	-	-	-
1180855	0	9	/	HYPH	-	-	-	-	-	-	-	-
1180855	0	10	Ei	NN	-	-	-	-	-	-	-	-
1180855	0	11	mice	NNS	-	-	-	-	-	-	-	-
1180855	0	12	24	CD	-	-	-	-	-	-	-	-
1180855	0	13	h	NN	-	-	-	-	-	-	-	-
1180855	0	14	after	IN	-	-	-	-	-	-	-	-
1180855	0	15	single	JJ	-	-	-	-	-	-	-	(79c)
1180855	0	16	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	17	1	CD	-	-	-	-	-	-	-	-
1180855	0	18	X	SYM	-	-	-	-	-	-	-	-
1180855	0	19	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	20	or	CC	-	-	-	-	-	-	-	-
1180855	0	21	repeated	VBN	-	-	-	-	-	-	-	-
1180855	0	22	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	23	5	CD	-	-	-	-	-	-	-	-
1180855	0	24	X	SYM	-	-	-	-	-	-	-	-
1180855	0	25	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	26	exposure	NN	-	-	-	-	-	-	-	(79c
1180855	0	27	to	IN	-	-	-	-	-	-	-	-
1180855	0	28	1.0	CD	-	-	-	-	-	-	-	(28
1180855	0	29	mg	NN	-	-	-	-	-	-	-	-
1180855	0	30	/	SYM	-	-	-	-	-	-	-	-
1180855	0	31	m3	NN	-	-	-	-	-	-	-	-
1180855	0	32	ZnO	NN	-	-	-	-	-	-	-	79c)|28)
1180855	0	33	or	CC	-	-	-	-	-	-	-	-
1180855	0	34	air	NN	-	-	-	-	-	-	-	-
1180855	0	35	for	IN	-	-	-	-	-	-	-	-
1180855	0	36	3	CD	-	-	-	-	-	-	-	-
1180855	0	37	h	NN	-	-	-	-	-	-	-	-
1180855	0	38	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Protein	NN	-	-	-	-	-	-	-	(57)
1180855	0	2	levels	NNS	-	-	-	-	-	-	-	-
1180855	0	3	of	IN	-	-	-	-	-	-	-	-
1180855	0	4	BALB	NN	-	-	-	-	-	-	-	(16b|(90a
1180855	0	5	/	HYPH	-	-	-	-	-	-	-	-
1180855	0	6	cByJ	NN	-	-	-	-	-	-	-	90a)|16b)
1180855	0	7	and	CC	-	-	-	-	-	-	-	-
1180855	0	8	DBA	NN	-	-	-	-	-	-	-	(17|(17
1180855	0	9	/	HYPH	-	-	-	-	-	-	-	-
1180855	0	10	2J	NN	-	-	-	-	-	-	-	-
1180855	0	11	mouse	NN	-	-	-	-	-	-	-	(16b|(90a)|17)
1180855	0	12	strains	NNS	-	-	-	-	-	-	-	17)|16b)
1180855	0	13	following	VBG	-	-	-	-	-	-	-	-
1180855	0	14	ZnO	NN	-	-	-	-	-	-	-	(65|(10)
1180855	0	15	exposure	NN	-	-	-	-	-	-	-	65)
1180855	0	16	are	VBP	-	-	-	-	-	-	-	-
1180855	0	17	also	RB	-	-	-	-	-	-	-	-
1180855	0	18	shown	VBN	-	-	-	-	-	-	-	-
1180855	0	19	for	IN	-	-	-	-	-	-	-	-
1180855	0	20	comparison	NN	-	-	-	-	-	-	-	-
1180855	0	21	purposes	NNS	-	-	-	-	-	-	-	-
1180855	0	22	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Values	NNS	-	-	-	-	-	-	-	-
1180855	0	2	are	VBP	-	-	-	-	-	-	-	-
1180855	0	3	means	NNS	-	-	-	-	-	-	-	-
1180855	0	4	±	SYM	-	-	-	-	-	-	-	-
1180855	0	5	SE	NN	-	-	-	-	-	-	-	-
1180855	0	6	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	7	n	NN	-	-	-	-	-	-	-	-
1180855	0	8	=	SYM	-	-	-	-	-	-	-	-
1180855	0	9	4	CD	-	-	-	-	-	-	-	-
1180855	0	10	–	SYM	-	-	-	-	-	-	-	-
1180855	0	11	5	CD	-	-	-	-	-	-	-	-
1180855	0	12	MOLF	NN	-	-	-	-	-	-	-	-
1180855	0	13	/	HYPH	-	-	-	-	-	-	-	-
1180855	0	14	Ei	NN	-	-	-	-	-	-	-	-
1180855	0	15	mice	NNS	-	-	-	-	-	-	-	-
1180855	0	16	/	SYM	-	-	-	-	-	-	-	-
1180855	0	17	exposure	NN	-	-	-	-	-	-	-	-
1180855	0	18	group	NN	-	-	-	-	-	-	-	-
1180855	0	19	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	20	.	.	-	-	-	-	-	-	-	-

1180855	0	1	*	SYM	-	-	-	-	-	-	-	-
1180855	0	2	indicates	VBZ	-	-	-	-	-	-	-	-
1180855	0	3	significantly	RB	-	-	-	-	-	-	-	-
1180855	0	4	different	JJ	-	-	-	-	-	-	-	-
1180855	0	5	from	IN	-	-	-	-	-	-	-	-
1180855	0	6	air	NN	-	-	-	-	-	-	-	-
1180855	0	7	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	8	exposed	VBN	-	-	-	-	-	-	-	-
1180855	0	9	MOLF	NN	-	-	-	-	-	-	-	-
1180855	0	10	/	HYPH	-	-	-	-	-	-	-	-
1180855	0	11	Ei	NN	-	-	-	-	-	-	-	-
1180855	0	12	controls	NNS	-	-	-	-	-	-	-	-
1180855	0	13	,	,	-	-	-	-	-	-	-	-
1180855	0	14	P	NN	-	-	-	-	-	-	-	(183
1180855	0	15	<	SYM	-	-	-	-	-	-	-	-
1180855	0	16	0.05	CD	-	-	-	-	-	-	-	183)
1180855	0	17	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	18	Student	NNP	-	-	-	-	-	-	-	(196
1180855	0	19	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	20	Newman	NNP	-	-	-	-	-	-	-	-
1180855	0	21	Keuls	NNP	-	-	-	-	-	-	-	-
1180855	0	22	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	23	SNK	NNP	-	-	-	-	-	-	-	-
1180855	0	24	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	25	test	NN	-	-	-	-	-	-	-	196)
1180855	0	26	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	27	.	.	-	-	-	-	-	-	-	-

1180855	0	1	+	SYM	-	-	-	-	-	-	-	-
1180855	0	2	indicates	VBZ	-	-	-	-	-	-	-	-
1180855	0	3	significantly	RB	-	-	-	-	-	-	-	-
1180855	0	4	different	JJ	-	-	-	-	-	-	-	-
1180855	0	5	from	IN	-	-	-	-	-	-	-	-
1180855	0	6	1	CD	-	-	-	-	-	-	-	(195
1180855	0	7	X	SYM	-	-	-	-	-	-	-	-
1180855	0	8	MOLF	NN	-	-	-	-	-	-	-	-
1180855	0	9	/	HYPH	-	-	-	-	-	-	-	-
1180855	0	10	Ei	NN	-	-	-	-	-	-	-	-
1180855	0	11	exposure	NN	-	-	-	-	-	-	-	-
1180855	0	12	group	NN	-	-	-	-	-	-	-	195)
1180855	0	13	,	,	-	-	-	-	-	-	-	-
1180855	0	14	P	NN	-	-	-	-	-	-	-	(183
1180855	0	15	<	SYM	-	-	-	-	-	-	-	-
1180855	0	16	0.05	CD	-	-	-	-	-	-	-	183)
1180855	0	17	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	18	SNK	NNP	-	-	-	-	-	-	-	(196
1180855	0	19	test	NN	-	-	-	-	-	-	-	196)
1180855	0	20	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	21	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Discussion	NN	-	-	-	-	-	-	-	-

1180855	0	1	Clinical	JJ	-	-	-	-	-	-	-	-
1180855	0	2	studies	NNS	-	-	-	-	-	-	-	-
1180855	0	3	on	IN	-	-	-	-	-	-	-	-
1180855	0	4	the	DT	-	-	-	-	-	-	-	-
1180855	0	5	acquisition	NN	-	-	-	-	-	-	-	-
1180855	0	6	of	IN	-	-	-	-	-	-	-	-
1180855	0	7	tolerance	NN	-	-	-	-	-	-	-	(70|(68)
1180855	0	8	to	IN	-	-	-	-	-	-	-	-
1180855	0	9	inhaled	VBN	-	-	-	-	-	-	-	(7
1180855	0	10	toxicants	NNS	-	-	-	-	-	-	-	70)|7)
1180855	0	11	suggest	VBP	-	-	-	-	-	-	-	-
1180855	0	12	that	IN	-	-	-	-	-	-	-	-
1180855	0	13	genetic	JJ	-	-	-	-	-	-	-	(9
1180855	0	14	background	NN	-	-	-	-	-	-	-	9)
1180855	0	15	and	CC	-	-	-	-	-	-	-	-
1180855	0	16	gene	NN	-	-	-	-	-	-	-	(76
1180855	0	17	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	18	environment	NN	-	-	-	-	-	-	-	-
1180855	0	19	interactions	NNS	-	-	-	-	-	-	-	76)
1180855	0	20	contribute	VBP	-	-	-	-	-	-	-	-
1180855	0	21	to	IN	-	-	-	-	-	-	-	-
1180855	0	22	the	DT	-	-	-	-	-	-	-	(77
1180855	0	23	development	NN	-	-	-	-	-	-	-	-
1180855	0	24	of	IN	-	-	-	-	-	-	-	-
1180855	0	25	pulmonary	JJ	-	-	-	-	-	-	-	-
1180855	0	26	tolerance	NN	-	-	-	-	-	-	-	-
1180855	0	27	in	IN	-	-	-	-	-	-	-	-
1180855	0	28	humans	NNS	-	-	-	-	-	-	-	(69)|77)
1180855	0	29	.	.	-	-	-	-	-	-	-	-

1180855	0	1	We	PRP	-	-	-	-	-	-	-	(8)
1180855	0	2	have	VBP	-	-	-	-	-	-	-	-
1180855	0	3	previously	RB	-	-	-	-	-	-	-	-
1180855	0	4	determined	VBN	-	-	-	-	-	-	-	-
1180855	0	5	that	IN	-	-	-	-	-	-	-	-
1180855	0	6	a	DT	-	-	-	-	-	-	-	-
1180855	0	7	genetic	JJ	-	-	-	-	-	-	-	-
1180855	0	8	component	NN	-	-	-	-	-	-	-	-
1180855	0	9	exists	VBZ	-	-	-	-	-	-	-	-
1180855	0	10	in	IN	-	-	-	-	-	-	-	-
1180855	0	11	a	DT	-	-	-	-	-	-	-	(197
1180855	0	12	mouse	NN	-	-	-	-	-	-	-	(4)
1180855	0	13	model	NN	-	-	-	-	-	-	-	-
1180855	0	14	of	IN	-	-	-	-	-	-	-	-
1180855	0	15	pulmonary	JJ	-	-	-	-	-	-	-	-
1180855	0	16	tolerance	NN	-	-	-	-	-	-	-	-
1180855	0	17	to	IN	-	-	-	-	-	-	-	-
1180855	0	18	repeated	VBN	-	-	-	-	-	-	-	(60
1180855	0	19	ZnO	NN	-	-	-	-	-	-	-	(10)
1180855	0	20	exposure	NN	-	-	-	-	-	-	-	60)|197)
1180855	0	21	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	22	8	CD	-	-	-	-	-	-	-	-
1180855	0	23	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	24	.	.	-	-	-	-	-	-	-	-

1180855	0	1	In	IN	-	-	-	-	-	-	-	-
1180855	0	2	the	DT	-	-	-	-	-	-	-	(19
1180855	0	3	present	JJ	-	-	-	-	-	-	-	-
1180855	0	4	study	NN	-	-	-	-	-	-	-	19)
1180855	0	5	,	,	-	-	-	-	-	-	-	-
1180855	0	6	we	PRP	-	-	-	-	-	-	-	(8)
1180855	0	7	performed	VBD	-	-	-	-	-	-	-	-
1180855	0	8	linkage	NN	-	-	-	-	-	-	-	(97
1180855	0	9	analyses	NNS	-	-	-	-	-	-	-	97)
1180855	0	10	on	IN	-	-	-	-	-	-	-	-
1180855	0	11	an	DT	-	-	-	-	-	-	-	-
1180855	0	12	F2	NN	-	-	-	-	-	-	-	(22
1180855	0	13	mouse	NN	-	-	-	-	-	-	-	22)
1180855	0	14	population	NN	-	-	-	-	-	-	-	-
1180855	0	15	derived	VBN	-	-	-	-	-	-	-	-
1180855	0	16	from	IN	-	-	-	-	-	-	-	-
1180855	0	17	tolerant	JJ	-	-	-	-	-	-	-	(16c
1180855	0	18	CBy	NN	-	-	-	-	-	-	-	16c)
1180855	0	19	and	CC	-	-	-	-	-	-	-	-
1180855	0	20	non-tolerant	JJ	-	-	-	-	-	-	-	(198
1180855	0	21	D2	NN	-	-	-	-	-	-	-	-
1180855	0	22	strains	NNS	-	-	-	-	-	-	-	(16c)|198)
1180855	0	23	to	TO	-	-	-	-	-	-	-	-
1180855	0	24	further	RB	-	-	-	-	-	-	-	-
1180855	0	25	ascertain	VB	-	-	-	-	-	-	-	-
1180855	0	26	the	DT	-	-	-	-	-	-	-	-
1180855	0	27	contribution	NN	-	-	-	-	-	-	-	-
1180855	0	28	of	IN	-	-	-	-	-	-	-	-
1180855	0	29	genetic	JJ	-	-	-	-	-	-	-	(9
1180855	0	30	background	NN	-	-	-	-	-	-	-	9)
1180855	0	31	to	IN	-	-	-	-	-	-	-	-
1180855	0	32	the	DT	-	-	-	-	-	-	-	(99
1180855	0	33	development	NN	-	-	-	-	-	-	-	-
1180855	0	34	of	IN	-	-	-	-	-	-	-	-
1180855	0	35	pulmonary	JJ	-	-	-	-	-	-	-	(71
1180855	0	36	tolerance	NN	-	-	-	-	-	-	-	99)|71)
1180855	0	37	,	,	-	-	-	-	-	-	-	-
1180855	0	38	and	CC	-	-	-	-	-	-	-	-
1180855	0	39	identify	VB	-	-	-	-	-	-	-	-
1180855	0	40	candidate	NN	-	-	-	-	-	-	-	-
1180855	0	41	genes	NNS	-	-	-	-	-	-	-	-
1180855	0	42	that	WDT	-	-	-	-	-	-	-	-
1180855	0	43	may	MD	-	-	-	-	-	-	-	-
1180855	0	44	be	VB	-	-	-	-	-	-	-	-
1180855	0	45	important	JJ	-	-	-	-	-	-	-	-
1180855	0	46	regulators	NNS	-	-	-	-	-	-	-	-
1180855	0	47	in	IN	-	-	-	-	-	-	-	-
1180855	0	48	the	DT	-	-	-	-	-	-	-	-
1180855	0	49	acquisition	NN	-	-	-	-	-	-	-	-
1180855	0	50	of	IN	-	-	-	-	-	-	-	-
1180855	0	51	tolerance	NN	-	-	-	-	-	-	-	(68)
1180855	0	52	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Initial	JJ	-	-	-	-	-	-	-	-
1180855	0	2	analysis	NN	-	-	-	-	-	-	-	-
1180855	0	3	using	VBG	-	-	-	-	-	-	-	-
1180855	0	4	the	DT	-	-	-	-	-	-	-	-
1180855	0	5	most	RBS	-	-	-	-	-	-	-	-
1180855	0	6	tolerant	JJ	-	-	-	-	-	-	-	-
1180855	0	7	and	CC	-	-	-	-	-	-	-	-
1180855	0	8	non-tolerant	JJ	-	-	-	-	-	-	-	-
1180855	0	9	F2	NN	-	-	-	-	-	-	-	-
1180855	0	10	mice	NNS	-	-	-	-	-	-	-	-
1180855	0	11	with	IN	-	-	-	-	-	-	-	-
1180855	0	12	respect	NN	-	-	-	-	-	-	-	-
1180855	0	13	to	IN	-	-	-	-	-	-	-	-
1180855	0	14	BAL	NN	-	-	-	-	-	-	-	(23|(14)
1180855	0	15	protein	NN	-	-	-	-	-	-	-	23)
1180855	0	16	generated	VBD	-	-	-	-	-	-	-	-
1180855	0	17	a	DT	-	-	-	-	-	-	-	(199
1180855	0	18	putative	JJ	-	-	-	-	-	-	-	-
1180855	0	19	QTL	NN	-	-	-	-	-	-	-	-
1180855	0	20	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	21	designated	VBN	-	-	-	-	-	-	-	-
1180855	0	22	as	IN	-	-	-	-	-	-	-	-
1180855	0	23	the	DT	-	-	-	-	-	-	-	-
1180855	0	24	zinc	NN	-	-	-	-	-	-	-	-
1180855	0	25	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	26	induced	VBN	-	-	-	-	-	-	-	-
1180855	0	27	tolerance	NN	-	-	-	-	-	-	-	-
1180855	0	28	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	29	ZIT1	NN	-	-	-	-	-	-	-	(200)
1180855	0	30	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	31	locus	NN	-	-	-	-	-	-	-	-
1180855	0	32	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	33	on	IN	-	-	-	-	-	-	-	-
1180855	0	34	the	DT	-	-	-	-	-	-	-	(156
1180855	0	35	distal	JJ	-	-	-	-	-	-	-	-
1180855	0	36	end	NN	-	-	-	-	-	-	-	-
1180855	0	37	of	IN	-	-	-	-	-	-	-	-
1180855	0	38	chromosome	NN	-	-	-	-	-	-	-	(43|(42)
1180855	0	39	1	CD	-	-	-	-	-	-	-	43)|199)|156)
1180855	0	40	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Further	JJ	-	-	-	-	-	-	-	-
1180855	0	2	assessment	NN	-	-	-	-	-	-	-	-
1180855	0	3	of	IN	-	-	-	-	-	-	-	-
1180855	0	4	the	DT	-	-	-	-	-	-	-	(128
1180855	0	5	entire	JJ	-	-	-	-	-	-	-	-
1180855	0	6	F2	NN	-	-	-	-	-	-	-	-
1180855	0	7	cohort	NN	-	-	-	-	-	-	-	128)
1180855	0	8	demonstrated	VBD	-	-	-	-	-	-	-	-
1180855	0	9	that	IN	-	-	-	-	-	-	-	-
1180855	0	10	the	DT	-	-	-	-	-	-	-	(199
1180855	0	11	QTL	NN	-	-	-	-	-	-	-	-
1180855	0	12	on	IN	-	-	-	-	-	-	-	-
1180855	0	13	chromosome	NN	-	-	-	-	-	-	-	(43|(42)
1180855	0	14	1	CD	-	-	-	-	-	-	-	43)|199)
1180855	0	15	attained	VBD	-	-	-	-	-	-	-	-
1180855	0	16	an	DT	-	-	-	-	-	-	-	-
1180855	0	17	LRS	NN	-	-	-	-	-	-	-	-
1180855	0	18	value	NN	-	-	-	-	-	-	-	-
1180855	0	19	for	IN	-	-	-	-	-	-	-	-
1180855	0	20	significant	JJ	-	-	-	-	-	-	-	(167
1180855	0	21	linkage	NN	-	-	-	-	-	-	-	167)
1180855	0	22	,	,	-	-	-	-	-	-	-	-
1180855	0	23	and	CC	-	-	-	-	-	-	-	-
1180855	0	24	also	RB	-	-	-	-	-	-	-	-
1180855	0	25	identified	VBD	-	-	-	-	-	-	-	-
1180855	0	26	two	CD	-	-	-	-	-	-	-	(46
1180855	0	27	suggestive	JJ	-	-	-	-	-	-	-	-
1180855	0	28	QTLs	NNS	-	-	-	-	-	-	-	-
1180855	0	29	located	VBN	-	-	-	-	-	-	-	-
1180855	0	30	on	IN	-	-	-	-	-	-	-	-
1180855	0	31	chromosomes	NNS	-	-	-	-	-	-	-	(47|(48|(42)|(49h)
1180855	0	32	4	CD	-	-	-	-	-	-	-	47)
1180855	0	33	and	CC	-	-	-	-	-	-	-	-
1180855	0	34	5	CD	-	-	-	-	-	-	-	(49h)|48)|46)
1180855	0	35	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Using	VBG	-	-	-	-	-	-	-	-
1180855	0	2	a	DT	-	-	-	-	-	-	-	-
1180855	0	3	variation	NN	-	-	-	-	-	-	-	-
1180855	0	4	of	IN	-	-	-	-	-	-	-	-
1180855	0	5	the	DT	-	-	-	-	-	-	-	(122
1180855	0	6	Wright	NN	-	-	-	-	-	-	-	(123)
1180855	0	7	equation	NN	-	-	-	-	-	-	-	122)
1180855	0	8	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	9	17	CD	-	-	-	-	-	-	-	-
1180855	0	10	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	11	,	,	-	-	-	-	-	-	-	-
1180855	0	12	a	DT	-	-	-	-	-	-	-	-
1180855	0	13	minimum	NN	-	-	-	-	-	-	-	-
1180855	0	14	of	IN	-	-	-	-	-	-	-	-
1180855	0	15	three	CD	-	-	-	-	-	-	-	(56
1180855	0	16	loci	NNS	-	-	-	-	-	-	-	56)
1180855	0	17	were	VBD	-	-	-	-	-	-	-	-
1180855	0	18	estimated	VBN	-	-	-	-	-	-	-	-
1180855	0	19	to	TO	-	-	-	-	-	-	-	-
1180855	0	20	be	VB	-	-	-	-	-	-	-	-
1180855	0	21	independently	RB	-	-	-	-	-	-	-	-
1180855	0	22	segregating	VBG	-	-	-	-	-	-	-	-
1180855	0	23	with	IN	-	-	-	-	-	-	-	-
1180855	0	24	the	DT	-	-	-	-	-	-	-	(15
1180855	0	25	BAL	NN	-	-	-	-	-	-	-	(23
1180855	0	26	protein	NN	-	-	-	-	-	-	-	23)
1180855	0	27	phenotype	NN	-	-	-	-	-	-	-	15)
1180855	0	28	following	VBG	-	-	-	-	-	-	-	-
1180855	0	29	5	CD	-	-	-	-	-	-	-	(80
1180855	0	30	X	SYM	-	-	-	-	-	-	-	-
1180855	0	31	ZnO	NN	-	-	-	-	-	-	-	(10)
1180855	0	32	exposure	NN	-	-	-	-	-	-	-	80)
1180855	0	33	,	,	-	-	-	-	-	-	-	-
1180855	0	34	thus	RB	-	-	-	-	-	-	-	-
1180855	0	35	in	IN	-	-	-	-	-	-	-	-
1180855	0	36	agreement	NN	-	-	-	-	-	-	-	-
1180855	0	37	with	IN	-	-	-	-	-	-	-	-
1180855	0	38	the	DT	-	-	-	-	-	-	-	-
1180855	0	39	results	NNS	-	-	-	-	-	-	-	-
1180855	0	40	of	IN	-	-	-	-	-	-	-	-
1180855	0	41	the	DT	-	-	-	-	-	-	-	-
1180855	0	42	linkage	NN	-	-	-	-	-	-	-	-
1180855	0	43	analysis	NN	-	-	-	-	-	-	-	-
1180855	0	44	.	.	-	-	-	-	-	-	-	-

1180855	0	1	There	EX	-	-	-	-	-	-	-	-
1180855	0	2	are	VBP	-	-	-	-	-	-	-	-
1180855	0	3	several	JJ	-	-	-	-	-	-	-	-
1180855	0	4	approaches	NNS	-	-	-	-	-	-	-	-
1180855	0	5	that	WDT	-	-	-	-	-	-	-	-
1180855	0	6	can	MD	-	-	-	-	-	-	-	-
1180855	0	7	be	VB	-	-	-	-	-	-	-	-
1180855	0	8	pursued	VBN	-	-	-	-	-	-	-	-
1180855	0	9	to	TO	-	-	-	-	-	-	-	-
1180855	0	10	focus	VB	-	-	-	-	-	-	-	-
1180855	0	11	in	RP	-	-	-	-	-	-	-	-
1180855	0	12	on	IN	-	-	-	-	-	-	-	-
1180855	0	13	the	DT	-	-	-	-	-	-	-	-
1180855	0	14	QTL	NN	-	-	-	-	-	-	-	(36)
1180855	0	15	intervals	NNS	-	-	-	-	-	-	-	-
1180855	0	16	that	WDT	-	-	-	-	-	-	-	-
1180855	0	17	were	VBD	-	-	-	-	-	-	-	-
1180855	0	18	identified	VBN	-	-	-	-	-	-	-	-
1180855	0	19	.	.	-	-	-	-	-	-	-	-

1180855	0	1	For	IN	-	-	-	-	-	-	-	-
1180855	0	2	instance	NN	-	-	-	-	-	-	-	-
1180855	0	3	,	,	-	-	-	-	-	-	-	-
1180855	0	4	increasing	VBG	-	-	-	-	-	-	-	(201
1180855	0	5	the	DT	-	-	-	-	-	-	-	-
1180855	0	6	number	NN	-	-	-	-	-	-	-	-
1180855	0	7	of	IN	-	-	-	-	-	-	-	-
1180855	0	8	F2	NN	-	-	-	-	-	-	-	-
1180855	0	9	mice	NNS	-	-	-	-	-	-	-	-
1180855	0	10	used	VBN	-	-	-	-	-	-	-	-
1180855	0	11	in	IN	-	-	-	-	-	-	-	-
1180855	0	12	the	DT	-	-	-	-	-	-	-	-
1180855	0	13	QTL	NN	-	-	-	-	-	-	-	(36)
1180855	0	14	analysis	NN	-	-	-	-	-	-	-	201)
1180855	0	15	is	VBZ	-	-	-	-	-	-	-	-
1180855	0	16	one	CD	-	-	-	-	-	-	-	-
1180855	0	17	alternative	NN	-	-	-	-	-	-	-	-
1180855	0	18	.	.	-	-	-	-	-	-	-	-

1180855	0	1	The	DT	-	-	-	-	-	-	-	-
1180855	0	2	major	JJ	-	-	-	-	-	-	-	-
1180855	0	3	disadvantage	NN	-	-	-	-	-	-	-	-
1180855	0	4	of	IN	-	-	-	-	-	-	-	-
1180855	0	5	this	DT	-	-	-	-	-	-	-	(201)
1180855	0	6	,	,	-	-	-	-	-	-	-	-
1180855	0	7	however	RB	-	-	-	-	-	-	-	-
1180855	0	8	,	,	-	-	-	-	-	-	-	-
1180855	0	9	is	VBZ	-	-	-	-	-	-	-	-
1180855	0	10	that	IN	-	-	-	-	-	-	-	-
1180855	0	11	segregating	VBG	-	-	-	-	-	-	-	-
1180855	0	12	QTLs	NNS	-	-	-	-	-	-	-	(36)
1180855	0	13	contribute	VBP	-	-	-	-	-	-	-	-
1180855	0	14	a	DT	-	-	-	-	-	-	-	-
1180855	0	15	great	JJ	-	-	-	-	-	-	-	-
1180855	0	16	deal	NN	-	-	-	-	-	-	-	-
1180855	0	17	of	IN	-	-	-	-	-	-	-	-
1180855	0	18	phenotypic	JJ	-	-	-	-	-	-	-	-
1180855	0	19	``	``	-	-	-	-	-	-	-	-
1180855	0	20	noise	NN	-	-	-	-	-	-	-	-
1180855	0	21	,	,	-	-	-	-	-	-	-	-
1180855	0	22	''	''	-	-	-	-	-	-	-	-
1180855	0	23	making	VBG	-	-	-	-	-	-	-	-
1180855	0	24	it	PRP	-	-	-	-	-	-	-	-
1180855	0	25	problematic	JJ	-	-	-	-	-	-	-	-
1180855	0	26	when	WRB	-	-	-	-	-	-	-	-
1180855	0	27	determining	VBG	-	-	-	-	-	-	-	-
1180855	0	28	whether	IN	-	-	-	-	-	-	-	-
1180855	0	29	or	CC	-	-	-	-	-	-	-	-
1180855	0	30	not	RB	-	-	-	-	-	-	-	-
1180855	0	31	a	DT	-	-	-	-	-	-	-	-
1180855	0	32	given	JJ	-	-	-	-	-	-	-	-
1180855	0	33	mouse	NN	-	-	-	-	-	-	-	-
1180855	0	34	has	VBZ	-	-	-	-	-	-	-	-
1180855	0	35	inherited	VBN	-	-	-	-	-	-	-	-
1180855	0	36	a	DT	-	-	-	-	-	-	-	-
1180855	0	37	particular	JJ	-	-	-	-	-	-	-	-
1180855	0	38	QTL	NN	-	-	-	-	-	-	-	-
1180855	0	39	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	40	9	CD	-	-	-	-	-	-	-	-
1180855	0	41	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	42	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Thus	RB	-	-	-	-	-	-	-	-
1180855	0	2	,	,	-	-	-	-	-	-	-	-
1180855	0	3	in	IN	-	-	-	-	-	-	-	-
1180855	0	4	order	NN	-	-	-	-	-	-	-	-
1180855	0	5	to	TO	-	-	-	-	-	-	-	-
1180855	0	6	separate	VB	-	-	-	-	-	-	-	-
1180855	0	7	the	DT	-	-	-	-	-	-	-	-
1180855	0	8	effects	NNS	-	-	-	-	-	-	-	-
1180855	0	9	of	IN	-	-	-	-	-	-	-	-
1180855	0	10	multiple	JJ	-	-	-	-	-	-	-	-
1180855	0	11	loci	NNS	-	-	-	-	-	-	-	-
1180855	0	12	,	,	-	-	-	-	-	-	-	-
1180855	0	13	congenic	JJ	-	-	-	-	-	-	-	-
1180855	0	14	mouse	NN	-	-	-	-	-	-	-	-
1180855	0	15	strains	NNS	-	-	-	-	-	-	-	-
1180855	0	16	for	IN	-	-	-	-	-	-	-	-
1180855	0	17	each	DT	-	-	-	-	-	-	-	(33
1180855	0	18	QTL	NN	-	-	-	-	-	-	-	33)
1180855	0	19	could	MD	-	-	-	-	-	-	-	-
1180855	0	20	be	VB	-	-	-	-	-	-	-	-
1180855	0	21	generated	VBN	-	-	-	-	-	-	-	-
1180855	0	22	,	,	-	-	-	-	-	-	-	-
1180855	0	23	which	WDT	-	-	-	-	-	-	-	-
1180855	0	24	could	MD	-	-	-	-	-	-	-	-
1180855	0	25	then	RB	-	-	-	-	-	-	-	-
1180855	0	26	be	VB	-	-	-	-	-	-	-	-
1180855	0	27	used	VBN	-	-	-	-	-	-	-	-
1180855	0	28	to	TO	-	-	-	-	-	-	-	-
1180855	0	29	breed	VB	-	-	-	-	-	-	-	-
1180855	0	30	multicongenic	JJ	-	-	-	-	-	-	-	-
1180855	0	31	lines	NNS	-	-	-	-	-	-	-	-
1180855	0	32	to	TO	-	-	-	-	-	-	-	-
1180855	0	33	examine	VB	-	-	-	-	-	-	-	-
1180855	0	34	the	DT	-	-	-	-	-	-	-	-
1180855	0	35	existence	NN	-	-	-	-	-	-	-	-
1180855	0	36	of	IN	-	-	-	-	-	-	-	-
1180855	0	37	any	DT	-	-	-	-	-	-	-	-
1180855	0	38	epistatic	JJ	-	-	-	-	-	-	-	-
1180855	0	39	effects	NNS	-	-	-	-	-	-	-	-
1180855	0	40	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Additionally	RB	-	-	-	-	-	-	-	-
1180855	0	2	,	,	-	-	-	-	-	-	-	-
1180855	0	3	future	NN	-	-	-	-	-	-	-	-
1180855	0	4	studies	NNS	-	-	-	-	-	-	-	-
1180855	0	5	could	MD	-	-	-	-	-	-	-	-
1180855	0	6	employ	VB	-	-	-	-	-	-	-	-
1180855	0	7	the	DT	-	-	-	-	-	-	-	-
1180855	0	8	use	NN	-	-	-	-	-	-	-	-
1180855	0	9	of	IN	-	-	-	-	-	-	-	-
1180855	0	10	a	DT	-	-	-	-	-	-	-	-
1180855	0	11	backcross	NN	-	-	-	-	-	-	-	-
1180855	0	12	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	13	CByD2F1	NN	-	-	-	-	-	-	-	(92)
1180855	0	14	×	SYM	-	-	-	-	-	-	-	-
1180855	0	15	CBy	NN	-	-	-	-	-	-	-	-
1180855	0	16	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	17	mouse	NN	-	-	-	-	-	-	-	-
1180855	0	18	population	NN	-	-	-	-	-	-	-	-
1180855	0	19	to	TO	-	-	-	-	-	-	-	-
1180855	0	20	expand	VB	-	-	-	-	-	-	-	-
1180855	0	21	the	DT	-	-	-	-	-	-	-	-
1180855	0	22	evaluation	NN	-	-	-	-	-	-	-	-
1180855	0	23	of	IN	-	-	-	-	-	-	-	-
1180855	0	24	the	DT	-	-	-	-	-	-	-	-
1180855	0	25	QTL	NN	-	-	-	-	-	-	-	(36)
1180855	0	26	effects	NNS	-	-	-	-	-	-	-	-
1180855	0	27	to	IN	-	-	-	-	-	-	-	-
1180855	0	28	the	DT	-	-	-	-	-	-	-	(37
1180855	0	29	overall	JJ	-	-	-	-	-	-	-	-
1180855	0	30	BAL	NN	-	-	-	-	-	-	-	(23
1180855	0	31	protein	NN	-	-	-	-	-	-	-	23)
1180855	0	32	phenotype	NN	-	-	-	-	-	-	-	37)
1180855	0	33	.	.	-	-	-	-	-	-	-	-

1180855	0	1	To	TO	-	-	-	-	-	-	-	-
1180855	0	2	measure	VB	-	-	-	-	-	-	-	-
1180855	0	3	the	DT	-	-	-	-	-	-	-	(30d|(31|(32b
1180855	0	4	contribution	NN	-	-	-	-	-	-	-	-
1180855	0	5	of	IN	-	-	-	-	-	-	-	30d)
1180855	0	6	each	DT	-	-	-	-	-	-	-	(33|(34
1180855	0	7	individual	JJ	-	-	-	-	-	-	-	-
1180855	0	8	QTL	NN	-	-	-	-	-	-	-	33)|32b)
1180855	0	9	and	CC	-	-	-	-	-	-	-	-
1180855	0	10	each	DT	-	-	-	-	-	-	-	(30d|(33|(35
1180855	0	11	QTL	NN	-	-	-	-	-	-	-	33)
1180855	0	12	combination	NN	-	-	-	-	-	-	-	35)|34)
1180855	0	13	to	IN	-	-	-	-	-	-	-	(32b
1180855	0	14	the	DT	-	-	-	-	-	-	-	(37
1180855	0	15	overall	JJ	-	-	-	-	-	-	-	-
1180855	0	16	BAL	NN	-	-	-	-	-	-	-	(23
1180855	0	17	protein	NN	-	-	-	-	-	-	-	23)
1180855	0	18	phenotype	NN	-	-	-	-	-	-	-	37)|32b)|31)|30d)
1180855	0	19	,	,	-	-	-	-	-	-	-	-
1180855	0	20	the	DT	-	-	-	-	-	-	-	-
1180855	0	21	protein	NN	-	-	-	-	-	-	-	(57)
1180855	0	22	levels	NNS	-	-	-	-	-	-	-	-
1180855	0	23	for	IN	-	-	-	-	-	-	-	-
1180855	0	24	F2	NN	-	-	-	-	-	-	-	-
1180855	0	25	mice	NNS	-	-	-	-	-	-	-	-
1180855	0	26	with	IN	-	-	-	-	-	-	-	-
1180855	0	27	each	DT	-	-	-	-	-	-	-	-
1180855	0	28	particular	JJ	-	-	-	-	-	-	-	-
1180855	0	29	haplotype	NN	-	-	-	-	-	-	-	-
1180855	0	30	were	VBD	-	-	-	-	-	-	-	-
1180855	0	31	compared	VBN	-	-	-	-	-	-	-	-
1180855	0	32	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Mice	NNS	-	-	-	-	-	-	-	-
1180855	0	2	with	IN	-	-	-	-	-	-	-	-
1180855	0	3	opposite	JJ	-	-	-	-	-	-	-	-
1180855	0	4	allelic	JJ	-	-	-	-	-	-	-	-
1180855	0	5	combinations	NNS	-	-	-	-	-	-	-	-
1180855	0	6	for	IN	-	-	-	-	-	-	-	-
1180855	0	7	QTLs	NNS	-	-	-	-	-	-	-	(184|(186b
1180855	0	8	on	IN	-	-	-	-	-	-	-	-
1180855	0	9	chromosomes	NNS	-	-	-	-	-	-	-	(43|(55|(42)|(49b)|186b)
1180855	0	10	1	CD	-	-	-	-	-	-	-	43)|184)
1180855	0	11	and	CC	-	-	-	-	-	-	-	-
1180855	0	12	5	CD	-	-	-	-	-	-	-	(186b)|(49b)|55)
1180855	0	13	had	VBD	-	-	-	-	-	-	-	-
1180855	0	14	a	DT	-	-	-	-	-	-	-	-
1180855	0	15	difference	NN	-	-	-	-	-	-	-	-
1180855	0	16	of	IN	-	-	-	-	-	-	-	-
1180855	0	17	310	CD	-	-	-	-	-	-	-	-
1180855	0	18	μg	NN	-	-	-	-	-	-	-	-
1180855	0	19	/	SYM	-	-	-	-	-	-	-	-
1180855	0	20	ml	NN	-	-	-	-	-	-	-	-
1180855	0	21	BAL	NN	-	-	-	-	-	-	-	-
1180855	0	22	protein	NN	-	-	-	-	-	-	-	-
1180855	0	23	,	,	-	-	-	-	-	-	-	-
1180855	0	24	which	WDT	-	-	-	-	-	-	-	-
1180855	0	25	accounts	VBZ	-	-	-	-	-	-	-	-
1180855	0	26	for	IN	-	-	-	-	-	-	-	-
1180855	0	27	approximately	RB	-	-	-	-	-	-	-	-
1180855	0	28	one	CD	-	-	-	-	-	-	-	-
1180855	0	29	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	30	third	NN	-	-	-	-	-	-	-	-
1180855	0	31	of	IN	-	-	-	-	-	-	-	-
1180855	0	32	the	DT	-	-	-	-	-	-	-	-
1180855	0	33	total	JJ	-	-	-	-	-	-	-	-
1180855	0	34	difference	NN	-	-	-	-	-	-	-	-
1180855	0	35	in	IN	-	-	-	-	-	-	-	-
1180855	0	36	mean	NN	-	-	-	-	-	-	-	(126
1180855	0	37	BAL	NN	-	-	-	-	-	-	-	-
1180855	0	38	protein	NN	-	-	-	-	-	-	-	126)
1180855	0	39	between	IN	-	-	-	-	-	-	-	-
1180855	0	40	the	DT	-	-	-	-	-	-	-	-
1180855	0	41	parental	JJ	-	-	-	-	-	-	-	-
1180855	0	42	CBy	NN	-	-	-	-	-	-	-	-
1180855	0	43	and	CC	-	-	-	-	-	-	-	-
1180855	0	44	D2	NN	-	-	-	-	-	-	-	-
1180855	0	45	strains	NNS	-	-	-	-	-	-	-	-
1180855	0	46	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Additionally	RB	-	-	-	-	-	-	-	-
1180855	0	2	,	,	-	-	-	-	-	-	-	-
1180855	0	3	the	DT	-	-	-	-	-	-	-	-
1180855	0	4	mean	NN	-	-	-	-	-	-	-	(126
1180855	0	5	BAL	NN	-	-	-	-	-	-	-	-
1180855	0	6	protein	NN	-	-	-	-	-	-	-	126)
1180855	0	7	level	NN	-	-	-	-	-	-	-	-
1180855	0	8	of	IN	-	-	-	-	-	-	-	-
1180855	0	9	F2	NN	-	-	-	-	-	-	-	-
1180855	0	10	mice	NNS	-	-	-	-	-	-	-	-
1180855	0	11	with	IN	-	-	-	-	-	-	-	-
1180855	0	12	a	DT	-	-	-	-	-	-	-	-
1180855	0	13	DD	NN	-	-	-	-	-	-	-	-
1180855	0	14	haplotype	NN	-	-	-	-	-	-	-	-
1180855	0	15	for	IN	-	-	-	-	-	-	-	-
1180855	0	16	QTLs	NNS	-	-	-	-	-	-	-	(184|(185b|(186c|(56
1180855	0	17	on	IN	-	-	-	-	-	-	-	-
1180855	0	18	chromosomes	NNS	-	-	-	-	-	-	-	(187|(43|(42)|(47c)|(49d)|186c)|185b)
1180855	0	19	1	CD	-	-	-	-	-	-	-	43)|184)
1180855	0	20	,	,	-	-	-	-	-	-	-	-
1180855	0	21	4	CD	-	-	-	-	-	-	-	(185b)|(47c)
1180855	0	22	,	,	-	-	-	-	-	-	-	-
1180855	0	23	and	CC	-	-	-	-	-	-	-	-
1180855	0	24	5	CD	-	-	-	-	-	-	-	(186c)|(49d)|56)|187)
1180855	0	25	was	VBD	-	-	-	-	-	-	-	-
1180855	0	26	over	IN	-	-	-	-	-	-	-	-
1180855	0	27	half	PDT	-	-	-	-	-	-	-	-
1180855	0	28	that	DT	-	-	-	-	-	-	-	-
1180855	0	29	of	IN	-	-	-	-	-	-	-	-
1180855	0	30	the	DT	-	-	-	-	-	-	-	-
1180855	0	31	non-tolerant	JJ	-	-	-	-	-	-	-	-
1180855	0	32	D2	NN	-	-	-	-	-	-	-	-
1180855	0	33	parental	JJ	-	-	-	-	-	-	-	-
1180855	0	34	strain	NN	-	-	-	-	-	-	-	-
1180855	0	35	.	.	-	-	-	-	-	-	-	-

1180855	0	1	These	DT	-	-	-	-	-	-	-	-
1180855	0	2	analyses	NNS	-	-	-	-	-	-	-	-
1180855	0	3	suggest	VBP	-	-	-	-	-	-	-	-
1180855	0	4	that	IN	-	-	-	-	-	-	-	-
1180855	0	5	although	IN	-	-	-	-	-	-	-	-
1180855	0	6	three	CD	-	-	-	-	-	-	-	(56
1180855	0	7	QTLs	NNS	-	-	-	-	-	-	-	56)
1180855	0	8	were	VBD	-	-	-	-	-	-	-	-
1180855	0	9	identified	VBN	-	-	-	-	-	-	-	-
1180855	0	10	,	,	-	-	-	-	-	-	-	-
1180855	0	11	the	DT	-	-	-	-	-	-	-	(89
1180855	0	12	development	NN	-	-	-	-	-	-	-	-
1180855	0	13	of	IN	-	-	-	-	-	-	-	-
1180855	0	14	pulmonary	JJ	-	-	-	-	-	-	-	(62
1180855	0	15	tolerance	NN	-	-	-	-	-	-	-	-
1180855	0	16	to	IN	-	-	-	-	-	-	-	-
1180855	0	17	BAL	NN	-	-	-	-	-	-	-	(23|(14)
1180855	0	18	protein	NN	-	-	-	-	-	-	-	89)|62)|23)
1180855	0	19	is	VBZ	-	-	-	-	-	-	-	-
1180855	0	20	a	DT	-	-	-	-	-	-	-	-
1180855	0	21	decidedly	RB	-	-	-	-	-	-	-	-
1180855	0	22	complex	JJ	-	-	-	-	-	-	-	-
1180855	0	23	phenotype	NN	-	-	-	-	-	-	-	-
1180855	0	24	that	WDT	-	-	-	-	-	-	-	-
1180855	0	25	is	VBZ	-	-	-	-	-	-	-	-
1180855	0	26	regulated	VBN	-	-	-	-	-	-	-	-
1180855	0	27	by	IN	-	-	-	-	-	-	-	-
1180855	0	28	a	DT	-	-	-	-	-	-	-	-
1180855	0	29	number	NN	-	-	-	-	-	-	-	-
1180855	0	30	of	IN	-	-	-	-	-	-	-	-
1180855	0	31	different	JJ	-	-	-	-	-	-	-	-
1180855	0	32	genes	NNS	-	-	-	-	-	-	-	-
1180855	0	33	,	,	-	-	-	-	-	-	-	-
1180855	0	34	some	DT	-	-	-	-	-	-	-	-
1180855	0	35	of	IN	-	-	-	-	-	-	-	-
1180855	0	36	which	WDT	-	-	-	-	-	-	-	-
1180855	0	37	were	VBD	-	-	-	-	-	-	-	-
1180855	0	38	likely	RB	-	-	-	-	-	-	-	-
1180855	0	39	not	RB	-	-	-	-	-	-	-	-
1180855	0	40	identified	VBN	-	-	-	-	-	-	-	-
1180855	0	41	by	IN	-	-	-	-	-	-	-	-
1180855	0	42	linkage	NN	-	-	-	-	-	-	-	(202
1180855	0	43	analysis	NN	-	-	-	-	-	-	-	-
1180855	0	44	using	VBG	-	-	-	-	-	-	-	-
1180855	0	45	an	DT	-	-	-	-	-	-	-	-
1180855	0	46	F2	NN	-	-	-	-	-	-	-	-
1180855	0	47	cohort	NN	-	-	-	-	-	-	-	202)
1180855	0	48	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Candidate	NN	-	-	-	-	-	-	-	-
1180855	0	2	genes	NNS	-	-	-	-	-	-	-	-
1180855	0	3	within	IN	-	-	-	-	-	-	-	-
1180855	0	4	the	DT	-	-	-	-	-	-	-	(199
1180855	0	5	significant	JJ	-	-	-	-	-	-	-	-
1180855	0	6	QTL	NN	-	-	-	-	-	-	-	-
1180855	0	7	on	IN	-	-	-	-	-	-	-	-
1180855	0	8	chromosome	NN	-	-	-	-	-	-	-	(43|(42)
1180855	0	9	1	CD	-	-	-	-	-	-	-	43)
1180855	0	10	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	11	ZIT1	NN	-	-	-	-	-	-	-	(200)
1180855	0	12	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	13	that	WDT	-	-	-	-	-	-	-	-
1180855	0	14	could	MD	-	-	-	-	-	-	-	-
1180855	0	15	play	VB	-	-	-	-	-	-	-	-
1180855	0	16	a	DT	-	-	-	-	-	-	-	-
1180855	0	17	role	NN	-	-	-	-	-	-	-	-
1180855	0	18	in	IN	-	-	-	-	-	-	-	-
1180855	0	19	controlling	VBG	-	-	-	-	-	-	-	-
1180855	0	20	the	DT	-	-	-	-	-	-	-	(203
1180855	0	21	development	NN	-	-	-	-	-	-	-	-
1180855	0	22	of	IN	-	-	-	-	-	-	-	-
1180855	0	23	tolerance	NN	-	-	-	-	-	-	-	(68)
1180855	0	24	to	IN	-	-	-	-	-	-	-	-
1180855	0	25	BAL	NN	-	-	-	-	-	-	-	(23|(14)
1180855	0	26	protein	NN	-	-	-	-	-	-	-	23)
1180855	0	27	following	VBG	-	-	-	-	-	-	-	-
1180855	0	28	repeated	VBN	-	-	-	-	-	-	-	(60
1180855	0	29	ZnO	NN	-	-	-	-	-	-	-	(10)
1180855	0	30	exposure	NN	-	-	-	-	-	-	-	60)|203)|199)
1180855	0	31	are	VBP	-	-	-	-	-	-	-	-
1180855	0	32	presented	VBN	-	-	-	-	-	-	-	-
1180855	0	33	in	IN	-	-	-	-	-	-	-	-
1180855	0	34	Table	NN	-	-	-	-	-	-	-	(192
1180855	0	35	1	CD	-	-	-	-	-	-	-	192)
1180855	0	36	.	.	-	-	-	-	-	-	-	-

1180855	0	1	The	DT	-	-	-	-	-	-	-	-
1180855	0	2	Duffy	NN	-	-	-	-	-	-	-	-
1180855	0	3	blood	NN	-	-	-	-	-	-	-	-
1180855	0	4	group	NN	-	-	-	-	-	-	-	-
1180855	0	5	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	6	Dfy	NN	-	-	-	-	-	-	-	-
1180855	0	7	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	8	has	VBZ	-	-	-	-	-	-	-	-
1180855	0	9	been	VBN	-	-	-	-	-	-	-	-
1180855	0	10	shown	VBN	-	-	-	-	-	-	-	-
1180855	0	11	to	TO	-	-	-	-	-	-	-	-
1180855	0	12	modulate	VB	-	-	-	-	-	-	-	-
1180855	0	13	the	DT	-	-	-	-	-	-	-	-
1180855	0	14	intensity	NN	-	-	-	-	-	-	-	-
1180855	0	15	of	IN	-	-	-	-	-	-	-	-
1180855	0	16	inflammation	NN	-	-	-	-	-	-	-	-
1180855	0	17	following	VBG	-	-	-	-	-	-	-	-
1180855	0	18	endotoxin	NN	-	-	-	-	-	-	-	(83)
1180855	0	19	exposure	NN	-	-	-	-	-	-	-	-
1180855	0	20	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	21	26	CD	-	-	-	-	-	-	-	-
1180855	0	22	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	23	,	,	-	-	-	-	-	-	-	-
1180855	0	24	and	CC	-	-	-	-	-	-	-	-
1180855	0	25	has	VBZ	-	-	-	-	-	-	-	-
1180855	0	26	a	DT	-	-	-	-	-	-	-	-
1180855	0	27	role	NN	-	-	-	-	-	-	-	-
1180855	0	28	in	IN	-	-	-	-	-	-	-	-
1180855	0	29	enhancing	VBG	-	-	-	-	-	-	-	-
1180855	0	30	inflammatory	JJ	-	-	-	-	-	-	-	-
1180855	0	31	cell	NN	-	-	-	-	-	-	-	(104)
1180855	0	32	recruitment	NN	-	-	-	-	-	-	-	-
1180855	0	33	to	IN	-	-	-	-	-	-	-	-
1180855	0	34	sites	NNS	-	-	-	-	-	-	-	-
1180855	0	35	of	IN	-	-	-	-	-	-	-	-
1180855	0	36	inflammation	NN	-	-	-	-	-	-	-	(204)
1180855	0	37	by	IN	-	-	-	-	-	-	-	-
1180855	0	38	facilitating	VBG	-	-	-	-	-	-	-	-
1180855	0	39	movement	NN	-	-	-	-	-	-	-	-
1180855	0	40	of	IN	-	-	-	-	-	-	-	-
1180855	0	41	chemokines	NNS	-	-	-	-	-	-	-	(205)
1180855	0	42	across	IN	-	-	-	-	-	-	-	-
1180855	0	43	the	DT	-	-	-	-	-	-	-	-
1180855	0	44	endothelium	NN	-	-	-	-	-	-	-	-
1180855	0	45	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	46	27	CD	-	-	-	-	-	-	-	-
1180855	0	47	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	48	.	.	-	-	-	-	-	-	-	-

1180855	0	1	ADP	NN	-	-	-	-	-	-	-	-
1180855	0	2	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	3	ribosyltransferase	NN	-	-	-	-	-	-	-	-
1180855	0	4	1	CD	-	-	-	-	-	-	-	-
1180855	0	5	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	6	Adprt1	NN	-	-	-	-	-	-	-	-
1180855	0	7	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	8	and	CC	-	-	-	-	-	-	-	-
1180855	0	9	tumor	NN	-	-	-	-	-	-	-	-
1180855	0	10	necrosis	NN	-	-	-	-	-	-	-	-
1180855	0	11	factor	NN	-	-	-	-	-	-	-	-
1180855	0	12	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	13	TNF	NN	-	-	-	-	-	-	-	-
1180855	0	14	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	15	receptor	NN	-	-	-	-	-	-	-	-
1180855	0	16	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	17	associated	VBN	-	-	-	-	-	-	-	-
1180855	0	18	factor	NN	-	-	-	-	-	-	-	-
1180855	0	19	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	20	Traf5	NN	-	-	-	-	-	-	-	-
1180855	0	21	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	22	are	VBP	-	-	-	-	-	-	-	-
1180855	0	23	functionally	RB	-	-	-	-	-	-	-	-
1180855	0	24	associated	VBN	-	-	-	-	-	-	-	-
1180855	0	25	with	IN	-	-	-	-	-	-	-	-
1180855	0	26	nuclear	JJ	-	-	-	-	-	-	-	(206
1180855	0	27	factor	NN	-	-	-	-	-	-	-	-
1180855	0	28	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	29	NF	NN	-	-	-	-	-	-	-	-
1180855	0	30	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	31	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	32	κB	NN	-	-	-	-	-	-	-	206)
1180855	0	33	,	,	-	-	-	-	-	-	-	-
1180855	0	34	a	DT	-	-	-	-	-	-	-	-
1180855	0	35	key	JJ	-	-	-	-	-	-	-	-
1180855	0	36	transcription	NN	-	-	-	-	-	-	-	-
1180855	0	37	factor	NN	-	-	-	-	-	-	-	-
1180855	0	38	in	IN	-	-	-	-	-	-	-	-
1180855	0	39	the	DT	-	-	-	-	-	-	-	-
1180855	0	40	regulation	NN	-	-	-	-	-	-	-	-
1180855	0	41	of	IN	-	-	-	-	-	-	-	-
1180855	0	42	the	DT	-	-	-	-	-	-	-	-
1180855	0	43	inflammatory	JJ	-	-	-	-	-	-	-	-
1180855	0	44	process	NN	-	-	-	-	-	-	-	-
1180855	0	45	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	46	28	CD	-	-	-	-	-	-	-	-
1180855	0	47	,	,	-	-	-	-	-	-	-	-
1180855	0	48	29	CD	-	-	-	-	-	-	-	-
1180855	0	49	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	50	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Additionally	RB	-	-	-	-	-	-	-	-
1180855	0	2	,	,	-	-	-	-	-	-	-	-
1180855	0	3	activation	NN	-	-	-	-	-	-	-	-
1180855	0	4	of	IN	-	-	-	-	-	-	-	-
1180855	0	5	ADPRT1	NN	-	-	-	-	-	-	-	-
1180855	0	6	plays	VBZ	-	-	-	-	-	-	-	-
1180855	0	7	a	DT	-	-	-	-	-	-	-	-
1180855	0	8	role	NN	-	-	-	-	-	-	-	-
1180855	0	9	in	IN	-	-	-	-	-	-	-	-
1180855	0	10	endotoxin	NN	-	-	-	-	-	-	-	-
1180855	0	11	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	12	induced	VBN	-	-	-	-	-	-	-	-
1180855	0	13	BAL	NN	-	-	-	-	-	-	-	-
1180855	0	14	protein	NN	-	-	-	-	-	-	-	-
1180855	0	15	increases	NNS	-	-	-	-	-	-	-	-
1180855	0	16	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	17	30	CD	-	-	-	-	-	-	-	-
1180855	0	18	,	,	-	-	-	-	-	-	-	-
1180855	0	19	31	CD	-	-	-	-	-	-	-	-
1180855	0	20	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	21	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Activated	VBN	-	-	-	-	-	-	-	-
1180855	0	2	transforming	VBG	-	-	-	-	-	-	-	-
1180855	0	3	growth	NN	-	-	-	-	-	-	-	-
1180855	0	4	factor	NN	-	-	-	-	-	-	-	-
1180855	0	5	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	6	β	NN	-	-	-	-	-	-	-	-
1180855	0	7	has	VBZ	-	-	-	-	-	-	-	-
1180855	0	8	been	VBN	-	-	-	-	-	-	-	-
1180855	0	9	shown	VBN	-	-	-	-	-	-	-	-
1180855	0	10	to	TO	-	-	-	-	-	-	-	-
1180855	0	11	be	VB	-	-	-	-	-	-	-	-
1180855	0	12	a	DT	-	-	-	-	-	-	-	-
1180855	0	13	mediator	NN	-	-	-	-	-	-	-	-
1180855	0	14	of	IN	-	-	-	-	-	-	-	-
1180855	0	15	bleomycin	NN	-	-	-	-	-	-	-	-
1180855	0	16	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	17	and	CC	-	-	-	-	-	-	-	-
1180855	0	18	endotoxin	NN	-	-	-	-	-	-	-	-
1180855	0	19	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	20	induced	VBN	-	-	-	-	-	-	-	-
1180855	0	21	lung	NN	-	-	-	-	-	-	-	(72)
1180855	0	22	permeability	NN	-	-	-	-	-	-	-	-
1180855	0	23	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	24	i.e.	FW	-	-	-	-	-	-	-	-
1180855	0	25	,	,	-	-	-	-	-	-	-	-
1180855	0	26	BAL	NN	-	-	-	-	-	-	-	(23|(14)
1180855	0	27	protein	NN	-	-	-	-	-	-	-	23)
1180855	0	28	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	29	in	IN	-	-	-	-	-	-	-	-
1180855	0	30	mice	NNS	-	-	-	-	-	-	-	(4)
1180855	0	31	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	32	32	CD	-	-	-	-	-	-	-	-
1180855	0	33	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	34	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Finally	RB	-	-	-	-	-	-	-	-
1180855	0	2	,	,	-	-	-	-	-	-	-	-
1180855	0	3	solute	NN	-	-	-	-	-	-	-	-
1180855	0	4	carrier	NN	-	-	-	-	-	-	-	-
1180855	0	5	family	NN	-	-	-	-	-	-	-	-
1180855	0	6	30	CD	-	-	-	-	-	-	-	-
1180855	0	7	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	8	zinc	NN	-	-	-	-	-	-	-	(207|(74)
1180855	0	9	transporter	NN	-	-	-	-	-	-	-	207)
1180855	0	10	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	11	,	,	-	-	-	-	-	-	-	-
1180855	0	12	member	NN	-	-	-	-	-	-	-	-
1180855	0	13	1	CD	-	-	-	-	-	-	-	-
1180855	0	14	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	15	Slc30a1	NN	-	-	-	-	-	-	-	-
1180855	0	16	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	17	is	VBZ	-	-	-	-	-	-	-	-
1180855	0	18	a	DT	-	-	-	-	-	-	-	-
1180855	0	19	metal	NN	-	-	-	-	-	-	-	-
1180855	0	20	transporter	NN	-	-	-	-	-	-	-	-
1180855	0	21	on	IN	-	-	-	-	-	-	-	-
1180855	0	22	the	DT	-	-	-	-	-	-	-	-
1180855	0	23	plasma	NN	-	-	-	-	-	-	-	-
1180855	0	24	membrane	NN	-	-	-	-	-	-	-	-
1180855	0	25	that	WDT	-	-	-	-	-	-	-	-
1180855	0	26	confers	VBZ	-	-	-	-	-	-	-	-
1180855	0	27	resistance	NN	-	-	-	-	-	-	-	-
1180855	0	28	to	IN	-	-	-	-	-	-	-	-
1180855	0	29	zinc	NN	-	-	-	-	-	-	-	(74)
1180855	0	30	and	CC	-	-	-	-	-	-	-	-
1180855	0	31	cadmium	NN	-	-	-	-	-	-	-	-
1180855	0	32	toxicity	NN	-	-	-	-	-	-	-	-
1180855	0	33	in	FW	-	-	-	-	-	-	-	-
1180855	0	34	vitro	FW	-	-	-	-	-	-	-	-
1180855	0	35	via	IN	-	-	-	-	-	-	-	-
1180855	0	36	an	DT	-	-	-	-	-	-	-	-
1180855	0	37	efflux	NN	-	-	-	-	-	-	-	-
1180855	0	38	mechanism	NN	-	-	-	-	-	-	-	-
1180855	0	39	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	40	33	CD	-	-	-	-	-	-	-	-
1180855	0	41	,	,	-	-	-	-	-	-	-	-
1180855	0	42	34	CD	-	-	-	-	-	-	-	-
1180855	0	43	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	44	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Candidate	NN	-	-	-	-	-	-	-	(20
1180855	0	2	genes	NNS	-	-	-	-	-	-	-	-
1180855	0	3	for	IN	-	-	-	-	-	-	-	-
1180855	0	4	BAL	NN	-	-	-	-	-	-	-	(23|(14)
1180855	0	5	protein	NN	-	-	-	-	-	-	-	23)
1180855	0	6	tolerance	NN	-	-	-	-	-	-	-	-
1180855	0	7	identified	VBN	-	-	-	-	-	-	-	-
1180855	0	8	within	IN	-	-	-	-	-	-	-	-
1180855	0	9	the	DT	-	-	-	-	-	-	-	-
1180855	0	10	suggestive	JJ	-	-	-	-	-	-	-	-
1180855	0	11	QTL	NN	-	-	-	-	-	-	-	-
1180855	0	12	intervals	NNS	-	-	-	-	-	-	-	-
1180855	0	13	on	IN	-	-	-	-	-	-	-	-
1180855	0	14	chromosomes	NNS	-	-	-	-	-	-	-	(47|(48|(42)|(49g)
1180855	0	15	4	CD	-	-	-	-	-	-	-	47)
1180855	0	16	and	CC	-	-	-	-	-	-	-	-
1180855	0	17	5	CD	-	-	-	-	-	-	-	(49g)|48)|20)
1180855	0	18	are	VBP	-	-	-	-	-	-	-	-
1180855	0	19	also	RB	-	-	-	-	-	-	-	-
1180855	0	20	presented	VBN	-	-	-	-	-	-	-	-
1180855	0	21	in	IN	-	-	-	-	-	-	-	-
1180855	0	22	Table	NN	-	-	-	-	-	-	-	(192
1180855	0	23	1	CD	-	-	-	-	-	-	-	192)
1180855	0	24	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Notable	JJ	-	-	-	-	-	-	-	-
1180855	0	2	candidates	NNS	-	-	-	-	-	-	-	-
1180855	0	3	include	VBP	-	-	-	-	-	-	-	-
1180855	0	4	platelet	NN	-	-	-	-	-	-	-	-
1180855	0	5	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	6	activating	VBG	-	-	-	-	-	-	-	-
1180855	0	7	factor	NN	-	-	-	-	-	-	-	-
1180855	0	8	receptor	NN	-	-	-	-	-	-	-	-
1180855	0	9	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	10	Ptafr	NN	-	-	-	-	-	-	-	-
1180855	0	11	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	12	and	CC	-	-	-	-	-	-	-	-
1180855	0	13	phospholipase	NN	-	-	-	-	-	-	-	-
1180855	0	14	A2	NN	-	-	-	-	-	-	-	-
1180855	0	15	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	16	Pla2	NN	-	-	-	-	-	-	-	-
1180855	0	17	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	18	that	WDT	-	-	-	-	-	-	-	-
1180855	0	19	have	VBP	-	-	-	-	-	-	-	-
1180855	0	20	been	VBN	-	-	-	-	-	-	-	-
1180855	0	21	implicated	VBN	-	-	-	-	-	-	-	-
1180855	0	22	as	IN	-	-	-	-	-	-	-	-
1180855	0	23	potential	JJ	-	-	-	-	-	-	-	-
1180855	0	24	mediators	NNS	-	-	-	-	-	-	-	-
1180855	0	25	of	IN	-	-	-	-	-	-	-	-
1180855	0	26	toxicant	NN	-	-	-	-	-	-	-	-
1180855	0	27	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	28	induced	VBN	-	-	-	-	-	-	-	-
1180855	0	29	BAL	NN	-	-	-	-	-	-	-	-
1180855	0	30	protein	NN	-	-	-	-	-	-	-	-
1180855	0	31	increases	NNS	-	-	-	-	-	-	-	-
1180855	0	32	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	33	35	CD	-	-	-	-	-	-	-	-
1180855	0	34	-	SYM	-	-	-	-	-	-	-	-
1180855	0	35	37	CD	-	-	-	-	-	-	-	-
1180855	0	36	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	37	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Interleukin	NN	-	-	-	-	-	-	-	(208
1180855	0	2	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	3	IL	NN	-	-	-	-	-	-	-	-
1180855	0	4	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	5	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	6	6	CD	-	-	-	-	-	-	-	-
1180855	0	7	protein	NN	-	-	-	-	-	-	-	208)
1180855	0	8	was	VBD	-	-	-	-	-	-	-	-
1180855	0	9	increased	VBN	-	-	-	-	-	-	-	-
1180855	0	10	following	VBG	-	-	-	-	-	-	-	-
1180855	0	11	ZnO	NN	-	-	-	-	-	-	-	(65|(10)
1180855	0	12	exposure	NN	-	-	-	-	-	-	-	65)
1180855	0	13	in	IN	-	-	-	-	-	-	-	-
1180855	0	14	humans	NNS	-	-	-	-	-	-	-	(69)
1180855	0	15	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	16	1	CD	-	-	-	-	-	-	-	-
1180855	0	17	,	,	-	-	-	-	-	-	-	-
1180855	0	18	38	CD	-	-	-	-	-	-	-	-
1180855	0	19	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	20	,	,	-	-	-	-	-	-	-	-
1180855	0	21	and	CC	-	-	-	-	-	-	-	-
1180855	0	22	was	VBD	-	-	-	-	-	-	-	-
1180855	0	23	hypothesized	VBN	-	-	-	-	-	-	-	-
1180855	0	24	to	TO	-	-	-	-	-	-	-	-
1180855	0	25	be	VB	-	-	-	-	-	-	-	-
1180855	0	26	an	DT	-	-	-	-	-	-	-	-
1180855	0	27	anti-inflammatory	JJ	-	-	-	-	-	-	-	-
1180855	0	28	suppressor	NN	-	-	-	-	-	-	-	-
1180855	0	29	of	IN	-	-	-	-	-	-	-	-
1180855	0	30	ZnO	NN	-	-	-	-	-	-	-	-
1180855	0	31	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	32	induced	VBN	-	-	-	-	-	-	-	-
1180855	0	33	lung	NN	-	-	-	-	-	-	-	(72)
1180855	0	34	injury	NN	-	-	-	-	-	-	-	-
1180855	0	35	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Interestingly	RB	-	-	-	-	-	-	-	-
1180855	0	2	,	,	-	-	-	-	-	-	-	-
1180855	0	3	increased	VBN	-	-	-	-	-	-	-	-
1180855	0	4	lung	NN	-	-	-	-	-	-	-	-
1180855	0	5	IL	NN	-	-	-	-	-	-	-	-
1180855	0	6	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	7	6	CD	-	-	-	-	-	-	-	-
1180855	0	8	levels	NNS	-	-	-	-	-	-	-	-
1180855	0	9	have	VBP	-	-	-	-	-	-	-	-
1180855	0	10	been	VBN	-	-	-	-	-	-	-	-
1180855	0	11	shown	VBN	-	-	-	-	-	-	-	-
1180855	0	12	to	TO	-	-	-	-	-	-	-	-
1180855	0	13	mediate	VB	-	-	-	-	-	-	-	-
1180855	0	14	pulmonary	JJ	-	-	-	-	-	-	-	-
1180855	0	15	tolerance	NN	-	-	-	-	-	-	-	-
1180855	0	16	to	IN	-	-	-	-	-	-	-	-
1180855	0	17	ozone	NN	-	-	-	-	-	-	-	(84)
1180855	0	18	in	IN	-	-	-	-	-	-	-	-
1180855	0	19	rats	NNS	-	-	-	-	-	-	-	-
1180855	0	20	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	21	39	CD	-	-	-	-	-	-	-	-
1180855	0	22	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	23	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Lastly	RB	-	-	-	-	-	-	-	-
1180855	0	2	,	,	-	-	-	-	-	-	-	-
1180855	0	3	solute	NN	-	-	-	-	-	-	-	-
1180855	0	4	carrier	NN	-	-	-	-	-	-	-	-
1180855	0	5	family	NN	-	-	-	-	-	-	-	-
1180855	0	6	30	CD	-	-	-	-	-	-	-	-
1180855	0	7	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	8	zinc	NN	-	-	-	-	-	-	-	(207|(74)
1180855	0	9	transporter	NN	-	-	-	-	-	-	-	207)
1180855	0	10	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	11	members	NNS	-	-	-	-	-	-	-	-
1180855	0	12	2	CD	-	-	-	-	-	-	-	-
1180855	0	13	and	CC	-	-	-	-	-	-	-	-
1180855	0	14	3	CD	-	-	-	-	-	-	-	-
1180855	0	15	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	16	Slc30a2	NN	-	-	-	-	-	-	-	-
1180855	0	17	and	CC	-	-	-	-	-	-	-	-
1180855	0	18	Slc30a3	NN	-	-	-	-	-	-	-	-
1180855	0	19	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	20	have	VBP	-	-	-	-	-	-	-	-
1180855	0	21	been	VBN	-	-	-	-	-	-	-	-
1180855	0	22	identified	VBN	-	-	-	-	-	-	-	-
1180855	0	23	as	IN	-	-	-	-	-	-	-	-
1180855	0	24	zinc	NN	-	-	-	-	-	-	-	(74)
1180855	0	25	transporters	NNS	-	-	-	-	-	-	-	-
1180855	0	26	that	WDT	-	-	-	-	-	-	-	-
1180855	0	27	protect	VBP	-	-	-	-	-	-	-	-
1180855	0	28	against	IN	-	-	-	-	-	-	-	-
1180855	0	29	zinc	NN	-	-	-	-	-	-	-	-
1180855	0	30	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	31	induced	VBN	-	-	-	-	-	-	-	-
1180855	0	32	toxicity	NN	-	-	-	-	-	-	-	-
1180855	0	33	in	IN	-	-	-	-	-	-	-	-
1180855	0	34	both	CC	-	-	-	-	-	-	-	-
1180855	0	35	cell	NN	-	-	-	-	-	-	-	(104)
1180855	0	36	culture	NN	-	-	-	-	-	-	-	-
1180855	0	37	and	CC	-	-	-	-	-	-	-	-
1180855	0	38	animal	NN	-	-	-	-	-	-	-	(85)
1180855	0	39	models	NNS	-	-	-	-	-	-	-	-
1180855	0	40	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	41	40	CD	-	-	-	-	-	-	-	-
1180855	0	42	,	,	-	-	-	-	-	-	-	-
1180855	0	43	41	CD	-	-	-	-	-	-	-	-
1180855	0	44	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	45	.	.	-	-	-	-	-	-	-	-

1180855	0	1	The	DT	-	-	-	-	-	-	-	-
1180855	0	2	development	NN	-	-	-	-	-	-	-	-
1180855	0	3	of	IN	-	-	-	-	-	-	-	-
1180855	0	4	pulmonary	JJ	-	-	-	-	-	-	-	(62
1180855	0	5	tolerance	NN	-	-	-	-	-	-	-	-
1180855	0	6	to	IN	-	-	-	-	-	-	-	-
1180855	0	7	BAL	NN	-	-	-	-	-	-	-	(23|(14)
1180855	0	8	protein	NN	-	-	-	-	-	-	-	62)|23)
1180855	0	9	in	IN	-	-	-	-	-	-	-	-
1180855	0	10	our	PRP$	-	-	-	-	-	-	-	(197|(8)
1180855	0	11	model	NN	-	-	-	-	-	-	-	197)
1180855	0	12	could	MD	-	-	-	-	-	-	-	-
1180855	0	13	be	VB	-	-	-	-	-	-	-	-
1180855	0	14	regulated	VBN	-	-	-	-	-	-	-	-
1180855	0	15	by	IN	-	-	-	-	-	-	-	-
1180855	0	16	any	DT	-	-	-	-	-	-	-	-
1180855	0	17	number	NN	-	-	-	-	-	-	-	-
1180855	0	18	of	IN	-	-	-	-	-	-	-	-
1180855	0	19	the	DT	-	-	-	-	-	-	-	(20
1180855	0	20	aforementioned	JJ	-	-	-	-	-	-	-	-
1180855	0	21	candidate	NN	-	-	-	-	-	-	-	-
1180855	0	22	genes	NNS	-	-	-	-	-	-	-	20)
1180855	0	23	.	.	-	-	-	-	-	-	-	-

1180855	0	1	These	DT	-	-	-	-	-	-	-	(20
1180855	0	2	candidates	NNS	-	-	-	-	-	-	-	20)
1180855	0	3	will	MD	-	-	-	-	-	-	-	-
1180855	0	4	be	VB	-	-	-	-	-	-	-	-
1180855	0	5	investigated	VBN	-	-	-	-	-	-	-	-
1180855	0	6	in	IN	-	-	-	-	-	-	-	-
1180855	0	7	future	NN	-	-	-	-	-	-	-	-
1180855	0	8	studies	NNS	-	-	-	-	-	-	-	-
1180855	0	9	of	IN	-	-	-	-	-	-	-	-
1180855	0	10	transcriptional	JJ	-	-	-	-	-	-	-	-
1180855	0	11	and	CC	-	-	-	-	-	-	-	-
1180855	0	12	protein	NN	-	-	-	-	-	-	-	(57)
1180855	0	13	regulation	NN	-	-	-	-	-	-	-	-
1180855	0	14	to	TO	-	-	-	-	-	-	-	-
1180855	0	15	determine	VB	-	-	-	-	-	-	-	-
1180855	0	16	their	PRP$	-	-	-	-	-	-	-	(20)
1180855	0	17	roles	NNS	-	-	-	-	-	-	-	-
1180855	0	18	in	IN	-	-	-	-	-	-	-	-
1180855	0	19	the	DT	-	-	-	-	-	-	-	-
1180855	0	20	development	NN	-	-	-	-	-	-	-	-
1180855	0	21	of	IN	-	-	-	-	-	-	-	-
1180855	0	22	tolerance	NN	-	-	-	-	-	-	-	(68)
1180855	0	23	.	.	-	-	-	-	-	-	-	-

1180855	0	1	The	DT	-	-	-	-	-	-	-	-
1180855	0	2	suggestive	JJ	-	-	-	-	-	-	-	-
1180855	0	3	QTLs	NNS	-	-	-	-	-	-	-	-
1180855	0	4	for	IN	-	-	-	-	-	-	-	-
1180855	0	5	tolerance	NN	-	-	-	-	-	-	-	(209|(210|(68)
1180855	0	6	to	IN	-	-	-	-	-	-	-	-
1180855	0	7	BAL	NN	-	-	-	-	-	-	-	(24|(14)
1180855	0	8	PMNs	NNS	-	-	-	-	-	-	-	24)|209)
1180855	0	9	and	CC	-	-	-	-	-	-	-	-
1180855	0	10	macrophages	NNS	-	-	-	-	-	-	-	210)
1180855	0	11	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	12	on	IN	-	-	-	-	-	-	-	-
1180855	0	13	chromosomes	NNS	-	-	-	-	-	-	-	(43|(55|(42)|(49e)
1180855	0	14	1	CD	-	-	-	-	-	-	-	43)
1180855	0	15	and	CC	-	-	-	-	-	-	-	-
1180855	0	16	5	CD	-	-	-	-	-	-	-	(49e)|55)
1180855	0	17	,	,	-	-	-	-	-	-	-	-
1180855	0	18	respectively	RB	-	-	-	-	-	-	-	-
1180855	0	19	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	20	were	VBD	-	-	-	-	-	-	-	-
1180855	0	21	also	RB	-	-	-	-	-	-	-	-
1180855	0	22	examined	VBN	-	-	-	-	-	-	-	-
1180855	0	23	for	IN	-	-	-	-	-	-	-	-
1180855	0	24	positional	JJ	-	-	-	-	-	-	-	(39
1180855	0	25	candidate	NN	-	-	-	-	-	-	-	-
1180855	0	26	genes	NNS	-	-	-	-	-	-	-	39)
1180855	0	27	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	28	Table	NN	-	-	-	-	-	-	-	(193
1180855	0	29	2	CD	-	-	-	-	-	-	-	193)
1180855	0	30	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	31	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Chemokine	NN	-	-	-	-	-	-	-	-
1180855	0	2	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	3	C	NN	-	-	-	-	-	-	-	-
1180855	0	4	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	5	C	NN	-	-	-	-	-	-	-	-
1180855	0	6	motif	NN	-	-	-	-	-	-	-	-
1180855	0	7	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	8	ligand	NN	-	-	-	-	-	-	-	-
1180855	0	9	20	CD	-	-	-	-	-	-	-	-
1180855	0	10	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	11	Ccl20	NN	-	-	-	-	-	-	-	-
1180855	0	12	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	13	,	,	-	-	-	-	-	-	-	-
1180855	0	14	chemokine	NN	-	-	-	-	-	-	-	(211
1180855	0	15	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	16	C	NN	-	-	-	-	-	-	-	(212
1180855	0	17	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	18	X	NN	-	-	-	-	-	-	-	-
1180855	0	19	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	20	C	NN	-	-	-	-	-	-	-	-
1180855	0	21	motif	NN	-	-	-	-	-	-	-	212)
1180855	0	22	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	23	receptor	NN	-	-	-	-	-	-	-	-
1180855	0	24	4	CD	-	-	-	-	-	-	-	211)
1180855	0	25	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	26	Cxcr4	NN	-	-	-	-	-	-	-	(211)
1180855	0	27	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	28	,	,	-	-	-	-	-	-	-	-
1180855	0	29	and	CC	-	-	-	-	-	-	-	-
1180855	0	30	interleukin	NN	-	-	-	-	-	-	-	(213
1180855	0	31	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	32	10	CD	-	-	-	-	-	-	-	213)
1180855	0	33	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	34	Il10	NN	-	-	-	-	-	-	-	-
1180855	0	35	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	36	were	VBD	-	-	-	-	-	-	-	-
1180855	0	37	identified	VBN	-	-	-	-	-	-	-	-
1180855	0	38	as	IN	-	-	-	-	-	-	-	-
1180855	0	39	candidates	NNS	-	-	-	-	-	-	-	-
1180855	0	40	for	IN	-	-	-	-	-	-	-	-
1180855	0	41	BAL	NN	-	-	-	-	-	-	-	(24
1180855	0	42	PMN	NN	-	-	-	-	-	-	-	24)
1180855	0	43	tolerance	NN	-	-	-	-	-	-	-	-
1180855	0	44	.	.	-	-	-	-	-	-	-	-

1180855	0	1	The	DT	-	-	-	-	-	-	-	-
1180855	0	2	movement	NN	-	-	-	-	-	-	-	-
1180855	0	3	of	IN	-	-	-	-	-	-	-	-
1180855	0	4	PMNs	NNS	-	-	-	-	-	-	-	(12)
1180855	0	5	into	IN	-	-	-	-	-	-	-	-
1180855	0	6	inflammatory	JJ	-	-	-	-	-	-	-	-
1180855	0	7	tissues	NNS	-	-	-	-	-	-	-	-
1180855	0	8	is	VBZ	-	-	-	-	-	-	-	-
1180855	0	9	regulated	VBN	-	-	-	-	-	-	-	-
1180855	0	10	by	IN	-	-	-	-	-	-	-	-
1180855	0	11	chemotactic	JJ	-	-	-	-	-	-	-	-
1180855	0	12	factors	NNS	-	-	-	-	-	-	-	-
1180855	0	13	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	14	e.g.	FW	-	-	-	-	-	-	-	-
1180855	0	15	,	,	-	-	-	-	-	-	-	-
1180855	0	16	chemokines	NNS	-	-	-	-	-	-	-	(205)
1180855	0	17	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	18	that	WDT	-	-	-	-	-	-	-	-
1180855	0	19	signal	VBP	-	-	-	-	-	-	-	-
1180855	0	20	through	IN	-	-	-	-	-	-	-	-
1180855	0	21	numerous	JJ	-	-	-	-	-	-	-	-
1180855	0	22	chemokine	NN	-	-	-	-	-	-	-	(205)
1180855	0	23	receptors	NNS	-	-	-	-	-	-	-	-
1180855	0	24	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	25	42	CD	-	-	-	-	-	-	-	-
1180855	0	26	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	27	.	.	-	-	-	-	-	-	-	-

1180855	0	1	PMNs	NNS	-	-	-	-	-	-	-	(12)
1180855	0	2	are	VBP	-	-	-	-	-	-	-	-
1180855	0	3	capable	JJ	-	-	-	-	-	-	-	-
1180855	0	4	of	IN	-	-	-	-	-	-	-	-
1180855	0	5	producing	VBG	-	-	-	-	-	-	-	-
1180855	0	6	several	JJ	-	-	-	-	-	-	-	-
1180855	0	7	chemokines	NNS	-	-	-	-	-	-	-	-
1180855	0	8	and	CC	-	-	-	-	-	-	-	-
1180855	0	9	proinflammatory	JJ	-	-	-	-	-	-	-	-
1180855	0	10	cytokines	NNS	-	-	-	-	-	-	-	-
1180855	0	11	,	,	-	-	-	-	-	-	-	-
1180855	0	12	indicating	VBG	-	-	-	-	-	-	-	-
1180855	0	13	that	IN	-	-	-	-	-	-	-	-
1180855	0	14	PMNs	NNS	-	-	-	-	-	-	-	(12)
1180855	0	15	may	MD	-	-	-	-	-	-	-	-
1180855	0	16	be	VB	-	-	-	-	-	-	-	-
1180855	0	17	important	JJ	-	-	-	-	-	-	-	-
1180855	0	18	in	IN	-	-	-	-	-	-	-	-
1180855	0	19	auto-direction	NN	-	-	-	-	-	-	-	-
1180855	0	20	of	IN	-	-	-	-	-	-	-	-
1180855	0	21	cell	NN	-	-	-	-	-	-	-	(104)
1180855	0	22	trafficking	NN	-	-	-	-	-	-	-	-
1180855	0	23	during	IN	-	-	-	-	-	-	-	-
1180855	0	24	inflammation	NN	-	-	-	-	-	-	-	(204)
1180855	0	25	.	.	-	-	-	-	-	-	-	-

1180855	0	1	CXCR4	NN	-	-	-	-	-	-	-	(211)
1180855	0	2	expression	NN	-	-	-	-	-	-	-	-
1180855	0	3	has	VBZ	-	-	-	-	-	-	-	-
1180855	0	4	been	VBN	-	-	-	-	-	-	-	-
1180855	0	5	detected	VBN	-	-	-	-	-	-	-	-
1180855	0	6	on	IN	-	-	-	-	-	-	-	-
1180855	0	7	human	JJ	-	-	-	-	-	-	-	(214
1180855	0	8	PMNs	NNS	-	-	-	-	-	-	-	214)
1180855	0	9	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	10	43	CD	-	-	-	-	-	-	-	-
1180855	0	11	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	12	,	,	-	-	-	-	-	-	-	-
1180855	0	13	and	CC	-	-	-	-	-	-	-	-
1180855	0	14	coordinated	VBN	-	-	-	-	-	-	-	-
1180855	0	15	chemokine	NN	-	-	-	-	-	-	-	-
1180855	0	16	receptor	NN	-	-	-	-	-	-	-	-
1180855	0	17	gene	NN	-	-	-	-	-	-	-	-
1180855	0	18	expression	NN	-	-	-	-	-	-	-	-
1180855	0	19	may	MD	-	-	-	-	-	-	-	-
1180855	0	20	control	VB	-	-	-	-	-	-	-	-
1180855	0	21	the	DT	-	-	-	-	-	-	-	-
1180855	0	22	tissue	NN	-	-	-	-	-	-	-	-
1180855	0	23	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	24	specific	JJ	-	-	-	-	-	-	-	-
1180855	0	25	migration	NN	-	-	-	-	-	-	-	-
1180855	0	26	and	CC	-	-	-	-	-	-	-	-
1180855	0	27	activation	NN	-	-	-	-	-	-	-	-
1180855	0	28	status	NN	-	-	-	-	-	-	-	-
1180855	0	29	of	IN	-	-	-	-	-	-	-	-
1180855	0	30	PMNs	NNS	-	-	-	-	-	-	-	(12)
1180855	0	31	into	IN	-	-	-	-	-	-	-	-
1180855	0	32	the	DT	-	-	-	-	-	-	-	(72
1180855	0	33	lung	NN	-	-	-	-	-	-	-	72)
1180855	0	34	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Human	JJ	-	-	-	-	-	-	-	(214
1180855	0	2	PMNs	NNS	-	-	-	-	-	-	-	214)
1180855	0	3	are	VBP	-	-	-	-	-	-	-	-
1180855	0	4	also	RB	-	-	-	-	-	-	-	-
1180855	0	5	able	JJ	-	-	-	-	-	-	-	-
1180855	0	6	to	TO	-	-	-	-	-	-	-	-
1180855	0	7	express	VB	-	-	-	-	-	-	-	-
1180855	0	8	CCL20	NN	-	-	-	-	-	-	-	-
1180855	0	9	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	10	44	CD	-	-	-	-	-	-	-	-
1180855	0	11	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	12	,	,	-	-	-	-	-	-	-	-
1180855	0	13	which	WDT	-	-	-	-	-	-	-	-
1180855	0	14	is	VBZ	-	-	-	-	-	-	-	-
1180855	0	15	able	JJ	-	-	-	-	-	-	-	-
1180855	0	16	to	TO	-	-	-	-	-	-	-	-
1180855	0	17	recruit	VB	-	-	-	-	-	-	-	-
1180855	0	18	immature	JJ	-	-	-	-	-	-	-	-
1180855	0	19	dendritic	JJ	-	-	-	-	-	-	-	-
1180855	0	20	cells	NNS	-	-	-	-	-	-	-	-
1180855	0	21	that	WDT	-	-	-	-	-	-	-	-
1180855	0	22	play	VBP	-	-	-	-	-	-	-	-
1180855	0	23	an	DT	-	-	-	-	-	-	-	-
1180855	0	24	important	JJ	-	-	-	-	-	-	-	-
1180855	0	25	role	NN	-	-	-	-	-	-	-	-
1180855	0	26	in	IN	-	-	-	-	-	-	-	-
1180855	0	27	the	DT	-	-	-	-	-	-	-	-
1180855	0	28	initiation	NN	-	-	-	-	-	-	-	-
1180855	0	29	of	IN	-	-	-	-	-	-	-	-
1180855	0	30	the	DT	-	-	-	-	-	-	-	-
1180855	0	31	immune	JJ	-	-	-	-	-	-	-	-
1180855	0	32	response	NN	-	-	-	-	-	-	-	-
1180855	0	33	as	RB	-	-	-	-	-	-	-	-
1180855	0	34	well	RB	-	-	-	-	-	-	-	-
1180855	0	35	as	IN	-	-	-	-	-	-	-	-
1180855	0	36	chronic	JJ	-	-	-	-	-	-	-	-
1180855	0	37	inflammation	NN	-	-	-	-	-	-	-	-
1180855	0	38	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	39	45	CD	-	-	-	-	-	-	-	-
1180855	0	40	-	SYM	-	-	-	-	-	-	-	-
1180855	0	41	47	CD	-	-	-	-	-	-	-	-
1180855	0	42	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	43	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Finally	RB	-	-	-	-	-	-	-	-
1180855	0	2	,	,	-	-	-	-	-	-	-	-
1180855	0	3	IL	NN	-	-	-	-	-	-	-	(213
1180855	0	4	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	5	10	CD	-	-	-	-	-	-	-	213)
1180855	0	6	can	MD	-	-	-	-	-	-	-	-
1180855	0	7	be	VB	-	-	-	-	-	-	-	-
1180855	0	8	produced	VBN	-	-	-	-	-	-	-	-
1180855	0	9	by	IN	-	-	-	-	-	-	-	-
1180855	0	10	T	NN	-	-	-	-	-	-	-	-
1180855	0	11	cells	NNS	-	-	-	-	-	-	-	-
1180855	0	12	and	CC	-	-	-	-	-	-	-	-
1180855	0	13	is	VBZ	-	-	-	-	-	-	-	-
1180855	0	14	able	JJ	-	-	-	-	-	-	-	-
1180855	0	15	to	TO	-	-	-	-	-	-	-	-
1180855	0	16	diminish	VB	-	-	-	-	-	-	-	-
1180855	0	17	PMN	NN	-	-	-	-	-	-	-	(12)
1180855	0	18	influx	NN	-	-	-	-	-	-	-	-
1180855	0	19	by	IN	-	-	-	-	-	-	-	-
1180855	0	20	inhibition	NN	-	-	-	-	-	-	-	-
1180855	0	21	of	IN	-	-	-	-	-	-	-	-
1180855	0	22	expression	NN	-	-	-	-	-	-	-	-
1180855	0	23	of	IN	-	-	-	-	-	-	-	-
1180855	0	24	proinflammatory	JJ	-	-	-	-	-	-	-	-
1180855	0	25	chemokines	NNS	-	-	-	-	-	-	-	-
1180855	0	26	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	27	48	CD	-	-	-	-	-	-	-	-
1180855	0	28	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	29	,	,	-	-	-	-	-	-	-	-
1180855	0	30	NF	NN	-	-	-	-	-	-	-	(206
1180855	0	31	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	32	κB	NN	-	-	-	-	-	-	-	206)
1180855	0	33	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	34	via	IN	-	-	-	-	-	-	-	-
1180855	0	35	I	NN	-	-	-	-	-	-	-	-
1180855	0	36	kappa	NN	-	-	-	-	-	-	-	-
1180855	0	37	kinase	NN	-	-	-	-	-	-	-	-
1180855	0	38	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	39	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	40	49	CD	-	-	-	-	-	-	-	-
1180855	0	41	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	42	,	,	-	-	-	-	-	-	-	-
1180855	0	43	and	CC	-	-	-	-	-	-	-	-
1180855	0	44	TNF	NN	-	-	-	-	-	-	-	-
1180855	0	45	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	46	50	CD	-	-	-	-	-	-	-	-
1180855	0	47	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	48	,	,	-	-	-	-	-	-	-	-
1180855	0	49	as	RB	-	-	-	-	-	-	-	-
1180855	0	50	well	RB	-	-	-	-	-	-	-	-
1180855	0	51	as	IN	-	-	-	-	-	-	-	-
1180855	0	52	modulate	VB	-	-	-	-	-	-	-	-
1180855	0	53	cells	NNS	-	-	-	-	-	-	-	(104)
1180855	0	54	and	CC	-	-	-	-	-	-	-	-
1180855	0	55	effector	NN	-	-	-	-	-	-	-	-
1180855	0	56	functions	NNS	-	-	-	-	-	-	-	-
1180855	0	57	associated	JJ	-	-	-	-	-	-	-	-
1180855	0	58	with	IN	-	-	-	-	-	-	-	-
1180855	0	59	an	DT	-	-	-	-	-	-	-	-
1180855	0	60	allergic	JJ	-	-	-	-	-	-	-	-
1180855	0	61	response	NN	-	-	-	-	-	-	-	-
1180855	0	62	.	.	-	-	-	-	-	-	-	-

1180855	0	1	With	IN	-	-	-	-	-	-	-	-
1180855	0	2	respect	NN	-	-	-	-	-	-	-	-
1180855	0	3	to	IN	-	-	-	-	-	-	-	-
1180855	0	4	the	DT	-	-	-	-	-	-	-	(54
1180855	0	5	BAL	NN	-	-	-	-	-	-	-	(215
1180855	0	6	macrophage	NN	-	-	-	-	-	-	-	215)
1180855	0	7	phenotype	NN	-	-	-	-	-	-	-	54)
1180855	0	8	,	,	-	-	-	-	-	-	-	-
1180855	0	9	the	DT	-	-	-	-	-	-	-	-
1180855	0	10	epidermal	JJ	-	-	-	-	-	-	-	(216
1180855	0	11	growth	NN	-	-	-	-	-	-	-	-
1180855	0	12	factor	NN	-	-	-	-	-	-	-	-
1180855	0	13	receptor	NN	-	-	-	-	-	-	-	216)
1180855	0	14	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	15	EGFR	NN	-	-	-	-	-	-	-	-
1180855	0	16	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	17	ligands	NNS	-	-	-	-	-	-	-	-
1180855	0	18	amphiregulin	NN	-	-	-	-	-	-	-	-
1180855	0	19	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	20	Areg	NN	-	-	-	-	-	-	-	-
1180855	0	21	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	22	and	CC	-	-	-	-	-	-	-	-
1180855	0	23	betacellulin	NN	-	-	-	-	-	-	-	-
1180855	0	24	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	25	Btc	NN	-	-	-	-	-	-	-	-
1180855	0	26	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	27	were	VBD	-	-	-	-	-	-	-	-
1180855	0	28	identified	VBN	-	-	-	-	-	-	-	-
1180855	0	29	as	IN	-	-	-	-	-	-	-	-
1180855	0	30	candidate	NN	-	-	-	-	-	-	-	(217
1180855	0	31	genes	NNS	-	-	-	-	-	-	-	-
1180855	0	32	within	IN	-	-	-	-	-	-	-	-
1180855	0	33	the	DT	-	-	-	-	-	-	-	-
1180855	0	34	suggestive	JJ	-	-	-	-	-	-	-	-
1180855	0	35	QTL	NN	-	-	-	-	-	-	-	-
1180855	0	36	on	IN	-	-	-	-	-	-	-	-
1180855	0	37	chromosome	NN	-	-	-	-	-	-	-	(42)
1180855	0	38	5	CD	-	-	-	-	-	-	-	217)
1180855	0	39	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Ligand	NN	-	-	-	-	-	-	-	-
1180855	0	2	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	3	dependent	JJ	-	-	-	-	-	-	-	-
1180855	0	4	activation	NN	-	-	-	-	-	-	-	-
1180855	0	5	of	IN	-	-	-	-	-	-	-	-
1180855	0	6	the	DT	-	-	-	-	-	-	-	(216
1180855	0	7	EGFR	NN	-	-	-	-	-	-	-	216)
1180855	0	8	by	IN	-	-	-	-	-	-	-	-
1180855	0	9	particles	NNS	-	-	-	-	-	-	-	-
1180855	0	10	rich	JJ	-	-	-	-	-	-	-	-
1180855	0	11	in	IN	-	-	-	-	-	-	-	-
1180855	0	12	metal	NN	-	-	-	-	-	-	-	-
1180855	0	13	content	NN	-	-	-	-	-	-	-	-
1180855	0	14	lead	VBP	-	-	-	-	-	-	-	-
1180855	0	15	to	IN	-	-	-	-	-	-	-	-
1180855	0	16	activation	NN	-	-	-	-	-	-	-	-
1180855	0	17	of	IN	-	-	-	-	-	-	-	-
1180855	0	18	the	DT	-	-	-	-	-	-	-	-
1180855	0	19	MAP	NN	-	-	-	-	-	-	-	-
1180855	0	20	kinase	NN	-	-	-	-	-	-	-	-
1180855	0	21	signaling	NN	-	-	-	-	-	-	-	-
1180855	0	22	cascade	NN	-	-	-	-	-	-	-	-
1180855	0	23	and	CC	-	-	-	-	-	-	-	-
1180855	0	24	cytokine	NN	-	-	-	-	-	-	-	-
1180855	0	25	expression	NN	-	-	-	-	-	-	-	-
1180855	0	26	and	CC	-	-	-	-	-	-	-	-
1180855	0	27	secretion	NN	-	-	-	-	-	-	-	-
1180855	0	28	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	29	51	CD	-	-	-	-	-	-	-	-
1180855	0	30	,	,	-	-	-	-	-	-	-	-
1180855	0	31	52	CD	-	-	-	-	-	-	-	-
1180855	0	32	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	33	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Secreted	VBN	-	-	-	-	-	-	-	(218
1180855	0	2	phosphoprotein	NN	-	-	-	-	-	-	-	-
1180855	0	3	1	CD	-	-	-	-	-	-	-	218)
1180855	0	4	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	5	Spp1	NN	-	-	-	-	-	-	-	-
1180855	0	6	,	,	-	-	-	-	-	-	-	-
1180855	0	7	also	RB	-	-	-	-	-	-	-	-
1180855	0	8	known	VBN	-	-	-	-	-	-	-	-
1180855	0	9	as	IN	-	-	-	-	-	-	-	-
1180855	0	10	osteopontin	NN	-	-	-	-	-	-	-	-
1180855	0	11	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	12	was	VBD	-	-	-	-	-	-	-	-
1180855	0	13	also	RB	-	-	-	-	-	-	-	-
1180855	0	14	identified	VBN	-	-	-	-	-	-	-	-
1180855	0	15	,	,	-	-	-	-	-	-	-	-
1180855	0	16	and	CC	-	-	-	-	-	-	-	-
1180855	0	17	it	PRP	-	-	-	-	-	-	-	(218)
1180855	0	18	can	MD	-	-	-	-	-	-	-	-
1180855	0	19	act	VB	-	-	-	-	-	-	-	-
1180855	0	20	as	IN	-	-	-	-	-	-	-	-
1180855	0	21	a	DT	-	-	-	-	-	-	-	-
1180855	0	22	chemoattractant	NN	-	-	-	-	-	-	-	-
1180855	0	23	for	IN	-	-	-	-	-	-	-	-
1180855	0	24	macrophages	NNS	-	-	-	-	-	-	-	(13)
1180855	0	25	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	26	53	CD	-	-	-	-	-	-	-	-
1180855	0	27	,	,	-	-	-	-	-	-	-	-
1180855	0	28	54	CD	-	-	-	-	-	-	-	-
1180855	0	29	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	30	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Lastly	RB	-	-	-	-	-	-	-	-
1180855	0	2	,	,	-	-	-	-	-	-	-	-
1180855	0	3	a	DT	-	-	-	-	-	-	-	-
1180855	0	4	host	NN	-	-	-	-	-	-	-	-
1180855	0	5	of	IN	-	-	-	-	-	-	-	-
1180855	0	6	chemokine	NN	-	-	-	-	-	-	-	(205)
1180855	0	7	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	8	C	NN	-	-	-	-	-	-	-	(212
1180855	0	9	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	10	X	NN	-	-	-	-	-	-	-	-
1180855	0	11	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	12	C	NN	-	-	-	-	-	-	-	-
1180855	0	13	motif	NN	-	-	-	-	-	-	-	212)
1180855	0	14	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	15	ligands	NNS	-	-	-	-	-	-	-	-
1180855	0	16	were	VBD	-	-	-	-	-	-	-	-
1180855	0	17	identified	VBN	-	-	-	-	-	-	-	-
1180855	0	18	between	IN	-	-	-	-	-	-	-	-
1180855	0	19	51	CD	-	-	-	-	-	-	-	-
1180855	0	20	and	CC	-	-	-	-	-	-	-	-
1180855	0	21	53	CD	-	-	-	-	-	-	-	-
1180855	0	22	cM	NN	-	-	-	-	-	-	-	-
1180855	0	23	that	WDT	-	-	-	-	-	-	-	-
1180855	0	24	could	MD	-	-	-	-	-	-	-	-
1180855	0	25	be	VB	-	-	-	-	-	-	-	-
1180855	0	26	involved	VBN	-	-	-	-	-	-	-	-
1180855	0	27	in	IN	-	-	-	-	-	-	-	-
1180855	0	28	macrophage	NN	-	-	-	-	-	-	-	(13)
1180855	0	29	chemotaxis	NN	-	-	-	-	-	-	-	-
1180855	0	30	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	31	55	CD	-	-	-	-	-	-	-	-
1180855	0	32	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	33	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Again	RB	-	-	-	-	-	-	-	-
1180855	0	2	,	,	-	-	-	-	-	-	-	-
1180855	0	3	tolerance	NN	-	-	-	-	-	-	-	(209|(210
1180855	0	4	to	IN	-	-	-	-	-	-	-	-
1180855	0	5	BAL	NN	-	-	-	-	-	-	-	(24|(14)
1180855	0	6	PMNs	NNS	-	-	-	-	-	-	-	24)|209)
1180855	0	7	and	CC	-	-	-	-	-	-	-	-
1180855	0	8	macrophages	NNS	-	-	-	-	-	-	-	210)
1180855	0	9	may	MD	-	-	-	-	-	-	-	-
1180855	0	10	be	VB	-	-	-	-	-	-	-	-
1180855	0	11	under	IN	-	-	-	-	-	-	-	-
1180855	0	12	the	DT	-	-	-	-	-	-	-	-
1180855	0	13	influence	NN	-	-	-	-	-	-	-	-
1180855	0	14	of	IN	-	-	-	-	-	-	-	-
1180855	0	15	any	DT	-	-	-	-	-	-	-	-
1180855	0	16	number	NN	-	-	-	-	-	-	-	-
1180855	0	17	of	IN	-	-	-	-	-	-	-	-
1180855	0	18	these	DT	-	-	-	-	-	-	-	(217
1180855	0	19	candidate	NN	-	-	-	-	-	-	-	-
1180855	0	20	genes	NNS	-	-	-	-	-	-	-	217)
1180855	0	21	.	.	-	-	-	-	-	-	-	-

1180855	0	1	In	IN	-	-	-	-	-	-	-	-
1180855	0	2	the	DT	-	-	-	-	-	-	-	(19
1180855	0	3	present	JJ	-	-	-	-	-	-	-	-
1180855	0	4	study	NN	-	-	-	-	-	-	-	19)
1180855	0	5	,	,	-	-	-	-	-	-	-	-
1180855	0	6	we	PRP	-	-	-	-	-	-	-	(8)
1180855	0	7	identified	VBD	-	-	-	-	-	-	-	-
1180855	0	8	toll	NN	-	-	-	-	-	-	-	(219
1180855	0	9	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	10	like	JJ	-	-	-	-	-	-	-	-
1180855	0	11	receptor	NN	-	-	-	-	-	-	-	219)
1180855	0	12	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	13	Tlr5	NN	-	-	-	-	-	-	-	(58)
1180855	0	14	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	15	as	IN	-	-	-	-	-	-	-	-
1180855	0	16	a	DT	-	-	-	-	-	-	-	-
1180855	0	17	candidate	NN	-	-	-	-	-	-	-	-
1180855	0	18	gene	NN	-	-	-	-	-	-	-	-
1180855	0	19	within	IN	-	-	-	-	-	-	-	-
1180855	0	20	the	DT	-	-	-	-	-	-	-	(199
1180855	0	21	significant	JJ	-	-	-	-	-	-	-	-
1180855	0	22	ZIT1	NN	-	-	-	-	-	-	-	(200)
1180855	0	23	QTL	NN	-	-	-	-	-	-	-	-
1180855	0	24	on	IN	-	-	-	-	-	-	-	-
1180855	0	25	chromosome	NN	-	-	-	-	-	-	-	(43|(42)
1180855	0	26	1	CD	-	-	-	-	-	-	-	43)|199)
1180855	0	27	for	IN	-	-	-	-	-	-	-	-
1180855	0	28	tolerance	NN	-	-	-	-	-	-	-	(220|(68)
1180855	0	29	to	IN	-	-	-	-	-	-	-	-
1180855	0	30	BAL	NN	-	-	-	-	-	-	-	(23|(14)
1180855	0	31	protein	NN	-	-	-	-	-	-	-	23)|220)
1180855	0	32	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Toll	NN	-	-	-	-	-	-	-	(219
1180855	0	2	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	3	like	JJ	-	-	-	-	-	-	-	-
1180855	0	4	receptors	NNS	-	-	-	-	-	-	-	219)
1180855	0	5	activate	VBP	-	-	-	-	-	-	-	-
1180855	0	6	intra-cellular	JJ	-	-	-	-	-	-	-	-
1180855	0	7	signaling	NN	-	-	-	-	-	-	-	-
1180855	0	8	that	WDT	-	-	-	-	-	-	-	-
1180855	0	9	culminates	VBZ	-	-	-	-	-	-	-	-
1180855	0	10	in	IN	-	-	-	-	-	-	-	-
1180855	0	11	the	DT	-	-	-	-	-	-	-	-
1180855	0	12	induction	NN	-	-	-	-	-	-	-	-
1180855	0	13	of	IN	-	-	-	-	-	-	-	-
1180855	0	14	a	DT	-	-	-	-	-	-	-	-
1180855	0	15	multitude	NN	-	-	-	-	-	-	-	-
1180855	0	16	of	IN	-	-	-	-	-	-	-	-
1180855	0	17	effector	NN	-	-	-	-	-	-	-	-
1180855	0	18	genes	NNS	-	-	-	-	-	-	-	-
1180855	0	19	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	20	56	CD	-	-	-	-	-	-	-	-
1180855	0	21	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	22	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Tlr5	NN	-	-	-	-	-	-	-	(58)
1180855	0	2	has	VBZ	-	-	-	-	-	-	-	-
1180855	0	3	been	VBN	-	-	-	-	-	-	-	-
1180855	0	4	shown	VBN	-	-	-	-	-	-	-	-
1180855	0	5	to	TO	-	-	-	-	-	-	-	-
1180855	0	6	be	VB	-	-	-	-	-	-	-	-
1180855	0	7	an	DT	-	-	-	-	-	-	-	-
1180855	0	8	important	JJ	-	-	-	-	-	-	-	-
1180855	0	9	gene	NN	-	-	-	-	-	-	-	-
1180855	0	10	in	IN	-	-	-	-	-	-	-	-
1180855	0	11	the	DT	-	-	-	-	-	-	-	-
1180855	0	12	immune	JJ	-	-	-	-	-	-	-	-
1180855	0	13	response	NN	-	-	-	-	-	-	-	-
1180855	0	14	to	IN	-	-	-	-	-	-	-	-
1180855	0	15	Gram	NN	-	-	-	-	-	-	-	-
1180855	0	16	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	17	positive	JJ	-	-	-	-	-	-	-	-
1180855	0	18	and	CC	-	-	-	-	-	-	-	-
1180855	0	19	Gram	NN	-	-	-	-	-	-	-	-
1180855	0	20	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	21	negative	JJ	-	-	-	-	-	-	-	-
1180855	0	22	bacterial	JJ	-	-	-	-	-	-	-	-
1180855	0	23	flagellin	NN	-	-	-	-	-	-	-	-
1180855	0	24	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	25	57	CD	-	-	-	-	-	-	-	-
1180855	0	26	,	,	-	-	-	-	-	-	-	-
1180855	0	27	58	CD	-	-	-	-	-	-	-	-
1180855	0	28	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	29	.	.	-	-	-	-	-	-	-	-

1180855	0	1	We	PRP	-	-	-	-	-	-	-	(8)
1180855	0	2	utilized	VBD	-	-	-	-	-	-	-	-
1180855	0	3	a	DT	-	-	-	-	-	-	-	(221
1180855	0	4	wild	JJ	-	-	-	-	-	-	-	-
1180855	0	5	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	6	derived	VBN	-	-	-	-	-	-	-	-
1180855	0	7	inbred	JJ	-	-	-	-	-	-	-	-
1180855	0	8	mouse	NN	-	-	-	-	-	-	-	-
1180855	0	9	strain	NN	-	-	-	-	-	-	-	-
1180855	0	10	called	VBN	-	-	-	-	-	-	-	-
1180855	0	11	MOLF	NN	-	-	-	-	-	-	-	-
1180855	0	12	/	HYPH	-	-	-	-	-	-	-	-
1180855	0	13	Ei	NN	-	-	-	-	-	-	-	-
1180855	0	14	which	WDT	-	-	-	-	-	-	-	-
1180855	0	15	has	VBZ	-	-	-	-	-	-	-	-
1180855	0	16	non-conservative	JJ	-	-	-	-	-	-	-	-
1180855	0	17	mutations	NNS	-	-	-	-	-	-	-	-
1180855	0	18	in	IN	-	-	-	-	-	-	-	-
1180855	0	19	Tlr5	NN	-	-	-	-	-	-	-	(58)
1180855	0	20	that	WDT	-	-	-	-	-	-	-	-
1180855	0	21	are	VBP	-	-	-	-	-	-	-	-
1180855	0	22	associated	JJ	-	-	-	-	-	-	-	-
1180855	0	23	with	IN	-	-	-	-	-	-	-	-
1180855	0	24	a	DT	-	-	-	-	-	-	-	-
1180855	0	25	lower	JJR	-	-	-	-	-	-	-	-
1180855	0	26	level	NN	-	-	-	-	-	-	-	-
1180855	0	27	of	IN	-	-	-	-	-	-	-	-
1180855	0	28	expression	NN	-	-	-	-	-	-	-	221)
1180855	0	29	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	30	25	CD	-	-	-	-	-	-	-	-
1180855	0	31	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	32	to	TO	-	-	-	-	-	-	-	-
1180855	0	33	determine	VB	-	-	-	-	-	-	-	-
1180855	0	34	whether	IN	-	-	-	-	-	-	-	-
1180855	0	35	Tlr5	NN	-	-	-	-	-	-	-	(58)
1180855	0	36	plays	VBZ	-	-	-	-	-	-	-	-
1180855	0	37	a	DT	-	-	-	-	-	-	-	-
1180855	0	38	role	NN	-	-	-	-	-	-	-	-
1180855	0	39	in	IN	-	-	-	-	-	-	-	-
1180855	0	40	the	DT	-	-	-	-	-	-	-	-
1180855	0	41	development	NN	-	-	-	-	-	-	-	-
1180855	0	42	of	IN	-	-	-	-	-	-	-	-
1180855	0	43	tolerance	NN	-	-	-	-	-	-	-	(68)
1180855	0	44	to	IN	-	-	-	-	-	-	-	-
1180855	0	45	BAL	NN	-	-	-	-	-	-	-	(23|(14)
1180855	0	46	protein	NN	-	-	-	-	-	-	-	23)
1180855	0	47	in	IN	-	-	-	-	-	-	-	-
1180855	0	48	our	PRP$	-	-	-	-	-	-	-	(197|(8)
1180855	0	49	ZnO	NN	-	-	-	-	-	-	-	(10)
1180855	0	50	model	NN	-	-	-	-	-	-	-	197)
1180855	0	51	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Because	IN	-	-	-	-	-	-	-	-
1180855	0	2	MOLF	NN	-	-	-	-	-	-	-	(59
1180855	0	3	/	HYPH	-	-	-	-	-	-	-	-
1180855	0	4	Ei	NN	-	-	-	-	-	-	-	-
1180855	0	5	mice	NNS	-	-	-	-	-	-	-	59)
1180855	0	6	have	VBP	-	-	-	-	-	-	-	-
1180855	0	7	a	DT	-	-	-	-	-	-	-	-
1180855	0	8	lower	JJR	-	-	-	-	-	-	-	-
1180855	0	9	level	NN	-	-	-	-	-	-	-	-
1180855	0	10	of	IN	-	-	-	-	-	-	-	-
1180855	0	11	TLR5	NN	-	-	-	-	-	-	-	-
1180855	0	12	mRNA	NN	-	-	-	-	-	-	-	-
1180855	0	13	expression	NN	-	-	-	-	-	-	-	-
1180855	0	14	compared	VBN	-	-	-	-	-	-	-	-
1180855	0	15	to	IN	-	-	-	-	-	-	-	-
1180855	0	16	other	JJ	-	-	-	-	-	-	-	-
1180855	0	17	strains	NNS	-	-	-	-	-	-	-	-
1180855	0	18	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	19	25	CD	-	-	-	-	-	-	-	-
1180855	0	20	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	21	,	,	-	-	-	-	-	-	-	-
1180855	0	22	it	PRP	-	-	-	-	-	-	-	-
1180855	0	23	was	VBD	-	-	-	-	-	-	-	-
1180855	0	24	unclear	JJ	-	-	-	-	-	-	-	-
1180855	0	25	whether	IN	-	-	-	-	-	-	-	-
1180855	0	26	we	PRP	-	-	-	-	-	-	-	(8)
1180855	0	27	would	MD	-	-	-	-	-	-	-	-
1180855	0	28	observe	VB	-	-	-	-	-	-	-	-
1180855	0	29	tolerance	NN	-	-	-	-	-	-	-	-
1180855	0	30	after	IN	-	-	-	-	-	-	-	-
1180855	0	31	a	DT	-	-	-	-	-	-	-	-
1180855	0	32	single	JJ	-	-	-	-	-	-	-	-
1180855	0	33	exposure	NN	-	-	-	-	-	-	-	-
1180855	0	34	to	IN	-	-	-	-	-	-	-	-
1180855	0	35	ZnO	NN	-	-	-	-	-	-	-	(10)
1180855	0	36	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Although	IN	-	-	-	-	-	-	-	-
1180855	0	2	the	DT	-	-	-	-	-	-	-	(221
1180855	0	3	MOLF	NN	-	-	-	-	-	-	-	-
1180855	0	4	/	HYPH	-	-	-	-	-	-	-	-
1180855	0	5	Ei	NN	-	-	-	-	-	-	-	-
1180855	0	6	strain	NN	-	-	-	-	-	-	-	221)
1180855	0	7	has	VBZ	-	-	-	-	-	-	-	-
1180855	0	8	no	DT	-	-	-	-	-	-	-	-
1180855	0	9	``	``	-	-	-	-	-	-	-	-
1180855	0	10	wild	JJ	-	-	-	-	-	-	-	-
1180855	0	11	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	12	type	NN	-	-	-	-	-	-	-	-
1180855	0	13	''	''	-	-	-	-	-	-	-	-
1180855	0	14	control	NN	-	-	-	-	-	-	-	-
1180855	0	15	strain	NN	-	-	-	-	-	-	-	-
1180855	0	16	per	FW	-	-	-	-	-	-	-	-
1180855	0	17	se	FW	-	-	-	-	-	-	-	-
1180855	0	18	,	,	-	-	-	-	-	-	-	-
1180855	0	19	MOLF	NN	-	-	-	-	-	-	-	(222|(59
1180855	0	20	/	HYPH	-	-	-	-	-	-	-	-
1180855	0	21	Ei	NN	-	-	-	-	-	-	-	-
1180855	0	22	mice	NNS	-	-	-	-	-	-	-	59)
1180855	0	23	were	VBD	-	-	-	-	-	-	-	-
1180855	0	24	tolerant	JJ	-	-	-	-	-	-	-	-
1180855	0	25	to	IN	-	-	-	-	-	-	-	-
1180855	0	26	increased	VBN	-	-	-	-	-	-	-	(223
1180855	0	27	BAL	NN	-	-	-	-	-	-	-	(14)
1180855	0	28	protein	NN	-	-	-	-	-	-	-	223)
1180855	0	29	following	VBG	-	-	-	-	-	-	-	-
1180855	0	30	repeated	VBN	-	-	-	-	-	-	-	(60
1180855	0	31	ZnO	NN	-	-	-	-	-	-	-	(10)
1180855	0	32	exposure	NN	-	-	-	-	-	-	-	60)
1180855	0	33	when	WRB	-	-	-	-	-	-	-	-
1180855	0	34	compared	VBN	-	-	-	-	-	-	-	-
1180855	0	35	to	IN	-	-	-	-	-	-	-	-
1180855	0	36	the	DT	-	-	-	-	-	-	-	(198
1180855	0	37	non-tolerant	JJ	-	-	-	-	-	-	-	-
1180855	0	38	D2	NN	-	-	-	-	-	-	-	-
1180855	0	39	strain	NN	-	-	-	-	-	-	-	222)|198)
1180855	0	40	.	.	-	-	-	-	-	-	-	-

1180855	0	1	These	DT	-	-	-	-	-	-	-	(222
1180855	0	2	data	NNS	-	-	-	-	-	-	-	222)
1180855	0	3	support	VBP	-	-	-	-	-	-	-	-
1180855	0	4	a	DT	-	-	-	-	-	-	-	-
1180855	0	5	role	NN	-	-	-	-	-	-	-	-
1180855	0	6	for	IN	-	-	-	-	-	-	-	-
1180855	0	7	Tlr5	NN	-	-	-	-	-	-	-	(58)
1180855	0	8	in	IN	-	-	-	-	-	-	-	-
1180855	0	9	the	DT	-	-	-	-	-	-	-	-
1180855	0	10	development	NN	-	-	-	-	-	-	-	-
1180855	0	11	of	IN	-	-	-	-	-	-	-	-
1180855	0	12	tolerance	NN	-	-	-	-	-	-	-	(220|(68)
1180855	0	13	to	IN	-	-	-	-	-	-	-	-
1180855	0	14	BAL	NN	-	-	-	-	-	-	-	(23|(14)
1180855	0	15	protein	NN	-	-	-	-	-	-	-	23)|220)
1180855	0	16	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Interestingly	RB	-	-	-	-	-	-	-	-
1180855	0	2	,	,	-	-	-	-	-	-	-	-
1180855	0	3	Kleeberger	NNP	-	-	-	-	-	-	-	-
1180855	0	4	and	CC	-	-	-	-	-	-	-	-
1180855	0	5	colleagues	NNS	-	-	-	-	-	-	-	-
1180855	0	6	identified	VBD	-	-	-	-	-	-	-	-
1180855	0	7	Tlr4	NN	-	-	-	-	-	-	-	(224)
1180855	0	8	as	IN	-	-	-	-	-	-	-	-
1180855	0	9	a	DT	-	-	-	-	-	-	-	-
1180855	0	10	candidate	NN	-	-	-	-	-	-	-	-
1180855	0	11	gene	NN	-	-	-	-	-	-	-	-
1180855	0	12	in	IN	-	-	-	-	-	-	-	-
1180855	0	13	a	DT	-	-	-	-	-	-	-	-
1180855	0	14	study	NN	-	-	-	-	-	-	-	-
1180855	0	15	of	IN	-	-	-	-	-	-	-	-
1180855	0	16	susceptibility	NN	-	-	-	-	-	-	-	-
1180855	0	17	to	IN	-	-	-	-	-	-	-	-
1180855	0	18	increased	VBN	-	-	-	-	-	-	-	(223
1180855	0	19	BAL	NN	-	-	-	-	-	-	-	-
1180855	0	20	protein	NN	-	-	-	-	-	-	-	223)
1180855	0	21	in	IN	-	-	-	-	-	-	-	-
1180855	0	22	mice	NNS	-	-	-	-	-	-	-	(4)
1180855	0	23	following	VBG	-	-	-	-	-	-	-	-
1180855	0	24	a	DT	-	-	-	-	-	-	-	-
1180855	0	25	single	JJ	-	-	-	-	-	-	-	-
1180855	0	26	exposure	NN	-	-	-	-	-	-	-	-
1180855	0	27	to	IN	-	-	-	-	-	-	-	-
1180855	0	28	0.3	CD	-	-	-	-	-	-	-	-
1180855	0	29	ppm	NN	-	-	-	-	-	-	-	-
1180855	0	30	ozone	NN	-	-	-	-	-	-	-	-
1180855	0	31	for	IN	-	-	-	-	-	-	-	-
1180855	0	32	72	CD	-	-	-	-	-	-	-	-
1180855	0	33	hours	NNS	-	-	-	-	-	-	-	-
1180855	0	34	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	35	22	CD	-	-	-	-	-	-	-	-
1180855	0	36	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	37	,	,	-	-	-	-	-	-	-	-
1180855	0	38	which	WDT	-	-	-	-	-	-	-	-
1180855	0	39	also	RB	-	-	-	-	-	-	-	-
1180855	0	40	suggests	VBZ	-	-	-	-	-	-	-	-
1180855	0	41	toll	NN	-	-	-	-	-	-	-	(219|(225
1180855	0	42	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	43	like	JJ	-	-	-	-	-	-	-	-
1180855	0	44	receptor	NN	-	-	-	-	-	-	-	219)
1180855	0	45	signaling	NN	-	-	-	-	-	-	-	225)
1180855	0	46	may	MD	-	-	-	-	-	-	-	-
1180855	0	47	be	VB	-	-	-	-	-	-	-	-
1180855	0	48	important	JJ	-	-	-	-	-	-	-	-
1180855	0	49	in	IN	-	-	-	-	-	-	-	-
1180855	0	50	the	DT	-	-	-	-	-	-	-	-
1180855	0	51	regulation	NN	-	-	-	-	-	-	-	-
1180855	0	52	of	IN	-	-	-	-	-	-	-	-
1180855	0	53	inhaled	VBN	-	-	-	-	-	-	-	-
1180855	0	54	toxicant	NN	-	-	-	-	-	-	-	-
1180855	0	55	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	56	induced	VBN	-	-	-	-	-	-	-	-
1180855	0	57	changes	NNS	-	-	-	-	-	-	-	-
1180855	0	58	in	IN	-	-	-	-	-	-	-	-
1180855	0	59	BAL	NN	-	-	-	-	-	-	-	(23|(14)
1180855	0	60	protein	NN	-	-	-	-	-	-	-	23)
1180855	0	61	.	.	-	-	-	-	-	-	-	-

1180855	0	1	The	DT	-	-	-	-	-	-	-	-
1180855	0	2	mechanism	NN	-	-	-	-	-	-	-	-
1180855	0	3	through	IN	-	-	-	-	-	-	-	-
1180855	0	4	which	WDT	-	-	-	-	-	-	-	-
1180855	0	5	Tlr5	NN	-	-	-	-	-	-	-	(58)
1180855	0	6	signaling	NN	-	-	-	-	-	-	-	-
1180855	0	7	may	MD	-	-	-	-	-	-	-	-
1180855	0	8	regulate	VB	-	-	-	-	-	-	-	-
1180855	0	9	the	DT	-	-	-	-	-	-	-	-
1180855	0	10	development	NN	-	-	-	-	-	-	-	-
1180855	0	11	of	IN	-	-	-	-	-	-	-	-
1180855	0	12	tolerance	NN	-	-	-	-	-	-	-	(226
1180855	0	13	to	IN	-	-	-	-	-	-	-	-
1180855	0	14	ZnO	NN	-	-	-	-	-	-	-	(10)|226)
1180855	0	15	is	VBZ	-	-	-	-	-	-	-	-
1180855	0	16	unknown	JJ	-	-	-	-	-	-	-	-
1180855	0	17	.	.	-	-	-	-	-	-	-	-

1180855	0	1	While	IN	-	-	-	-	-	-	-	-
1180855	0	2	endotoxin	NN	-	-	-	-	-	-	-	(83)
1180855	0	3	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	4	59	CD	-	-	-	-	-	-	-	-
1180855	0	5	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	6	and	CC	-	-	-	-	-	-	-	-
1180855	0	7	bacterial	JJ	-	-	-	-	-	-	-	(227
1180855	0	8	flagellin	NN	-	-	-	-	-	-	-	227)
1180855	0	9	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	10	60	CD	-	-	-	-	-	-	-	-
1180855	0	11	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	12	have	VBP	-	-	-	-	-	-	-	-
1180855	0	13	been	VBN	-	-	-	-	-	-	-	-
1180855	0	14	demonstrated	VBN	-	-	-	-	-	-	-	-
1180855	0	15	as	IN	-	-	-	-	-	-	-	-
1180855	0	16	the	DT	-	-	-	-	-	-	-	-
1180855	0	17	primary	JJ	-	-	-	-	-	-	-	-
1180855	0	18	ligands	NNS	-	-	-	-	-	-	-	-
1180855	0	19	for	IN	-	-	-	-	-	-	-	-
1180855	0	20	Tlr4	NN	-	-	-	-	-	-	-	(224)
1180855	0	21	and	CC	-	-	-	-	-	-	-	-
1180855	0	22	Tlr5	NN	-	-	-	-	-	-	-	(58)
1180855	0	23	,	,	-	-	-	-	-	-	-	-
1180855	0	24	respectively	RB	-	-	-	-	-	-	-	-
1180855	0	25	,	,	-	-	-	-	-	-	-	-
1180855	0	26	the	DT	-	-	-	-	-	-	-	-
1180855	0	27	ligand	NN	-	-	-	-	-	-	-	-
1180855	0	28	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	29	s	AFX	-	-	-	-	-	-	-	-
1180855	0	30	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	31	that	WDT	-	-	-	-	-	-	-	-
1180855	0	32	is	VBZ	-	-	-	-	-	-	-	-
1180855	0	33	responsible	JJ	-	-	-	-	-	-	-	-
1180855	0	34	for	IN	-	-	-	-	-	-	-	-
1180855	0	35	toll	NN	-	-	-	-	-	-	-	(219
1180855	0	36	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	37	like	JJ	-	-	-	-	-	-	-	-
1180855	0	38	receptor	NN	-	-	-	-	-	-	-	219)
1180855	0	39	signaling	NN	-	-	-	-	-	-	-	-
1180855	0	40	following	VBG	-	-	-	-	-	-	-	-
1180855	0	41	exposure	NN	-	-	-	-	-	-	-	-
1180855	0	42	to	IN	-	-	-	-	-	-	-	-
1180855	0	43	inhaled	VBN	-	-	-	-	-	-	-	-
1180855	0	44	toxicants	NNS	-	-	-	-	-	-	-	-
1180855	0	45	such	JJ	-	-	-	-	-	-	-	-
1180855	0	46	as	IN	-	-	-	-	-	-	-	-
1180855	0	47	ozone	NN	-	-	-	-	-	-	-	(84)
1180855	0	48	and	CC	-	-	-	-	-	-	-	-
1180855	0	49	ZnO	NN	-	-	-	-	-	-	-	(10)
1180855	0	50	is	VBZ	-	-	-	-	-	-	-	-
1180855	0	51	unknown	JJ	-	-	-	-	-	-	-	-
1180855	0	52	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Although	IN	-	-	-	-	-	-	-	-
1180855	0	2	there	EX	-	-	-	-	-	-	-	-
1180855	0	3	have	VBP	-	-	-	-	-	-	-	-
1180855	0	4	been	VBN	-	-	-	-	-	-	-	-
1180855	0	5	no	DT	-	-	-	-	-	-	-	-
1180855	0	6	studies	NNS	-	-	-	-	-	-	-	-
1180855	0	7	on	IN	-	-	-	-	-	-	-	-
1180855	0	8	endogenous	JJ	-	-	-	-	-	-	-	-
1180855	0	9	ligands	NNS	-	-	-	-	-	-	-	-
1180855	0	10	for	IN	-	-	-	-	-	-	-	-
1180855	0	11	Tlr5	NN	-	-	-	-	-	-	-	(58)
1180855	0	12	,	,	-	-	-	-	-	-	-	-
1180855	0	13	several	JJ	-	-	-	-	-	-	-	-
1180855	0	14	endogenous	JJ	-	-	-	-	-	-	-	-
1180855	0	15	ligands	NNS	-	-	-	-	-	-	-	-
1180855	0	16	for	IN	-	-	-	-	-	-	-	-
1180855	0	17	Tlr4	NN	-	-	-	-	-	-	-	(224)
1180855	0	18	have	VBP	-	-	-	-	-	-	-	-
1180855	0	19	been	VBN	-	-	-	-	-	-	-	-
1180855	0	20	identified	VBN	-	-	-	-	-	-	-	-
1180855	0	21	.	.	-	-	-	-	-	-	-	-

1180855	0	1	For	IN	-	-	-	-	-	-	-	-
1180855	0	2	example	NN	-	-	-	-	-	-	-	-
1180855	0	3	,	,	-	-	-	-	-	-	-	-
1180855	0	4	fibronectin	NN	-	-	-	-	-	-	-	-
1180855	0	5	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	6	61	CD	-	-	-	-	-	-	-	-
1180855	0	7	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	8	and	CC	-	-	-	-	-	-	-	-
1180855	0	9	hyaluronic	JJ	-	-	-	-	-	-	-	-
1180855	0	10	acid	NN	-	-	-	-	-	-	-	-
1180855	0	11	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	12	62	CD	-	-	-	-	-	-	-	-
1180855	0	13	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	14	are	VBP	-	-	-	-	-	-	-	-
1180855	0	15	produced	VBN	-	-	-	-	-	-	-	-
1180855	0	16	by	IN	-	-	-	-	-	-	-	-
1180855	0	17	lung	NN	-	-	-	-	-	-	-	(72)
1180855	0	18	cells	NNS	-	-	-	-	-	-	-	-
1180855	0	19	during	IN	-	-	-	-	-	-	-	-
1180855	0	20	lung	NN	-	-	-	-	-	-	-	(72)
1180855	0	21	injury	NN	-	-	-	-	-	-	-	-
1180855	0	22	and	CC	-	-	-	-	-	-	-	-
1180855	0	23	are	VBP	-	-	-	-	-	-	-	-
1180855	0	24	endogenous	JJ	-	-	-	-	-	-	-	-
1180855	0	25	Tlr4	NN	-	-	-	-	-	-	-	-
1180855	0	26	ligands	NNS	-	-	-	-	-	-	-	-
1180855	0	27	.	.	-	-	-	-	-	-	-	-

1180855	0	1	The	DT	-	-	-	-	-	-	-	-
1180855	0	2	downstream	JJ	-	-	-	-	-	-	-	-
1180855	0	3	pathway	NN	-	-	-	-	-	-	-	-
1180855	0	4	through	IN	-	-	-	-	-	-	-	-
1180855	0	5	which	WDT	-	-	-	-	-	-	-	-
1180855	0	6	Tlr5	NN	-	-	-	-	-	-	-	(58)
1180855	0	7	may	MD	-	-	-	-	-	-	-	-
1180855	0	8	regulate	VB	-	-	-	-	-	-	-	-
1180855	0	9	the	DT	-	-	-	-	-	-	-	(203
1180855	0	10	development	NN	-	-	-	-	-	-	-	-
1180855	0	11	of	IN	-	-	-	-	-	-	-	-
1180855	0	12	tolerance	NN	-	-	-	-	-	-	-	(68)
1180855	0	13	to	IN	-	-	-	-	-	-	-	-
1180855	0	14	ZnO	NN	-	-	-	-	-	-	-	-
1180855	0	15	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	16	induced	VBN	-	-	-	-	-	-	-	-
1180855	0	17	BAL	NN	-	-	-	-	-	-	-	-
1180855	0	18	protein	NN	-	-	-	-	-	-	-	203)
1180855	0	19	is	VBZ	-	-	-	-	-	-	-	-
1180855	0	20	potentially	RB	-	-	-	-	-	-	-	-
1180855	0	21	via	IN	-	-	-	-	-	-	-	-
1180855	0	22	NF	NN	-	-	-	-	-	-	-	(206
1180855	0	23	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	24	κB	NN	-	-	-	-	-	-	-	206)
1180855	0	25	,	,	-	-	-	-	-	-	-	-
1180855	0	26	a	DT	-	-	-	-	-	-	-	-
1180855	0	27	transcription	NN	-	-	-	-	-	-	-	-
1180855	0	28	factor	NN	-	-	-	-	-	-	-	-
1180855	0	29	that	WDT	-	-	-	-	-	-	-	-
1180855	0	30	is	VBZ	-	-	-	-	-	-	-	-
1180855	0	31	known	VBN	-	-	-	-	-	-	-	-
1180855	0	32	to	TO	-	-	-	-	-	-	-	-
1180855	0	33	induce	VB	-	-	-	-	-	-	-	-
1180855	0	34	several	JJ	-	-	-	-	-	-	-	-
1180855	0	35	cytokines	NNS	-	-	-	-	-	-	-	-
1180855	0	36	involved	JJ	-	-	-	-	-	-	-	-
1180855	0	37	in	IN	-	-	-	-	-	-	-	-
1180855	0	38	inhaled	VBN	-	-	-	-	-	-	-	(3
1180855	0	39	ZnO	NN	-	-	-	-	-	-	-	(10)|3)
1180855	0	40	responsiveness	NN	-	-	-	-	-	-	-	-
1180855	0	41	such	JJ	-	-	-	-	-	-	-	-
1180855	0	42	as	IN	-	-	-	-	-	-	-	-
1180855	0	43	IL	NN	-	-	-	-	-	-	-	-
1180855	0	44	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	45	8	CD	-	-	-	-	-	-	-	-
1180855	0	46	and	CC	-	-	-	-	-	-	-	-
1180855	0	47	IL	NN	-	-	-	-	-	-	-	(208
1180855	0	48	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	49	6	CD	-	-	-	-	-	-	-	208)
1180855	0	50	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	51	1	CD	-	-	-	-	-	-	-	-
1180855	0	52	,	,	-	-	-	-	-	-	-	-
1180855	0	53	63	CD	-	-	-	-	-	-	-	-
1180855	0	54	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	55	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Furthermore	RB	-	-	-	-	-	-	-	-
1180855	0	2	,	,	-	-	-	-	-	-	-	-
1180855	0	3	NF	NN	-	-	-	-	-	-	-	-
1180855	0	4	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	5	κB	NN	-	-	-	-	-	-	-	-
1180855	0	6	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	7	dependent	JJ	-	-	-	-	-	-	-	-
1180855	0	8	gene	NN	-	-	-	-	-	-	-	-
1180855	0	9	expression	NN	-	-	-	-	-	-	-	-
1180855	0	10	is	VBZ	-	-	-	-	-	-	-	-
1180855	0	11	decreased	VBN	-	-	-	-	-	-	-	-
1180855	0	12	in	IN	-	-	-	-	-	-	-	-
1180855	0	13	Tlr5	NN	-	-	-	-	-	-	-	-
1180855	0	14	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	15	mediated	VBN	-	-	-	-	-	-	-	-
1180855	0	16	tolerance	NN	-	-	-	-	-	-	-	-
1180855	0	17	to	IN	-	-	-	-	-	-	-	-
1180855	0	18	flagellin	NN	-	-	-	-	-	-	-	(227)
1180855	0	19	in	FW	-	-	-	-	-	-	-	-
1180855	0	20	vitro	FW	-	-	-	-	-	-	-	-
1180855	0	21	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	22	64	CD	-	-	-	-	-	-	-	-
1180855	0	23	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	24	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Thus	RB	-	-	-	-	-	-	-	-
1180855	0	2	,	,	-	-	-	-	-	-	-	-
1180855	0	3	it	PRP	-	-	-	-	-	-	-	-
1180855	0	4	is	VBZ	-	-	-	-	-	-	-	-
1180855	0	5	plausible	JJ	-	-	-	-	-	-	-	-
1180855	0	6	that	IN	-	-	-	-	-	-	-	-
1180855	0	7	a	DT	-	-	-	-	-	-	-	-
1180855	0	8	mutation	NN	-	-	-	-	-	-	-	-
1180855	0	9	in	IN	-	-	-	-	-	-	-	-
1180855	0	10	Tlr5	NN	-	-	-	-	-	-	-	(58)
1180855	0	11	,	,	-	-	-	-	-	-	-	-
1180855	0	12	a	DT	-	-	-	-	-	-	-	-
1180855	0	13	regulatory	JJ	-	-	-	-	-	-	-	-
1180855	0	14	element	NN	-	-	-	-	-	-	-	-
1180855	0	15	upstream	JJ	-	-	-	-	-	-	-	-
1180855	0	16	of	IN	-	-	-	-	-	-	-	-
1180855	0	17	NF	NN	-	-	-	-	-	-	-	(206
1180855	0	18	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	19	κB	NN	-	-	-	-	-	-	-	206)
1180855	0	20	signaling	NN	-	-	-	-	-	-	-	-
1180855	0	21	,	,	-	-	-	-	-	-	-	-
1180855	0	22	could	MD	-	-	-	-	-	-	-	-
1180855	0	23	modulate	VB	-	-	-	-	-	-	-	-
1180855	0	24	tolerance	NN	-	-	-	-	-	-	-	-
1180855	0	25	to	IN	-	-	-	-	-	-	-	-
1180855	0	26	BAL	NN	-	-	-	-	-	-	-	(23|(14)
1180855	0	27	protein	NN	-	-	-	-	-	-	-	23)
1180855	0	28	from	IN	-	-	-	-	-	-	-	-
1180855	0	29	repeated	VBN	-	-	-	-	-	-	-	(60
1180855	0	30	ZnO	NN	-	-	-	-	-	-	-	(10)
1180855	0	31	exposure	NN	-	-	-	-	-	-	-	60)
1180855	0	32	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Finally	RB	-	-	-	-	-	-	-	-
1180855	0	2	,	,	-	-	-	-	-	-	-	-
1180855	0	3	Tlr5	NN	-	-	-	-	-	-	-	(58)
1180855	0	4	may	MD	-	-	-	-	-	-	-	-
1180855	0	5	function	VB	-	-	-	-	-	-	-	-
1180855	0	6	as	IN	-	-	-	-	-	-	-	-
1180855	0	7	a	DT	-	-	-	-	-	-	-	-
1180855	0	8	danger	NN	-	-	-	-	-	-	-	-
1180855	0	9	signal	NN	-	-	-	-	-	-	-	-
1180855	0	10	receptor	NN	-	-	-	-	-	-	-	-
1180855	0	11	in	IN	-	-	-	-	-	-	-	-
1180855	0	12	the	DT	-	-	-	-	-	-	-	-
1180855	0	13	development	NN	-	-	-	-	-	-	-	-
1180855	0	14	of	IN	-	-	-	-	-	-	-	-
1180855	0	15	ZnO	NN	-	-	-	-	-	-	-	(226|(10)
1180855	0	16	tolerance	NN	-	-	-	-	-	-	-	226)
1180855	0	17	,	,	-	-	-	-	-	-	-	-
1180855	0	18	consistent	JJ	-	-	-	-	-	-	-	-
1180855	0	19	with	IN	-	-	-	-	-	-	-	-
1180855	0	20	the	DT	-	-	-	-	-	-	-	-
1180855	0	21	``	``	-	-	-	-	-	-	-	-
1180855	0	22	danger	NN	-	-	-	-	-	-	-	-
1180855	0	23	model	NN	-	-	-	-	-	-	-	-
1180855	0	24	''	''	-	-	-	-	-	-	-	-
1180855	0	25	of	IN	-	-	-	-	-	-	-	-
1180855	0	26	innate	JJ	-	-	-	-	-	-	-	-
1180855	0	27	immunity	NN	-	-	-	-	-	-	-	-
1180855	0	28	that	WDT	-	-	-	-	-	-	-	-
1180855	0	29	explicates	VBZ	-	-	-	-	-	-	-	-
1180855	0	30	activation	NN	-	-	-	-	-	-	-	-
1180855	0	31	of	IN	-	-	-	-	-	-	-	-
1180855	0	32	the	DT	-	-	-	-	-	-	-	-
1180855	0	33	innate	JJ	-	-	-	-	-	-	-	-
1180855	0	34	immune	JJ	-	-	-	-	-	-	-	-
1180855	0	35	system	NN	-	-	-	-	-	-	-	-
1180855	0	36	by	IN	-	-	-	-	-	-	-	-
1180855	0	37	factors	NNS	-	-	-	-	-	-	-	-
1180855	0	38	other	JJ	-	-	-	-	-	-	-	-
1180855	0	39	than	IN	-	-	-	-	-	-	-	-
1180855	0	40	foreign	JJ	-	-	-	-	-	-	-	-
1180855	0	41	antigens	NNS	-	-	-	-	-	-	-	-
1180855	0	42	[	-LRB-	-	-	-	-	-	-	-	-
1180855	0	43	65	CD	-	-	-	-	-	-	-	-
1180855	0	44	]	-RRB-	-	-	-	-	-	-	-	-
1180855	0	45	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Whatever	WDT	-	-	-	-	-	-	-	-
1180855	0	2	the	DT	-	-	-	-	-	-	-	-
1180855	0	3	case	NN	-	-	-	-	-	-	-	-
1180855	0	4	,	,	-	-	-	-	-	-	-	-
1180855	0	5	much	JJ	-	-	-	-	-	-	-	-
1180855	0	6	work	NN	-	-	-	-	-	-	-	-
1180855	0	7	is	VBZ	-	-	-	-	-	-	-	-
1180855	0	8	needed	VBN	-	-	-	-	-	-	-	-
1180855	0	9	in	IN	-	-	-	-	-	-	-	-
1180855	0	10	understanding	VBG	-	-	-	-	-	-	-	-
1180855	0	11	how	WRB	-	-	-	-	-	-	-	-
1180855	0	12	toxicants	NNS	-	-	-	-	-	-	-	(82)
1180855	0	13	function	VBP	-	-	-	-	-	-	-	-
1180855	0	14	through	IN	-	-	-	-	-	-	-	-
1180855	0	15	toll	NN	-	-	-	-	-	-	-	(225
1180855	0	16	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	17	like	JJ	-	-	-	-	-	-	-	-
1180855	0	18	receptor	NN	-	-	-	-	-	-	-	-
1180855	0	19	signaling	NN	-	-	-	-	-	-	-	225)
1180855	0	20	mechanisms	NNS	-	-	-	-	-	-	-	-
1180855	0	21	in	IN	-	-	-	-	-	-	-	-
1180855	0	22	the	DT	-	-	-	-	-	-	-	(72
1180855	0	23	lung	NN	-	-	-	-	-	-	-	72)
1180855	0	24	to	TO	-	-	-	-	-	-	-	-
1180855	0	25	regulate	VB	-	-	-	-	-	-	-	-
1180855	0	26	adverse	JJ	-	-	-	-	-	-	-	-
1180855	0	27	responses	NNS	-	-	-	-	-	-	-	-
1180855	0	28	such	JJ	-	-	-	-	-	-	-	-
1180855	0	29	as	IN	-	-	-	-	-	-	-	-
1180855	0	30	BAL	NN	-	-	-	-	-	-	-	(23|(14)
1180855	0	31	protein	NN	-	-	-	-	-	-	-	23)
1180855	0	32	.	.	-	-	-	-	-	-	-	-

1180855	0	1	In	IN	-	-	-	-	-	-	-	-
1180855	0	2	summary	NN	-	-	-	-	-	-	-	-
1180855	0	3	,	,	-	-	-	-	-	-	-	-
1180855	0	4	linkage	NN	-	-	-	-	-	-	-	(202
1180855	0	5	analysis	NN	-	-	-	-	-	-	-	-
1180855	0	6	of	IN	-	-	-	-	-	-	-	-
1180855	0	7	a	DT	-	-	-	-	-	-	-	-
1180855	0	8	large	JJ	-	-	-	-	-	-	-	-
1180855	0	9	F2	NN	-	-	-	-	-	-	-	-
1180855	0	10	mouse	NN	-	-	-	-	-	-	-	-
1180855	0	11	cohort	NN	-	-	-	-	-	-	-	202)
1180855	0	12	identified	VBD	-	-	-	-	-	-	-	-
1180855	0	13	significant	JJ	-	-	-	-	-	-	-	-
1180855	0	14	linkage	NN	-	-	-	-	-	-	-	-
1180855	0	15	of	IN	-	-	-	-	-	-	-	-
1180855	0	16	a	DT	-	-	-	-	-	-	-	-
1180855	0	17	QTL	NN	-	-	-	-	-	-	-	-
1180855	0	18	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	19	ZIT1	NN	-	-	-	-	-	-	-	(200)
1180855	0	20	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	21	on	IN	-	-	-	-	-	-	-	-
1180855	0	22	chromosome	NN	-	-	-	-	-	-	-	(43|(42)
1180855	0	23	1	CD	-	-	-	-	-	-	-	43)
1180855	0	24	associated	JJ	-	-	-	-	-	-	-	-
1180855	0	25	with	IN	-	-	-	-	-	-	-	-
1180855	0	26	tolerance	NN	-	-	-	-	-	-	-	-
1180855	0	27	to	IN	-	-	-	-	-	-	-	-
1180855	0	28	BAL	NN	-	-	-	-	-	-	-	(23|(14)
1180855	0	29	protein	NN	-	-	-	-	-	-	-	23)
1180855	0	30	following	VBG	-	-	-	-	-	-	-	-
1180855	0	31	repeated	VBN	-	-	-	-	-	-	-	-
1180855	0	32	exposure	NN	-	-	-	-	-	-	-	-
1180855	0	33	to	IN	-	-	-	-	-	-	-	-
1180855	0	34	inhaled	VBN	-	-	-	-	-	-	-	(3
1180855	0	35	ZnO	NN	-	-	-	-	-	-	-	3)
1180855	0	36	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Suggestive	JJ	-	-	-	-	-	-	-	-
1180855	0	2	QTLs	NNS	-	-	-	-	-	-	-	-
1180855	0	3	were	VBD	-	-	-	-	-	-	-	-
1180855	0	4	also	RB	-	-	-	-	-	-	-	-
1180855	0	5	identified	VBN	-	-	-	-	-	-	-	-
1180855	0	6	on	IN	-	-	-	-	-	-	-	-
1180855	0	7	chromosomes	NNS	-	-	-	-	-	-	-	(47|(48|(42)|(49f)
1180855	0	8	4	CD	-	-	-	-	-	-	-	47)
1180855	0	9	and	CC	-	-	-	-	-	-	-	-
1180855	0	10	5	CD	-	-	-	-	-	-	-	(49f)|48)
1180855	0	11	for	IN	-	-	-	-	-	-	-	-
1180855	0	12	BAL	NN	-	-	-	-	-	-	-	(23|(14)
1180855	0	13	protein	NN	-	-	-	-	-	-	-	23)
1180855	0	14	,	,	-	-	-	-	-	-	-	-
1180855	0	15	on	IN	-	-	-	-	-	-	-	-
1180855	0	16	chromosome	NN	-	-	-	-	-	-	-	(43|(42)
1180855	0	17	1	CD	-	-	-	-	-	-	-	43)
1180855	0	18	for	IN	-	-	-	-	-	-	-	-
1180855	0	19	BAL	NN	-	-	-	-	-	-	-	(24|(14)
1180855	0	20	PMNs	NNS	-	-	-	-	-	-	-	24)
1180855	0	21	,	,	-	-	-	-	-	-	-	-
1180855	0	22	and	CC	-	-	-	-	-	-	-	-
1180855	0	23	on	IN	-	-	-	-	-	-	-	-
1180855	0	24	chromosome	NN	-	-	-	-	-	-	-	(42)
1180855	0	25	5	CD	-	-	-	-	-	-	-	-
1180855	0	26	for	IN	-	-	-	-	-	-	-	-
1180855	0	27	BAL	NN	-	-	-	-	-	-	-	(215|(14)
1180855	0	28	macrophages	NNS	-	-	-	-	-	-	-	215)
1180855	0	29	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Haplotype	NN	-	-	-	-	-	-	-	(139
1180855	0	2	analysis	NN	-	-	-	-	-	-	-	139)
1180855	0	3	suggested	VBD	-	-	-	-	-	-	-	-
1180855	0	4	that	IN	-	-	-	-	-	-	-	-
1180855	0	5	the	DT	-	-	-	-	-	-	-	-
1180855	0	6	combinatorial	JJ	-	-	-	-	-	-	-	-
1180855	0	7	effects	NNS	-	-	-	-	-	-	-	-
1180855	0	8	of	IN	-	-	-	-	-	-	-	-
1180855	0	9	these	DT	-	-	-	-	-	-	-	(56
1180855	0	10	three	CD	-	-	-	-	-	-	-	-
1180855	0	11	loci	NNS	-	-	-	-	-	-	-	56)
1180855	0	12	contributed	VBD	-	-	-	-	-	-	-	-
1180855	0	13	to	IN	-	-	-	-	-	-	-	-
1180855	0	14	the	DT	-	-	-	-	-	-	-	-
1180855	0	15	overall	JJ	-	-	-	-	-	-	-	-
1180855	0	16	phenotype	NN	-	-	-	-	-	-	-	-
1180855	0	17	,	,	-	-	-	-	-	-	-	-
1180855	0	18	which	WDT	-	-	-	-	-	-	-	-
1180855	0	19	agrees	VBZ	-	-	-	-	-	-	-	-
1180855	0	20	with	IN	-	-	-	-	-	-	-	-
1180855	0	21	the	DT	-	-	-	-	-	-	-	-
1180855	0	22	calculated	VBN	-	-	-	-	-	-	-	-
1180855	0	23	number	NN	-	-	-	-	-	-	-	-
1180855	0	24	of	IN	-	-	-	-	-	-	-	-
1180855	0	25	segregating	VBG	-	-	-	-	-	-	-	-
1180855	0	26	loci	NNS	-	-	-	-	-	-	-	-
1180855	0	27	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Tlr5	NN	-	-	-	-	-	-	-	(58)
1180855	0	2	was	VBD	-	-	-	-	-	-	-	-
1180855	0	3	identified	VBN	-	-	-	-	-	-	-	-
1180855	0	4	within	IN	-	-	-	-	-	-	-	-
1180855	0	5	the	DT	-	-	-	-	-	-	-	(168
1180855	0	6	significant	JJ	-	-	-	-	-	-	-	-
1180855	0	7	QTL	NN	-	-	-	-	-	-	-	-
1180855	0	8	for	IN	-	-	-	-	-	-	-	-
1180855	0	9	BAL	NN	-	-	-	-	-	-	-	(23|(14)
1180855	0	10	protein	NN	-	-	-	-	-	-	-	23)
1180855	0	11	on	IN	-	-	-	-	-	-	-	-
1180855	0	12	chromosome	NN	-	-	-	-	-	-	-	(43|(42)
1180855	0	13	1	CD	-	-	-	-	-	-	-	43)|168)
1180855	0	14	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Wild	JJ	-	-	-	-	-	-	-	(59
1180855	0	2	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	3	derived	VBN	-	-	-	-	-	-	-	-
1180855	0	4	Tlr5	NN	-	-	-	-	-	-	-	-
1180855	0	5	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	6	mutant	NN	-	-	-	-	-	-	-	-
1180855	0	7	MOLF	NN	-	-	-	-	-	-	-	-
1180855	0	8	/	HYPH	-	-	-	-	-	-	-	-
1180855	0	9	Ei	NN	-	-	-	-	-	-	-	-
1180855	0	10	mice	NNS	-	-	-	-	-	-	-	59)
1180855	0	11	were	VBD	-	-	-	-	-	-	-	-
1180855	0	12	determined	VBN	-	-	-	-	-	-	-	-
1180855	0	13	to	TO	-	-	-	-	-	-	-	-
1180855	0	14	be	VB	-	-	-	-	-	-	-	-
1180855	0	15	tolerant	JJ	-	-	-	-	-	-	-	-
1180855	0	16	to	IN	-	-	-	-	-	-	-	-
1180855	0	17	BAL	NN	-	-	-	-	-	-	-	(23|(14)
1180855	0	18	protein	NN	-	-	-	-	-	-	-	23)
1180855	0	19	following	VBG	-	-	-	-	-	-	-	-
1180855	0	20	repeated	VBN	-	-	-	-	-	-	-	(60
1180855	0	21	ZnO	NN	-	-	-	-	-	-	-	(10)
1180855	0	22	exposure	NN	-	-	-	-	-	-	-	60)
1180855	0	23	,	,	-	-	-	-	-	-	-	-
1180855	0	24	suggesting	VBG	-	-	-	-	-	-	-	-
1180855	0	25	a	DT	-	-	-	-	-	-	-	-
1180855	0	26	role	NN	-	-	-	-	-	-	-	-
1180855	0	27	for	IN	-	-	-	-	-	-	-	-
1180855	0	28	Tlr5	NN	-	-	-	-	-	-	-	(58)
1180855	0	29	in	IN	-	-	-	-	-	-	-	-
1180855	0	30	the	DT	-	-	-	-	-	-	-	-
1180855	0	31	development	NN	-	-	-	-	-	-	-	-
1180855	0	32	of	IN	-	-	-	-	-	-	-	-
1180855	0	33	pulmonary	JJ	-	-	-	-	-	-	-	(70
1180855	0	34	tolerance	NN	-	-	-	-	-	-	-	-
1180855	0	35	to	IN	-	-	-	-	-	-	-	-
1180855	0	36	inhaled	VBN	-	-	-	-	-	-	-	(7
1180855	0	37	toxicants	NNS	-	-	-	-	-	-	-	70)|7)
1180855	0	38	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Conclusion	NN	-	-	-	-	-	-	-	(61)

1180855	0	1	These	DT	-	-	-	-	-	-	-	-
1180855	0	2	data	NNS	-	-	-	-	-	-	-	-
1180855	0	3	substantiate	VBP	-	-	-	-	-	-	-	-
1180855	0	4	genetic	JJ	-	-	-	-	-	-	-	(9
1180855	0	5	background	NN	-	-	-	-	-	-	-	9)
1180855	0	6	as	IN	-	-	-	-	-	-	-	-
1180855	0	7	an	DT	-	-	-	-	-	-	-	-
1180855	0	8	important	JJ	-	-	-	-	-	-	-	-
1180855	0	9	influence	NN	-	-	-	-	-	-	-	-
1180855	0	10	in	IN	-	-	-	-	-	-	-	-
1180855	0	11	the	DT	-	-	-	-	-	-	-	-
1180855	0	12	acquisition	NN	-	-	-	-	-	-	-	-
1180855	0	13	of	IN	-	-	-	-	-	-	-	-
1180855	0	14	pulmonary	JJ	-	-	-	-	-	-	-	-
1180855	0	15	tolerance	NN	-	-	-	-	-	-	-	-
1180855	0	16	following	VBG	-	-	-	-	-	-	-	-
1180855	0	17	exposure	NN	-	-	-	-	-	-	-	-
1180855	0	18	to	IN	-	-	-	-	-	-	-	-
1180855	0	19	inhaled	VBN	-	-	-	-	-	-	-	-
1180855	0	20	toxicants	NNS	-	-	-	-	-	-	-	-
1180855	0	21	such	JJ	-	-	-	-	-	-	-	-
1180855	0	22	as	IN	-	-	-	-	-	-	-	-
1180855	0	23	ZnO	NN	-	-	-	-	-	-	-	(10)
1180855	0	24	,	,	-	-	-	-	-	-	-	-
1180855	0	25	and	CC	-	-	-	-	-	-	-	-
1180855	0	26	promising	JJ	-	-	-	-	-	-	-	-
1180855	0	27	candidate	NN	-	-	-	-	-	-	-	-
1180855	0	28	genes	NNS	-	-	-	-	-	-	-	-
1180855	0	29	exist	VBP	-	-	-	-	-	-	-	-
1180855	0	30	within	IN	-	-	-	-	-	-	-	-
1180855	0	31	the	DT	-	-	-	-	-	-	-	(66
1180855	0	32	identified	VBN	-	-	-	-	-	-	-	-
1180855	0	33	QTL	NN	-	-	-	-	-	-	-	-
1180855	0	34	intervals	NNS	-	-	-	-	-	-	-	66)
1180855	0	35	that	WDT	-	-	-	-	-	-	-	-
1180855	0	36	would	MD	-	-	-	-	-	-	-	-
1180855	0	37	be	VB	-	-	-	-	-	-	-	-
1180855	0	38	good	JJ	-	-	-	-	-	-	-	(67
1180855	0	39	targets	NNS	-	-	-	-	-	-	-	-
1180855	0	40	for	IN	-	-	-	-	-	-	-	-
1180855	0	41	additional	JJ	-	-	-	-	-	-	-	-
1180855	0	42	studies	NNS	-	-	-	-	-	-	-	-
1180855	0	43	on	IN	-	-	-	-	-	-	-	-
1180855	0	44	the	DT	-	-	-	-	-	-	-	-
1180855	0	45	pathogenesis	NN	-	-	-	-	-	-	-	-
1180855	0	46	of	IN	-	-	-	-	-	-	-	-
1180855	0	47	tolerance	NN	-	-	-	-	-	-	-	(68)|67)
1180855	0	48	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Competing	VBG	-	-	-	-	-	-	-	-
1180855	0	2	interests	NNS	-	-	-	-	-	-	-	-

1180855	0	1	The	DT	-	-	-	-	-	-	-	(8
1180855	0	2	author	NN	-	-	-	-	-	-	-	-
1180855	0	3	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	4	s	AFX	-	-	-	-	-	-	-	-
1180855	0	5	)	-RRB-	-	-	-	-	-	-	-	8)
1180855	0	6	declare	VBP	-	-	-	-	-	-	-	-
1180855	0	7	that	IN	-	-	-	-	-	-	-	-
1180855	0	8	they	PRP	-	-	-	-	-	-	-	(8)
1180855	0	9	have	VBP	-	-	-	-	-	-	-	-
1180855	0	10	no	DT	-	-	-	-	-	-	-	-
1180855	0	11	competing	VBG	-	-	-	-	-	-	-	-
1180855	0	12	interests	NNS	-	-	-	-	-	-	-	-
1180855	0	13	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Authors	NNS	-	-	-	-	-	-	-	(8)
1180855	0	2	'	POS	-	-	-	-	-	-	-	-
1180855	0	3	contributions	NNS	-	-	-	-	-	-	-	-

1180855	0	1	SCW	NNP	-	-	-	-	-	-	-	-
1180855	0	2	:	:	-	-	-	-	-	-	-	-
1180855	0	3	Participated	VBN	-	-	-	-	-	-	-	-
1180855	0	4	in	IN	-	-	-	-	-	-	-	-
1180855	0	5	the	DT	-	-	-	-	-	-	-	(228|(230b|(229a)
1180855	0	6	design	NN	-	-	-	-	-	-	-	230b)
1180855	0	7	and	CC	-	-	-	-	-	-	-	-
1180855	0	8	coordination	NN	-	-	-	-	-	-	-	(229a
1180855	0	9	of	IN	-	-	-	-	-	-	-	(230b
1180855	0	10	the	DT	-	-	-	-	-	-	-	(19
1180855	0	11	study	NN	-	-	-	-	-	-	-	230b)|229a)|228)|19)
1180855	0	12	,	,	-	-	-	-	-	-	-	-
1180855	0	13	performed	VBD	-	-	-	-	-	-	-	-
1180855	0	14	the	DT	-	-	-	-	-	-	-	(19
1180855	0	15	study	NN	-	-	-	-	-	-	-	19)
1180855	0	16	,	,	-	-	-	-	-	-	-	-
1180855	0	17	and	CC	-	-	-	-	-	-	-	-
1180855	0	18	drafted	VBD	-	-	-	-	-	-	-	-
1180855	0	19	the	DT	-	-	-	-	-	-	-	(231
1180855	0	20	manuscript	NN	-	-	-	-	-	-	-	231)
1180855	0	21	.	.	-	-	-	-	-	-	-	-

1180855	0	1	LCC	NNP	-	-	-	-	-	-	-	-
1180855	0	2	:	:	-	-	-	-	-	-	-	-
1180855	0	3	Participated	VBD	-	-	-	-	-	-	-	-
1180855	0	4	in	IN	-	-	-	-	-	-	-	-
1180855	0	5	the	DT	-	-	-	-	-	-	-	(230
1180855	0	6	design	NN	-	-	-	-	-	-	-	-
1180855	0	7	of	IN	-	-	-	-	-	-	-	-
1180855	0	8	the	DT	-	-	-	-	-	-	-	(19
1180855	0	9	study	NN	-	-	-	-	-	-	-	230)|19)
1180855	0	10	and	CC	-	-	-	-	-	-	-	-
1180855	0	11	helped	VBD	-	-	-	-	-	-	-	-
1180855	0	12	draft	VB	-	-	-	-	-	-	-	-
1180855	0	13	the	DT	-	-	-	-	-	-	-	(231
1180855	0	14	manuscript	NN	-	-	-	-	-	-	-	231)
1180855	0	15	.	.	-	-	-	-	-	-	-	-

1180855	0	1	TG	NNP	-	-	-	-	-	-	-	-
1180855	0	2	:	:	-	-	-	-	-	-	-	-
1180855	0	3	Conceived	VBD	-	-	-	-	-	-	-	-
1180855	0	4	the	DT	-	-	-	-	-	-	-	(19
1180855	0	5	study	NN	-	-	-	-	-	-	-	19)
1180855	0	6	,	,	-	-	-	-	-	-	-	-
1180855	0	7	participated	VBD	-	-	-	-	-	-	-	-
1180855	0	8	in	IN	-	-	-	-	-	-	-	-
1180855	0	9	the	DT	-	-	-	-	-	-	-	(228|(230a|(229b)
1180855	0	10	design	NN	-	-	-	-	-	-	-	230a)
1180855	0	11	and	CC	-	-	-	-	-	-	-	-
1180855	0	12	coordination	NN	-	-	-	-	-	-	-	(229b
1180855	0	13	of	IN	-	-	-	-	-	-	-	(230a
1180855	0	14	the	DT	-	-	-	-	-	-	-	(19
1180855	0	15	study	NN	-	-	-	-	-	-	-	230a)|229b)|228)|19)
1180855	0	16	,	,	-	-	-	-	-	-	-	-
1180855	0	17	and	CC	-	-	-	-	-	-	-	-
1180855	0	18	helped	VBD	-	-	-	-	-	-	-	-
1180855	0	19	draft	VB	-	-	-	-	-	-	-	-
1180855	0	20	the	DT	-	-	-	-	-	-	-	(231
1180855	0	21	manuscript	NN	-	-	-	-	-	-	-	231)
1180855	0	22	.	.	-	-	-	-	-	-	-	-

1180855	0	1	Acknowledgements	NNS	-	-	-	-	-	-	-	-

1180855	0	1	The	DT	-	-	-	-	-	-	-	(8
1180855	0	2	authors	NNS	-	-	-	-	-	-	-	8)
1180855	0	3	would	MD	-	-	-	-	-	-	-	-
1180855	0	4	like	VB	-	-	-	-	-	-	-	-
1180855	0	5	to	TO	-	-	-	-	-	-	-	-
1180855	0	6	thank	VB	-	-	-	-	-	-	-	-
1180855	0	7	the	DT	-	-	-	-	-	-	-	(232
1180855	0	8	following	VBG	-	-	-	-	-	-	-	-
1180855	0	9	people	NNS	-	-	-	-	-	-	-	232)
1180855	0	10	for	IN	-	-	-	-	-	-	-	-
1180855	0	11	their	PRP$	-	-	-	-	-	-	-	(232)
1180855	0	12	contributions	NNS	-	-	-	-	-	-	-	-
1180855	0	13	to	IN	-	-	-	-	-	-	-	-
1180855	0	14	this	DT	-	-	-	-	-	-	-	(19
1180855	0	15	study	NN	-	-	-	-	-	-	-	19)
1180855	0	16	:	:	-	-	-	-	-	-	-	-
1180855	0	17	Karen	NNP	-	-	-	-	-	-	-	-
1180855	0	18	Galdanes	NNP	-	-	-	-	-	-	-	-
1180855	0	19	,	,	-	-	-	-	-	-	-	-
1180855	0	20	Margaret	NNP	-	-	-	-	-	-	-	-
1180855	0	21	Krasinski	NNP	-	-	-	-	-	-	-	-
1180855	0	22	,	,	-	-	-	-	-	-	-	-
1180855	0	23	Kathy	NNP	-	-	-	-	-	-	-	-
1180855	0	24	Baker	NNP	-	-	-	-	-	-	-	-
1180855	0	25	,	,	-	-	-	-	-	-	-	-
1180855	0	26	and	CC	-	-	-	-	-	-	-	-
1180855	0	27	Dr.	NNP	-	-	-	-	-	-	-	-
1180855	0	28	Moon	NNP	-	-	-	-	-	-	-	-
1180855	0	29	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	30	shong	NNP	-	-	-	-	-	-	-	-
1180855	0	31	Tang	NNP	-	-	-	-	-	-	-	-
1180855	0	32	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	33	New	NNP	-	-	-	-	-	-	-	(95
1180855	0	34	York	NNP	-	-	-	-	-	-	-	-
1180855	0	35	University	NNP	-	-	-	-	-	-	-	95)
1180855	0	36	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	37	;	:	-	-	-	-	-	-	-	-
1180855	0	38	Dr.	NNP	-	-	-	-	-	-	-	(141
1180855	0	39	George	NNP	-	-	-	-	-	-	-	-
1180855	0	40	D.	NNP	-	-	-	-	-	-	-	-
1180855	0	41	Leikauf	NNP	-	-	-	-	-	-	-	141)
1180855	0	42	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	43	University	NNP	-	-	-	-	-	-	-	-
1180855	0	44	of	IN	-	-	-	-	-	-	-	-
1180855	0	45	Cincinnati	NNP	-	-	-	-	-	-	-	(233)
1180855	0	46	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	47	;	:	-	-	-	-	-	-	-	-
1180855	0	48	Dr.	NNP	-	-	-	-	-	-	-	(140
1180855	0	49	Daniel	NNP	-	-	-	-	-	-	-	-
1180855	0	50	R.	NNP	-	-	-	-	-	-	-	-
1180855	0	51	Prows	NNP	-	-	-	-	-	-	-	140)
1180855	0	52	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	53	Cincinnati	NNP	-	-	-	-	-	-	-	(233)
1180855	0	54	Children	NNPS	-	-	-	-	-	-	-	-
1180855	0	55	's	POS	-	-	-	-	-	-	-	-
1180855	0	56	Hospital	NNP	-	-	-	-	-	-	-	-
1180855	0	57	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	58	;	:	-	-	-	-	-	-	-	-
1180855	0	59	Dr.	NNP	-	-	-	-	-	-	-	-
1180855	0	60	Steven	NNP	-	-	-	-	-	-	-	-
1180855	0	61	R.	NNP	-	-	-	-	-	-	-	-
1180855	0	62	Kleeberger	NNP	-	-	-	-	-	-	-	-
1180855	0	63	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	64	National	NNP	-	-	-	-	-	-	-	-
1180855	0	65	Institute	NNP	-	-	-	-	-	-	-	-
1180855	0	66	of	IN	-	-	-	-	-	-	-	-
1180855	0	67	Environmental	NNP	-	-	-	-	-	-	-	-
1180855	0	68	Health	NNP	-	-	-	-	-	-	-	-
1180855	0	69	Sciences	NNPS	-	-	-	-	-	-	-	-
1180855	0	70	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	71	;	:	-	-	-	-	-	-	-	-
1180855	0	72	Dr.	NNP	-	-	-	-	-	-	-	-
1180855	0	73	Carrie	NNP	-	-	-	-	-	-	-	-
1180855	0	74	L.	NNP	-	-	-	-	-	-	-	-
1180855	0	75	Welch	NNP	-	-	-	-	-	-	-	-
1180855	0	76	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	77	Columbia	NNP	-	-	-	-	-	-	-	-
1180855	0	78	University	NNP	-	-	-	-	-	-	-	-
1180855	0	79	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	80	.	.	-	-	-	-	-	-	-	-

1180855	0	1	This	DT	-	-	-	-	-	-	-	(19
1180855	0	2	study	NN	-	-	-	-	-	-	-	19)
1180855	0	3	was	VBD	-	-	-	-	-	-	-	-
1180855	0	4	supported	VBN	-	-	-	-	-	-	-	-
1180855	0	5	by	IN	-	-	-	-	-	-	-	-
1180855	0	6	USEPA	NNP	-	-	-	-	-	-	-	-
1180855	0	7	Grant	NNP	-	-	-	-	-	-	-	-
1180855	0	8	R	NN	-	-	-	-	-	-	-	-
1180855	0	9	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	10	826244	CD	-	-	-	-	-	-	-	-
1180855	0	11	,	,	-	-	-	-	-	-	-	-
1180855	0	12	USEPA	NNP	-	-	-	-	-	-	-	-
1180855	0	13	Particulate	NNP	-	-	-	-	-	-	-	-
1180855	0	14	Matter	NNP	-	-	-	-	-	-	-	-
1180855	0	15	Center	NNP	-	-	-	-	-	-	-	-
1180855	0	16	Grant	NN	-	-	-	-	-	-	-	-
1180855	0	17	R	NN	-	-	-	-	-	-	-	-
1180855	0	18	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	19	827351	CD	-	-	-	-	-	-	-	-
1180855	0	20	,	,	-	-	-	-	-	-	-	-
1180855	0	21	USEPA	NNP	-	-	-	-	-	-	-	-
1180855	0	22	STAR	NNP	-	-	-	-	-	-	-	-
1180855	0	23	Fellowship	NN	-	-	-	-	-	-	-	-
1180855	0	24	U	NN	-	-	-	-	-	-	-	-
1180855	0	25	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	26	91578301	CD	-	-	-	-	-	-	-	-
1180855	0	27	,	,	-	-	-	-	-	-	-	-
1180855	0	28	NIEHS	NNP	-	-	-	-	-	-	-	-
1180855	0	29	Center	NNP	-	-	-	-	-	-	-	-
1180855	0	30	Grant	NN	-	-	-	-	-	-	-	-
1180855	0	31	of	IN	-	-	-	-	-	-	-	-
1180855	0	32	Excellence	NN	-	-	-	-	-	-	-	-
1180855	0	33	ES	NN	-	-	-	-	-	-	-	-
1180855	0	34	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	35	00260	CD	-	-	-	-	-	-	-	-
1180855	0	36	,	,	-	-	-	-	-	-	-	-
1180855	0	37	and	CC	-	-	-	-	-	-	-	-
1180855	0	38	CDC	NNP	-	-	-	-	-	-	-	-
1180855	0	39	/	HYPH	-	-	-	-	-	-	-	-
1180855	0	40	NIOSH	NNP	-	-	-	-	-	-	-	-
1180855	0	41	(	-LRB-	-	-	-	-	-	-	-	-
1180855	0	42	via	IN	-	-	-	-	-	-	-	-
1180855	0	43	Mt.	NNP	-	-	-	-	-	-	-	-
1180855	0	44	Sinai	NNP	-	-	-	-	-	-	-	-
1180855	0	45	School	NNP	-	-	-	-	-	-	-	-
1180855	0	46	of	IN	-	-	-	-	-	-	-	-
1180855	0	47	Medicine	NNP	-	-	-	-	-	-	-	-
1180855	0	48	,	,	-	-	-	-	-	-	-	-
1180855	0	49	New	NNP	-	-	-	-	-	-	-	-
1180855	0	50	York	NNP	-	-	-	-	-	-	-	-
1180855	0	51	,	,	-	-	-	-	-	-	-	-
1180855	0	52	NY	NNP	-	-	-	-	-	-	-	-
1180855	0	53	)	-RRB-	-	-	-	-	-	-	-	-
1180855	0	54	Grant	NN	-	-	-	-	-	-	-	-
1180855	0	55	T	NN	-	-	-	-	-	-	-	-
1180855	0	56	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	57	42CCT210425	NN	-	-	-	-	-	-	-	-
1180855	0	58	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	59	06	CD	-	-	-	-	-	-	-	-
1180855	0	60	-	HYPH	-	-	-	-	-	-	-	-
1180855	0	61	01	CD	-	-	-	-	-	-	-	-
1180855	0	62	.	.	-	-	-	-	-	-	-	-

